<?xml version="1.0" encoding="utf-8"?>


<DOCUMENT xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dart3.xsd">

<DOCUMENT-NAME ACODE="11011">사업보고서</DOCUMENT-NAME>
<FORMULA-VERSION ADATE="20230220">5.0</FORMULA-VERSION>
<COMPANY-NAME AREGCIK="01516456">(주)인벤티지랩</COMPANY-NAME>

<SUMMARY>
<EXTRACTION ACODE="LINK_FLAG" AFEATURE="BOTH">N</EXTRACTION>
<EXTRACTION ACODE="FIN_TYPE" AFEATURE="BOTH">A</EXTRACTION>
<EXTRACTION ACODE="CRP_RGS_NO_TEMP" AFEATURE="BOTH">131111-0409481</EXTRACTION>
</SUMMARY>


<BODY>

<COVER>
<P></P>
<COVER-TITLE ATOC="Y" AASSOCNOTE="COVER">사 업 보 고 서</COVER-TITLE>
<P></P>
<P USERMARK="F-16">                                    (제 8 기)</P>

<TABLE-GROUP ACLASS="COVER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="211"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD CLASS="NORMAL" ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="218" HEIGHT="60" AUPDATECONT="N">사업연도</TD>
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODFROM" AUNITVALUE="20220101">2022년 01월 01일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 부터</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODTO" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 까지</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">금융위원회</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">한국거래소 귀중</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT">2023년      03월     22일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="PB_VAL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">제출대상법인 유형 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_TYPE" AUNITVALUE="1">주권상장법인</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">면제사유발생 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_CAMNT" AUNITVALUE="-">해당사항 없음</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">회      사      명 :</TD>
<TD WIDTH="400" HEIGHT="30">주식회사 인벤티지랩</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">대   표    이   사 :</TD>
<TD WIDTH="400" HEIGHT="30">김주희</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="53">본  점  소  재  지 :</TD>
<TD WIDTH="400" HEIGHT="53">경기도 성남시 중원구 둔촌대로388번길24, 101호, 601호, 612호(상대원동, 우림라이온스밸리3차) </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화)031-608-0514</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(홈페이지) http://www.inventagelab.com</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">작  성  책  임  자 :</TD>
<TD WIDTH="400" HEIGHT="30">(직  책) 상무                   (성  명)정병율</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화)031-608-0514</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</COVER>

<TITLE ATOC="N">목     차</TITLE>
<P></P>
<PGBRK></PGBRK>


<SECTION-1 AID="CEO-CERT" ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="TTL_CEO_CERT">【 대표이사 등의 확인 】</TITLE>

<IMAGE>
<IMG WIDTH="563" HEIGHT="796" ALIGN="CENTER" HSPACE="0">대표이사등 확인서_사업보고서.jpg</IMG>
<IMG-CAPTION ATOC="N">대표이사등 확인서</IMG-CAPTION>
</IMAGE>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">I. 회사의 개요</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-1-0">1. 회사의 개요</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 연결대상 종속회사 개황</SPAN>1. 연결대상 종속회사 현황(요약)
</P>

<TABLE-GROUP ACLASS="SUB_CMPN_SMR" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="592"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="601" HEIGHT="30" AUPDATECONT="N">(단위 : 사)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="1">

<COLGROUP>
<COL WIDTH="92"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="101" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">구분</TH>
<TH WIDTH="400" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="4" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">연결대상회사수</TH>
<TH WIDTH="100" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">주요종속회사수</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="100" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">기초</TH>
<TH WIDTH="100" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">증가</TH>
<TH WIDTH="100" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">감소</TH>
<TH WIDTH="100" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="101" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">상장</TD>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="LST_BASE">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="LST_INC">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="LST_DEC">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="LST_FIN">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="LST_MSUB">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="101" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비상장</TD>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ULST_BASE">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ULST_INC">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ULST_DEC">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ULST_FIN">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ULST_MSUB">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="101" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BASE_SUM">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="INC_SUM">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="DEC_SUM">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="FIN_SUM">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MSUB_SUM">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="593"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="602" HEIGHT="30" AUPDATECONT="N">
<A REFNO="XII. 상세표|NEF-001|ADX-001">※상세 현황은 '상세표-1. 연결대상 종속회사 현황(상세)' 참조</A>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>1-1. 연결대상회사의 변동내용</P>

<TABLE-GROUP ACLASS="CONT_CHG" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="66"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="335"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="75" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="183" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">자회사</TH>
<TH WIDTH="344" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">사 유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">신규연결</TD>
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NEW_CPY">-</TE>
<TE WIDTH="344" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NEW_RES">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NEW_CPY">-</TE>
<TE WIDTH="344" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NEW_RES">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">연결제외</TD>
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="EXP_CPY">-</TE>
<TE WIDTH="344" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="EXP_RES">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="EXP_CPY">-</TE>
<TE WIDTH="344" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="EXP_RES">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK=" B">나. 회사의 법적·상업적 명칭</P>
<P> </P>
<P>당사의 명칭은 '㈜ 인벤티지랩'으로 표기하며, 영문으로는 'Inventage Lab, Inc.'로 표기합니다.</P>
<P> </P>
<P USERMARK=" B">다. 설립일자 및 존속기간</P>
<P> </P>

<P>당사는 2015년 05월 14일에 설립되었습니다.
<SPAN USERMARK=" B">라. 본사의 주소, 전화번호, 홈페이지 주소</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ALIGN="CENTER" WIDTH="400" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="200" HEIGHT="53">주소</TD>
<TD ALIGN="CENTER" WIDTH="400" HEIGHT="53">경기도 성남시 중원구 둔촌대로388번길 24, 101호, 601호, 612호(상대원동, 우림라이온스밸리3차)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="200" HEIGHT="30">전화번호</TD>
<TD ALIGN="CENTER" WIDTH="400" HEIGHT="30">031-608-0514</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="200" HEIGHT="30">홈페이지주소</TD>
<TD ALIGN="CENTER" WIDTH="400" HEIGHT="30">https://www.inventagelab.com/ko/</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">마. 중소기업 등 해당 여부</SPAN>
</P>

<TABLE-GROUP ACLASS="SM_VEN_CMP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="31"></COL>
<COL WIDTH="251"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" COLSPAN="2">중소기업 해당 여부</TD>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="300" HEIGHT="30" AUNIT="SML_YN" AUNITVALUE="Y">해당</TU>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="40" HEIGHT="30" AUPDATECONT="N"></TD>
<TD WIDTH="260" HEIGHT="30" AUPDATECONT="N">벤처기업 해당 여부</TD>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="300" HEIGHT="30" AUNIT="VEN_YN" AUNITVALUE="Y">해당</TU>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" COLSPAN="2">중견기업 해당 여부</TD>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="300" HEIGHT="30" AUNIT="MID_YN" AUNITVALUE="N">미해당</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK=" B">바. 주요 사업의 내용 등에 관한 간략한 설명</SPAN>당사는 마이크로플루이딕 기술(microfluidics)을 의약품 연구개발에 적용하여 장기지속형 주사제 개발 및 양산 제조에 응용한 IVL-DrugFluidic® 플랫폼 및 유전물질 의약물 전달에 적용한 IVL-GeneFluidic®플랫폼을 보유한 DDS(Drug Delivery System, 약물전달시스템) 플랫폼 기업입니다.당사는 IVL-DrugFluidic® 플랫폼을 기반으로 자체 개발 중인 개량 신약 및 신약파이프라인, 동물의약품 등을 개발 중이며, 임상1/2상 전후로 License Out을 통한 사업화를 진행하고 있습니다. 당사는 개량신약 개발 실적을 바탕으로 타사와의 신약 공동 개발 모델인 Joint Development를 통한 사업화도 추진 중에 있습니다.또한 당사는 차세대 의약품으로 주목받는 mRNA 백신 및 유전자치료제의 DDS 전달체인 LNP(Lipid Nano Particle, 지질나노입자)를 제조할 수 있는 IVL-GeneFluidic® 플랫폼을 보유하고 있습니다. 현재 공동 개발 계약을 체결한 바이오사와 함께 당사 플랫폼 기술을 이용하여 LNP 등 나노전달체에 대한 Formulation 연구를 진행하고 있으며, 향후에는 임상샘플 제조뿐 아니라 완제 의약품 생산까지 가능한 CDMO 사업을 계획하고 있습니다.사업보고서 제출일 기준, (주)대웅제약, (주)종근당, 위더스제약(주), (주)노터스, Virbac S.A.과 장기지속형주사제 License Out 계약을 체결하였으며, 국내 제약사 및 바이오텍 등과 Joint Development(공동개발 및 사업화)계약 (장기지속형 주사제 및 LNP 개발포함)을 체결하였습니다.  상세한 내용은 「II. 사업의 내용」을 참조하시기 바랍니다.
<SPAN USERMARK=" B">사. 신용평가에 관한 사항</SPAN>본 보고서 제출일 기준으로 해당사항이 없습니다.
<SPAN USERMARK=" B">아. 회사의 주권상장(또는 등록ㆍ지정)여부 및 특례상장에 관한 사항</SPAN>
</P>

<TABLE-GROUP ACLASS="SPC_CRT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="679" BORDER="1">

<COLGROUP>
<COL WIDTH="161"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="177"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="170" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장(또는 등록ㆍ지정)여부</TH>
<TH WIDTH="170" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장(또는 등록ㆍ지정)일자</TH>
<TH WIDTH="153" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등여부</TH>
<TH WIDTH="186" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등적용법규</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="SPC_CHK">코스닥시장</TE>
<TU WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" AUNIT="SPC_DATE" AUNITVALUE="20221122">2022년 11월 22일</TU>
<TE WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="SPC_CHP">기술성장기업코스닥시장특례상장</TE>
<TE WIDTH="186" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="SPC_LAW">「코스닥시장 상장규정」제30조에 따라 기술력과성장성이 인정되는 기업</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<P>
<SPAN USERMARK=" B">자. 「상법」제290조에 따른 변태설립사항</SPAN>당사는 보고서 제출일 기준으로 해당사항이 없습니다.
<SPAN USERMARK=" B">차. 대한민국에 대리인이 있는 경우에는 이름(대표자), 주소 및 연락처</SPAN>[코스닥시장공시규정에 따른 공시대리인]- 공시대리인 명칭 : (주)씨에스컨설팅- 대표자 : 길봉- 주 소 : 서울특별시 영등포구 국제금융로6길 26- 전 화 : 82-2-780-1655- 팩 스 : 82-2-780-1639
</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-2-0">2. 회사의 연혁</TITLE>

<P>
<SPAN USERMARK=" B">가. 회사의 연혁</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="706" BORDER="1">

<COLGROUP>
<COL WIDTH="62"></COL>
<COL WIDTH="626"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">일자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="635" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2015.05</TD>
<TD WIDTH="635" HEIGHT="30">회사 설립 (본점: 경기도 성남시 분당구 판교로319번길 13, 540호(삼평동, 디테라스))</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2015.08</TD>
<TD WIDTH="635" HEIGHT="30">김주희 외 4인 유상증자 (금액: 100백만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2015.08</TD>
<TD WIDTH="635" HEIGHT="30">무상증자 (준비금의 자본전입, 주식발행초과금 67백만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2015.11</TD>
<TD WIDTH="635" HEIGHT="30">벤처기업 인증(1차, 2015.11.11~2017.11.10, 제20150112043호)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2015.12</TD>
<TD WIDTH="635" HEIGHT="30">기업부설연구소 인정(1차, 제2015115980호)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2016.01</TD>
<TD WIDTH="635" HEIGHT="30">무상증자 (준비금의 자본전입, 주식발행초과금 74백만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2016.06</TD>
<TD WIDTH="635" HEIGHT="30">시리즈 Pre-A 자본조달 (총 15.4억원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2016.06</TD>
<TD WIDTH="635" HEIGHT="30">무상증자 (준비금의 자본전입, 주식발행초과금 74백만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2017.06</TD>
<TD WIDTH="635" HEIGHT="30">시리즈 A 자본조달 (총 30억원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="53">2017.12</TD>
<TD WIDTH="635" HEIGHT="53">의료기기 GMP (4등급) 승인 (2017.12.05-2020.12.04, 제KCL-AAB-611호, 경인지방식품이약품안전청, 한국건설생활환경시험연구원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2018.06</TD>
<TD WIDTH="635" HEIGHT="30">시리즈 B 자본조달 (총 80억원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2020.02</TD>
<TD WIDTH="635" HEIGHT="30">시리즈 C 자본조달 (총 130억원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2020.05</TD>
<TD WIDTH="635" HEIGHT="30">탈모치료제(IVL3001, IVL3002) CMO 파트너링 계약 체결(위더스제약㈜)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2020.05</TD>
<TD WIDTH="635" HEIGHT="30">일반법인 지분투자 유치 (대웅제약 1,000백만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2020.07</TD>
<TD WIDTH="635" HEIGHT="30">IVL2001 (심장사상충예방 및 치료제 3개월) 품목허가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2020.07</TD>
<TD WIDTH="635" HEIGHT="30">탈모치료제(IVL3001, IVL3002) 임상시험용의약품 제조위수탁 계약 체결 (위더스제약㈜)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2020.09</TD>
<TD WIDTH="635" HEIGHT="30">탈모치료제(IVL3001, IVL3002) 공동개발 및 독점적 기술 사용에 대한 계약 체결(㈜대웅제약)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2020.09</TD>
<TD WIDTH="635" HEIGHT="30">일반법인 지분투자 유치 (위더스제약㈜ 2,000백만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2020.11</TD>
<TD WIDTH="635" HEIGHT="30">IVL2005, IVL2006(화학적거세제 12개월,3개월) License Out 계약 체결 (Virbac S.A.)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="53">2020.11</TD>
<TD WIDTH="635" HEIGHT="53">기술혁신형 중소기업(Inno-Biz) 선정 (2020.11.24~2023.11.23, 제200605-01202호, 중소벤처기업부)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="53">2021.01</TD>
<TD WIDTH="635" HEIGHT="53">3개월 지속형, 6개월 지속형 심장사상충 예방 및 치료제(IVL2001, IVL2002) 제품 독점 판매 및 사업제휴에 대한 계약 (㈜노터스)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="53">2021.04</TD>
<TD WIDTH="635" HEIGHT="53">소재·부품·장비 전문기업 선정 (2021.04.19~2024.04.18, 제24997호, 한국산업기술평가관리원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="53">2021.04</TD>
<TD WIDTH="635" HEIGHT="53">의료기기 GMP (4등급) 승인(2차, 2021.04.28~2024.04.27, KCL-ABBA-11097호, 경인지방식품이약품안전청, 한국건설생활환경시험연구원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2021.06</TD>
<TD WIDTH="635" HEIGHT="30">3자간 업무협약(㈜대웅제약, 위더스제약㈜)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2021.07</TD>
<TD WIDTH="635" HEIGHT="30">시리즈 Pre-IPO 자본조달 (총 159.4억원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2021.08</TD>
<TD WIDTH="635" HEIGHT="30">동물의약품 KVGMP 승인 (농림축산검역본부)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2021.08</TD>
<TD WIDTH="635" HEIGHT="30">LNP 플랫폼 기술의 사업화를 위한 공동연구 계약 (에스티팜㈜)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2021.09</TD>
<TD WIDTH="635" HEIGHT="30">일반법인 지분투자 유치 (에스티팜 2,000백만원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2021.09</TD>
<TD WIDTH="635" HEIGHT="30">CMO 사업제휴 계약(위더스제약㈜) </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2021.09</TD>
<TD WIDTH="635" HEIGHT="30">듀라하트 SR-3 주사액(목시덱틴) 출시</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="53">2021.11</TD>
<TD WIDTH="635" HEIGHT="53">김주희 대표이사, 2021년 보건의료기술진흥 유공자 정부포상 「보건의료기술 우수개발 부문」보건복지부장관 표창 수상</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2021.11</TD>
<TD WIDTH="635" HEIGHT="30">전립선 비대증 치료제 (IVL3013) 독점적 License Out 계약 체결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2022.01</TD>
<TD WIDTH="635" HEIGHT="30">신약 물질 AIDS 치료제(IVL5002) 공동개발 계약(에스티팜㈜)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2022.02</TD>
<TD WIDTH="635" HEIGHT="30">동물용 치매치료제(IVL2007, IVL2008 독점 License Out 계약(㈜노터스)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2022.02</TD>
<TD WIDTH="635" HEIGHT="30">한국거래소 기술평가 승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2022.04</TD>
<TD WIDTH="635" HEIGHT="30">mRNA 기반 항체의약품 개발을 위한 공동연구 계약(에이피트바이오㈜)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2022.11</TD>
<TD WIDTH="635" HEIGHT="30">기술성장기업 코스닥시장특례상장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2022.12</TD>
<TD WIDTH="635" HEIGHT="30">알코올 의존성 및 opioid 의존성 치료제(IVL3004) 호주 임상 제1상 시험계획 신청</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2023.01</TD>
<TD WIDTH="635" HEIGHT="30">미소구체 제조 시스템 특허권 취득</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="53">2023.01</TD>
<TD WIDTH="635" HEIGHT="53">지질 나노 입자 제조용 칩, 이를 포함하는 지질 나노 입자 제조 시스템 및 지질 나노 입자 제조 방법 특허권 취득</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2023.01</TD>
<TD WIDTH="635" HEIGHT="30">알코올 의존성 및 opioid 의존성 치료제(IVL3004) 호주 임상 제1상 HREC 시험계획 승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2023.02</TD>
<TD WIDTH="635" HEIGHT="30">조직 수복용 주사제 조성물 및 이의 제조 방법 특허권 취득</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="30">2023.03</TD>
<TD WIDTH="635" HEIGHT="30">데슬로렐린을 포함하는 서방성 마이크로 입자 및 이의 제조 방법 일본 특허 취득</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">나. 회사의 본점소재지 및 그 변경</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="701">

<COLGROUP>
<COL WIDTH="106"></COL>
<COL WIDTH="577"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">일자</TH>
<TH WIDTH="586" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2015.05.14</TD>
<TD WIDTH="586" VALIGN="MIDDLE" HEIGHT="30">회사 설립 (본점: 경기도 성남시 분당구 판교로319번길 13, 540호(삼평동, 디테라스))</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2015.09.18</TD>
<TD WIDTH="586" VALIGN="MIDDLE" HEIGHT="53">본점 소재지 변경 (경기도 성남시 수정구 성남대로 1342, 비110호(복정동, 가천대학교아이티대학내 창업보육센터))</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2016.01.06</TD>
<TD WIDTH="586" VALIGN="MIDDLE" HEIGHT="53">본점 소재지 변경 (경기도 성남시 중원구 성남대로997번길 51-20, 4층(여수동, 트윈스빌딩))</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2016.07.14</TD>
<TD WIDTH="586" VALIGN="MIDDLE" HEIGHT="53">본점 소재지 이전 (경기도 성남시 중원구 둔촌대로388번길 24, 801호(상대원동, 우림라이온스밸리3차))</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2017.10.26</TD>
<TD WIDTH="586" VALIGN="MIDDLE" HEIGHT="53">본점 소재지 이전 (경기도 성남시 중원구 둔촌대로388번길 24, 801호,802호,101호,812-1호(상대원동, 우림라이온스밸리3차))</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2018.06.04</TD>
<TD WIDTH="586" VALIGN="MIDDLE" HEIGHT="53">본점 소재지 이전 (경기도 성남시 중원구 둔촌대로388번길 24, 801호,802호,101호,612호,812-1호(상대원동, 우림라이온스밸리3차))</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2018.11.19</TD>
<TD WIDTH="586" VALIGN="MIDDLE" HEIGHT="53">본점 소재지 이전 (경기도 성남시 중원구 둔촌대로388번길 24, 801호,802호,101호,602호,603호,612호(상대원동, 우림라이온스밸리3차))</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2019.09.30</TD>
<TD WIDTH="586" VALIGN="MIDDLE" HEIGHT="53">본점 소재지 이전 (경기도 성남시 중원구 둔촌대로388번길 24, 101호,601호,602호,603호(상대원동, 우림라이온스밸리3차))</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.05.14</TD>
<TD WIDTH="586" VALIGN="MIDDLE" HEIGHT="53">본점 소재지 이전 (경기도 성남시 중원구 둔촌대로388번길 24, 101호,601호,612호(상대원동, 우림라이온스밸리3차))</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<LIBRARY>
<P>
<SPAN USERMARK=" B">다. 경영진의 중요한 변동</SPAN>
</P>

<TABLE-GROUP ACLASS="MNG_IMP_CHG" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="728" BORDER="1">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">변동일자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주총종류</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="306" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">선임</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">임기만료또는 해임</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">신규</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">재선임</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="CHG_DT" AUNITVALUE="20190328">2019년 03월 28일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" AUNIT="GM_TYPE" AUNITVALUE="1">정기주총</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30" ACODE="NAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30" ACODE="RAPP_NM"> 사내이사 류충호</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACODE="DISM_NM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="CHG_DT" AUNITVALUE="20200325">2020년 03월 25일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" AUNIT="GM_TYPE" AUNITVALUE="1">정기주총</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="173" HEIGHT="53" ACODE="NAPP_NM">사내이사 전찬희기타비상무이사 김태헌</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="53" ACODE="RAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="53" ACODE="DISM_NM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="CHG_DT" AUNITVALUE="20210331">2021년 03월 31일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" AUNIT="GM_TYPE" AUNITVALUE="1">정기주총</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="173" HEIGHT="53" ACODE="NAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="53" ACODE="RAPP_NM">사내이사 김주희감사 김병철</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="53" ACODE="DISM_NM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="CHG_DT" AUNITVALUE="20210727">2021년 07월 27일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" AUNIT="GM_TYPE" AUNITVALUE="2">임시주총</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30" ACODE="NAPP_NM">사외이사 문응필</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30" ACODE="RAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACODE="DISM_NM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="CHG_DT" AUNITVALUE="20210930">2021년 09월 30일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" AUNIT="GM_TYPE" AUNITVALUE="-">-</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30" ACODE="NAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30" ACODE="RAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACODE="DISM_NM">기타비상무이사 최동열 주2)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="CHG_DT" AUNITVALUE="20211026">2021년 10월 26일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" AUNIT="GM_TYPE" AUNITVALUE="2">임시주총</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30" ACODE="NAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30" ACODE="RAPP_NM">사내이사 김동훈</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACODE="DISM_NM">기타비상무이사 강정훈 주3)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="CHG_DT" AUNITVALUE="20220325">2022년 03월 25일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" AUNIT="GM_TYPE" AUNITVALUE="1">정기주총</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30" ACODE="NAPP_NM">사내이사 이마세</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30" ACODE="RAPP_NM"> 사내이사 류충호</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACODE="DISM_NM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="CHG_DT" AUNITVALUE="20220719">2022년 07월 19일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" AUNIT="GM_TYPE" AUNITVALUE="-">-</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30" ACODE="NAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30" ACODE="RAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACODE="DISM_NM">사외이사 문응필 주4)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="CHG_DT" AUNITVALUE="20220831">2022년 08월 31일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" AUNIT="GM_TYPE" AUNITVALUE="2">임시주총</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="173" HEIGHT="30" ACODE="NAPP_NM">사외이사 김후균</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30" ACODE="RAPP_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACODE="DISM_NM">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>


<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="617">

<COLGROUP>
<COL WIDTH="37"></COL>
<COL WIDTH="562"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" HEIGHT="53">주1)</TD>
<TD WIDTH="571" HEIGHT="53">변동일자에는 주주총회 개최일을 기재하였으며, 주주총회가 개최되지 않은 경영진의 변동의 경우에는 실제 변동이 발생한 일자를 기재하였습니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" HEIGHT="30">주2)</TD>
<TD WIDTH="571" HEIGHT="30">2021.09.30 기타비상무이사 최동열은 일신상의 사유로 사임하였습니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" HEIGHT="30">주3)</TD>
<TD WIDTH="571" HEIGHT="30">2021.10.26 기타비상무이사 강정훈은 임기의 만료로 사임하였습니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" HEIGHT="30">주4)</TD>
<TD WIDTH="571" HEIGHT="30">2022.07.19 사외이사 문응필은 일신상의 사유로 사임하였습니다.</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">라. 최대주주의 변동</SPAN>당사의 최대주주는 설립부터 본 보고서 제출일 현재까지 김주희 대표이사로 변동사항이 없습니다.
<SPAN USERMARK=" B">마. 상호의 변경</SPAN>해당사항이 없습니다.
<SPAN USERMARK=" B">바. 회사가 화의, 회사정리절차 그 밖에 이에 준하는 절차를 밟은 적이 있거나 현재 진행중인 경우 그 내용과 결과</SPAN>해당사항이 없습니다.
</P>

<P>
<SPAN USERMARK=" B">사. 회사가 합병 등을 한 경우 그 내용</SPAN>해당사항이 없습니다.
</P>

<P>
<SPAN USERMARK=" B">아. 회사의 업종 또는 주된 사업의 변화</SPAN>해당사항이 없습니다.
<SPAN USERMARK=" B">자. 그 밖에 경영활동과 관련된 중요한 사항의 발생내용</SPAN>해당사항이 없습니다.
</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-3-0">3. 자본금 변동사항</TITLE>
<P></P>
<P USERMARK=" B">가. 자본금 변동추이</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="643" BORDER="0">

<COLGROUP>
<COL WIDTH="301"></COL>
<COL WIDTH="324"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="310" HEIGHT="30"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="333" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="649" BORDER="1">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="150"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="160" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말(제8기)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="159" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2021년말(제7기)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="159" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년말(제6기)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="90">보통주</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">발행주식총수</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30"> 8,351,348</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30"> 7,134,148 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30"> 6,416,548 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">액면금액</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">500</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30">500</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30">500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">자본금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30"> 4,175,674,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30">3,567,074,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30"> 3,208,274,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="90">우선주</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">발행주식총수</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">액면금액</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">자본금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="90">기타</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">발행주식총수</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">액면금액</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">자본금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">합계</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">자본금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30"> 4,175,674,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30">3,567,074,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30"> 3,208,274,000 </TD>
</TR>
</TBODY>
</TABLE>
<P>주) 2023년 2월 주식매수선택권 행사로 15,208주가 발행되어 2023년 3월 현재 발행주식총수는 8,366,556주 입니다.</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-4-0">4. 주식의 총수 등</TITLE>
<P></P>
<P USERMARK=" B">가. 주식의 총수 현황</P>

<TABLE-GROUP ACLASS="TOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="663" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="316"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="106" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="325" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="665" BORDER="1">

<COLGROUP>
<COL WIDTH="25"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="95"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="247" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구  분</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="314" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="N" ACODE="STK_KND_TOT" ADELETECOL="N" AMOVECOL="N">보통주 주1)</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ACODE="STK_KND_TOT" ADELETECOL="Y" AMOVECOL="N">우선주</TE>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅰ. 발행할 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK1">50,000,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK1">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK1">50,000,000</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅱ. 현재까지 발행한 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK2"> 8,351,348</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK2">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK2"> 8,351,348</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE1">주2)</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅲ. 현재까지 감소한 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TOT_RST">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TOT_RST">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RST">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="4" VALIGN="MIDDLE" WIDTH="34" HEIGHT="120" AUPDATECONT="N"></TD>
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 1. 감자</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RDC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RDC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RDC_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 2. 이익소각</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="DST_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="DST_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_DST_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 3. 상환주식의 상환</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RFD_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RFD_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RFD_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE5">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 4. 기타</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ETC_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE6">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅳ. 발행주식의 총수 (Ⅱ-Ⅲ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK3">8,351,348</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK3">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK3">8,351,348</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE7">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅴ. 자기주식수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TRS_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TRS_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_TRS_STK">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE8">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅵ. 유통주식수 (Ⅳ-Ⅴ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="FLT_STK">8,351,348</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="FLT_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_FLT_STK">8,351,348</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE9">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>주1) 보통주에 표기된 발행할 주식의 총수는 보통주와 우선주의 합입니다주2) 2023년 2월 주식매수선택권 행사로 15,208주가 발행되어 2023년 3월 현재 발행주식총수는 8,366,556주 입니다.
<SPAN USERMARK=" B">나. 자기주식 취득 및 처분 현황</SPAN>해당사항이 없습니다.
<SPAN USERMARK=" B">다. 종류주식 발행현황</SPAN>해당사항이 없습니다.
</P>

<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-5-0">5. 정관에 관한 사항</TITLE>

<P>
<SPAN USERMARK=" B">가. 정관의 최근 개정일</SPAN>당사 정관의 최근 개정일은 2022년 03월 25일이며, 2022년 03월 25일 정기주주총회에서 정관 일부 변경의 건 의안이 원안대로 승인되었습니다.
</P>

<LIBRARY>
<P USERMARK=" B">나. 정관 변경 이력</P>

<TABLE-GROUP ACLASS="ART_BCK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="850" BORDER="1">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="307"></COL>
<COL WIDTH="280"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">정관변경일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해당주총명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="316" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요변경사항</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="289" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">변경이유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="306" AUNIT="ART_DATE" AUNITVALUE="20220325" VALIGN="MIDDLE">2022년 03월 25일</TU>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="306" ACODE="ART_NAME" VALIGN="MIDDLE">정기주주총회</TE>
<TE WIDTH="316" HEIGHT="306" ACODE="ART_CHN" VALIGN="MIDDLE">제 8 조 (주식의 종류)제 11 조 (주식매수선택권)제 12 조 (신주의 동등배당)제 16 조 (주주명부의 폐쇄 및 기준일)제 18 조 (신주인수권부사채의 발행)제 20 조 (사채발행에 관한 준용규정)제 20 조의 2 (사채 및 신주인수권증권에 표시되어야 할 권리의 전자등록)제 26 조 (주주의 의결권)제 30 조 (주주총회의 결의 및 의결정족수)제 52 조 (외부감사인의 선임)부칙 제 2 조 (감사 선임에 관한 적용)부칙 제 3 조 (감사 해임에 관한 적용)</TE>
<TE WIDTH="289" HEIGHT="306" ACODE="ART_RSN" VALIGN="MIDDLE">코스닥 표준정관 반영을 위한 일부 개정</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="122" AUNIT="ART_DATE" AUNITVALUE="20230330" VALIGN="MIDDLE">2023년 03월 30일</TU>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="122" ACODE="ART_NAME" VALIGN="MIDDLE">정기주주총회</TE>
<TE WIDTH="316" HEIGHT="122" ACODE="ART_CHN" VALIGN="MIDDLE">제2조(목적)제17조(전환사채의 발행)제18조(신주인수권부사채의 발행)제37조 (이사의 보수와 퇴직금)부칙 제1조(시행일)</TE>
<TE WIDTH="289" HEIGHT="122" ACODE="ART_RSN" VALIGN="MIDDLE">사업 다각화에 따른 사업목적 추가전환사채, 신주인수권부사채의 한도 증액적대적 인수합병시 퇴직보상액 추가</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P>주) 2023.03.30 정관 변경 안건은 제8기 정기주주총회 안건에 포함된 안건으로써 2023.03.30 개최되는 정기주주총회 결과에 따라 변경여부가 결정될 예정입니다.</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-2-0-0">II. 사업의 내용</TITLE>
<P></P>
<P>당사가 영위하는 사업의 내용을 이해하기 위하여 개념정리가 필요한 용어에 대한 참고해설은 다음과 같습니다.</P>

<TABLE BORDER="0" WIDTH="849" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="840"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="849" ALIGN="CENTER" HEIGHT="30">
<P>【 주요 용어 설명 (알파벳순) 】</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="848" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="95"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="573"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="266" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>용어(ENG)</P>
</TD>

<TD ROWSPAN="2" WIDTH="582" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>용어(KOR) 설명</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>줄임말</P>
</TD>

<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>원말</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>API</P>
</TD>

<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>Active Pharmaceutical Ingredient</P>
</TD>

<TD WIDTH="582" VALIGN="MIDDLE" HEIGHT="53">
<P>의약품 제조에 사용되는 활성성분 또는 활성성분들의 혼합물로서, 약효을 나타내는 주성분</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Batch</P>
</TD>

<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>좌동</P>
</TD>

<TD WIDTH="582" VALIGN="MIDDLE" HEIGHT="53">
<P>생산공정에서 동일한 제조공정하에 균질성을 갖도록 제조된 의약품의 일정한 분량을 의미</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>Burst</P>
</TD>

<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="76" ALIGN="CENTER">
<P>좌동</P>
</TD>

<TD WIDTH="582" VALIGN="MIDDLE" HEIGHT="76">
<P>약물의 방출로 약물 혈중농도-시간 그래프에서 약물 농도가 급격하게 증가하는 구간을 의미. 투여직후 초기(최대 2일 이내)의 급격한 방출을 Initial Burst, 초기 방출 이후에 단시간에 다량의 약물이 방출되는 경우를 일반적인 Burst 구간으로 구별</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>CMO,</P>
<P>CDMO</P>
</TD>

<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="76" ALIGN="CENTER">
<P>Contract(Development and) Manufacturing Control</P>
</TD>

<TD WIDTH="582" VALIGN="MIDDLE" HEIGHT="76">
<P>계약을 통해 비임상 실험(in vitro, in vivo), 임상용 시험의약품 생산, 시판용 의약품 생산 등 다양한 의약품 제조 및 개발 관련 용역을 대행하는 업무를 수행하며, 산업 특성상 GMP 인증이 요구됨</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>CRO</P>
</TD>

<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>Contract Research Organizations</P>
</TD>

<TD WIDTH="582" VALIGN="MIDDLE" HEIGHT="53">
<P>계약을 통해 후보물질에 대한 효능 독성 등 비임상 실험(in vitro, in vivo) 및 임상용 시험의약품 테스트 및 생산을 하는 기관</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>Drug -Repositioning</P>
</TD>

<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>좌동</P>
</TD>

<TD WIDTH="582" VALIGN="MIDDLE" HEIGHT="76">
<P>기존에 나와있는 약물을 신규한 다른 적응증에도 치료효과가 있는 것을 발굴해내는 활동. 이미 출시된 약물에 대하여 새로운 기전을 찾아 새로운 적응증에 적용할 수 있도록 개발을 진행하는 전략</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Encapsulation</P>
</TD>

<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>좌동</P>
</TD>

<TD WIDTH="582" VALIGN="MIDDLE" HEIGHT="30">
<P>API를 고분자 입자나 LNP 내에 담지하는 것</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>FDA</P>
</TD>

<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Food and Drug Administration</P>
</TD>

<TD WIDTH="582" VALIGN="MIDDLE" HEIGHT="53">
<P>미국 보건복지부(HHS) 산하 식품과 의약품에 대한 관리 규제를 하는 기관</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>GMP</P>
</TD>

<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Good Manufacturing Practice)</P>
</TD>

<TD WIDTH="582" VALIGN="MIDDLE" HEIGHT="53">
<P>각국의 규제기관이 인정하는 의약품 품질관리 기준. 미국과 EU 등에서는 의약품 수입허가시 각각 cGMP, EUGMP 규정에 따른 제조 및 관리를 필수적으로 요구함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>in vitro</P>
</TD>

<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>좌동</P>
</TD>

<TD WIDTH="582" VALIGN="MIDDLE" HEIGHT="53">
<P>‘유리안에서’라는 뜻으로 살아있는 생명체 내부가 아니라 시험관처럼 제어가능한 외부 환경에서 수행되는 실험</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>in vivo</P>
</TD>

<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>좌동</P>
</TD>

<TD WIDTH="582" VALIGN="MIDDLE" HEIGHT="30">
<P>‘생체 안에서’라는 뜻으로 쥐, 개 등 동물을 활용해 수행하는 생화학, 생물학 실험</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>IND</P>
</TD>

<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>Investigation New Drug Application</P>
</TD>

<TD WIDTH="582" VALIGN="MIDDLE" HEIGHT="76">
<P>특정 의약품의 안전성, 유효성에 대한 자료수집 목적으로 비임상자료와 임상시험계획서를 취합하여 임상시험에 대한 승인을 신청하는 절차로서, FDA 등 규제기관에 임상시험에 대한 승인을 신청하는 과정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Initial Burst</P>
</TD>

<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>좌동</P>
</TD>

<TD WIDTH="582" VALIGN="MIDDLE" HEIGHT="53">
<P>약물 투여직후(최대 2일 이내)에 혈중 약물농도 값이 급격하게 높아지는 현상(초기 과방출)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>LNP</P>
</TD>

<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>Lipid Nano Particle</P>
</TD>

<TD WIDTH="582" VALIGN="MIDDLE" HEIGHT="76">
<P>지질을 원재료로 핵산을 전달 대상체로 하는 약물 전달체 나노 입자. 평균적으로 50~150nm의 크기를 가지며, 입자 내부에 mRNA 등의 유전 물질(핵산)을 봉입함. COVID-19 mRNA백신에 적용된 약물 전달체</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Microfluidics</P>
</TD>

<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>좌동</P>
</TD>

<TD WIDTH="582" VALIGN="MIDDLE" HEIGHT="53">
<P>마이크로 단위의 좁은 관로를 흐르는 유체의 고유한 특성에 기반한 유체역학의 응용분야로서, 반도체, 신소재, 진단기기 분야 등에서 다양한 방식으로 활용된 기술</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>Microsphere</P>
</TD>

<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>좌동</P>
</TD>

<TD WIDTH="582" VALIGN="MIDDLE" HEIGHT="76">
<P>고분자화합물들이 구형으로 모여서 형성된 마이크로 사이즈의 입자. 생분해성 고분자 사용시 장기지속형 주사제 개발에 사용되며, 체내에서 목표유지기간 동안 약물을 지속적으로 방출하는 특징을 보임</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>NDA</P>
</TD>

<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>New Drug Application</P>
</TD>

<TD WIDTH="582" VALIGN="MIDDLE" HEIGHT="53">
<P>국내 식약처, 미국 FDA 등 규제당국에 동물시험까지 비임상시험결과와 인체를 대상으로 하는 임상시험 결과를 종합하여 의약품 시판 허가를 신청하는 절차</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>SEM</P>
</TD>

<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Scanning Electron Microscope</P>
</TD>

<TD WIDTH="582" VALIGN="MIDDLE" HEIGHT="53">
<P>전자현미경의 한 종류로 광학현미경으로 관측이 어려운 작은 표본을 관측할 때 사용</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>TNF-α</P>
</TD>

<TD WIDTH="162" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Tumor Necrosis Factor alpha</P>
</TD>

<TD WIDTH="582" VALIGN="MIDDLE" HEIGHT="53">
<P>TNF-α는 주로 활성화된 대식세포에 의해 분비되는데, 보조 T 세포, 자연살해세포, 그리고 손상된 뉴런 등의 다양한 세포에서도 분비됨</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<LIBRARY>
<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-1-L1">1. 사업의 개요</TITLE>
<P>당사는 유체역학을 의약품 연구·개발에 융합한 원천 플랫폼인 Laminar-FLUIDigm™을 기반으로, 이를 장기지속형 주사제 개발 및 양산 제조에 응용한 IVL-DrugFluidic® 플랫폼 및 유전물질의 약물전달에 적용한 IVL-GeneFluidic® 플랫폼을 보유한 DDS(Drug Delivery System) 플랫폼 기업입니다.당사는  IVL-DrugFluidic® 플랫폼을 기반으로 장기지속형 주사제(개량신약, 자체개발 신약, 공동개발 신약)을 개발 중이며,  나노전달체 제조를 위한 IVL-GeneFluidic® 플랫폼 기반으로 유전자치료제/mRNA 백신의 제형화 연구를 진행하고 있으며 플랫폼의 상업화를 진행 중입니다.</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="361" ALIGN="CENTER" HSPACE="0">사업의 개요.jpg</IMG>
<IMG-CAPTION ATOC="N">사업의 개요</IMG-CAPTION>
</IMAGE>

<P>
<SPAN USERMARK=" B">가. 핵심 기술의 개요(1)  IVL-DrugFluidic® 플랫폼</SPAN>
</P>
<P>IVL-DrugFluidic® 플랫폼은 기존의 Microsphere 기반 장기지속형 주사제의 단점으로 알려진 요소를 제거하고, 장기지속형 주사제의 품질을 극대화한 플랫폼입니다. 당사는 현재 IVL-DrugFluidic® 플랫폼을 적용한 동물의약품인 듀라하트 SR-3 주사액(목시덱틴)을 자체 KVGMP 제조소에서 제조하여 2021년부터 시판하고 있으며, 개량신약 IVL3001 1개월 지속형 남성형 탈모치료제는 호주 1/2상 임상을 완료하였습니다.IVL3003 치매치료제 및 IVL3004 마약 및 알코올 중독 치료제는 호주 임상 1상 IND 승인을 받았으며, 2023년 임상 진입을 계획하고 있습니다. </P>
<P>또한 LAI(Long Acting Injectable, 장기지속형 주사제) 플랫폼에 의한 고품질 의약품의 안정적인 개발이 확인되면서, 당사는 기존 개량신약에서 신약의 부가가치를 가지는 프로젝트로 의약품 개발의 범위를 넓히고 있습니다. 먼저 자체적으로 발굴한 신규 적응증에 대한 프로젝트의 성과를 확보해 왔으며, 협력 기업이 보유한 신약물질을 당사의 장기지속 주사제형 플랫폼에 탑재하는 Open Innovation 성격의 공동개발 및 사업화 계약 실적들도 지속적으로 확보하고 있습니다.</P>
<P> </P>

<P USERMARK=" B">(2) IVL-GeneFluidic® 플랫폼
<SPAN USERMARK=" !B">당사는 최근 Covid-19에 대한 성공적인 백신개발로 유명해진 LNP(Lipid Nano Particle, 지질나노입자) 및 리포좀 등 나노전달체를 제조할 수 있는 공정 프로세스 기술인 IVL-GeneFluidic® 플랫폼을 보유하고 있습니다.mRNA와 같은 유전체를 안전하게 보호하고, 생체내로 효과적으로 전달하기 위해서는 mRNA를 인지질(Lipid) 물질로 효과적으로 감싼 나노입자인 LNP를 제조하여야 합니다. 이러한 LNP를 높은 봉입율(Encapsulation efficiency)과 수율로 제조하기 위해서는 우수한 품질의 mRNA와 Lipid 원료물질 확보와 함께, LNP를 재현성 높게 제조할수 있는 고도의(Advanced) 공정기술이 요구됩니다.당사는 기존에 자체적으로 수행한 장기지속형 주사제 공정 및 장비개발 연구를 통하여 축적된 마이크로플루이딕스 공정 엔지니어링 노하우를 LNP 분야에 최적화하여, 단기간 내에 세계 최고수준의 Reference 기업과 비교가능한 자체 공정 프로세스 및 장비개발을 달성하였습니다. 당사는 우수한 개발 실적으로 바탕으로 2022년 산업통상자원부 주관의 mRNA 백신 제조플랫폼 개발 국가과제에 선정되어 mRNA 백신의 대량생산 시스템을 개발 중에 있습니다. (과제명: mRNA 백신의 제형화와 대량생산을 위한 GMP 적용가능 제조시스템 제작 및 공정 기술 개발, 과제규모: 58억원) 또한 IVL-GeneFluidic® 플랫폼 기반의 본격적인 CDMO 사업화를 위해 국내외 제약바이오 기업들과 파트너링을 논의하고 있습니다.</SPAN>
</P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-2-L1">2. 주요 제품 및 서비스</TITLE>

<P>
<SPAN USERMARK=" B">가. 주요 제품(1) IVL-DrugFluidic® 플랫폼 기반 파이프라인</SPAN>
</P>
<P>현재 당사에서 자체 개발 중인 주요 파이프라인과 파트너사와 공동 개발 중인 주요 파이프라인은 아래와 같습니다.</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="323" ALIGN="CENTER" HSPACE="0">개량신약 파이프라인.jpg</IMG>
<IMG-CAPTION ATOC="N">개량신약 파이프라인</IMG-CAPTION>
</IMAGE>
<P></P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="267" ALIGN="CENTER" HSPACE="0">자채개발 신약 및 공동개발 신약 파이프라인.jpg</IMG>
<IMG-CAPTION ATOC="N">자체개발 신약 및 공동개발 신약 파이프라인</IMG-CAPTION>
</IMAGE>

<P>당사가 개발한 자체개발 개량신약 파이프라인은 국내 유수의 제약사인 대웅제약, 종근당 등에 기술이전하여 사업화를 진행 중이며, 함께 글로벌 라이선스 아웃을 추진 중에 있습니다. 또한 당사는 파트너사가 제공하는 신약물질을 당사의 DDS 플랫폼 에 탑재 한 후 파트너사는 효력/임상 연구에 집중하고 당사는 제제 및 공정 연구에 집중하는 협업 연구 모델인 공동 개발(Joint Development) 프로그램을 운영하고 있으며, 유한건강생활 및 신약개발 바이오텍과 함께 장기지속형 주사제 기반의 신약을 공동으로 개발하고 있습니다. 제품화가 완료된 장기지속형 주사제는 동물의약품인 심장사상충 예방약 '듀라하트 SR-3'으로 2021년 9월 출시하였습니다.
<SPAN USERMARK=" B">(2) IVL-GeneFluidic® 플랫폼 기반 서비스</SPAN>
</P>
<P>당사는 IVL-GeneFluidic® 플랫폼 기반의 CDMO서비스 사업을 추진중에 있습니다.LNP Formulation의 초기 연구 장비인 IVL-Handy의 개발 및 장비화를 완료하였으며, 비임상 및 임상 샘플의 제조가 가능한 Pilot Scale 생산 장비/설비인 IVL-Supra의 개발을 완료하고 설비 구축 중에 있습니다. 또한 대량생산 시스템인 IVL-Pana를 산업통산자원부 과제를 통해 개발 중입니다.</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="307" ALIGN="CENTER" HSPACE="0">자동화 gmp 설비 기반의 cdmo 사업.jpg</IMG>
<IMG-CAPTION ATOC="N">자동화 gmp 설비 기반의 cdmo 사업</IMG-CAPTION>
</IMAGE>
<P></P>
<P USERMARK=" B">나. 주요제품 가격 변동 추이 및 가격변동원인</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="692">

<COLGROUP>
<COL WIDTH="683"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="692" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="691" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="75"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">품목</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요제품</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2022년</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2021년</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019년</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30">동물약</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30">듀라하트 SR-3 주사액 주1)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30">63,000</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30">63,000</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">주1) 동물약 산출기준은 포장단위인 카톤당 판매가입니다.</SPAN>
</P>
<P USERMARK=" B">다. 주요제품 등 관련 각종 산업 표준</P>
<P>개발중인 의약품들의 경우, 조성물, 제형관련 특허를 보유하고 있어서, 판매금지를 통한 경쟁사 진입 방어 및 시장을 선점할 수 있습니다.  대부분의 당사 파이프라인은 기 허가 품목의 개량제품으로서 신약 승인 후 자료 독점기간 (4년 또는 6년) 동안 타사 진입 차단 및 시장독점건을 보장받을 수 있습니다. 또한, 우수 의약품 제조를 위하여 공장에서 원료의 구입부터 제조, 출하 등에 이르는 모든 과정에 필요한 관리기준에 적합하도록 GMP 하에 제조 및 품질관리를 하고 있으며, GLP 기관에서 비임상시험 자료 확보 및 GCP 에 따라서 임상시험을 진행함으로써, 우수사례품질지침 및 규정에 따라 우수한 품질 확보 및 자료의 신뢰성을 확보하고 있습니다.</P>
<P> </P>
<P>동물용의약품의 경우도 규제당국만 다를 뿐, 인의약품과 동일하게 약사법을 준수합니다. 우수한 의약품을 제조하기 위하여 공장에서 원료의 구입부터 제조, 출하 등에 이르는 모든 과정에 필요한 관리기준을 규정하여 KVGMP  (KVGMP, Korea Veterinary Good Manufacturing Practice) 하에 제조 및 품질관리를 하고 있습니다.</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-3-L1">3. 원재료 및 생산설비</TITLE>
<P USERMARK=" B"></P>

<P>
<SPAN USERMARK=" B">가. 주요 원재료 매입에 관한 사항</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="666">

<COLGROUP>
<COL WIDTH="657"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="666" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="666">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="297"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="117" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">제품구분</TH>
<TH WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">매입유형</TH>
<TH WIDTH="73" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">품 목</TH>
<TH WIDTH="75" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">매입액</TH>
<TH WIDTH="306" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">비 고 (매입처)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="117" HEIGHT="30">듀라하트 SR-3</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="95" HEIGHT="30">원재료</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="73" HEIGHT="30">원료 등</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="75" HEIGHT="30">43,294</TD>
<TD VALIGN="MIDDLE" WIDTH="306" HEIGHT="30">휴템, 제이더블유에스미디어,브이에스팜 등</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="285" HEIGHT="30">합 계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="75" HEIGHT="30">43,294</TD>
<TD VALIGN="MIDDLE" WIDTH="306" HEIGHT="30">　</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B">나. 원재료 가격변동 추이 및 가격변동 원인</P>

<P>국내외 원자재 품목을 생산하는 제조사의 제조원가 상승에 따른 가격 인상 정책에 따라 원재료 가격 변동에 영향을 받고 있으며 특히 해외 수입 품목의 경우 추가로 환율 변동이 가격에 영향을 미치고 있습니다. 당사는 매 구입시마다 거래처와의 협의를 통해 가격을 결정하게 됩니다. 
<SPAN USERMARK=" B">다. 생산 및 생산설비에 관한 사항</SPAN>
<SPAN USERMARK=" B">(1) 생산능력 및 생산실적</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="669">

<COLGROUP>
<COL WIDTH="660"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="669" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(단위: 카톤, 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="668">

<COLGROUP>
<COL WIDTH="110"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="59"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="88" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제 품 품목명</P>
</TH>

<TH ROWSPAN="2" WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="88" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구  분</P>
</TH>

<TH COLSPAN="2" WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="58" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2020연도</P>
<P>(제06기)</P>
</TH>

<TH COLSPAN="2" WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="58" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2021연도</P>
<P>(제07기)</P>
</TH>

<TH COLSPAN="2" WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="58" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2022연도(제08기)</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수량</P>
</TH>

<TH WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금액</P>
</TH>

<TH WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수량</P>
</TH>

<TH WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금액</P>
</TH>

<TH WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수량</P>
</TH>

<TH WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금액</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="119" VALIGN="MIDDLE" HEIGHT="120">
<P>듀라하트 SR-3</P>
</TD>

<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">
<P>생산능력</P>
</TD>

<TD WIDTH="69" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">
<P>-</P>
</TD>

<TD WIDTH="69" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">
<P>-</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>18,447</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,162</P>
</TD>
<TD WIDTH="69" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">18,447</TD>
<TD WIDTH="68" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,162</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">
<P>생산실적 주1)</P>
</TD>

<TD WIDTH="69" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">
<P>-</P>
</TD>

<TD WIDTH="69" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">
<P>-</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,466</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>92</P>
</TD>
<TD WIDTH="69" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">869</TD>
<TD WIDTH="68" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">55</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">
<P> 가 동 율 주2)</P>
</TD>

<TD COLSPAN="2" WIDTH="138" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD COLSPAN="2" WIDTH="138" ALIGN="CENTER" HEIGHT="30">
<P>25.8%</P>
</TD>
<TD COLSPAN="2" WIDTH="137" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">4.71%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">
<P> 기말재고</P>
</TD>

<TD WIDTH="69" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">
<P>-</P>
</TD>

<TD WIDTH="69" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">
<P>-</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>449</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>28</P>
</TD>
<TD WIDTH="69" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,097</TD>
<TD WIDTH="68" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">69</TD>
</TR>
</TBODY>
</TABLE>
<P>주1) 2021년 9월부터 생산</P>
<P>주2) 2021년 가동율은 수량기준으로 산출하였으며, 2021년 9월부터 12월까지의 생산능력 대비 생산실적으로 산출하였습니다.</P>

<P>
<SPAN USERMARK=" B">(2) 생산설비에 관한 사항</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="750">

<COLGROUP>
<COL WIDTH="741"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="750" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="751">

<COLGROUP>
<COL WIDTH="94"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="94"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="103" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">자산별</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기  초</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">취  득</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">처  분</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">상 각</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">대체</TH>
<TH WIDTH="103" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="103" VALIGN="MIDDLE" HEIGHT="30">사용권자산</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">202,959 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                  -</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(61,221)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">141,738 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="103" VALIGN="MIDDLE" HEIGHT="30">기계장치</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">262,915 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">293,645 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(134,509)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,000 </TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">482,051 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="103" VALIGN="MIDDLE" HEIGHT="30">비품</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">81,092 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,450 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(22,183)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">72,359 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="103" VALIGN="MIDDLE" HEIGHT="30">시설장치</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">337,213 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(84,296)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">252,917 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="103" VALIGN="MIDDLE" HEIGHT="30">건설중인자산</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60,000 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">197,570 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(257,570)</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="103" VALIGN="MIDDLE" HEIGHT="30">합  계</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">944,179 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">504,665 </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(302,209)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(197,570)</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">949,065 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK=" B">(3) 생산설비의 투자계획</P>
<P>당사가 개발 중인 장기지속형 주사제의 임상시료 및 상업용 제품 생산은 국내외의 CMO(Contract Manufacturing Organization:위탁 전문 생산기관)을 통해 생산을 추진중에 있습니다. CMO site에서 당사 제품의 생산을 위해 IVL-DrugFluidic® 기술 기반의 생산 장비 및 설비에 대한 투자가 필요합니다. 남성형탈모치료제의 CMO인 위더스제약 공장에 설치될 장비는 제작이 진행 중입니다. 또한 IVL-GeneFluidic®플랫폼 기반의 유전자치료제 CDMO 사업의 경우 연구개발을 진행 중이며 구체적인 투자의 규모나 계획은 향후 사업의 파트너링에 따라 변동될 가능성이 있습니다.</P>
<P USERMARK=" B">(4) 제품별 생산 체계</P>
<P></P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="193" ALIGN="CENTER" HSPACE="0">22. ivl2001 (출시명 듀라하트 sr-3주사액(목시덱틴) 제조공정도).jpg</IMG>
<IMG-CAPTION ATOC="N">[IVL2001 출시명: 듀라하트 SR-3주사액(목시덱틴) 제조공정도]</IMG-CAPTION>
</IMAGE>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-4-L1">4. 매출 및 수주상황</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 매출실적</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="491">

<COLGROUP>
<COL WIDTH="482"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="491" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 백만원, 천유로)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="493">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="80" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">매출유형</TH>
<TH ROWSPAN="2" WIDTH="74" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">국/내외</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">2020연도</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">2021연도</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">2022연도</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30"> (제06기)</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30"> (제07기)</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30"> (제08기)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113">기술이전 </TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">수 출</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">132(€100)</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">119(€88)</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,439(€1,082)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">400</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,500</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,200</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소 계</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">532</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,619</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,639</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">판권매출</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수 출</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">150</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소 계</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">150</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">제품매출</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수 출</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">92</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">55</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소 계</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">92</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">55</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">용역매출</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수 출</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">소 계</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113">합     계</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">수 출</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">132(€100)</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">119(€88)</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,439(€1,082)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내 수</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">400</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,742</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,285</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">532</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,861</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,724</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B">나. 매출원가</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="616"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="625" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(단위: 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="625" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="62"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="83">
<P>매출유형</P>
</TH>

<TH ROWSPAN="2" WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="83">
<P>품  목</P>
</TH>

<TH COLSPAN="2" WIDTH="144" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>2020연도(제06기)</P>
</TH>

<TH COLSPAN="2" WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>2021연도(제07기)</P>
</TH>

<TH COLSPAN="2" WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>2022연도(제08기)</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>금 액</P>
</TH>

<TH WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>원가율</P>
</TH>

<TH WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>금 액</P>
</TH>

<TH WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>원가율</P>
</TH>

<TH WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>금 액</P>
</TH>

<TH WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>원가율</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품매출</P>
</TD>

<TD WIDTH="119" VALIGN="MIDDLE" HEIGHT="30">
<P>듀라하트 SR-3</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>235</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>254%</P>
</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">      401</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">733%</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">주1) 듀라하트 SR-3는 2021년 9월부터 생산하여 생산초기단계의 특성상 원가율이 다소 높습니다.</P>
<P USERMARK="F-GL11">주2) 기술이전 및 판권매출은 매출원가에 기재하지 않았습니다.  </P>
<P USERMARK=" B">다. 판매전략  </P>

<P>
<SPAN USERMARK=" B">(1) 판매조직</SPAN>당사는 영업을 위한 판매조직을 별도로 갖추고 있지 않습니다. 당사가 개발한 파이프라인 의약품의 최종 제품은 라이선스 계약을 체결한 국내외 파트너사에서 마케팅 및 판매를 담당하게 됩니다.당사는 파이프라인의 라이선스 아웃을 위한 사업개발(Business Development) 조직을 별도로 운영하고 있으며, 다년간의 제약바이오 산업에서 국내외 라이선스 계약의 경험을 기반으로 전문성과 네트워크를 보유한 전문인력들로 구성이 되어있습니다. 
<SPAN USERMARK=" B">(2) 판매전략</SPAN>
</P>
<P>당사는 각 파이프라인의 사업성을 극대화하기 위해 시장 특수성과 고객의 니즈를 기반으로 1) 파이프라인 License Out, 2) Joint Development(공동개발 및 사업화), 3) CDMO Business 등 사업모델별로 다음의 표와 같은 판매 전략을 수립하여 개별 사업에 반영/실행하고 있습니다. </P>

<TABLE BORDER="1" ACLASS="NORMAL" AFIXTABLE="N" WIDTH="607">

<COLGROUP>
<COL WIDTH="164"></COL>
<COL WIDTH="425"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="173" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>사업모델 </P>
</TD>

<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="434" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>판매전략 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="173" HEIGHT="122">파이프라인License Out</TD>

<TD VALIGN="MIDDLE" WIDTH="434" HEIGHT="122">
<P>1. 국내외 파트너링 미팅 통한 잠재 파트너 발굴 </P>
<P>2. 국내 제약사와의 네트워크 활용 - 국내 시장 진출 및 L/O 후 국내 파트너사의 해외 제약사 네트워크 활용 </P>
<P>3. 해외 소재 Consulting firm 과의 사업제휴 통한 지속적인 해외 파트너 발굴 및 당사 파이프라인 홍보 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="173" HEIGHT="99">
<P>Joint Development(공동개발 및 사업화)</P>
</TD>

<TD VALIGN="MIDDLE" WIDTH="434" HEIGHT="99">
<P>1.  국내외 유수의 학회에 당사 기술에 대한 연구 논문 발간 통한 전문가 수준의 홍보 </P>
<P>2. 신약 개발 벤처 및 제약사와의 네트워크 활용 </P>
<P>3. 국내외 파트너링 미팅 통한 공동 개발 파트너 발굴 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="173" HEIGHT="214">
<P>CDMO business </P>
</TD>

<TD VALIGN="MIDDLE" WIDTH="434" HEIGHT="214">
<P>1. 국내외 제약회사의 제품 및 기술을 정밀 분석하여, 당사의 기술을 활용한 CDMO Business 공동사업화(당사의 Microsphere 혹은 LNP 제조장비를 CMO 파트너사의 GMP 공장에 설치 후 고객사들의 위탁 생산 의뢰를 수주하고 당사와 CMO 파트너사간에 이익을 공유하는 사업모델)에 적합한 잠재 후보군 선택과 집중 통해 발굴 및 사업화 제안 </P>
<P>2. 국내외 유수의 학회에 당사 보유 기술에 대한 연구 논문 발간하여 당사 기술에 대한 전문가 수준의 홍보 활동 진행 </P>
<P>3. 국내외 파트너링 미팅 통한 제제 및 생산 수요처 발굴 </P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK=" B">라. 수주현황</P>
<P></P>
<P>당사의 주된 영업활동은 의약품, 동물의약품, 의료기기의 연구개발업이며, 수주 산업이 아니므로 해당사항이 없습니다.</P>

<P></P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-5-L1">5. 위험관리 및 파생거래</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 시장위험</SPAN>
</P>
<P>당사는 금리위험, 가격위험, 환위험 등 다양한 시장위험에 노출되어 있습니다. 당사는 이러한 위험요소들을 관리하기 위하여 각각의 위험요인에 대해 면밀하게 모니터링하고 대응하는 위험관리 정책을 운용하고 있습니다. 이에 대한 자세한 사항은 III. 재무에 관한 사항 - 5. 재무제표 주석』 을 참고해주시기 바랍니다.</P>
<P></P>
<P USERMARK=" B">나. 파생상품 거래현황</P>
<P> </P>
<P>현재 해당사항이 없습니다.</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-6-L1">6. 주요계약 및 연구개발활동</TITLE>
<P></P>
<P USERMARK=" B">가. 경영상의 주요계약 등</P>

<P>
<SPAN USERMARK=" B">(1) License Out(기술이전) 계약</SPAN>
</P>
<P> </P>
<P>현재 당사가 체결한 License Out(기술이전) 계약 현황은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="623">

<COLGROUP>
<COL WIDTH="614"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="623" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" B">[국내외 제약 및 바이오회사와의 계약 체결 실적]</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="623" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(기준일: 2022.12. 31 기준)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="624">

<COLGROUP>
<COL WIDTH="30"></COL>
<COL WIDTH="147"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="165"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="39" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">구분</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="156" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>품목</P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="133" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>계약</P>
<P>상대방</P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="122" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>계약</P>
<P>체결일</P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="174" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>총 계약 금액주1)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="39" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">1</TD>

<TD WIDTH="156" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<P>남성형 탈모치료제 IVL3001(1개월) </P>
<P>IVL3002(3개월)</P>
</TD>

<TD WIDTH="133" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>㈜대웅제약</P>
</TD>

<TD WIDTH="122" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>'20.09.25</P>
</TD>
<TD WIDTH="174" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">3,200 백만원로열티 별도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>위더스제약㈜</P>
</TD>

<TD WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>'21.09.01</P>
</TD>
<TD WIDTH="174" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">로열티</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="39" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2</TD>
<TD WIDTH="156" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">치매치료제IVL3003(1개월)</TD>
<TD WIDTH="133" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">㈜종근당</TD>
<TD WIDTH="122" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">'22.10.14</TD>
<TD WIDTH="174" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">8,000 백만원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="39" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">3</TD>

<TD WIDTH="156" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>전립선비대증 치료제 IVL3013(3개월)</P>
</TD>

<TD WIDTH="133" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>위더스제약㈜</P>
</TD>

<TD WIDTH="122" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>'21.11.30</P>
</TD>
<TD WIDTH="174" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">5,000 백만원로열티 별도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="39" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">4</TD>

<TD WIDTH="156" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>심장사상충예방 </P>
<P>IVL2001(3개월),</P>
<P>IVL2002(6개월)</P>
</TD>

<TD WIDTH="133" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>㈜노터스</P>
</TD>

<TD WIDTH="122" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>'21.01.29</P>
</TD>
<TD WIDTH="174" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">300 백만원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="39" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">5</TD>

<TD WIDTH="156" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">
<P>동물용 의약품 주2)</P>
<P>IVL2002</P>
<P>IVL2004</P>
<P>IVL2009</P>
</TD>

<TD WIDTH="133" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Virbac S.A.</P>
</TD>

<TD WIDTH="122" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">
<P>'22.07.26</P>
</TD>
<TD WIDTH="174" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">12,923 백만원(EUR 9,810,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="39" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">6</TD>

<TD WIDTH="156" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>화학적 거세제 IVL2005(12개월), IVL2006(3개월)</P>
</TD>

<TD WIDTH="133" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Virbac S.A.</P>
</TD>

<TD WIDTH="122" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>'20.11.24</P>
</TD>
<TD WIDTH="174" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2,358 백만원(EUR 1,760,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="39" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">7</TD>

<TD WIDTH="156" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>동물용 치매치료제</P>
<P>IVL2007(1개월), IVL2008(3개월)</P>
</TD>

<TD WIDTH="133" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>㈜노터스</P>
</TD>

<TD WIDTH="122" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>'22.02.15</P>
</TD>
<TD WIDTH="174" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">3,000 백만원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="450" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="174" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">34,781 백만원</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="629">

<COLGROUP>
<COL WIDTH="44"></COL>
<COL WIDTH="567"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" HEIGHT="30">
<P>주1)</P>
</TD>
<TD WIDTH="576" HEIGHT="30">외화 계약 금액은 각 계약체결일의 서울외국환중개 유로 환율로 계산하였습니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="53">주2) </TD>
<TD WIDTH="576" HEIGHT="53">파트너사와의 요청으로 해당 파이프라인의 적응증 및 약효지속기간을 비공개하였습니다.</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">(가) 남성형 탈모치료제 IVL3001, IVL3002 주요 계약 내용</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="510"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="108" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구 분</P>
</TH>

<TH WIDTH="519" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주요 내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>계약상대방</P>
</TD>

<TD WIDTH="519" HEIGHT="30" VALIGN="MIDDLE">
<P>㈜대웅제약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>계약종류</P>
</TD>

<TD WIDTH="519" HEIGHT="30" VALIGN="MIDDLE">
<P>License Out</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대상지역</P>
</TD>

<TD WIDTH="519" HEIGHT="30" VALIGN="MIDDLE">
<P>전세계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>계약기간</P>
</TD>

<TD WIDTH="519" HEIGHT="53" VALIGN="MIDDLE">
<P>계약체결일 : 2020년 9월 25일 계약종료일 : 제품 허가 후 10년 (2년씩 자동 연장)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>총 계약금</P>
</TD>
<TD WIDTH="519" HEIGHT="30" VALIGN="MIDDLE">3,200백만원 (각 1,600백만원), 로열티 별도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">수취금액</TD>
<TD WIDTH="519" HEIGHT="30" VALIGN="MIDDLE">600백만원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">계약조건</TD>
<TD WIDTH="519" HEIGHT="76" VALIGN="MIDDLE">마일스톤(기술료) : 각 개발 단계에 따라 차등 수령로열티 : 순매출액의 두자리수% 수령Sublicense 시 기술료 수령금액 양사 합의 후 배분</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">회계처리방법</TD>
<TD WIDTH="519" HEIGHT="53" VALIGN="MIDDLE">반환의무 없는 계약금은 금액수령시 수익인식하며, 마일스톤은 수행 의무가 완료되는 시점에 수익으로 인식</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대상기술</TD>
<TD WIDTH="519" HEIGHT="30" VALIGN="MIDDLE">IVL-DrugFluidic®</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B"></P>
<P USERMARK=" B">(나) 남성형 탈모치료제 IVL3001, IVL3002 관련 CMO 사업 제휴 계약 </P>

<TABLE BORDER="1" WIDTH="625" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="508"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구 분</P>
</TH>

<TH WIDTH="517" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>주요 내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계약상대방</P>
</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">
<P>위더스제약㈜</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계약종류</P>
</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">
<P>CMO 사업제휴 계약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>대상지역</P>
</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">
<P>대한민국 및 의약품실사상호협력기구 가입국</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">계약기간</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="53">
<P>계약체결일 : 2021년 09월 01일 계약종료일 : KGMP 인증 후 10년(2년씩 자동 연장)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">총 계약금</TD>
<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">없음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수취금액</TD>
<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">없음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">계약조건</TD>
<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="53">장기지속형 주사제 전용 GMP 공장 설립에 대한 위더스 제약의 자체 투자로열티 : 본 공장에서 생산 후 출하되는 제품 출하가 대비 두자리수 % 수령</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회계처리방법</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">반환의무 없는 계약금은 금액수령시 수익인식하며, 마일스톤은 수행 의무가 완료되는 시점에 수익으로 인식</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대상기술</TD>
<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">IVL-DrugFluidic®</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B">(다) 치매 치료제 IVL3003 주요 계약 내용</P>

<TABLE BORDER="1" WIDTH="627" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="510"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구 분</P>
</TH>

<TH WIDTH="519" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>주요 내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계약상대방</P>
</TD>

<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">
<P>㈜종근당</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계약종류</P>
</TD>
<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">License Out</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>대상지역</P>
</TD>
<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">대한민국 및 단순수출국가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>계약기간</P>
</TD>

<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="53">
<P>계약체결일 : 2022년 10월 14일계약종료일 : 품목허가일로부터 10년(2년씩 자동 연장)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>총 계약금</P>
</TD>
<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">8,000백만원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수취금액</TD>

<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" 0XFF1200">
<SPAN USERMARK=" 0X000000">1,000백만원</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">계약조건</TD>
<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="53">마일스톤(기술료) : 각 개발 단계에 따라 차등 지급글로벌 독점권에 대한 우선협상권</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회계처리방법</TD>

<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">반환의무 없는 계약금은 금액수령시 수익인식하며, 마일스톤은 수행 의무가 완료되는 시점에 수익으로 인식</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대상기술</TD>
<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">IVL-DrugFluidic®</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B">(라) 전립선 비대증 치료제 IVL3013 주요 계약 내용</P>

<TABLE BORDER="1" WIDTH="627" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="510"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구 분</P>
</TH>

<TH WIDTH="519" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>주요 내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계약상대방</P>
</TD>

<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">
<P>위더스제약㈜</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계약종류</P>
</TD>

<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">
<P>독점적 License Out</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>대상지역</P>
</TD>

<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">
<P>전세계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>계약기간</P>
</TD>

<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="53">
<P>계약체결일 : 2021년 11월 30일 계약종료일 : 품목허가일로부터 10년(2년씩 자동 연장)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>총 계약금</P>
</TD>
<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">5,000백만원, 로열티 별도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수취금액</TD>
<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">1,500백만원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">계약조건</TD>
<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="76">마일스톤(기술료) : 각 개발 단계에 따라 차등 지급로열티 : 순매출액의 두자리수% 수령Sublicense 시 기술료 수령금액 양사 합의 후 배분</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회계처리방법</TD>

<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">반환의무 없는 계약금은 금액수령시 수익인식하며, 마일스톤은 수행 의무가 완료되는 시점에 수익으로 인식</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대상기술</TD>
<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">IVL-DrugFluidic®</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B"></P>

<P>
<SPAN USERMARK=" B">(마) 심장사상충 예방 3/6개월 주사제 IVL2001, IVL2002 주요 계약 내용</SPAN>
</P>

<TABLE BORDER="1" WIDTH="625" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="508"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구 분</P>
</TH>

<TH WIDTH="517" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>주요 내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계약상대방</P>
</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">
<P>㈜노터스</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계약종류</P>
</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">
<P>독점 판매 및 사업 제휴</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>대상지역</P>
</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">
<P>한국</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>계약기간</P>
</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="53">
<P>계약체결일 : 2021년 1월 29일계약종료일 : 제품 출시일로부터 3년(2년씩 자동 연장)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>총 계약금</P>
</TD>
<TD WIDTH="517" HEIGHT="30">300백만원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수취금액</TD>
<TD WIDTH="517" HEIGHT="30">150백만원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">계약조건</TD>
<TD WIDTH="517" HEIGHT="30">의무 구매 수량 및 판매량에 연동되어 차등 적용되는 제품 공급가 명시</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회계처리방법</TD>

<TD WIDTH="517" HEIGHT="53" USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">반환의무 없는 계약금은 금액수령시 수익인식하며, 마일스톤은 수행 의무가 완료되는 시점에 수익으로 인식</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대상기술</TD>
<TD WIDTH="517" HEIGHT="30">IVL-DrugFluidic®</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B">(바) 동물의약품 IVL2002, IVL2004 및 IVL2009 주요 계약 내용 </P>
<P USERMARK=" B">1) IVL2002</P>

<TABLE BORDER="1" WIDTH="626" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="509"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구 분</P>
</TH>

<TH WIDTH="518" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>주요 내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계약상대방</P>
</TD>

<TD WIDTH="518" VALIGN="MIDDLE" HEIGHT="30">
<P>Virbac S.A (프랑스)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계약종류</P>
</TD>
<TD WIDTH="518" VALIGN="MIDDLE" HEIGHT="30">License Out</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>대상지역</P>
</TD>

<TD WIDTH="518" VALIGN="MIDDLE" HEIGHT="30">
<P>전세계(한국 제외)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>계약기간</P>
</TD>

<TD WIDTH="518" VALIGN="MIDDLE" HEIGHT="53">
<P>계약체결일 : 2022년 7월 26일계약종료일 : 제품출시일로부터 10년 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>총 계약금</P>
</TD>
<TD WIDTH="518" VALIGN="MIDDLE" HEIGHT="30">3,755백만원 (EUR 2,850,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수취금액</TD>
<TD WIDTH="518" VALIGN="MIDDLE" HEIGHT="30">398백만원 (EUR 300,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">계약조건</TD>
<TD WIDTH="518" VALIGN="MIDDLE" HEIGHT="53">마일스톤(기술료) : 개발 단계별 차등 수령로열티 : Virbac 순매출액 대비 한자리수 % 수령 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회계처리방법</TD>

<TD WIDTH="518" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">반환의무 없는 계약금은 금액수령시 수익인식하며, 마일스톤은 수행 의무가 완료되는 시점에 수익으로 인식</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대상기술</TD>
<TD WIDTH="518" VALIGN="MIDDLE" HEIGHT="30">IVL-DrugFluidic®</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="629">

<COLGROUP>
<COL WIDTH="44"></COL>
<COL WIDTH="567"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" HEIGHT="30">
<P>주1)</P>
</TD>
<TD WIDTH="576" HEIGHT="30">외화 계약 금액은 각 계약체결일의 서울외국환중개 유로 환율로 계산하였습니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30">주2) </TD>
<TD WIDTH="576" HEIGHT="30">수취 금액은 당사가 인식한 매출액(인보이스 발행일)을 기준으로 작성하였습니다.</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK=" B">2) IVL2004</P>

<TABLE BORDER="1" WIDTH="627" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="510"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구 분</P>
</TH>

<TH WIDTH="519" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>주요 내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계약상대방</P>
</TD>

<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">
<P>Virbac S.A (프랑스)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계약종류</P>
</TD>
<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">License Out</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>대상지역</P>
</TD>

<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">
<P>전세계(한국 제외)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>계약기간</P>
</TD>

<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="53">
<P>계약체결일 : 2022년 7월 26일계약종료일 : 제품출시일로부터 10년 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>총 계약금</P>
</TD>
<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">4,216백만원 (EUR 3,200,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수취금액</TD>
<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">398백만원 (EUR 300,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">계약조건</TD>
<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="53">마일스톤(기술료) : 개발 단계별 차등 수령로열티 : Virbac 순매출액 대비 한자리수 % 수령 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회계처리방법</TD>
<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="53">반환의무 없는 계약금은 금액수령시 수익인식하며, 마일스톤은 수행 의무가 완료되는 시점에 수익으로 인식</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대상기술</TD>
<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">IVL-DrugFluidic®</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="629">

<COLGROUP>
<COL WIDTH="44"></COL>
<COL WIDTH="567"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" HEIGHT="30">
<P>주1)</P>
</TD>
<TD WIDTH="576" HEIGHT="30">외화 계약 금액은 각 계약체결일의 서울외국환중개 유로 환율로 계산하였습니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30">주2) </TD>
<TD WIDTH="576" HEIGHT="30">수취 금액은 당사가 인식한 매출액(인보이스 발행일)을 기준으로 작성하였습니다.</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B">3) IVL2009</P>

<TABLE BORDER="1" WIDTH="627" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="510"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구 분</P>
</TH>

<TH WIDTH="519" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>주요 내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계약상대방</P>
</TD>

<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">
<P>Virbac S.A (프랑스)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계약종류</P>
</TD>
<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">License Out</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>대상지역</P>
</TD>

<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">
<P>전세계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>계약기간</P>
</TD>

<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="53">
<P>계약체결일:  2022년 7월 26일 </P>
<P>계약종료일: 제품 출시일로부터 10년</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>총 계약금</P>
</TD>

<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" 0X0000FF">
<P>4,953백만원 (EUR 3,760,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수취금액</TD>

<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">
<P>531백만원 (EUR 400,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">계약조건</TD>
<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="53">마일스톤(기술료) : 개발 단계별 차등 수령로열티 : Virbac 순매출액 대비 한자리수 % 수령 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회계처리방법</TD>

<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">반환의무 없는 계약금은 금액수령시 수익인식하며, 마일스톤은 수행 의무가 완료되는 시점에 수익으로 인식</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대상기술</TD>
<TD WIDTH="519" VALIGN="MIDDLE" HEIGHT="30">IVL-DrugFluidic®</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="629">

<COLGROUP>
<COL WIDTH="44"></COL>
<COL WIDTH="567"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" HEIGHT="30">
<P>주1)</P>
</TD>
<TD WIDTH="576" HEIGHT="30">외화 계약 금액은 각 계약체결일의 서울외국환중개 유로 환율로 계산하였습니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30">주2) </TD>
<TD WIDTH="576" HEIGHT="30">수취 금액은 당사가 인식한 매출액(인보이스 발행일)을 기준으로 작성하였습니다.</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">(사) 화학적 거세제 IVL2005, IVL2006 주요 계약 내용</SPAN>
</P>

<TABLE BORDER="1" WIDTH="625" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="508"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구 분</P>
</TH>

<TH WIDTH="517" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>주요 내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계약상대방</P>
</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">
<P>Virbac S.A (프랑스)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계약종류</P>
</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">
<P>License Out</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>대상지역</P>
</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">
<P>전세계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>계약기간</P>
</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="53">
<P>계약체결일:  2020년 11월 24일 </P>
<P>계약종료일: 제품 출시일로부터 10년</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>총 계약금</P>
</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">
<P>2,358백만원 (EUR 1,760,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수취금액</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">
<P>349백만원 (EUR 260,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">계약조건</TD>
<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="53">마일스톤(기술료) : 개발 단계별 차등 수령로열티 : Virbac 순매출액 대비 한자리수 % 수령 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회계처리방법</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">반환의무 없는 계약금은 금액수령시 수익인식하며, 마일스톤은 수행 의무가 완료되는 시점에 수익으로 인식</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대상기술</TD>
<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">IVL-DrugFluidic®</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="629">

<COLGROUP>
<COL WIDTH="44"></COL>
<COL WIDTH="567"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="53" HEIGHT="30">
<P>주1)</P>
</TD>
<TD WIDTH="576" HEIGHT="30">외화 계약 금액은 각 계약체결일의 서울외국환중개 유로 환율로 계산하였습니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="53" HEIGHT="30">주2) </TD>
<TD WIDTH="576" HEIGHT="30">수취 금액은 당사가 인식한 매출액(인보이스 발행일)을 기준으로 작성하였습니다.</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B">(아) 동물 치매치료제 IVL2007, IVL2008 주요 계약 내용</P>

<TABLE BORDER="1" WIDTH="625" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="508"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구 분</P>
</TH>

<TH WIDTH="517" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>주요 내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계약상대방</P>
</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">
<P>㈜노터스</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계약종류</P>
</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">
<P>독점적 License Out</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>대상지역</P>
</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">
<P>한국 및 아시아 국가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>계약기간</P>
</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="53">
<P>계약체결일:  2022년 2월 15일 </P>
<P>계약종료일: 품목허가일로부터 10년 (2년씩 자동연장)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>총 계약금</P>
</TD>
<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">3,000백만원, 로열티 별도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수취금액</TD>
<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">1,000백만원 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">계약조건</TD>
<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="53">마일스톤(기술료) : 개발 단계별 차등 수령로열티 : Virbac 순매출액 대비 두자리수 % 수령  </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회계처리방법</TD>

<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" 0X0000FF">
<SPAN USERMARK=" 0X000000">반환의무 없는 계약금은 금액수령시 수익인식하며, 마일스톤은 수행 의무가 완료되는 시점에 수익으로 인식</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대상기술</TD>
<TD WIDTH="517" VALIGN="MIDDLE" HEIGHT="30">IVL-DrugFluidic®</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">(2) Joint Development(공동개발 및 사업화) 계약 </SPAN>Joint Development 프로그램은 제제연구 초기 단계로, 향후 본격적인 사업화가 진행되어 라이선스 아웃 계약이 체결되는 시점에 공시할 예정입니다.
</P>
<P USERMARK=" B">(3) 주요 연구 계약 (정부연구과제)</P>
<P>당사는 2022년말 현재 4건의 정부연구과제를 수행하고 있습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="713" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="183"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="254"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약상대방</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="192" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약기간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">총 사업비(백만원)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="263" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과제명</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">보건복지부</TD>
<TD WIDTH="192" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">2020.07.22 ~ 2023.12.31</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="76">2,816</TD>
<TD WIDTH="263" HEIGHT="76">제어 최적화된 제조기술을 이용한 오피오이드 및 알코올 의존성 치료용 장기지속형 주사제 개발</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">질병관리청 </TD>
<TD WIDTH="192" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">2022.05.17 ~ 2023.12.31</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="53">800</TD>
<TD WIDTH="263" HEIGHT="53">지질나노입자 기반 mRNA 백신 완제 생산 공정 및 scale-up 연구</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">한국보건산업진흥원</TD>
<TD WIDTH="192" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">2022.07.11 ~ 2022.12.31</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="53">111</TD>
<TD WIDTH="263" HEIGHT="53">mRNA를 포함하는 LNP 대량생산 장비의 성능 및 제조된 LNP의 품질 시험</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">산업통상자원부</TD>
<TD WIDTH="192" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">2022.08.01 ~ 2025.12.31</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="76">5,819</TD>
<TD WIDTH="263" HEIGHT="76">mRNA 백신의 제형화와 대량생산을 위한 GMP 생산 장비 설계 및 공정 기술 개발</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK=" B">나. 연구개발 활동</P>
<P USERMARK=" B">(1) 연구개발 조직  (가) 연구개발 조직 개요</P>
<P>당사의 연구조직은 IVL Value-Up Center(IVC), IVL Formulation Center(IFC), IVL Platform Center(IPC) 로 구성되어 있습니다. IVC는 인허가, 임상전략, 특허관리, 마케팅 전략 수립 등의 업무를 수행하며, IFC는 제제연구소로서 파이프라인별 제제연구와 그 분석방법 개발을 연구합니다. 그리고 IPC는 일반적인 제약사에는 유례를 찾아볼 수 없는 공정개발을 담당하는 조직으로서, CTO 가 총괄하며 당사의 IVL-DrugFluidic® 과 IVL-GeneFluidic®의 제조 공정 기술 및 기술 구현에 필요한 장비까지 전부 내재화 하였습니다. </P>
<P> </P>
<P USERMARK=" B">(나) 연구소 및 연구개발 조직도</P>
<P> </P>
<P>당사의 연구소는 파이프라인별 Formulation과 분석방법을 연구하는 제제연구소인 IVL Formulation Center(IFC) 와 Platform 공정 기술을 연구, 개발하는 공정개발연구소인 IVL Platform Center(IPC)를 두고 연구개발을 해왔습니다. 또한 IVL Value-Up Center(IVC)는 임상전략 및 전략을 유기적으로 수립하고, 다양한 개발 단계에서 License Out 계약을 진행하고 있습니다.</P>

<TABLE BORDER="0" WIDTH="630" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="621"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="630" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 【 연구소 현황 】</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>

<TABLE BORDER="1" WIDTH="675" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="178"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="227"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="187" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>연구소 명칭</P>
</TH>

<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>부서명</P>
</TH>

<TH WIDTH="236" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>위치</P>
</TH>

<TH WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="187" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>IVL Formulation Center(IFC)</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제제연구소</P>
</TD>

<TD WIDTH="236" VALIGN="MIDDLE" HEIGHT="53">
<P>경기도 성남시 중원구 양현로405번길 12, 티엘아이빌딩 6층</P>
</TD>

<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>기업부설연구소</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="187" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>IVL Platform Center(IPC)</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>공정개발연구소</P>
</TD>

<TD WIDTH="236" VALIGN="MIDDLE" HEIGHT="53">
<P>경기도 성남시 중원구 양현로405번길 4-3 9층, 10층 </P>
</TD>

<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>IPC 기업부설연구소</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P>상세한 연구개발 조직의 구성도 및 업무 내용은 다음과 같습니다. </P>

<TABLE BORDER="0" WIDTH="602" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="593"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="602" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>【 ㈜인벤티지랩 연구개발 조직 현황 】</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>

<IMAGE>
<IMG WIDTH="474" HEIGHT="335" ALIGN="CENTER" HSPACE="0">(주)인벤티지랩 연구개발 조직도.jpg</IMG>
<IMG-CAPTION ATOC="N">(주)인벤티지랩 연구개발 조직도</IMG-CAPTION>
</IMAGE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="598">

<COLGROUP>
<COL WIDTH="589"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="598" HEIGHT="30">
<P>출처: 당사 내부자료</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>        
<SPAN USERMARK="F-GL11">          【 ㈜인벤티지랩 연구개발 부문 단위 조직별 역할 및 인원 】</SPAN>
</P>

<TABLE BORDER="1" WIDTH="717" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="174"></COL>
<COL WIDTH="423"></COL>
<COL WIDTH="93"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>조직명</P>
</TH>

<TH WIDTH="432" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>주요 업무 내역</P>
</TH>

<TH WIDTH="102" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>현 인원(명)</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="183" VALIGN="MIDDLE" HEIGHT="76" ALIGN="CENTER">
<P>IFC </P>
<P>(IVL Formulation Center)</P>
</TD>

<TD WIDTH="432" HEIGHT="76">
<P> - 파이프라인별 제제연구 - 공동연구 수행 - 제제의 시험 방법 분석법 개발 및 평가</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>20명</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="183" HEIGHT="122" VALIGN="MIDDLE" ALIGN="CENTER">
<P>IPC</P>
<P>(IVL Platform Center)</P>
</TD>

<TD WIDTH="432" HEIGHT="122">
<P> - Microfluidics 기반 platform 기술 연구 및 공정 최적화 및 생산성 연구 - Scale-up 연구 및 생산본부 기술이전 - 생산장비의 설계 및 제작 - LNP formulation 연구, LNP production process 개발</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>14명</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="183" HEIGHT="122" VALIGN="MIDDLE" ALIGN="CENTER">
<P>IVC </P>
<P>(IVL Value-Up Center)</P>
</TD>

<TD WIDTH="432" HEIGHT="122">
<P> - 품목별 시장동향 파악 및 마케팅 전략 수립, License Out 계약 체결 - 신제품 연구 등 연구 전략 수립 - 개발제품의 임상허가진행, 품목허가 진행, 규제당국 대응 - 임상 전략 수립 등</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P> 9명</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="615" HEIGHT="30" COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER">합      계</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">43명</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>

<TABLE BORDER="0" WIDTH="631" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="622"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="631" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>【 ㈜인벤티지랩 연구개발 인력 현황 】</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="719">

<COLGROUP>
<COL WIDTH="140"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="149" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>조직</P>
</TH>

<TH WIDTH="570" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>인원(명)</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>박사</P>
</TH>

<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>석사</P>
</TH>

<TH WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>기타</P>
</TH>

<TH WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>합계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="149" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>IFC</P>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">19</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">20</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="149" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>IPC</P>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">5</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">5</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">14</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="149" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>IVC</P>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">9</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합   계</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">7</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">30</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">43</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P USERMARK=" B">(다) 핵심 연구인력</P>
<P> </P>
<P>당사의 핵심 연구인력은 전사적으로 R&D를 총괄하고 있는 김주희 대표이사, IVC의 이마세 부사장(CSO), IPC의 전찬희 전무(CTO), IFC의 류충호 전무 등이 있습니다.</P>

<TABLE BORDER="0" WIDTH="726" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="717"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="726" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>【 핵심연구개발 인력 현황 】</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="721" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="358"></COL>
<COL WIDTH="105"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>직위</P>
</TH>

<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>성명</P>
</TH>

<TH WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>담당업무</P>
</TH>

<TH WIDTH="367" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주요 경력</P>
</TH>

<TH WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주요 연구실적</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="191">
<P>대표이사</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="191">
<P>김주희</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="191">
<P>R&D 총괄</P>
</TD>

<TD WIDTH="367" VALIGN="MIDDLE" HEIGHT="191">
<P>-경북대학교 생화학 박사</P>
<P>-광동제약 연구소 연구원 </P>
<P>-한양대학교 의생명연구소 연구원</P>
<P>-씨젠 학술부 </P>
<P>-한국슈넬제약 인허가 연구원</P>
<P>-휴버트바이오 임상분석</P>
<P>-비씨월드제약 인허가 수석연구원</P>
<P>-㈜인벤티지랩 대표이사 (현재)</P>
</TD>

<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="191">
<P>논문 11건 등록특허 26건</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="237">
<P>부사장</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="237">
<P>이마세</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="237">
<P>CSO</P>
</TD>

<TD WIDTH="367" VALIGN="MIDDLE" HEIGHT="237">
<P>-일본 큐슈대학교 약학 박사</P>
<P>-일본 큐슈대학 약학부 조교수</P>
<P>-Virginia Commonwealth Univ. 의약화학 연구원 </P>
<P>-메디프렉스 신약개발 디렉터 </P>
<P>-건일제약 R&D 본부장 </P>
<P>-현대약품 중앙연구원 부사장 </P>
<P>-JW중외제약 CMC 연구센터장 </P>
<P>-동화약품 연구소장 </P>
<P>-유틸렉스 CTO</P>
<P>-(주)인벤티지랩 IVL Value-Up Center 본부장(현재)</P>
</TD>

<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="237">
<P>논문 24건등록특허 9건</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>전무</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>전찬희</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>CTO/</P>
<P>IPC본부장</P>
</TD>

<TD WIDTH="367" VALIGN="MIDDLE" HEIGHT="168">
<P>-Univ. of Tennessee 공학박사 </P>
<P>-대우자동차 기술연구소 연구원 </P>
<P>-Microfluidics&LOC Lab Vanderbilt Univ 연구원</P>
<P>-U of Waterloo(Canada) 연구소 책임연구원 </P>
<P>-㈜인포피아 연구소 부소장</P>
<P>-㈜세종메디칼 진단연구소 연구소장 </P>
<P>-(주)인벤티지랩 IVL Platform Center 본부장 (현재)</P>
</TD>

<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="168">
<P>논문 19건등록특허 9건</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="122" VALIGN="MIDDLE">
<P>전무</P>
</TD>

<TD WIDTH="63" ALIGN="CENTER" HEIGHT="122" VALIGN="MIDDLE">
<P>류충호</P>
</TD>

<TD WIDTH="99" ALIGN="CENTER" HEIGHT="122" VALIGN="MIDDLE">
<P>IFC연구소장</P>
</TD>

<TD WIDTH="367" VALIGN="MIDDLE" HEIGHT="122">
<P>-중앙대학교 제약산업학 석사 졸업</P>
<P>-삼아제약 제제연구 차장대우</P>
<P>-비씨월드제약 제제연구 실장 </P>
<P>-㈜인벤티지랩 연구소장, IVL Manufacturing Center(생산) 본부장 (현재)</P>
</TD>

<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="122">
<P>논문 4건등록특허 8건</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B">(2) 연구개발비용</P>
<P>당사의 최근 3년간 연구개발비용은 다음과 같습니다.</P>
<P> </P>

<TABLE BORDER="0" WIDTH="642" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="336"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="4" WIDTH="642" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>【 연구개발비용 현황 (별도재무제표 기준) 】</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="BOTTOM" HEIGHT="30"></TD>
<TD WIDTH="137" VALIGN="BOTTOM" HEIGHT="30"></TD>
<TD WIDTH="81" VALIGN="BOTTOM" HEIGHT="30"></TD>

<TD WIDTH="345" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">
<P>(단위: 천원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="642" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" WIDTH="264" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2022년</P>
<P>(제8기)</P>
</TH>

<TH WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2021년 </P>
<P>(제7기)</P>
</TH>

<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2020년</P>
<P>(제6기)</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="8" WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="240">
<P>비용의성격별분류</P>
</TD>

<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>원재료비</P>
</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>인건비</P>
</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,129,480</TD>

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>3,262,481</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>2,058,468</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>감가상각비</P>
</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,914,138</TD>

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,350,364</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>708,387</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위탁용역비</P>
</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　3,302,406</TD>

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>2,781,482</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>723,945</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타</P>
</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,611,521</TD>

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,401,220</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>763,263</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>연구개발비용 합계</P>
</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,957,545</TD>

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>8,795,547</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>4,254,063</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>(정부보조금) 주1)</P>
</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>보조금 차감 후 금액</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0X0000FF B">
<SPAN USERMARK=" 0X000000 !B">10,957,545</SPAN>
</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,795,547</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,254,063</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">
<P>회계처리내역</P>
</TD>

<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>판매비와 관리비</P>
</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,957,545</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,795,547</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,254,063</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제조경비</P>
</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>개발비(무형자산)</P>
</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>회계처리금액 계</P>
</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,957,545</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,795,547</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,254,063</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="264" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>연구개발비 / 매출액 비율[연구개발비용계÷당기매출액×100]</P>
</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">294.3%</TD>

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>472.4%</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>800.0%</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="645" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="40"></COL>
<COL WIDTH="587"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" VALIGN="MIDDLE" HEIGHT="53">주1)</TD>

<TD WIDTH="596" VALIGN="MIDDLE" HEIGHT="53">
<P>연구개발비용 정부보조금은 2022년 992,275천원, 2021년 571,746천원, 2020년 313,865천원이며 연구개발비용에서 차감되었습니다.</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">(3) 연구개발 실적  (가) 연구개발 진행 현황</SPAN> 당사가 연구개발 진행 중인 개량신약 및 신약의 현황은 다음과 같습니다. 
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="873">

<COLGROUP>
<COL WIDTH="864"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="873" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">[연구개발 진행 현황 총괄표]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="873">

<COLGROUP>
<COL WIDTH="43"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="211"></COL>
<COL WIDTH="223"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="107" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>종류</P>
</TH>

<TH WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>파이프라인</P>
</TH>

<TH WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>적응증</P>
</TH>

<TH WIDTH="220" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>개발 단계</P>
</TH>

<TH WIDTH="232" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>세부 내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="52" HEIGHT="503" ROWSPAN="16" ALIGN="CENTER" VALIGN="MIDDLE">
<P>개량신약</P>
</TD>

<TD WIDTH="55" HEIGHT="240" ROWSPAN="8" ALIGN="CENTER" VALIGN="MIDDLE">
<P>인</P>
<P>의</P>
<P>약</P>
<P>품</P>
</TD>

<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>IVL3001(1개월)</P>
</TD>

<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>남성형 탈모</P>
</TD>

<TD WIDTH="220" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>임상 1/2상 완료(호주)</P>
</TD>

<TD WIDTH="232" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<P>㈜대웅제약 L/O</P>
<P>위더스제약㈜ CMO 사업 제휴</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">IVL3002(3개월)</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">남성형 탈모</TD>
<TD WIDTH="220" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">비임상완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>IVL3003(1개월)</P>
</TD>

<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>치매</P>
</TD>

<TD WIDTH="220" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>임상 1/2상 IND 승인(호주)</P>
</TD>

<TD WIDTH="232" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>㈜종근당 L/O </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>IVL3004(1개월)</P>
</TD>

<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>약물중독 </P>
</TD>
<TD WIDTH="220" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">임상 1상 IND 승인(호주)</TD>

<TD WIDTH="232" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">IVL3005(1개월)</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">당뇨병</TD>

<TD WIDTH="220" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>제제연구 완료</P>
</TD>
<TD WIDTH="232" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>IVL3008(3개월)</P>
</TD>

<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>전립선암 </P>
</TD>

<TD WIDTH="220" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>제제연구 완료</P>
</TD>

<TD WIDTH="232" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">IVL3016(6개월)</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">전립선암 </TD>
<TD WIDTH="220" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">제제연구 완료</TD>
<TD WIDTH="232" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>IVL3013(3개월)</P>
</TD>

<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>전립선 비대증 </P>
</TD>

<TD WIDTH="220" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>제제연구 완료</P>
</TD>

<TD WIDTH="232" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>위더스제약㈜ L/O</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="55" HEIGHT="263" ROWSPAN="8" ALIGN="CENTER" VALIGN="MIDDLE">
<P>동</P>
<P>물</P>
<P>의</P>
<P>약</P>
<P>품</P>
</TD>

<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>IVL2001(3개월)</P>
</TD>

<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>심장사상충 예방</P>
</TD>

<TD WIDTH="220" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>국내 출시</P>
</TD>

<TD WIDTH="232" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>국내 독점권 (㈜노터스 )</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>IVL2002(6개월)</P>
</TD>
<TD WIDTH="168" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">심장사상충 예방</TD>
<TD WIDTH="220" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">국내 허가 준비 중</TD>

<TD WIDTH="232" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>국내 독점 판권 (노터스)</P>
<P>전세계 독점권 (Virbac S.A.)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>IVL2004 주)</P>
</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">동물용의약품 주1)</TD>
<TD WIDTH="220" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">제제연구 진행 </TD>
<TD WIDTH="232" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">전세계 독점권 (Virbac S.A.)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>IVL2009 주1)</P>
</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">동물용의약품 주1)</TD>
<TD WIDTH="220" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">제제연구 진행 </TD>
<TD WIDTH="232" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">전세계 독점권 (Virbac S.A.)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>IVL2005(12개월)</P>
</TD>

<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>화학적 거세제</P>
</TD>

<TD WIDTH="220" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>제제연구 완료</P>
</TD>
<TD WIDTH="232" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">전세계 독점권 (Virbac S.A.)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">IVL2006(3개월)</TD>

<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>화학적 거세제</P>
</TD>

<TD WIDTH="220" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>제제연구 완료</P>
</TD>
<TD WIDTH="232" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">전세계 독점권 (Virbac S.A.)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>IVL2007(1개월)</P>
</TD>

<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>동물용 치매치료</P>
</TD>
<TD WIDTH="220" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">제제연구 완료</TD>
<TD WIDTH="232" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">국내 독점권 (㈜노터스 )</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">IVL2008(3개월)</TD>

<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>동물용 치매치료</P>
</TD>
<TD WIDTH="220" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">제제연구 진행</TD>
<TD WIDTH="232" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">국내 독점권 (㈜노터스 )</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="107" HEIGHT="83" COLSPAN="2" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<P>DrugRe-Discovery </P>
<P>신약 </P>
</TD>

<TD WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>IVL4001</P>
</TD>

<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>류마티스 관절염</P>
</TD>
<TD WIDTH="220" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">비임상 완료</TD>

<TD WIDTH="232" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>IVL4002</P>
</TD>

<TD WIDTH="168" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>다발성 </P>
<P>경화증</P>
</TD>

<TD WIDTH="220" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>비임상 완료</P>
<P>개발단계 희귀의약품 지정 완료</P>
</TD>

<TD WIDTH="232" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="107" HEIGHT="235" COLSPAN="2" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">
<P>공동개발 및 사업화 신약Joint</P>
<P>Development주2)</P>
</TD>

<TD WIDTH="146" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>IVL5003</P>
</TD>

<TD WIDTH="168" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>알츠하이머</P>
</TD>

<TD WIDTH="220" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>제제연구 진행</P>
</TD>

<TD WIDTH="232" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>㈜프레이저테라퓨틱스 </P>
<P>공동개발 및 사업화 계약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>IVL5004</P>
</TD>

<TD WIDTH="168" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Autophagy 치매</P>
</TD>

<TD WIDTH="220" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>제제연구 진행</P>
</TD>

<TD WIDTH="232" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>㈜라이조테크</P>
<P>공동개발 및 사업화 계약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">IVL5005</TD>
<TD WIDTH="168" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">염증성질환</TD>
<TD WIDTH="220" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">제제연구 진행</TD>
<TD WIDTH="232" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">㈜유한건강생활공동개발 및 사업화 계약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>IVL6001</P>
</TD>

<TD WIDTH="168" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>유방암 및 두경부암치료제PROTACs</P>
</TD>

<TD WIDTH="220" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>제제연구 진행</P>
</TD>

<TD WIDTH="232" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>㈜이노큐어테라퓨틱스</P>
<P>공동개발 및 사업화 계약</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="872">

<COLGROUP>
<COL WIDTH="40"></COL>
<COL WIDTH="814"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="31" VALIGN="MIDDLE">주1)</TD>
<TD WIDTH="823" HEIGHT="31" VALIGN="MIDDLE">파트너사의 요청으로 적응증 및 약효지속기간을 비공개하였습니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="49" HEIGHT="53" VALIGN="MIDDLE">주2)</TD>
<TD WIDTH="823" HEIGHT="53" VALIGN="MIDDLE">파트너사가 제공하는 신약물질을 당사의 플랫폼 DDS 기술에 탑재 한 후 파트너사는 효력/임상 연구에 집중하고 당사는 제제 및 공정 연구에 집중하는 협업 연구 모델</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">(나) 연구개발 진행 현황 및 향후계획1) IVL3001, IVL3002</SPAN>
</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="460"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>적응증</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>남성형 탈모</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>작용기전</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>테스토스테론이 dihydrotestosterone(이하 ‘DHT’)으로 전환되는데 작용하는 5-α-reductase를 저해함으로써 강력한 남성호르몬인 DHT의 생성을 억제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>제품의특성</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="53">
<P>현재까지 경구제로만 개발된 피나스테라이드의 최초 장기지속형 제형으로, 기존 경구제품의 단점(복약 순응도, 부작용)을 극복</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>진행경과</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="53">
<P>IVL3001: 임상 1/2상 완료 (호주)IVL3002: 비임상완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>추진계획</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>기술이전 상대방인 ㈜대웅제약에서 임상 3상 시험 진행</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>경쟁제품</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>Pfizer, Lilly : JAK 저해제 기반 원형 탈모 치료제</P>
<P>올릭스, JW : 신규 modality(모달리티) 기반 남성형 탈모치료제</P>
<P>종근당, 보령 : 기허가 약물 기반 개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145" USERMARK=" BC0XD7D7D7">
<P>관련논문 등</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="145">
<P>‘Development of finasteride polymer microspheres for systemic application in androgenic alopecia’, International Journal of Molecular Medicine, 2019 June; 43(6): 2409-2419,</P>
<P>‘Pharmacokinetic-pharmacodynamic modeling approach for dose prediction of the optimal long-acting injectable formulation of finasteride’, International Journal Pharmaceutics, 2021 May 15;601:120527</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>시장규모</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>전세계 탈모 시장 규모: 8조원(2020), 년 평균 8% 성장 예상</P>
<P>남성형 탈모와 원형 탈모가 시장의 2/3 이상 차지</P>
<P>전체 탈모 환자의 10%만 치료제 복용 중 (높은 성장 잠재력)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>기타사항</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>기술이전 계약 체결[2020.09 ㈜대웅제약, 2021.09 위더스제약㈜]</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P USERMARK=" B">2) IVL3003  </P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="460"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>적응증</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>치매</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>작용기전</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>도네페질은 아세틸콜린을 분해하여 콜린으로 만드는 효소인 아세틸콜린 에스터레이즈를 저해하여 아세틸콜린 농도를 높임으로써 치료 효과를 가짐 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>제품의특성</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>도네페질 성분의 장기지속형 주사 제형으로, 기존 경구/경피흡수형 치매치료제의 단점(낮은 복약 순응도, 낮은 피부 투과율, 피부 부작용 등) 극복 가능</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>진행경과</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>임상 1/2상 IND 승인 (호주)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>추진계획</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>임상 1/2상 진행(호주)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" USERMARK=" BC0XD7D7D7">
<P>경쟁제품</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="99">
<P>Biogen : Aduhelm 조건부 허가</P>
<P>Roche : crenezumab 3상 실패</P>
<P>장기지속형 주사제 개발사 : 지투지바이오, 동국제약, 대웅제약</P>
<P>패취제 개발사 : 셀트리온/아이큐어, 보령제약/라파스</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>관련논문 등</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>‘Long-acting Injectable Donepezil Microspheres: Formulation Development and Evaluation’, Journal of Controlled Release, Volume 340, 10 December 2021, Pages 72-86</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>시장규모</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>전세계 치매 치료제 시장 규모 : 8.5조원(2021, GlobeNewswire)</P>
<P>2014년~2020년까지 연평균 성장률 13%</P>
<P>전세계 도네페질 치료제 시장 규모 : 1.9조원(2019, IQVIA)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>기타사항</P>
</TD>
<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">License Out 계약 체결[2022.10.㈜종근당]</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P USERMARK=" B">3) IVL3004  </P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="460"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>적응증</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>약물중독</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>작용기전</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="53">
<P>날트렉손을 주성분으로 하여, 오피오이드 수용체를 차단함으로써 알코올 의존성 치료 및 외인성 아편류의 중독을 치료함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>제품의특성</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>이미 출시된 날트렉손 장기지속형 주사제인 Vivitrol보다 개선된 제형적 특성(초기 과방출 없음, 0차 방출패턴 구현)으로 부작용 및 약효 개선</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>진행경과</P>
</TD>
<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">임상 1상 IND 승인(호주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>추진계획</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>임상 1상 진행</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>경쟁제품</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="53">
<P>Indivior: Sublocade (부프레노르핀 장기지속형 주사제) </P>
<P>Alkermes : Vivitrol (날트렉손 장기지속형 주사제)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>관련논문 등</P>
</TD>
<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>시장규모</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>전세계 마약중독증 치료제 시장 규모 : $1.8bil (2017)</P>
<P>2017년~2027년까지 연평균 성장률 : 10.3% (Globaldata)</P>
<P>Vivitrol 매출액 : $408mil (IQVIA)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>기타사항</P>
</TD>
<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P USERMARK=" B">4) IVL3008, IVL3016  </P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="460"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>적응증</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>전립선암 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>작용기전</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="53">
<P>전립선암 환자에게 류프로렐린은 테스토스테론의 혈중 농도를 낮춰주어 전립선암의 성장을 막음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>제품의특성</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>이미 출시된 류프로렐린 장기지속형 주사제 제품들(Lupron, Eligard 등)  보다 개선된 제형적 특성(초기 과방출 없음, 0차 방출패턴 구현)으로 부작용 및 약효 개선</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>진행경과</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>제제연구 완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>추진계획</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>임상 1상 IND 준비</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" USERMARK=" BC0XD7D7D7">
<P>경쟁제품</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="99">
<P>Takeda: 각 국가별 Lupron 현지 파트너 선정 통한 매출유지</P>
<P>대웅제약: 루피어데포(Lupron 제네릭) 마케팅 집중, 3개월 제제 임상 준비</P>
<P>한올바이오파마: 엘리가드 국내 독점 판매</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" USERMARK=" BC0XD7D7D7">
<P>관련논문 등</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="99">
<P>‘New long-acting injectable microspheres prepared by IVL-DrugFluidic® system: 1-month and 3-month in vivo drug delivery of leuprolide’, International Journal of Pharmaceutics, Volume 622, 25 June 2022, 121875</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>시장규모</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>전세계 전립선암 치료제 시장 규모 : $9.3bil (Global data)</P>
<P>전세계 ADT(남성호르몬박탈요법제) 시장 규모 : $2.3bil(IQVIA)</P>
<P>전세계 Lupron 매출:  $905mil (2019, IQVIA)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>기타사항</P>
</TD>
<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P USERMARK=" B">5) IVL3013</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="460"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>적응증</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>전립선 비대증</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>작용기전</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>테스토스테론을 dihydrotestosterone (DHT)으로 전환시키는 효소인 5-α-reductase를 강력하게 억제하여 혈중 DHT 수치를 낮추는 androgen 호르몬 억제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>제품의특성</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>현재까지 경구제로만 개발된 두타스테라이드의 최초 장기지속형 제형으로, 경구제 대비 낮은 용량으로 기존 경구제품의 단점(복약 순응도, 부작용)을 극복</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>진행경과</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>제제연구 완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>추진계획</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>임상 1상 IND 준비</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>경쟁제품</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="53">
<P>한미약품 : 한미탐스 등 α 차단제 제네릭 시장 성장</P>
<P>GSK : 아보다트 등 기존의 전통적 경구형 5 α-reductase 억제제 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>관련논문 등</P>
</TD>
<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>시장규모</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>전세계 전립선비대증 치료제 시장 규모 : $1.08bil (Globalinformation) (2021)</P>
<P>2021년~2026년까지 연평균 성장률 : 5.3% (Globalinformation)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>기타사항</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>독점적 라이선스 아웃 계약 체결[2021.11 위더스제약㈜]</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P USERMARK=" B">6) IVL4001</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="460"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>Re-Discovery 신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>적응증</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>류마티스 관절염</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>작용기전</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>자가면역질환 중 많은 경우의 발병과 악화의 원인이 되며 염증반응 및 급성, 만성 질병을 유발하는 TLR4를 차단함으로써 류마티스 관절염을 치료함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>제품의특성</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>기존 제품들과 차별화되는 염증조절기전을 통해 단일투여 혹은 기존 제품과의 복합 투여가 가능하며, 오랜 시간 널리 쓰이고 있는 성분의 재발견으로 안전성이 입증되어 있음. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>진행경과</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>비임상 완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>추진계획</P>
</TD>
<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">임상 1/2상 IND 준비</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" USERMARK=" BC0XD7D7D7">
<P>경쟁제품</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="99">
<P>GSK : Otilimab (과립구/대식세포 콜로니 형성 촉진인자 억제)</P>
<P>Galapagos NV : Filgotinib maleate (선택적 JAK1 억제제)</P>
<P>R-pharm : Olokizumab (IL-6 수용체 억제제)</P>
<P>Taisho pharma : Ozoralizumab (TNF-α 혹은 TNF 억제제)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>관련논문 등</P>
</TD>
<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>시장규모</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>전세계 류마티스관절염 치료제 시장 규모 : $26.2bil (Globaldata) (2019)</P>
<P>2019~2029년까지 연평균 성장률 : 7.6% (Globaldata)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>기타사항</P>
</TD>
<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P USERMARK=" B">7) IVL4002</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="460"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>Re-Discovery 신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>적응증</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>다발성 경화증</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>작용기전</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>다발성경화증의 발병이나 악화를 일으키며, 전신홍반 루푸스, 전신경화증, 쇼그렌 증후군, 근염 및 염증성 장질환을 일으키는 TLR4를 차단함으로써 다발성 경화증을 치료함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>제품의특성</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>기존 제품들과 차별화되는 염증조절기전을 통해 단일투여 혹은 기존 제품과의 복합 투여가 가능하며, 오랜 시간 널리 쓰이고 있는 성분의 재발견으로 안전성이 입증되어 있음.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>진행경과</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>비임상 완료 및 개발단계 희귀의약품 지정 완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>추진계획</P>
</TD>
<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">임상 2상 IND 준비</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>경쟁제품</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>Teva : Copaxone (면역억제 T세포 생성자극, 면역조절)</P>
<P>Eisai : Tysabri (면역세포의 뇌내 염증부위 이동 억제)</P>
<P>Biogen : Tecfidera (Nrf2 pathway자극하여 항염증 효과)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>관련논문 등</P>
</TD>
<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>시장규모</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="53">
<P>전세계 다발성 경화증 치료제 시장 규모 : $20bil (Globaldata) (2018)</P>
<P>2018~2028년까지 연평균 성장률 : 5.2% (Globaldata)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>기타사항</P>
</TD>
<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P USERMARK=" B">8) IVL2001, IVL2002</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="460"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>동물의약품</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>적응증</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>심장사상충 예방</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>작용기전</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>기생충의 글루탐산 염화물 이온통로(Glutamate-gated Chloride Channel)에 선택적으로 결합하여 염소이온의 유입량을 증가시키고 신경 과흥분을 이용해 내·외부 기생충을 사멸함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>제품의특성</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>이미 출시된 목시덱틴 장기지속형 주사제인 Proheart보다 개선된 제형적 특성(초기 과방출 없음, 0차 방출패턴 구현)으로 부작용 및 약효 개선</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>진행경과</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="53">
<P>IVL2001(국내 출시), IVL2002(국내 허가 준비 중), IVL2004(제제연구 진행), IVL2009(제제연구 진행)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>추진계획</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="53">
<P>IVL2002(국내 허가 진행), IVL2004(제제연구 완료), IVL2009(제제연구 완료)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>경쟁제품</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>Zoetis : Proheart SR (목시덱틴 장기지속형 주사제)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>관련논문 등</P>
</TD>
<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>시장규모</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="53">
<P>전세계 심장사상충 치료제 시장 규모 : $11bil (Credit Suisse) (2018)</P>
<P>2018~2028년까지 연평균 성장률 : 3.9% (Credit Suisse)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>기타사항</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="53">
<P>독점판매 및 사업제휴 계약 체결[2021.01 ㈜노터스[U3] ]</P>
<P>L/O 체결[2022.07. Virbac S.A.]</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P> 
<SPAN USERMARK=" B">9) IVL2004, IVL2009 </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="600">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="460"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XD7D7D7" WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>구분</P>
</TD>

<TD WIDTH="469" HEIGHT="30" VALIGN="MIDDLE">
<P>동물의약품</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XD7D7D7" WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>적응증</P>
</TD>
<TD WIDTH="469" HEIGHT="30" VALIGN="MIDDLE">비공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XD7D7D7" WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>작용기전</P>
</TD>
<TD WIDTH="469" HEIGHT="30" VALIGN="MIDDLE">비공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XD7D7D7" WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>제품의특성</P>
</TD>
<TD WIDTH="469" HEIGHT="30" VALIGN="MIDDLE">비공개</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XD7D7D7" WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>진행경과</P>
</TD>

<TD WIDTH="469" HEIGHT="30" VALIGN="MIDDLE">
<P>IVL2004(제제연구 진행), IVL2009(제제연구 진행)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XD7D7D7" WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>추진계획</P>
</TD>

<TD WIDTH="469" HEIGHT="30" VALIGN="MIDDLE">
<P>IVL2004(제제연구 완료), IVL2009(제제연구 완료)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XD7D7D7" WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>경쟁제품</P>
</TD>
<TD WIDTH="469" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XD7D7D7" WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>관련논문 등</P>
</TD>
<TD WIDTH="469" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XD7D7D7" WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>시장규모</P>
</TD>
<TD WIDTH="469" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XD7D7D7" WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>기타사항</P>
</TD>

<TD WIDTH="469" HEIGHT="30" VALIGN="MIDDLE">
<P>L/O 체결[2022.07. Virbac S.A.]</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">10) IVL2005, IVL2006  </SPAN>
</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="460"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>동물의약품</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>적응증</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>동물용 화학적 거세제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>작용기전</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="53">
<P>합성 gonadrophin-releasing hormone(GnRH) 유사체로, 저용량 지속 투여 시 pituitary-gonadal axis의 기능을 억제하여 거세효과 발휘함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>제품의특성</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">
<P>이미 출시된 데스로렐린 장기지속형 주사제인 Suprelorin보다 개선된 제형적 특성(초기 과방출 없음, 0차 방출패턴 구현)으로 부작용 및 약효 개선</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>진행경과</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>제제연구 완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>추진계획</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>비공개(Virbac S.A.측 요청)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>경쟁제품</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>Suprelorin (데스로렐린 장기지속형 주사제)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>관련논문 등</P>
</TD>
<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>시장규모</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>N/A (독점 개발사인 Virbac S.A.측 요청으로 비공개)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>기타사항</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>독점 제품 보유한 Virbac S.A.와 공동개발 계약 체결 [2020.11]</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P USERMARK=" B">11) IVL2007, IVL2008 </P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="460"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>동물의약품</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>적응증</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>동물용 치매 치료제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>작용기전</P>
</TD>
<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="76">도네페질은 아세틸콜린을 분해하여 콜린으로 만드는 효소인 아세틸콜린 에스터레이즈를 저해하여 아세틸콜린 농도를 높임으로써 치료 효과를 가짐</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>제품의특성</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="53">
<P>동물의 치매 치료를 위해 off-label로 처방되는 사람용 경구 도네페질을 대신하여, 동물 치매 치료에 적합한 장기지속형 주사제 제형</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>진행경과</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>IVL2007(제제연구 완료), IVL2008(제제연구 진행)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>추진계획</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>제제연구 완료 후 License Out 파트너 탐색</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>경쟁제품</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>Anipryl (Selegiline 정제)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>관련논문 등</P>
</TD>
<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>시장규모</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30">
<P>N/A </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>기타사항</P>
</TD>

<TD WIDTH="469" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P> -</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P USERMARK=" B">12) 공동개발 및 사업화 신약: Joint Development </P>

<TABLE BORDER="1" WIDTH="638" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="189"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="236"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품목</P>
<P>(타겟)</P>
</TH>

<TH WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>적응증</P>
</TH>

<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>진행단계</P>
</TH>

<TH WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="212">
<P>신약</P>
</TD>

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>IVL5003</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>알츠하이머 치료제</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제제연구진행</P>
</TD>

<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="53">
<P>공동개발 및 사업화 계약</P>
<P>[2022.05, ㈜프레이저테라퓨틱스]</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>IVL5004</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Autophagy</P>
<P>치매치료제</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제제연구진행</P>
</TD>

<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="53">
<P>공동개발 및 사업화 계약[2022.09, ㈜라이조테크]</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">IVL5005</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">염증성질환 치료제</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">제제연구진행</TD>
<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="53">공동연구 및 사업화계약[2022.10, ㈜유한건강생활</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>IVL6001</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>유방암 및 두경부암 치료제(PROTACs)</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제제연구진행</P>
</TD>

<TD WIDTH="245" VALIGN="MIDDLE" HEIGHT="53">
<P>공동개발 및 사업화 계약 [2022.09, ㈜이노큐어테라퓨틱스]</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>당사는 현재 파트너사가 제공하는 신약물질을 당사의 플랫폼 DDS 기술에 탑재 한 후 파트너사는 효력/임상 연구에 집중하고 당사는 제제 및 공정 연구에 집중하는 협업 연구 모델인 Joint Development(공동개발 및 사업화) 프로그램을 운영중입니다.본 프로그램을 통해서 개발된 파이프라인은 파트너사와 공동으로 IP를 보유하게 되며, 향후 License Out시 기술료 및 로열티 등 파이프라인으로 발생되는 수익을 계약에서 정한 비율로 나누어 배분하게 됩니다.  </P>

<P>
<SPAN USERMARK=" B">(다) 연구개발 완료 실적</SPAN>당사는 현재 IVL2001의 개발을 완료하여 듀랴하트 SR-3(목시덱틴) 제품으로 출시(2021년 9월 출시)하였습니다.
</P>
<P></P>

<P>
<SPAN USERMARK=" B">(라) 국책 과제 실적</SPAN>현재 당사의 국책 과제 실적은 다음과 같습니다.
</P>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="31"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="250"></COL>
<COL WIDTH="128"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="40" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>  </P>
</TD>

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>정부 지원 사업명</P>
</TD>

<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>과제명</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>지원부처</P>
<P>(기관)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="40" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>1</P>
</TD>

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>'15 창업맞춤형사업화 지원사업</P>
</TD>

<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>안면성형용 조직수복용 재료개발 및 </P>
<P>시장진입을 위한 사업모델 개발과 </P>
<P>인허가 전략 개발</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>중소기업청</P>
<P>(창업진흥원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="40" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>2</P>
</TD>

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>'15 투자연계형 기업성장 R&D 지원사업</P>
</TD>

<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>미세유체기술(microfluidics)을 이용한 안면성형용 입자 및 중합체 필러(particle & polymer filler, PPFM) 제조 기술 개발</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>미래창조과학부</P>
<P>(KOITA)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="40" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>3</P>
</TD>

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>'16 기술사업화 도움닫기 플랫폼 사업화 개발과제</P>
</TD>

<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>신규 제조기술 기반 </P>
<P>장기지속형 의료용 미소구체 제품 개발</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>산업통상자원부</P>
<P>(KIAT)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="40" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>4</P>
</TD>

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>‘17 구매조건부 </P>
<P>신제품 개발사업 </P>
<P>(구매조건부 R&D 과제)</P>
</TD>

<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>조직수복용 복합 기능성 </P>
<P>파티클 필러 개발</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>중소기업청</P>
<P>(중소벤처기업부)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="40" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>5</P>
</TD>

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>‘2018 사업화연계 </P>
<P>기술개발 사업</P>
<P>(범부처연계형)</P>
</TD>

<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>microfluidics 기반 남성 탈모 치료용 </P>
<P>1개월 이상 장기지속형 주사제 개발</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>산업통상자원부</P>
<P>(KIAT)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="40" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>6</P>
</TD>

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>창업도약 패키지 지원 사업(기술창업</P>
<P>스카우터)</P>
</TD>

<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>의료용 미소구체 제품 개발을 위한 </P>
<P>시스템 고도화</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>중소기업청</P>
<P>(창업진흥원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="40" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>7</P>
</TD>

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>창업도약 패키지 지원 사업(제품개선 </P>
<P>프로그램)</P>
</TD>

<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>안면성형용 필러 제품 개선</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>중소기업청</P>
<P>(창업진흥원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="40" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>8</P>
</TD>

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>2019년도 제약산업글로벌 컨설팅 지원사업</P>
</TD>

<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>장기지속형 남성 탈모치료 주사제 </P>
<P>美 임상진행을 위한 IND 신청</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>보건복지부</P>
<P>(한국보건산업진흥원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="40" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>9</P>
</TD>

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>2020년 하반기 IP-R&D</P>
<P>전략지원 사업 시행</P>
<P>(세부사업: 지재권</P>
<P>연계 연구개발</P>
<P>전략지원 사업)</P>
</TD>

<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>장기 지속형 오피오이드 의존성 치료 주사제의 미국시장 진출을 위한 전략적 특허 분석 및 R&D 개발전략 수립</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>특허청</P>
<P>(한국특허전략개발원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="40" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>10</P>
</TD>

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>2020년 바이오헬스 </P>
<P>투자인프라 연계형 R&D</P>
</TD>

<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>제어 체적화된 제조기술을 이용한 </P>
<P>오피오이드(opioid) 및 알코올 의존성</P>
<P>치료용 장기지속형 주사제 개발</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>보건복지부</P>
<P>(한국보건산업진흥원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="40" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>11</P>
</TD>

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>2021년 IP-R&D 후속 지원 특허 컨설팅(권리화 전략</P>
<P>세부사업: 지재권 연계 연구개발 전략지원 사업</P>
</TD>

<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>장기 지속형 오피오이드 의존성 치료 주사제의 미국시장 진출을 위한 전략적 특허 분석 및 R&D 개발전략 수립</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>특허청</P>
<P>(한국특허전략개발원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="40" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>12</P>
</TD>

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>2021년 정부 R&D </P>
<P>특허설계 지원사업</P>
</TD>

<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>정부주도형 mRNA 백신-LNP</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>특허청</P>
<P>(한국특허전략개발원),</P>
<P>질병관리청</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="40" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>13</P>
</TD>

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>2022년도 질병관리청 국립보건연구원 학술연구용역</P>
</TD>

<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>지질나노입자 기반 mRNA 백신 완제 생산 공정 및 scale-up 연구</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>질병관리청</P>
<P>(국립보건연구원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="40" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>14</P>
</TD>

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>국산 백신(바이오의약품)·원부자재, 장비 성능시험 지원</P>
</TD>

<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>mRNA를 포함하는 LNP 대량생산 장비의 성능 및 제조된 LNP의 품질 시험</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>한국보건산업진흥원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="40" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>15</P>
</TD>

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>2022년도 백신원부자재생산고도화기술개발사업</P>
</TD>

<TD WIDTH="259" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>mRNA 백신의 제형화와 대량생산을 위한 GMP 생산 장비 설계 및 공정 기술 개발</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>산업통상자원부(한국산업기술평가관리원)</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B"></P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-7-L1">7. 기타 참고사항</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 지적재산권 현황</SPAN>
</P>

<P>제출일 현재 당사는 IVL-DrugFluidic® 플랫폼 특허 및 IVL-GeneFluidic® 플랫폼 특허를 바탕으로 하여, 전략적으로 파이프라인별 특허를 출원, 등록 및 관리하고 있습니다. 당사는 연구개발 초기부터 플랫폼 기술 특허와 개별 파이프라인 특허로 나누어 각 특허별로 전문성을 갖춘 특허법인과 함께 IP 분석을 통한 R&D 방향 수립, 핵심특허 대응, 주요 특허를 도출하는 전략을 추구하고 있습니다.  현재 당사가 보유하고 있는 특허의 출원 및 등록 요약 현황은 다음과 같습니다.                  
<SPAN USERMARK="F-GL11">                                【 지적재산권 현황 요약 】</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="704" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="319"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="73"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" WIDTH="456" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">
<P>구분</P>
</TH>

<TH WIDTH="83" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">
<P>등록</P>
</TH>

<TH WIDTH="83" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">
<P>출원</P>
</TH>

<TH WIDTH="82" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">
<P>소계</P>
</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="456" HEIGHT="30">
<P>IVL-DrugFluidic® 플랫폼 특허</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30">26</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30">30</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30">56</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="456" HEIGHT="30">
<P>IVL-GeneFluidic® 플랫폼 특허</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30">9</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30">10</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="9" VALIGN="MIDDLE" WIDTH="128" HEIGHT="477">파이프라인 특허</TD>

<TD WIDTH="328" HEIGHT="53">
<P>[IVL3001, IVL3002]</P>
<P>남성형 탈모치료제 1개월/3개월</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53">5</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53">9</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="53">14</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="328" HEIGHT="53">
<P>[IVL3003]</P>
<P>치매치료제 1개월</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53">3</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="53">4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="328" HEIGHT="53">
<P>[IVL3013]</P>
<P>전립선 비대증 치료제 3개월</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53">2</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53">3</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="53">5</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="328" HEIGHT="53">
<P>[IVL3008, IVL3016]</P>
<P>전립선암 치료제 3개월/6개월</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53">3</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="53">4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="328" HEIGHT="53">
<P>[IVL4001, IVL4002]</P>
<P>류마티스 관절염 치료제, 다발성경화증 치료제</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53">0</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53">3</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="53">3</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="328" HEIGHT="53">
<P>[IVL2005, IVL2006]</P>
<P>화학적 거세제 3개월/12개월</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53">18</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="53">19</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="328" HEIGHT="53">
<P>[IVL2001, IVL2002, IVL2004] 심장사상충 예방 및 치료제 3개월/6개월/12개월</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53">4</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53">6</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="53">10</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="328" HEIGHT="53">
<P>[IVL3004]</P>
<P>약물중독 치료제 1개월</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53">0</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53">6</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="53">6</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="328" HEIGHT="53">
<P>[IVL1002]</P>
<P>의료기기 (조직수복용재료 )</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53">3</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="53">4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="456" HEIGHT="30">
<P>기타(제법 및 장치) 특허</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30">5</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30">14</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30">19</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="456" HEIGHT="30">
<P>상표</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30">12</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30">0</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30">12</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="456" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>합계</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30">61</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30">105</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30">166</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">주1) 해외출원 및 등록 포함</P>
<P></P>
<P>본 보고서 제출일 기준 당사 보유 모든 지적재산권의 권리자는 ㈜인벤티지랩에 있습니다. </P>
<P></P>

<P>
<SPAN USERMARK=" B">나. 산업의 특성 및 성장성</SPAN>
</P>
<P USERMARK=" B">(1) Microsphere 기반 장기지속형 주사제</P>
<P USERMARK=" B">(가) Microsphere 기반 LAI란?</P>
<P>Microsphere를 기반으로 한 장기지속형 주사제는 생분해성 고분자 내에 API를 담지하여 주사후 적정한 양의 약물을 효율적으로 방출하도록 구현한 주사제형입니다.  Microsphere 기반 장기지속형 주사제를 피하/근육 조직에 주사할 경우 입자를 구성하는 고분자가 투여부위에서 서서히 분해되며, 그 과정에서 그림과 같이 지속적으로 약물이 방출됩니다.</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="229" ALIGN="CENTER" HSPACE="0">1. microsphere 기반 장기지속형 주사제 기술 개념(p.11).jpg</IMG>
<IMG-CAPTION ATOC="N">[Microsphere 기반 장기지속형 주사제 기술 개념]</IMG-CAPTION>
</IMAGE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="598">

<COLGROUP>
<COL WIDTH="589"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="598" HEIGHT="30">
<P>출처: Frontiers in Bioscience 10, 643-655, January 1, 2005  의 그림을 재구성함</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>이러한 기술을 적용할 경우의 장점으로는, 약효의 지속적 유지 가능, 펩타이드, 단백질, 항체 등 불안정하거나 반감기가 짧은 약물의 안정적 전달, 부작용 최소화 및 환자의 복약순응도의 현저한 개선, 약효 및 부작용에 대한 높은 예측성, 만성 질환에 광범위하게 적용 가능한 점을 들 수 있습니다. </P>
<P></P>
<P USERMARK=" B">(나) 시장의 규모 및 성장 잠재력</P>
<P USERMARK=" B"></P>
<P>장기지속형 주사제의 시장 규모는 정확한 자료가 없으나 장기지속형 주사제 시장 규모가 지속적으로 성장할 것이라고 전망하는 이유는 다음과 같습니다. 먼저, 장기지속형 주사제는 경구 투여가 어려운 난용성 신약 물질을 체내에 전달하는 데에 있어 여러 제형 중 가장 적합한 제형입니다. 이에 따라 장기지속형 주사제는 신약물질의 가치를 증대시키는데에 활용될 수 있으며, 기존 약물의 line extension에 있어서도 좋은 선택지로 활용될 수 있다는 장점을 지닙니다.</P>
<P>장기지속형 주사제 제제기술에 대한 시장의 선호도는 최근 글로벌 제약사의 장기지속형 주사제에 대한 지속적인 투자를 통해서도 확인할 수 있습니다. 글로벌 제약사는 내부 연구개발뿐 아니라 기술이전을 통해서도 장기지속형 주사제에 대한 투자를 계속하고 있으며 그 규모는 지속적으로 증가하고 있습니다. 최근 5년간 공개된 기술이전 사례는 약 21 건이며, 2000년 이후 금액이 공개된 기술이전 사례들이 대형 딜 규모로 라이선스 계약이 체결되는 사례를 확인할 수 있어 장기지속형 주사제에 대한 높은 시장성을 반영한다고 볼 수 있습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="824">

<COLGROUP>
<COL WIDTH="815"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="824" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">[장기지속형 주사제 주요 기술이전 사례]</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="824" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: USD mil)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="818" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="41"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="169"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="206"></COL>
<COL WIDTH="154"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>Year</P>
</TD>

<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>Licensee</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>Licensor</P>
</TD>

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>Deal Value</P>
</TD>

<TD WIDTH="215" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>Product/Item</P>
</TD>
<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">적응증</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2021</P>
</TD>

<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>Intas Pharmaceuticals</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>Foresee Pharmaceuticals</P>
</TD>

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>207</P>
</TD>
<TD WIDTH="215" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">FP-001 (leuprorelin depot 3M/6M)</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">전립선암, 성조숙증</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2020</P>
</TD>

<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>GeneScience Pharmaceuticals</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>Foresee Pharmaceuticals</P>
</TD>

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>132</P>
</TD>
<TD WIDTH="215" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">FP-001 (leuprorelin depot 3M/6M)</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">전립선암, 성조숙증</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019</P>
</TD>

<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>Accord Healthcare</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>Foresee Pharmaceuticals</P>
</TD>

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>86</P>
</TD>
<TD WIDTH="215" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">FP-001 (leuprorelin depot 3M/6M)</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">전립선암, 성조숙증</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2019</P>
</TD>

<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>DURECT</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>Gilead Sciences</P>
</TD>

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>320</P>
</TD>
<TD WIDTH="215" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">Long-acting injectable for HIV</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">HIV</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2016</P>
</TD>

<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>Ocular Therapeutix</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>Regeneron Pharmaceuticals</P>
</TD>

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>305</P>
</TD>
<TD WIDTH="215" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">Sustained release formulation of Aflibercept</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">황반변성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2014</P>
</TD>

<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>Braeburn</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>Camurus</P>
</TD>

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>161</P>
</TD>
<TD WIDTH="215" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">Buprenorphine injection products (CAM2038), 1W/1M</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">약물중독증, 통증</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2013</P>
</TD>

<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>Camurus</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>Novartis</P>
</TD>

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>710</P>
</TD>
<TD WIDTH="215" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">Octreotide product (CAM2029)</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">말단비대증, 신경내분비종양</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2011</P>
</TD>

<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>H. Lundbeck</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>Otsuka Pharmaceutical</P>
</TD>

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>1,800</P>
</TD>
<TD WIDTH="215" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">Aripiprazole, OPC-34712(신규물질) 외 3개</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">조현병</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2011</P>
</TD>

<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>Zogenix</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>DURECT</P>
</TD>

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>105</P>
</TD>
<TD WIDTH="215" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">Long-acting formulation of risperidone</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">조현병</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2009</P>
</TD>

<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>Vanda Pharmaceuticals</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>Novartis</P>
</TD>

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>465</P>
</TD>
<TD WIDTH="215" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">Fanapt oral and depot formulations </TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">조현병</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>2005</P>
</TD>

<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="99" ALIGN="CENTER">
<P>Indevus Pharmaceuticals</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="99" ALIGN="CENTER">
<P>Bayer HealthCare Pharmaceuticals</P>
</TD>

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="99">
<P>30</P>
</TD>
<TD WIDTH="215" VALIGN="MIDDLE" HEIGHT="99" ALIGN="CENTER">Long-acting injectable testosterone preparation for the treatment of male hypogonadism</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="99" ALIGN="CENTER">남성 성선기능부전증</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2004</P>
</TD>

<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>Allergan</P>
</TD>

<TD WIDTH="178" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>Debiopharm International</P>
</TD>

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>33</P>
</TD>
<TD WIDTH="215" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">TRELSTAR DEPOT 1M/3M</TD>
<TD WIDTH="163" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">전립선암, 자궁내막증</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="811" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="802"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="811" HEIGHT="30">출처: Global Data</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>이처럼 글로벌 제약사의 장기지속형 주사제에 대한 투자 및 개발이 지속되는 배경에는 또 다른 이유가 있습니다. 해당 의약품의 높은 시장성을 기타 다른 제형의 의약품 보다 장기간 유지할 수 있기 때문입니다. </P>
<P>일반적인 제형의 신약은 특허권이 만료되면 바로 제네릭이 출시되어, 제네릭의 수가 늘어나는 만큼 오리지널의 매출이 급격히 감소하는 현상이 일어납니다. FDA 분석에 따르면 미국의 경우 특허권 만료 후, 제네릭의 수가 1개일 경우 오리지널 가격의 60~70% 정도가 유지되나, 5개의 경우 오리지널의 20%, 10개 이상이 되면 오리지널 약의 5%보다 더 낮은 가격으로 인하됩니다. </P>
<P>하지만 장기지속형 주사제의 경우 특허권이 만료된 이후에도 기존의 매출을 지속적으로 유지되는 경향을 보입니다. 이는 장기지속형 주사제의 개발/생산에 대한 기술적 난이도로 인해 제네릭 허가를 위한 조건들을 쉽게 충족하기 어렵기 때문입니다. 이러한 이유로 대표적인 장기지속형 주사제 브랜드 중에는 특허권 만료 후에도 매출이 1조원이 넘는 블록버스터 약품들이 존재합니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="607">

<COLGROUP>
<COL WIDTH="598"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="607" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">[주요 장기지속형 주사제(LAI)의 특허권 만료 제품의 매출액 현황]</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="607" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: USD mil)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="604">

<COLGROUP>
<COL WIDTH="190"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="94"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XD7D7D7" WIDTH="199" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Product</P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="166" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>LAI Tech</P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="72" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Approval year</P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="64" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Patent Expiry</P>
</TD>

<TD USERMARK=" BC0XD7D7D7" WIDTH="103" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Revenue</P>
<P>(2021)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="199" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Invega® Sustenna®</P>
</TD>

<TD WIDTH="166" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Suspended Solid</P>
</TD>

<TD WIDTH="72" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2009</P>
</TD>

<TD WIDTH="64" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Expired</P>
</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,022</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="199" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Abilify Maintena®</P>
</TD>

<TD WIDTH="166" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Suspended Solid</P>
</TD>

<TD WIDTH="72" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2013</P>
</TD>

<TD WIDTH="64" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2025</P>
</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,420</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="199" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Sandostatin® LAR</P>
</TD>

<TD WIDTH="166" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Polymer Microsphere</P>
</TD>

<TD WIDTH="72" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>1998</P>
</TD>

<TD WIDTH="64" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Expired</P>
</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"> 1,413</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="199" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Somatuline Depot®</P>
</TD>

<TD WIDTH="166" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Other</P>
</TD>

<TD WIDTH="72" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2007</P>
</TD>

<TD WIDTH="64" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Expired</P>
</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,202</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="199" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Lupron Depot®</P>
</TD>

<TD WIDTH="166" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Polymer Microsphere</P>
</TD>

<TD WIDTH="72" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>1989</P>
</TD>

<TD WIDTH="64" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Expired</P>
</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">783</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="199" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Risperdal Consta®</P>
</TD>

<TD WIDTH="166" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Polymer Microsphere</P>
</TD>

<TD WIDTH="72" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2003</P>
</TD>

<TD WIDTH="64" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Expired</P>
</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">592</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="199" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Vivitrol®</P>
</TD>

<TD WIDTH="166" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Polymer Microsphere</P>
</TD>

<TD WIDTH="72" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2006</P>
</TD>

<TD WIDTH="64" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>Expired</P>
</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">343</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="607">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="550"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="53">출처</TD>
<TD WIDTH="559" HEIGHT="53">:Challenges and opportunities in the development of complex generic long-acting injectable drug products(2021), 매출은 각사 Annual Report</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK=" B">(다) 경쟁현황</P>
<P></P>
<P>장기지속형 주사제는 탈모 치료제, 치매 치료제, 만성 질환 등에 적합한 제형이고, 부작용을 줄일 수 있는 등 여러 장점을 지니고 있어 시장에서의 높은 수요를 보입니다. 하지만 개발의 난이도가 높아 신규 제품의 출시가 드물며, 제네릭의 개발 또한 어려운 편으로 특허권이 만료된 이후에도 지속적으로 높은 매출을 창출할 수 있다는 특징을 가지고 있습니다. </P>
<P>당사가 연구/개발 및 사업화를 진행 중인 Microsphere 기반의 장기지속형 주사제는 일본 대형 제약사인 Takeda의 전립선암 치료제 Lupron Depot로 1989년에 처음 상용화되었으며, 이후 많은 제약사 및 바이오텍이 Microsphere 기반의 장기지속형 주사제의 개발에 대규모 투자를 하였으나 30년이 지난 현재에도 출시된 제품이 많지 않습니다. 전 세계적으로 Alkermes, Takeda 등 제품화에 성공한 기술 기업의 수가 적고, 제제별 생산기술 확장성이 떨어져 제한된 파이프라인을 보유하고 있습니다. 미국 FDA 기준 장기지속형 주사제로 허가 받은 사례는 지난 10년간 출시된 제품 4개를 포함하여 2021년 기준 총 10개 제품이 전부입니다.(출처: O'Brien et al., Challenges and opportunities in the development of complex generic long-acting injectable drug products, JCR, 2021)국내 개발사들도 높은 시장성과 장기간 경쟁우위를 보유할 수 있는 장기지속형 주사제 연구개발을 꾸준히 해왔습니다. 하지만 현재까지 실제 출시된 장기지속형 주사제는 Takeda의 전립선암 치료제 Lupron Depot 1개월 제형의 제네릭 제품 2개로 국내 개발사 중 독자적으로 제네릭이 아닌 신규 제품을 출시한 사례는 없습니다.</P>
<P></P>
<P USERMARK=" B">(2) Lipid Nano Particle</P>

<P USERMARK="F-GL">
<SPAN USERMARK="F-BT B">(가) LNP란?</SPAN>
</P>
<P>LNP(Lipid Nano Particle, 지질나노입자)는 유전체 물질(DNA, RNA 등)을 지질(Lipid) 물질로 감싸서 안정적으로 보관할 수 있고, 또한 세포질내로 효율적으로 전달하기 위한 나노 단위의(50~150nm) 약물전달시스템입니다. </P>

<IMAGE>
<IMG WIDTH="528" HEIGHT="267" ALIGN="CENTER" HSPACE="0">2. mrna-lnp 개념도(p.13).jpg</IMG>
<IMG-CAPTION ATOC="N">[mRNA-LNP 개념도]</IMG-CAPTION>
</IMAGE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="598">

<COLGROUP>
<COL WIDTH="589"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="598" HEIGHT="30">
<P>출처: Vaccines 2021, 9(1), 65; https://doi.org/10.3390/vaccines9010065</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>Pfizer/BioNTech, Moderna의 mRNA 백신은 LNP 기술이 적용된 것으로, 이를 통해 COVID-19라는 글로벌위기에 효과적으로 대응할 수 있었습니다. 나노입자 기반의 DDS 기술인 LNP는 그 구성원리상 어떠한 유전체(mRNA, siRNA 등)에 대해서도 동일한 공정 프로세스로 제조가 가능하기 때문에 특정 유전물질에 제한되지 않은 범용적인 DDS 플랫폼으로써 확장성을 보유하고 있습니다.그리고 LNP의 제조를 위한 가장 최신의 공정 프로세스가 마이크로플루이딕스(Microfluidics) 공정입니다. 가장 고도화된 기술인 마이크로플루이딕스 공정의 경우에는 상대적으로 낮은 생산량(Throughput)의 특성이 있으나 타겟 물질에 대한 봉입율(Encapsulation efficiency)이 높고, 안정적인 Scale-up이 가능하며, 통합공정 관점의 수율 최적화가 용이한 기술적 특징을 가집니다.</P>
<P USERMARK=" B">(나) 시장규모 및 성장성</P>
<P>LNP 제조 기술은 mRNA 코딩 기술, Lipid 관련 디자인 기술과 더불어 mRNA 관련 플랫폼 기술의 한 부분입니다. mRNA는 열 안정성이 낮고 혈액 혹은 세포질 내에서 다양한 효소에 의해 분해되는 특성을 지니고 있어, 이에 따라 mRNA가 안정적으로 표적 세포질 내로 잘 전달될 수 있도록 Lipid를 이용하여 mRNA를 봉입(encapsulation)하는 기술이 mRNA 관련 치료제 개발의 key technology로 인식되고 있습니다.</P>
<P>동시에 다양한 의약품에 적용될 수 있는 mRNA약물 전달 기술(DDS) 중 현재까지 안전성과 효율이 확인된 기술은 LNP 기술이 유일한 상황입니다. 따라서 현재 출시/개발 중인 많은 mRNA 관련 치료제 개발사들은 LNP 기반기술을 보유한 회사와 라이선스 계약을 체결하여 공동개발하거나 자체적인 LNP 기술을 확보하기 위한 연구를 진행하고 있습니다.</P>
<P>해당 부분을 고려했을 때, LNP 기술은 향후 mRNA 기술의 De facto Standard로 사용되며, mRNA 백신 및 치료제 시장의 성장이 곧 LNP 시장의 성장을 대변할 것으로 예상됩니다.</P>
<P></P>

<P>
<SPAN USERMARK=" B">1) 글로벌 mRNA 백신 및 치료제 시장</SPAN>
</P>
<P>mRNA 기반 백신 및 치료제는 COVID-19 백신 출시 이후 연구 및 개발이 빠르게 진행되고 있습니다. Nature Review에 따르면 현재 31개 기업이 총 180개의 mRNA 기반의 백신 및 치료제를 개발 중에 있습니다 (2021년 7월 기준).</P>
<P>Nature Review는 상기 180개의 파이프라인의 개발 단계 및 개발 성공률을 고려하여 추정한 mRNA 기반 백신/치료제 시장은 COVID-19 백신 필요성의 감소 및 신제품 출시 부족으로 인해 감소세를 보이다가 신규 mRNA 백신 및 치료제가 본격적으로 출시되는 2028년부터 2035년 230억달러까지 시장이 성장할 것으로 전망하였습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="607">

<COLGROUP>
<COL WIDTH="598"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="607" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">[mRNA 백신 및 치료제 시장 전망]</TD>
</TR>
</TBODY>
</TABLE>

<IMAGE>
<IMG WIDTH="600" HEIGHT="247" ALIGN="CENTER" HSPACE="0">mrna 백신 및 치료제 시장 전망.jpg</IMG>
<IMG-CAPTION ATOC="N">mRNA 백신 및 치료제 시장 전망</IMG-CAPTION>
</IMAGE>

<TABLE WIDTH="623" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="37"></COL>
<COL WIDTH="568"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" HEIGHT="30">출처:</TD>
<TD WIDTH="577" HEIGHT="30">Nature Review</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>규모의 차이는 있지만 한국제약바이오협회에서 인용한 다른 산업 리서치 기관인 Global Market Trajectory & Analytics 추정에 따르면 mRNA 백신 및 치료제 시장 규모는 2021년 640억 달러로 예측되며, 연평균 11.9% 성장하여 2027년 1,270억 달러로 성장할 것으로 전망하였습니다.</P>
<P>이러한 성장은 mRNA 기술의 장점 및 검증으로 인해 mRNA 기반 백신 및 치료제 개발에 투입되는 투자금이 기하급수적으로 상승한 것에 기인합니다. </P>
<P>2019년말 기준으로 150억 달러에 불과했던 mRNA 플랫폼에 대한 투자금액은 2021년 8월 기준 3,000억 달러까지 증가하였습니다. (mRNA 기술 기반 5개 상장사 투자액). 이러한 적극적이고 집중적인 개발 및 투자금은 mRNA백신 및 치료제 시장성 및 성장 잠재력을 충분히 반영한다고 볼 수 있습니다. </P>

<P>
<SPAN USERMARK=" B">2) mRNA 기반 항체치료제 시장</SPAN>
</P>
<P>Evaluate Pharma에 따르면, 글로벌 항체의약품 시장은 2025년까지 2,820억 달러 규모로 성장할 것으로 예측되며 그 중 면역항암제 치료제 시장은 1,300억 달러에 이를 것으로 예측됩니다.</P>
<P>항체의약품은 체내 특정 단백질을 억제할 수 있는 항체 생성에 대한 유전 정보를 탑재한 동물세포 혹은 미생물을 대규모 바이오 리액터에서 배양하는 공정을 통해 생산됩니다. 이러한 대규모 항체의약품 산업은 체내 항체 생성을 유도할 수 있는 mRNA 플랫폼 기술에 의해 대변혁을 맞게 될 것으로 예측되며, 그러한 흐름을 단적으로 보여주는 영역이 면역 항암제 시장입니다.</P>
<P>현재 면역 항암제 시장에서는 면역관문 억제제가 2019년 기준 약 25억 달러로 가장 큰 매출을 가지고 있으며, 2026년 660억 달러로 더욱 성장할 것으로 예상됩니다.</P>
<P>이러한 면역관문 억제제의 성분은 단일 복제 항체(monoclonal Antibody, mAb)이며, 이는 mRNA로 대체될 수 있습니다. 외부에서 생산한 항체를 정제하여 주입하는 대신, 환자의 체내에서 스스로 면역관문 억제제 성분 mAb을 생산하게 하는 원리입니다.</P>
<P USERMARK="F-GL11"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="782">

<COLGROUP>
<COL WIDTH="773"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="782" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">[ mRNA 기반 면역 항암제 개발 현황]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="781" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="247"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>분류</P>
</TD>

<TD WIDTH="163" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>개발사</P>
</TD>

<TD WIDTH="256" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>항원</P>
</TD>

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>적응증</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>임상년도</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>임상단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>항체</P>
</TD>

<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>Duke Univ</P>
</TD>

<TD WIDTH="256" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>GITRL/anti CTLA-4 mAb</P>
</TD>

<TD WIDTH="92" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>Melanoma</P>
</TD>

<TD WIDTH="78" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>2010</P>
</TD>

<TD WIDTH="78" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>P1</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="114" HEIGHT="90" VALIGN="MIDDLE" ALIGN="CENTER">
<P>싸이토카인</P>
</TD>

<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>Moderna/Medimmune</P>
</TD>

<TD WIDTH="256" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>IL-12</P>
</TD>

<TD WIDTH="92" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>Solid tumor</P>
</TD>

<TD WIDTH="78" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>2019</P>
</TD>

<TD WIDTH="78" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>P1</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>Moderna/AstraZeneca</P>
</TD>

<TD WIDTH="256" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>OX40L, IL-23, IL-36</P>
</TD>

<TD WIDTH="92" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>Solid tumor</P>
</TD>

<TD WIDTH="78" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>2018</P>
</TD>

<TD WIDTH="78" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>P1</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>BioNTech/Sanofi</P>
</TD>

<TD WIDTH="256" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>scIL-12, IL-15sushi, IFNa, GM-CSF</P>
</TD>

<TD WIDTH="92" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>Solid tumor</P>
</TD>

<TD WIDTH="78" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>2019</P>
</TD>

<TD WIDTH="78" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>P2</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="114" HEIGHT="60" VALIGN="MIDDLE" ALIGN="CENTER">
<P>리간드/수용체</P>
</TD>

<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>eTheRNA</P>
</TD>

<TD WIDTH="256" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>CD70, CD40L, caTLR4, TAA</P>
</TD>

<TD WIDTH="92" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>Melanoma</P>
</TD>

<TD WIDTH="78" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>2018</P>
</TD>

<TD WIDTH="78" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>P1</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="163" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>Moderna</P>
</TD>

<TD WIDTH="256" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>OX40L</P>
</TD>

<TD WIDTH="92" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>Solid tumor</P>
</TD>

<TD WIDTH="78" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>2017</P>
</TD>

<TD WIDTH="78" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>P1/2</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="779" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="770"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="779" HEIGHT="30">출처: Beck et al., Mulecular Cancer, 2021</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P>기존의 면역관문억제제와 동일한 효과를 내기 위해 환자에게 투약되는 mRNA 약품의 용량은 기존 제품 대비 1/10~1/100으로 기대됩니다. 이를 통해 기존의 mAb 생산에 필요한 비용(생산 부지, 시설, 비용 등)을 획기적으로 줄일 수 있어 기존 mAb 성분 의약품의 플랫폼을 mAb에서 효율적으로 mRNA로 대체할 수 있을 것으로 예상됩니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="716">

<COLGROUP>
<COL WIDTH="707"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="716" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">[ mRNA 치료제와 항체 치료제 생산 능력 비교]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="716" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>제품</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>매출액</P>
</TD>

<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>환자수 추정(K)</P>
</TD>

<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>환자당 필요한 용량(mg)</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>연간 필요한 생산량(Kg)</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>연간 필요 CAPA (K liter)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">
<P>항체의약품</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" HEIGHT="30">
<P>Humira</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" HEIGHT="30">
<P>USD 204억(’20)</P>
</TD>

<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>650</P>
</TD>

<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,040</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>676</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>520</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">
<P>mRNA 백신</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" HEIGHT="30">
<P>BNT162b</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" HEIGHT="30">
<P>USD446억(‘21E)</P>
</TD>

<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,000,000</P>
</TD>

<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>50(2회)</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>50</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>100</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="715">

<COLGROUP>
<COL WIDTH="706"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="715" HEIGHT="30" VALIGN="MIDDLE">참조: 항체의약품 수율 2.6g/L, mRNA 수율 5g/L로 가정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="715" HEIGHT="30" VALIGN="MIDDLE">출처: 삼성증권</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">3) 글로벌 항암백신 및 유전자 치료제 시장</SPAN>
</P>
<P>mRNA 백신 시장이 급속도로 성장하면서, 암 백신시장도 함께 성장 중입니다. mRNA 백신을 암에 적용하면, 개별 환자의 DNA 정보를 이용해 환자 맞춤형 백신 개발이 가능합니다. 환자 별, 암의 종류별로 특이한 변이를 갖고 있어 변이 유전자 정보를 이용하면 환자 한 사람만을 위한 암 백신 개발이 가능합니다.</P>
<P>2020년 암 백신의 임상 실험은 2상 임상 67건 진행중이며, 3상 임상은 14건으로 면역항암제 중 가장 많은 수의 임상이 진행되고 있습니다.</P>
<P USERMARK="F-GL11"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="648">

<COLGROUP>
<COL WIDTH="639"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="648" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">[주요 mRNA 암 백신 개발 현황]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="649" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="167"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="66"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>개발사</P>
</TD>
<TD WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">항원</TD>
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">적응증</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>임상년도</P>
</TD>
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">임상단계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="120" ALIGN="CENTER" HEIGHT="60" VALIGN="MIDDLE">
<P>Moderna/Merck</P>
</TD>

<TD ROWSPAN="2" WIDTH="176" ALIGN="CENTER" HEIGHT="60" VALIGN="MIDDLE">
<P>neoAg</P>
</TD>

<TD WIDTH="200" ALIGN="CENTER" HEIGHT="30">
<P>Solid Tumors</P>
</TD>

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">
<P>2017</P>
</TD>

<TD WIDTH="75" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">
<P>P1</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="200" ALIGN="CENTER" HEIGHT="30">
<P>Melanoma</P>
</TD>

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">
<P>2019</P>
</TD>

<TD WIDTH="75" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">
<P>P2</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="5" WIDTH="120" ALIGN="CENTER" HEIGHT="173" VALIGN="MIDDLE">
<P>BioNTech</P>
</TD>

<TD WIDTH="176" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">
<P>NY-ESO-1, MAGE-A3, tyrosinase, TPTE</P>
</TD>

<TD WIDTH="200" ALIGN="CENTER" HEIGHT="53">
<P>Melanoma</P>
</TD>

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="53">
<P>2020</P>
</TD>

<TD WIDTH="75" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE">
<P>P2</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="176" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>CLDN6</P>
</TD>

<TD WIDTH="200" ALIGN="CENTER" HEIGHT="30">
<P>Solid tumors</P>
</TD>

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">
<P>2020</P>
</TD>

<TD WIDTH="75" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">
<P>P1/2</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="176" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>HPV16</P>
</TD>

<TD WIDTH="200" ALIGN="CENTER" HEIGHT="30">
<P>HPV16+and PD-L1+HNSCC</P>
</TD>

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">
<P>2020</P>
</TD>

<TD WIDTH="75" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">
<P>P2</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="176" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>Ovarian TAAs</P>
</TD>

<TD WIDTH="200" ALIGN="CENTER" HEIGHT="30">
<P>Ovarian cancer</P>
</TD>

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">
<P>2019</P>
</TD>

<TD WIDTH="75" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">
<P>P1</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="176" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>Prostate TAAs</P>
</TD>

<TD WIDTH="200" ALIGN="CENTER" HEIGHT="30">
<P>Prostate cancer</P>
</TD>

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">
<P>2019</P>
</TD>

<TD WIDTH="75" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">
<P>P1/2</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="651">

<COLGROUP>
<COL WIDTH="642"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="651" HEIGHT="30" VALIGN="MIDDLE">참고: TAA: Tumor-associated antigen</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="651" HEIGHT="30" VALIGN="MIDDLE">출처: Beck et al., Mulecular Cancer, 2021</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11">
<SPAN USERMARK="F-BT12">인체 고유의 면역 체계를 이용하는 치료 기전 상, 면역관문 억제제와 가장 좋은 시너지를 낼 것으로 기대됩니다. BioNTech은 BNT111 mRNA 암 백신과 Lybtayo의 흑색종 암 환자 대상 병용 요법 임상을 진행 중이며, Moderna는 mRNA-4157 mRNA 암 백신과 Keytruda의 고형암 대상 1,2상 임상을 진행하고 있습니다. 병용요법을 통해 단일요법의 약효를 극복하고 최근 mRNA 백신에 대한 관심을 통해 인지도를 높일 수 있습니다.</SPAN>
</P>
<P>세포내 특정 유전정보를 첨삭 및 편집하는 기전을 가진 유전자 치료제는 목표로 하는 세포에 약물을 안정적으로 전달하는 delivery 기술이 가장 중요한 요소로 여겨집니다. </P>
<P>최근까지 개발된 유전자 치료제의 경우 유전물질의 전달체로서 바이러스 벡터를 사용하였지만 바이러스 벡터 자체의 안전성 이슈가 전통적으로 제기되어 왔습니다. 또한 CRISPR 등의 새로운 개념이 도입됨에 따라 유전자 치료제를 안정적으로 delivery 하기 위해서는 새로운 기술에 대한 수요는 증가 중입니다. </P>
<P></P>

<P>
<SPAN USERMARK=" B">(다) 경쟁현황</SPAN>
</P>
<P>mRNA 백신 및 치료제 산업의 핵심 기술은 크게 mRNA 합성 기술, Lipid 기술, LNP 기술 이렇게 세 가지로 구분할 수 있습니다. 해당 산업은 아직 시장 초기 단계에 있어 각 기술이 모두 소수의 기업에 집중되어 있는 모습을 보입니다. 각 기술 별 공정, 관련 기술 및 주요 출원인은 아래와 같습니다.</P>
<P USERMARK="F-GL11"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="683">

<COLGROUP>
<COL WIDTH="674"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="683" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">[mRNA 백신 공정별 기술 개요 및 주요 기업]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="683" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="89"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="215"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="106" USERMARK=" BC0XD7D7D7">
<P>공정</P>
</TD>

<TD COLSPAN="3" WIDTH="361" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>1. mRNA 합성 기술</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>2. Lipid 기술</P>
<P>3. LNP 기술</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">
<P>항원 최적화</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>mRNA 합성</P>
<P>및 변형</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>분리 정제</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>mRNA-LNP 제조</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168" USERMARK=" BC0XD7D7D7">
<P>관련 기술</P>
</TD>

<TD WIDTH="125" HEIGHT="168" VALIGN="MIDDLE" ALIGN="CENTER">
<P>프로모터</P>
<P>5‘UTR</P>
<P>signal sequence</P>
<P>항원 최적화</P>
<P>코돈 최적화</P>
<P>3’UTR</P>
<P>Poly A tail</P>
</TD>

<TD WIDTH="143" HEIGHT="168" VALIGN="MIDDLE" ALIGN="CENTER">
<P>RNA polymerase</P>
<P>RNA 변형핵산</P>
<P>뉴클레오티드 종류</P>
<P>캡핑 종류</P>
<P>관련 효소</P>
</TD>

<TD WIDTH="93" HEIGHT="168" VALIGN="MIDDLE" ALIGN="CENTER">
<P> </P>
</TD>

<TD WIDTH="224" HEIGHT="168" VALIGN="MIDDLE" ALIGN="CENTER">
<P>Lipid 물질 개발</P>
<P>LNP 조성비</P>
<P>LNP 제조방법→동사 기술 영역</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122" USERMARK=" BC0XD7D7D7">
<P>주요 출원인</P>
</TD>

<TD WIDTH="125" HEIGHT="122" VALIGN="MIDDLE" ALIGN="CENTER">
<P>모더나</P>
<P>바이오앤텍</P>
<P>큐어백</P>
<P>USA</P>
</TD>

<TD WIDTH="143" HEIGHT="122" VALIGN="MIDDLE" ALIGN="CENTER">
<P>모더나</P>
<P>UPenn</P>
<P>TriLink</P>
</TD>

<TD WIDTH="93" HEIGHT="122" VALIGN="MIDDLE" ALIGN="CENTER">
<P>모더나</P>
<P>바이오앤텍</P>
<P>UPenn</P>
<P>큐어백</P>
</TD>

<TD WIDTH="224" HEIGHT="122" VALIGN="MIDDLE" ALIGN="CENTER">
<P>아뷰터스</P>
<P>모더나</P>
<P>아퀴타스</P>
<P>큐어백</P>
<P>바이오앤텍</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="682">

<COLGROUP>
<COL WIDTH="673"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="682" HEIGHT="30" VALIGN="MIDDLE">출처: 특허청, mRNA 백신 특허분석 보고서(2021)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>현재 mRNA 백신 및 치료제의 기반 기술을 선도하고 있는 기업은 Pfizer와 Moderna로 코로나19 백신의 연구/개발뿐 아니라 제조부터 유통까지 전체 밸류체인을 독자적으로 구축하고 있습니다. 동사가 연구/개발 및 사업화를 진행 중인 LNP 제조 공정의 경우 Pfizer 및 Moderna가 핵심기술 중 하나로 취급하고 있어 LNP의 제조 기술이나 노하우 등은 공개되고 있지 않은 상황입니다. 이에 따라 당분간은 Pfizer와 Moderna가 LNP 제조 기술에 대한 독점적 우위를 지속해 나갈 것으로 예상되며, 새로운 경쟁자의 진입 장벽도 높을 것으로 예상됩니다.</P>
<P>국내의 경우에도 고효율의 LNP 제조 기술 및 양산 제조기술은 부재한 상황입니다. 최근 DS 공정의 위탁 또는 mRNA 백신 및 치료제의 생산이 가능한 것으로 발표하는 국내 업체의 경우에도 낮은 효율의 T-mixing 공정이나 Microfludizer를 이용한 제조 공정을 구축 혹은 계획하고 있는 실정입니다. 이에 mRNA 백신 및 치료제 산업의 밸류체인에서 높은 생산 효율을 지닌 LNP 제조 공정에 대한 수요는 높으며, 특히 mRNA 백신 및 치료제를 개발 중인 업체뿐 아니라 mRNA 및 세포/유전자 치료제 CMO 및 CDMO 사업에 진출하고자 하는 업체도 높은 수요를 가지고 있습니다.</P>
<PGBRK></PGBRK>
</SECTION-2>
</LIBRARY>

</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-0-0">III. 재무에 관한 사항</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-1-0">1. 요약재무정보</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL B">가. 요약 연결 재무정보</SPAN>
<SPAN USERMARK="F-GL">당사는 보고서 작성기준일 현재 해당사항이 없습니다.</SPAN>
</P>

<P>
<SPAN USERMARK=" B">나. 요약 재무정보</SPAN>※ 제8기(2022년도), 제7기(2021년도) 및 제6기(2020년도) 요약 재무제표는 한국채택회계기준(K-IFRS)에 따라 외부감사를 받은 요약 재무제표입니다.
</P>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="656">

<COLGROUP>
<COL WIDTH="647"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="656" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="656" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="200"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="209" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업연도구 분</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2022년</P>
<P>(2022년 12월말)</P>
</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2021년(2021년 12월말)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년(2020년 12월말)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" WIDTH="209" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(제8기)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(제7기)</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>(제6기)</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH VALIGN="MIDDLE" WIDTH="209" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">
<P>회계처리 기준</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>K-IFRS</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>K-IFRS</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>K-IFRS</P>
</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>[유동자산]</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">25,277,936,416</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">22,173,786,896</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">12,214,225,981</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>ㆍ당좌자산</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">25,146,569,677</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">22,102,410,602</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">12,214,225,981</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>ㆍ재고자산</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">131,366,739</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">71,376,294</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>[비유동자산]</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">9,583,966,320</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">9,550,499,822</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">10,122,907,669</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>ㆍ유형자산</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">7,554,824,110</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">8,313,086,625</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">9,225,416,063</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>ㆍ무형자산</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">731,022,482</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">495,237,469</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">331,584,606</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>ㆍ기타비유동자산</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">1,298,119,728</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">742,175,728</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">565,907,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="209" HEIGHT="30">
<P USERMARK=" B">자산총계</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" USERMARK=" B">34,861,902,736</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" USERMARK=" B">31,724,286,718</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" USERMARK=" B">22,337,133,650</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>[유동부채]</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">2,609,080,266</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">2,403,479,859</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">1,498,290,931</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>[비유동부채]</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">1,818,017,004</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">2,829,612,172</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">4,130,014,183</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="209" HEIGHT="30">
<P USERMARK=" B">부채총계</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" USERMARK=" B">4,427,097,270</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" USERMARK=" B">5,233,092,031</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" USERMARK=" B">5,628,305,114</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>[자본금]</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">4,175,674,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">3,567,074,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">3,208,274,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>[자본잉여금]</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">43,462,314,660</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">29,534,726,723</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">54,916,280,496</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>[기타자본항목]</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">2,663,407,062</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">2,660,655,228</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">1,543,553,533</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>[이익잉여금(결손금)]</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">(19,866,590,256)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">(9,271,261,264)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">(42,959,279,493)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="209" HEIGHT="30">
<P USERMARK=" B">자본총계</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" USERMARK=" B">30,434,805,466 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" USERMARK=" B">26,491,194,687</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" USERMARK=" B">16,708,828,536</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="209" HEIGHT="53">구 분</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="53">2022년 1월~ 2022년 12월</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="53">2021년 1월~2021년 12월</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="53">2020년 1월~2020년 12월</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>매출액</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">3,723,683,006</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">1,861,755,394</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">531,737,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>영업이익(영업손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">(10,901,805,103)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">(9,557,905,983)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">(5,536,819,928)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>계속사업이익(계속사업손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">(10,595,328,992)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">(9,271,261,264)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">(12,880,030,309)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>당기순이익(당기순손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">(10,595,328,992)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">(9,271,261,264)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">(12,880,030,309)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>주당순이익(주당순손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">(1,457)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">(1,376)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">(4,678)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">희석주당순이익(주당순손실)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">(1,457)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">(1,376)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30">(4,678)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>
</SECTION-2><LIBRARY>
<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-2-0">2. 연결재무제표</TITLE>
<P></P>
<P>당사는 보고서 작성기준일 현재 해당사항이 없습니다.</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-3-0">3. 연결재무제표 주석</TITLE>
<P></P>
<P>당사는 보고서 작성기준일 현재 해당사항이 없습니다.</P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-4-0">4. 재무제표</TITLE>

<TABLE-GROUP ACLASS="{XBRL}BS_S" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">재무상태표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 8 기          2022.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 7 기          2021.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 6 기          2020.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 8 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 7 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 6 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>자산</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>25,277,936,416</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>22,173,786,896</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>12,214,225,981</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>23,819,469,762</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>19,256,127,356</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>11,930,185,094</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　매출채권 및 기타유동채권</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>548,002,521</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2,786,503,444</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>133,934,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　재고자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>131,366,739</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>71,376,294</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　기타유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>761,061,224</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>55,766,262</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>141,644,857</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　당기법인세자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>18,036,170</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,013,540</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>8,462,030</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　비유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>9,583,966,320</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>9,550,499,822</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>10,122,907,669</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　유형자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>7,554,824,110</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>8,313,086,625</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>9,225,416,063</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　무형자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>731,022,482</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>495,237,469</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>331,584,606</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　기타비유동금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,298,119,728</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>742,175,728</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>516,407,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　기타비유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>49,500,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　자산총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>34,861,902,736</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>31,724,286,718</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>22,337,133,650</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>부채</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,609,080,266</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,403,479,859</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,498,290,931</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　매입채무 및 기타채무</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,516,308,998</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,112,117,074</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>713,271,260</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　유동성리스부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,070,240,361</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,214,088,185</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>738,305,631</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　기타유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>22,530,907</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>77,274,600</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>46,714,040</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　비유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,818,017,004</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,829,612,172</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,130,014,183</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　　장기매입채무 및 기타비유동채무</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>13,815,270</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>8,747,524</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　장기차입금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,800,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　장기리스부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,730,027,491</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,757,577,232</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,295,032,292</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　　복구충당부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>74,174,243</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>72,034,940</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>26,234,367</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　부채총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,427,097,270</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>5,233,092,031</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>5,628,305,114</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>자본</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　자본금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,175,674,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,567,074,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,208,274,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　자본잉여금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>43,462,314,660</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>29,534,726,723</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>54,916,280,496</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　기타자본</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,663,407,062</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,660,655,228</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,543,553,533</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　이익잉여금(결손금)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(19,866,590,256)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(9,271,261,264)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(42,959,279,493)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　자본총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>30,434,805,466</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>26,491,194,687</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>16,708,828,536</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>자본과부채총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>34,861,902,736</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>31,724,286,718</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>22,337,133,650</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<PGBRK></PGBRK>

<TABLE-GROUP ACLASS="{XBRL}IS_S1" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">포괄손익계산서</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 8 기 2022.01.01 부터 2022.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 7 기 2021.01.01 부터 2021.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 6 기 2020.01.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 8 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 7 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 6 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>수익(매출액)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,723,683,006</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,861,755,394</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>531,737,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>매출원가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>401,221,285</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>234,682,999</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>매출총이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,322,461,721</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,627,072,395</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>531,737,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>판매비와관리비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>14,224,266,824</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>11,184,978,378</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>6,068,556,928</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>영업이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(10,901,805,103)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(9,557,905,983)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(5,536,819,928)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>기타이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>149,450,732</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>402,609,066</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>11,507,134</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>기타손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,209,220</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>26,206,935</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>29,648,863</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>금융수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>292,481,166</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>42,089,553</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>50,521,156</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>금융비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>132,246,567</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>131,846,965</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>7,375,589,808</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>법인세비용차감전순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(10,595,328,992)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(9,271,261,264)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(12,880,030,309)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>법인세비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>당기순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(10,595,328,992)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(9,271,261,264)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(12,880,030,309)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>기타포괄손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>총포괄손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(10,595,328,992)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(9,271,261,264)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(12,880,030,309)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>주당이익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　기본주당이익(손실) (단위 : 원)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,457)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,376)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(4,678)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　희석주당이익(손실) (단위 : 원)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,457)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,376)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(4,678)</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<PGBRK></PGBRK>

<TABLE-GROUP ACLASS="{XBRL}EF_S" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="900" BORDER="0">

<COLGROUP>
<COL WIDTH="891"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="900" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">자본변동표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="900" HEIGHT="30" AUPDATECONT="N">
<P>제 8 기 2022.01.01 부터 2022.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="900" HEIGHT="30" AUPDATECONT="N">
<P>제 7 기 2021.01.01 부터 2021.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="900" HEIGHT="30" AUPDATECONT="N">
<P>제 6 기 2020.01.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="900" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="900" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150" ROWSPAN="2">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="750" COLSPAN="5">
<P>자본</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>자본금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>자본잉여금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>기타자본구성요소</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>이익잉여금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>자본  합계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2020.01.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,306,731,000</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(205,409,662)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(30,079,249,184)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(28,977,927,846)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>당기순이익(손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(12,880,030,309)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(12,880,030,309)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>유상증자</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>120,827,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,871,969,965</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,992,797,465</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>결손금 보전</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>전환상환우선주의 전환</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,780,715,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>52,044,310,531</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>936,390,421</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>54,761,416,452</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>주식매수선택권</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>812,572,774</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>812,572,774</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>자본 증가(감소) 합계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,901,543,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>54,916,280,496</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,748,963,195</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(12,880,030,309)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>45,686,756,382</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2020.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>3,208,274,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>54,916,280,496</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,543,553,533</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(42,959,279,493)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>16,708,828,536</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2021.01.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>3,208,274,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>54,916,280,496</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,543,553,533</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(42,959,279,493)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>16,708,828,536</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>당기순이익(손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(9,271,261,264)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(9,271,261,264)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>유상증자</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>358,800,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>17,577,725,720</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>17,936,525,720</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>결손금 보전</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(42,959,279,493)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>42,959,279,493</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>전환상환우선주의 전환</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>주식매수선택권</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,117,101,695</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,117,101,695</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>자본 증가(감소) 합계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>358,800,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>17,577,725,720</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,117,101,695</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(9,271,261,264)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>9,782,366,151</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2021.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>3,567,074,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>29,534,726,723</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2,660,655,228</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(9,271,261,264)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>26,491,194,687</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2022.01.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>3,567,074,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>29,534,726,723</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2,660,655,228</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(9,271,261,264)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>26,491,194,687</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>당기순이익(손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(10,595,328,992)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(10,595,328,992)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>유상증자</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>608,600,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>13,927,587,937</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>14,536,187,937</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>결손금 보전</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>전환상환우선주의 전환</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>주식매수선택권</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,751,834</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,751,834</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>자본 증가(감소) 합계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>608,600,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>13,927,587,937</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2,751,834</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(10,595,328,992)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>3,943,610,779</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2022.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>4,175,674,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>43,462,314,660</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2,663,407,062</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(19,866,590,256)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>30,434,805,466</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<PGBRK></PGBRK>

<TABLE-GROUP ACLASS="{XBRL}CF_S" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">현금흐름표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 8 기 2022.01.01 부터 2022.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 7 기 2021.01.01 부터 2021.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>제 6 기 2020.01.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 8 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 7 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150">
<P>제 6 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>영업활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(5,189,236,763)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(8,512,503,709)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(3,682,687,219)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　당기순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(10,595,328,992)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(9,271,261,264)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(12,880,030,309)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　당기순이익조정을 위한 가감</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>3,520,360,545</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2,760,557,007</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>9,283,326,737</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　영업활동으로인한자산ㆍ부채의변동</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>1,782,175,056</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,995,544,795)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(91,230,631)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　이자수취(영업)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>117,579,258</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>26,070,740</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>55,558,746</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　이자지급(영업)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(36,773,887)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(49,006,392)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　법인세납부(환급)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(14,022,630)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>4,448,490</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(1,305,370)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>투자활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(2,535,706,638)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>654,869,740</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(1,603,703,961)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　단기금융상품의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>400,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　유형자산의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>3,400,000,070</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>410,909</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　임차보증금의 감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>146,664,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>17,504,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>30,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　대여금의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(692,608,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　유형자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(1,682,223,261)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(2,290,858,986)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(1,770,131,132)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　무형자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(297,539,377)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(206,502,616)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(173,983,738)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　임차보증금의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(10,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(265,272,728)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(90,000,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>재무활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>12,288,285,807</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>15,183,576,231</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>13,288,572,884</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　정부보조금의 수취</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,469,140,427</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>593,038,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>300,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　전환상환우선주 발행</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>10,999,996,128</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　유상증자</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>14,536,187,937</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>17,936,525,720</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>2,992,797,465</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　금융리스부채의 상환</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,304,840,240)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(952,949,489)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(704,220,709)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　정부보조금의 사용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(1,432,229,100)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(593,038,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(300,000,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>　차입금의 상환</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(1,800,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>　주식선택권행사의 행사</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(979,973,217)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>현금및현금성자산의순증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>4,563,342,406</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>7,325,942,262</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>8,002,181,704</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>기초현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>19,256,127,356</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>11,930,185,094</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>3,928,003,390</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>기말현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>23,819,469,762</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>19,256,127,356</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>11,930,185,094</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-5-0">5. 재무제표 주석</TITLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="CENTER">제 8 기  2022년 1월 1일부터  2022년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="CENTER">제 7 기  2021년 1월 1일부터  2021년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="53">주식회사 인벤티지랩</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>1. 일반 사항 주식회사 인벤티지랩(이하 "회사")는 2015년 5월 14일에 설립되었으며, 인의약품, 동물의약품 및 의료기기의 연구개발 및 제조 등을 주요 사업으로 영위하고 있습니다. 한편, 회사는 2022년 11월 22일 코스닥(KOSDAQ) 시장에 주식을 상장하였습니다.당기말 현재 주요 주주의 구성내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="342"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="351" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P> 주 주 명</P>
</TH>

<TH WIDTH="136" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>주식수(주)</P>
</TH>

<TH WIDTH="135" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>지분율(%)</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="351" HEIGHT="30">김주희</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,453,514</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17.4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="351" HEIGHT="30">임직원및개인</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,035,750</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">36.35</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="351" HEIGHT="30">스마일게이트소재부품 투자펀드2014-3호</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">589,361</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7.06</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="351" HEIGHT="30">스타셋제2호 창업벤처전문사모투자(합)</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">450,313</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5.39</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="351" HEIGHT="30">스틱4차산업혁명펀드</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">224,944</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.7</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="351" HEIGHT="30">기타주주</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,597,466</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">31.1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="351" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,351,348</TD>
<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100.00</TD>
</TR>
</TBODY>
</TABLE>
<P>2. 재무제표 작성기준 및 중요한 회계정책 가. 재무제표 작성기준 회사의 재무제표는 한국채택국제회계기준(이하 기업회계기준)에 따라 작성됐습니다.한국채택국제회계기준은 국제회계기준위원회("IASB")가 발표한 기준서와 해석서 중대한민국이 채택한 내용을 의미합니다.</P>
<PGBRK></PGBRK>
<P>한국채택국제회계기준은 재무제표 작성 시 중요한 회계추정의 사용을 허용하고 있으며, 회계정책을 적용함에 있어 경영진의 판단을 요구하고 있습니다. 보다 복잡하고 높은 수준의 판단이 필요한 부분이나 중요한 가정 및 추정이 필요한 부분은 주석 3에서 설명하고 있습니다.</P>
<P>당사는 2022년 1월 1일로 개시하는 회계기간부터 다음의 제 · 개정 기준서를 신규로 적용하였습니다.</P>
<P>(1) 기업회계기준서 제1103호 ‘사업결합’(개정): ‘개념체계’에 대한 참조</P>
<P>개정사항은 사업결합 시 인식할 자산과 부채는 개정된 재무보고를 위한 개념체계의 자산과 부채의 정의를 참조하도록 하되, 기준서 제1037호 ‘충당부채, 우발부채 및 우발자산’ 및 해석서 제2121호 ‘부담금’의 적용범위에 포함되는 부채 및 우발부채에 대해서는 해당 기준서에서 정의한 과거사건, 현재의무 및 의무발생사건 등의 기준을 적용하도록 기준서 제1103호 인식 예외를 추가하고, 취득자는 취득일에 우발자산을 인식하지 않는다는 점을 포함하고 있습니다. 동 개정사항이 재무제표에 미치는 영향은 중요하지 않습니다.</P>
<P> </P>
<P>(2) 기업회계기준서 제1016호 ‘유형자산’(개정): 의도한 방식으로 사용하기 전에 생산된 재화의 매각</P>
<P>개정사항은 경영진이 의도한 방식으로 유형자산을 가동될 수 있는 장소와 상태에 이르기 전에 생산된 재화(예: 시제품)의 판매에서 발생하는 매각금액과 그 재화의 원가는 유형자산의 취득원가의 차감으로 인식하지 않고 당기손익으로 인식한다는 것을 주된 내용으로 하고 있습니다. 동 개정사항이 재무제표에 미치는 영향은 중요하지 않습니다.</P>
<P>(3) 기업회계기준서 제1037호 ‘충당부채, 우발부채 및 우발자산’(개정): 손실부담계약의 계약이행원가</P>
<P>개정사항은 손실부담계약의 회피불가능 원가를 구성하는 계약이행원가가, 그 계약을 이행하는데 드는 증분원가와 계약을 이행하는데 직접 관련되는 그 밖의 원가 배분액으로 구성됨을 명확히 하고 있습니다. 동 개정사항이 재무제표에 미치는 영향은 중요하지 않습니다.  (4) 한국채택국제회계기준 2018-2020 연차개선</P>
<P>한국채택국제회계기준 2018-2020연차개선은 다음과 같으며, 동 개정사항이 재무제표에 미치는 영향은 중요하지 않습니다.</P>
<P>-   제1101호 ‘한국채택국제회계기준의 최초 채택’: 최초채택기업인 종속기업</P>
<P>-   제1109호 ‘금융상품’: 금융부채 제거 목적의 10% 테스트 관련 수수료</P>
<P>-   제1116호 ‘리스’: 리스 인센티브</P>
<P>-   제1041호 ‘농림어업’: 공정가치 측정</P>
<P>나. 회사가 적용하지 않은 제 ·개정 기준서</P>
<P>제정ㆍ공표되었으나 아직 시행일이 도래하지 않아 적용하지 아니한 한국채택국제회계기준의 내역은 다음과 같습니다. </P>
<P>  </P>
<P>(1) 기업회계기준서 제1001호 ‘재무제표 표시’(개정): 유동부채와 비유동부채의 분류</P>
<P>개정사항은 보고기간말 현재 존재하는 실질적인 권리에 따라 유동 또는 비유동으로 분류되며, 부채의 결제를 연기할 수 있는 권리의 행사가능성이나 경영진의 기대는 고려하지 않으며 부채의 결제에 자기지분상품의 이전도 포함되나, 복합금융상품에서 자기지분상품으로 결제하는 옵션이 지분상품의 정의를 충족하여 부채와 분리하여 인식된 경우는 제외됨을 명확히 하고 있습니다. </P>
<P>   (2) 기업회계기준서 제1001호 ‘재무제표 표시’(개정): 중요한 회계정책 공시, 리픽싱 조건 금융부채 공시 개정사항은 유의적인 회계정책이 아닌 중요한 회계정책을 공시하고, 중요하지 않은 회계정책을 공시하는 경우에는 그 정보가 중요한 회계정책 정보를 불분명하게 하지 않도록 하고 있습니다. 또한, 발행자의 주가 변동에 따라 행사가격이 조정되는 조건(리픽싱 조건)이 있는 금융상품의 전부나 일부가 금융부채로 분류되는 경우에는 그 전환권이나 신주인수권에 대해 보고기간에 발생한 평가손익을 제외한 법인세비용차감전계속사업손익을 주석으로 공시하도록 2022년 12월 추가 개정되었습니다. 개정사항은 2023년1월1일 이후 시작하는 회계연도부터 적용하며, 조기적용이 허용됩니다. 회사는 동 개정사항이 재무제표에 미치는 영향을 검토 중에 있습니다</P>
<P>  </P>
<P>(3) 기업회계기준서 제1008호 ‘회계정책, 회계추정치 변경 및 오류’(개정): 회계추정치 정의</P>
<P>개정사항은 ‘회계추정의 변경’에 대한 정의를 삭제하고 ‘회계추정치’에 대한 정의를 추가하여, 회계정책에서 측정불확실성을 고려하여 회계추정치를 개발하도록 하는 경우 추정치 개발 시 사용한 측정기법과 투입변수는 회계추정치에 포함되어 측정기법이나 투입변수의 변경이 전기오류수정으로 인한 것이 아닌 한 회계정책의 변경이 아닌 회계추정치의 변경임을 명확히 하고 있습니다. 개정사항은 2023년 1월 1일 이후 시작하는 회계연도부터 적용하며, 조기적용이 허용됩니다. 회사는 동 개정사항이 재무제표에 미치는 영향이 중요하지 않을 것으로 예상하고 있습니다.</P>
<P>  </P>
<P>(4) 기업회계기준서 제1012호 ‘법인세’(개정): 이연법인세 최초 인식 예외 규정의 요건 추가</P>
<P>개정사항은 이연법인세의 최초 인식 예외 규정에 '거래 당시 동일한 금액으로 가산할 일시적차이와 차감할 일시적차이가 생기지는 않는다'는 요건을 추가하여, 단일 거래에서 자산과 부채를 최초 인식할 때 동일한 금액의 가산할 일시적차이와 차감할 일시적차이가 생기는 경우에는 이연법인세 자산과 부채를 모두 인식해야 함을 명확히 하고 있습니다. 개정사항은 2023년1월1일 이후 시작하는 회계연도부터 적용하며, 조기적용이 허용됩니다. 회사는 동 개정사항이 재무제표에 미치는 영향이 중요하지 않을 것으로 예상하고 있습니다.</P>
<P>  </P>
<P>(5) 기업회계기준서 제1117호 ‘보험계약’(제정): 기준서 제1104호 ‘보험계약’ 대체</P>
<P>기준서 제1117호 ‘보험계약’은 보험계약의 인식과 측정을 다룬 종전 기준서 제1104호 ‘보험계약’을 대체합니다. 해당 기준서는 보험계약을 발행한 기업의 유형과 관계없이 모든 보험계약에 포괄적이고 일반적인 모형을 제시합니다. 동 기준서는 2023년 1월 1일 이후 최초로 시작하는 회계연도부터 적용되며, 기준서 제1109호 '금융상품'을 적용한 기업은 조기적용이 허용됩니다. 회사는 동 개정사항이 재무제표에 미치는 영향이 중요하지 않을 것으로 예상하고 있습니다.</P>
<PGBRK></PGBRK>
<P></P>
<P>다. 현금및현금성자산 현금및현금성자산은 보유중인 현금, 요구불예금 및 취득일 현재 확정된 금액의 현금으로 전환이 용이하고, 가치변동의 위험이 경미한 매우 유동적인 단기 투자자산으로 구성되어 있습니다.라. 외화환산 </P>
<P>(1) 기능통화와 표시통화</P>
<P>회사는 재무제표에 포함되는 항목들을 각각의 영업활동이 이뤄지는 주된 경제 환경에서의 통화("기능통화")를 적용하여 측정하고 있습니다. 회사의 기능통화는 대한민국 원화이며, 재무제표는 대한민국 원화로 표시되어 있습니다.</P>
<P>(2) 외화거래와 보고기간말의 환산</P>
<P>외화거래는 거래일의 환율 또는 재측정되는 항목인 경우 평가일의 환율을 적용한 기능통화로 인식됩니다.  외화거래의 결제나 화폐성 외화 자산ㆍ부채의 환산에서 발생하는 외환차이는 당기손익으로 인식됩니다. 다만, 조건을 충족하는 현금흐름위험회피나 순투자의 위험회피의 효과적인 부분과 관련되거나 보고기업의 해외사업장에 대한 순투자의 일부인 화폐성항목에서 생기는 손익은 기타포괄손익으로 인식합니다.</P>
<P> </P>
<P>외환손익은 포괄손익계산서에 '금융수익'  또는 '금융비용'으로 표시됩니다. </P>
<P> </P>
<P>비화폐성 금융자산ㆍ부채로부터 발생하는 외환차이는 공정가치 변동손익의 일부로 보아 당기손익-공정가치 측정 지분상품으로부터 발생하는 외환차이는 당기손익으로, 기타포괄손익-공정가치 측정 지분상품의 외환차이는 기타포괄손익에 포함하여 인식됩니다.</P>
<PGBRK></PGBRK>
<P>마. 금융자산 (1) 분류</P>
<P>회사는 다음의 측정 범주로 금융자산을 분류합니다.</P>
<P>- 당기손익-공정가치 측정 금융자산</P>
<P>- 기타포괄손익-공정가치 측정 금융자산</P>
<P>- 상각후원가 측정 금융자산</P>
<P> </P>
<P>금융자산은 금융자산의 관리를 위한 사업모형과 금융자산의 계약상 현금흐름 특성에근거하여 분류합니다.</P>
<P> </P>
<P>공정가치로 측정하는 금융자산의 손익은 당기손익 또는 기타포괄손익으로 인식합니다. 채무상품에 대한 투자는 해당 자산을 보유하는 사업모형에 따라 그 평가손익을 당기손익 또는 기타포괄손익으로 인식합니다. 회사는 금융자산을 관리하는 사업모형을 변경하는 경우에만 채무상품을 재분류합니다. </P>
<P> </P>
<P>단기매매항목이 아닌 지분상품에 대한 투자는 최초 인식시점에 후속적인 공정가치 변동을 기타포괄손익으로 표시할 것을 지정하는 취소불가능한 선택을 할 수 있습니다. 지정되지 않은 지분상품에 대한 투자의 공정가치 변동은 당기손익으로 인식합니다.</P>
<P></P>
<P>(2) 측정</P>
<P>회사는 최초 인식시점에 금융자산을 공정가치로 측정하며, 당기손익-공정가치 측정 금융자산이 아닌 경우에 해당 금융자산의 취득과 직접 관련되는 거래원가는 공정가치에 가산합니다. 당기손익-공정가치 측정 금융자산의 거래원가는 당기손익으로 비용처리합니다. </P>
<P> </P>
<P>내재파생상품을 포함하는 복합계약은 계약상 현금흐름이 원금과 이자로만 구성되어 있는지를 결정할 때 해당 복합계약 전체를 고려합니다.</P>
<PGBRK></PGBRK>
<P>① 채무상품</P>
<P>금융자산의 후속적인 측정은 금융자산의 계약상 현금흐름 특성과 그 금융자산을 관리하는 사업모형에 근거합니다. 회사는 채무상품을 다음의 세 범주로 분류합니다. </P>
<P>(가) 상각후원가계약상 현금흐름을 수취하기 위해 보유하는 것이 목적인 사업모형 하에서 금융자산을 보유하고, 계약상 현금흐름이 원리금만으로 구성되어 있는 자산은 상각후원가로 측정합니다. 상각후원가로 측정하는 금융자산으로서 위험회피관계의 적용 대상이 아닌 금융자산의 손익은 해당 금융자산을 제거하거나 손상할 때 당기손익으로 인식합니다. 유효이자율법에 따라 인식하는 금융자산의 이자수익은 '금융수익'에 포함됩니다. </P>
<P>(나) 기타포괄손익-공정가치 측정 금융자산계약상 현금흐름의 수취와 금융자산의 매도 둘 다를 통해 목적을 이루는 사업모형 하에서 금융자산을 보유하고, 계약상 현금흐름이 원리금만으로 구성되어 있는 금융자산은 기타포괄손익-공정가치로 측정합니다. 손상차손(환입)과 이자수익 및 외환손익을 제외하고는, 공정가치로 측정하는 금융자산의 평가손익은 기타포괄손익으로 인식합니다. 금융자산을 제거할 때에는 인식한 기타포괄손익누계액을 자본에서 당기손익으로 재분류합니다. 유효이자율법에 따라 인식하는 금융자산의 이자수익은  '금융수익'에 포함됩니다. 외환손익은 '금융수익'  또는 '금융비용'으로 표시하고 손상차손은'기타비용'으로 표시합니다.  </P>
<P></P>
<P>(다) 당기손익-공정가치 측정 금융자산상각후원가 측정이나 기타포괄손익-공정가치 측정 금융자산이 아닌 채무상품은 당기손익-공정가치로 측정됩니다. 위험회피관계가 적용되지 않는 당기손익-공정가치 측정 채무상품의 손익은 당기손익으로 인식하고 발생한 기간에 포괄손익계산서에    '금융수익' 또는 '금융비용'으로 표시합니다.</P>
<PGBRK></PGBRK>
<P></P>
<P>② 지분상품</P>
<P>회사는 모든 지분상품에 대한 투자를 후속적으로 공정가치로 측정합니다. 공정가치 변동을 기타포괄손익으로 표시할 것을 선택한 장기적 투자목적 또는 전략적 투자목적의 지분상품에 대해 기타포괄손익으로 인식한 금액은 해당 지분상품을 제거할 때에도 당기손익으로 재분류하지 않습니다. 이러한 지분상품에 대한 배당수익은 회사가 배당을 받을 권리가 확정된 때 '금융수익'으로 당기손익으로 인식합니다.</P>
<P> </P>
<P>당기손익-공정가치로 측정하는 금융자산의 공정가치 변동은 포괄손익계산서에 '금융수익' 또는 '금융비용'으로 표시합니다. 기타포괄손익-공정가치로 측정하는 지분상품에 대한 손상차손(환입)은 별도로 구분하여 인식하지 않습니다.</P>
<P></P>
<P>(3) 손상 </P>
<P>회사는 미래전망정보에 근거하여 상각후원가로 측정하거나 기타포괄손익-공정가치로 측정하는 채무상품에 대한 기대신용손실을 평가합니다. 손상 방식은 신용위험의 유의적인 증가 여부에 따라 결정됩니다. 단, 매출채권, 리스채권 및 계약자산에 대해 회사는 개별채권별 회수가능성을 판단하여 손상을 인식합니다.</P>
<P></P>
<P>(4) 인식과 제거</P>
<P>금융자산의 정형화된 매입 또는 매도는 매매일에 인식하거나 제거합니다. 금융자산은 현금흐름에 대한 계약상 권리가 소멸하거나 금융자산을 양도하고 소유에 따른 위험과 보상의 대부분을 이전한 경우에 제거됩니다.</P>
<P> </P>
<P>회사가 금융자산을 양도한 경우라도 채무자의 채무불이행시의 소구권 등으로 양도한금융자산의 소유에 따른 위험과 보상의 대부분을 회사가 보유하는 경우에는 이를 제거하지 않고 그 양도자산 전체를 계속하여 인식하되, 수취한 대가를 금융부채로 인식합니다. 해당 금융부채는 재무상태표에 차입금으로 분류하고 있습니다.</P>
<PGBRK></PGBRK>
<P></P>
<P>(5) 금융상품의 상계</P>
<P>금융자산과 부채는 인식한 자산과 부채에 대해 법적으로 집행가능한 상계권리를 현재 보유하고 있고, 순액으로 결제하거나 자산을 실현하는 동시에 부채를 결제할 의도를 가지고 있을 때 상계하여 재무상태표에 순액으로 표시합니다. 법적으로 집행가능한 상계권리는 미래사건에 좌우되지 않으며, 정상적인 사업과정의 경우와 채무불이행의 경우 및 지급불능이나 파산의 경우에도 집행가능한 것을 의미합니다.</P>
<P></P>
<P>바. 파생상품 파생상품은 파생상품 계약 체결 시점에 공정가치로 최초 인식되며 이후 공정가치로 재측정됩니다. 위험회피회계의 적용 요건을 충족하지 않는 파생상품의 공정가치변동은 거래의 성격에 따라 '금융수익(비용)'으로 포괄손익계산서에 인식됩니다.</P>
<P>사. 매출채권 </P>
<P>매출채권은 유의적인 금융요소를 포함하지 않는 경우에는 무조건적인 대가의 금액으로, 유의적인 금융요소를 포함하는 경우에는 공정가치로 최초 인식합니다. 매출채권은 후속적으로 유효이자율법을 적용한 상각후원가에 손실충당금을 차감하여 측정됩니다. 회사는 보고기간말 현재 고객의 신용도, 거래형태, 규모, 결제조건 등 미래 전망 정보를 포함하는 합리적이고 뒷받침될 수 있는 모든 정보를 고려하여 기대신용손실을 개별적으로 추정하고 있으며 이에 따라 대손충당금을 설정하고 있습니다. </P>
<P>아. 재고자산 재고자산은 원가와 순실현가능가치 중 작은 금액으로 표시되고, 재고자산의 원가는 총평균법에 의해 산정된 취득원가를 장부금액으로 하고 있으며, 연중 계속기록법에 의하여 수량 및 금액을 계산하고 매 기말 실지재고조사를 실시하여 그 기록을 조정하고 있습니다. </P>
<PGBRK></PGBRK>
<P>보고기간 종료일 현재 재고자산의 시가(제품, 상품 및 재공품은 순실현가능가치, 원재료 등은 현행대체원가)가 취득원가보다 하락한 경우에는 시가를 장부금액으로 하고 있습니다. 재고자산의 저가법 적용은 항목별로 적용하고 있으며 재고자산의 저가법 적용으로 발생하는 재고자산평가손실은 당해 재고자산에서 차감하는 형식으로 표시하고 이를 매출원가에 가산하고 있습니다. </P>
<P>자. 유형자산 유형자산은 최초에 원가로 측정하여 인식하고 있습니다. 유형자산의 원가에는 경영진이 의도하는 방식으로 자산을 가동하는데 필요한 장소와 상태에 이르게 하는데 직접 관련되는 원가 및 자산을 해체, 제거하거나 부지를 복구하는데 소요될 것으로 추정되는 원가가 포함됩니다.유형자산은 최초 인식 후에 원가에서 감가상각누계액과 손상차손누계액, 국고보조금액을 차감한 금액을 장부금액으로 하고 있습니다.회사에서 인식하는 유형자산의 자본적지출은 내용연수를 연장시키거나 자산의 가치를 현실적으로 증가시키기 위하여 투입된 비용만을 반영합니다.</P>
<P>토지를 제외한 자산은 취득원가에서 잔존가치를 제외하고, 다음의 추정 경제적 내용연수에 걸쳐 정액법으로 상각됩니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="595">

<COLGROUP>
<COL WIDTH="269"></COL>
<COL WIDTH="308"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="278" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>과     목 </P>
</TH>

<TH WIDTH="317" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>추정 내용연수 </P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="278" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>건     물 </P>
</TD>
<TD WIDTH="317" HEIGHT="30" ALIGN="CENTER">30년, 40년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="278" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>기계장치 </P>
</TD>
<TD WIDTH="317" HEIGHT="30" ALIGN="CENTER">5년 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="278" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">
<P>비     품 </P>
</TD>

<TD WIDTH="317" HEIGHT="30" ALIGN="CENTER">
<P>5년 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="278" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">시설장치</TD>
<TD WIDTH="317" HEIGHT="30" ALIGN="CENTER">5년 </TD>
</TR>
</TBODY>
</TABLE>
<P>유형자산의 감가상각방법과 잔존가치 및 경제적 내용연수는 매 회계연도 말에 재검토되고 필요한 경우 추정의 변경으로 조정됩니다.</P>
<P>차. 정부보조금  정부보조금은 보조금의 수취와 정부보조금에 부가된 조건의 준수에 대한 합리적인 확신이 있을 때 공정가치로 인식됩니다. 자산관련보조금은 자산의 장부금액을 계산할 때 차감하여 표시되며, 수익관련보조금은 이연하여 정부보조금의 교부 목적과 관련된 비용에서 차감하여 표시됩니다. 카. 무형자산 무형자산은 역사적 원가로 최초 인식되고, 원가에서 상각누계액과 손상차손누계액, 국고보조금액을 차감한 금액으로 표시됩니다. </P>
<P> </P>
<P>한정된 내용연수를 가지는 다음의 무형자산은 추정내용연수동안 정액법으로 상각됩니다. </P>

<TABLE BORDER="1" WIDTH="593" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="288"></COL>
<COL WIDTH="287"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="297" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">
<P>과     목 </P>
</TH>

<TH WIDTH="296" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">
<P>추정 내용연수 </P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="297" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">산업재산권</TD>
<TD WIDTH="296" HEIGHT="30" ALIGN="CENTER">5년, 7년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="297" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">소프트웨어</TD>

<TD WIDTH="296" HEIGHT="30" ALIGN="CENTER">
<P>5년</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>타. 비금융자산의 손상내용연수가 비한정인 무형자산에 대하여는 매년, 상각대상 자산에 대하여는 자산손상을 시사하는 징후가 있을 때 손상검사를 수행하고 있습니다. 손상차손은 회수가능액(사용가치 또는 처분부대원가를 차감한 공정가치 중 높은 금액)을 초과하는 장부금액만큼 인식되고 영업권 이외의 비금융자산에 대한 손상차손은 매 보고기간말에 환입가능성이 검토됩니다.</P>
<P>파. 매입채무와 기타채무</P>
<P>매입채무와 기타채무는 회사가 보고기간말 전에 재화나 용역을 제공받았으나 지급되지 않은 부채입니다. 해당 채무는 무담보이며, 보통 인식 후 60일 이내에 지급됩니다. 매입채무와 기타 채무는 지급기일이 보고기간 후 12개월 후가 아니라면 유동부채로 표시되었습니다. 해당 채무들은 최초에 공정가치로 인식되고 후속적으로 유효이자율법을 적용한 상각후원가로 측정됩니다.</P>
<PGBRK></PGBRK>
<P></P>
<P>하. 금융부채 (1)  분류 및 측정</P>
<P>회사의 당기손익-공정가치 측정 금융부채는 단기매매목적의 금융상품입니다. 주로 단기간 내에 재매입할 목적으로 부담하는 금융부채는 단기매매금융부채로 분류됩니다. 또한, 위험회피회계의 수단으로 지정되지 않은 파생상품이나 금융상품으로부터 분리된 내재파생상품도 단기매매금융부채로 분류됩니다.</P>
<P> </P>
<P>당기손익-공정가치 측정 금융부채, 금융보증계약, 금융자산의 양도가 제거조건을 충족하지 못하는 경우에 발생하는 금융부채를 제외한 모든 비파생금융부채는 상각후원가로 측정하는 금융부채로 분류되고 있으며, 재무상태표 상 '기타채무', '차입금' 등으로 표시됩니다. </P>
<P> </P>
<P>특정일에 의무적으로 상환해야 하는 우선주는 부채로 분류됩니다. 이러한 우선주에 대한 유효이자율법에 따른 이자비용은 다른 금융부채에서 인식한 이자비용과 함께 포괄손익계산서 상 '금융원가'로 인식됩니다.</P>
<P></P>
<P>(2)  제거</P>
<P>금융부채는 계약상 의무가 이행, 취소 또는 만료되어 소멸되거나 기존 금융부채의 조건이 실질적으로 변경된 경우에 재무상태표에서 제거됩니다. 소멸하거나 제3자에게 양도한 금융부채의 장부금액과 지급한 대가(양도한 비현금자산이나 부담한 부채를 포함)의 차액은 당기손익으로 인식합니다.</P>
<P>거. 충당부채 및 우발부채회사는 과거사건의 결과로 존재하는 현재의 법적의무 또는 의제의무 이행을 위하여 경제적 효익을 갖는 자원이 유출될 가능성이 높으며 그 의무의 이행에 소요되는 금액의 신뢰성 있는 추정이 가능한 경우 충당부채를 인식하고 있습니다. </P>
<PGBRK></PGBRK>
<P>충당부채로 인식하는 금액은 관련된 사건과 상황에 대한 불가피한 위험과 불확실성을 고려하여 현재의무를 보고기간말에 이행하기 위하여 소요되는 지출에 대한 최선의 추정치입니다. 화폐의 시간가치 효과가 중요한 경우 충당부채는 의무를 이행하기위하여 예상되는 지출액의 현재가치로 평가하고 있습니다.또한 과거사건은 발생하였으나 불확실한 미래사건의 발생여부에 의해서 존재여부가 확인되는 잠재적인 의무가 있는 경우 또는 과거사건이나 거래의 결과 현재 의무가 존재하나 자원이 유출될 가능성이 매우 높지 않거나 당해 의무를 이행하여야 할 금액을신뢰성 있게 추정할 수 없는 경우 우발부채로 주석기재하고 있습니다.너. 당기법인세 및 이연법인세 법인세비용은 당기법인세와 이연법인세로 구성됩니다. 법인세는 기타포괄손익이나 자본에 직접 인식된 항목과 관련된 금액은 해당 항목에서 직접 인식하며, 이를 제외하고는 당기손익으로 인식됩니다.당기법인세비용은 보고기간말 현재 제정되었거나 실질적으로 제정된 세법에 근거하여 측정합니다. 경영진은 적용 가능한 세법 규정이 해석에 따라 달라질 수 있는 상황에 대하여 회사가 세무신고 시 적용한 세무정책에 대하여 주기적으로 평가하고 있으며, 세무당국이 불확실한 법인세 처리를 수용할 가능성이 높은지 고려합니다. 회사는법인세 측정 시 가장 가능성이 높은 금액 또는 기댓값 중 불확실성의 해소를 더 잘 예측할 것으로 예상되는 방법을 사용하여 불확실성의 영향을 반영합니다.이연법인세는 자산과 부채의 장부금액과 세무기준액의 차이로 발생하는 일시적차이에 대하여 장부금액을 회수하거나 결제할 때의 예상 법인세효과로 인식됩니다. 다만,사업결합 및 리스 이외의 거래에서 자산 ·부채를 최초로 인식할 때 발생하는 이연법인세 자산과 부채는 거래가 회계이익이나 과세소득에 영향을 미치지 않는다면 인식되지 않습니다.이연법인세자산은 차감할 일시적차이가 사용될 수 있는 미래 과세소득의 발생가능성이 높은 경우에 인식됩니다.이연법인세 자산과 부채는 법적으로 당기법인세자산과 당기법인세부채를 상계할 수 있는 권리를 회사가 보유하고 있고, 이연법인세 자산과 부채가 동일한 과세당국에 의해서 부과되는 법인세와 관련된 경우에 상계합니다. 당기법인세 자산과 부채는 법적으로 상계할 수 있는 권리를 회사가 보유하고 있고, 순액으로 결제할 의도가 있거나 자산을 실현하는 동시에 부채를 결제하려는 의도가 있는 경우에 상계합니다.</P>
<P>더. 납입자본</P>
<P>보통주는 자본으로 분류하며 자본거래와 직접 관련되어 발생하는 증분원가는 세금효과를 반영한 순액으로 자본에서 차감하고 있습니다. 러. 종업원급여 (1) 퇴직급여  회사의 퇴직연금제도는 확정기여제도입니다. 확정기여제도는 회사가 고정된 금액의 기여금을 별도 기금에 지급하는 퇴직연금제도이며, 기여금은 종업원이 근무 용역을 제공했을 때 비용으로 인식됩니다.(2) 주식기준보상  종업원에게 부여한 주식결제형 주식기준보상은 부여일에 지분상품의 공정가치로 측정되며, 가득기간에 걸쳐 종업원 급여비용으로 인식됩니다.</P>
<P> </P>
<P>주식선택권의 행사시점에 신주를 발행할 때 직접적으로 관련되는 거래비용을 제외한순유입액은 자본금(명목가액)과 주식발행초과금으로 인식됩니다. </P>
<P>머. 수익인식 회사는 제1115호에 따라 모든 유형의 계약에 5단계 수익인식모형(① 계약 식별 → ② 수행의무 식별 → ③ 거래가격 산정 → ④ 거래가격을 수행의무에 배분 →⑤ 수행의무 이행 시 수익 인식)을 적용하여 수익을 인식합니다.</P>
<PGBRK></PGBRK>
<P></P>
<P>(1) 변동대가회사는 의약품을 제조 및 판매하는 사업을 영위하고 있으며 재화의 판매에 따른 수익은 재화가 구매자에게 인도되는 시점에 인식하고 있습니다. 회사는 고객에게 지급할 대가인 변동대가와 관련하여 불확실성이 나중에 해소 될 때, 이미 인식한 누적 수익 금액 중 유의적인 부분을 되돌리지 않을 가능성이 매우 높은 정도까지만 변동대가를 거래가격에 포함하여 수익으로 인식합니다.</P>
<P>(2) 수행의무의 식별회사는 신약개발과 관련된 기술이전으로 인한 수익이 발생하고 있습니다. 기술이전으로 인한 수익은 통상 계약체결시점에 수령하는 계약금(Upfront payment), 일정요건 달성시점에 수령하는 마일스톤 금액(Milestone payment), 및 매출액의 일정비율로 수령하는 로열티로 구성되어 있습니다. 계약금(Upfront payment)은 반환의무가 없고, 기술이전 시점 이후에 수행할 추가적인 의무가 없는 경우 일시에 수익으로 인식하고 있습니다. 특정 임상실험의 완료 등 추가적인 의무가 있다면, 의무가 종료될 것으로 예상되는 기간 동안 안분하여 수익으로 인식하고 있습니다. 마일스톤 금액(Milestone payment)은 특정 임상실험의 착수 및 종료, 규제당국의 승인 등 계약에서 규정된 일정요건이 만족되는 시점에 수익으로 인식하고 있습니다. 로열티(Royalty)는 관련된 계약의 경제적 실질을 반영하여 발생기준에 따라 인식하고 있습니다. 회사는 과거에 체결했던 라이선스 계약 중 수행의무를 이행한 때 또는 기간에 걸쳐 이행하는지에 따라 수익을 인식합니다.버.  리스 </P>
<P>회사는 사무실 등을 리스하고 있습니다. 리스계약은 일반적으로 고정기간으로 체결되지만 아래에서 설명하는 연장선택권이 있을 수 있습니다.</P>
<P> </P>
<P>계약에는 리스요소와 비리스요소가 모두 포함될 수 있습니다. 회사는 상대적 개별 가격에 기초하여 계약 대가를 리스요소와 비리스요소에 배분하였습니다.  </P>
<P></P>
<P>리스조건은 개별적으로 협상되며 다양한 계약조건을 포함합니다. 리스계약에 따라 부과되는 다른 제약은 없지만 리스자산을 차입금의 담보로 제공할 수는 없습니다.</P>
<P> </P>
<P>회사는 계약이 집행가능한 기간 내에서 해지불능기간에 리스이용자가 연장선택권을 행사할 것이 상당히 확실한 경우의 그 대상기간과 종료선택권을 행사하지 않을 것이 상당히 확실한 경우의 그 대상기간을 포함하여 리스기간을 산정합니다. 회사는 리스이용자와 리스제공자가 각각 다른 당사자의 동의 없이 종료할 수 있는 권리가 있는 경우 계약을 종료할 때 부담할 경제적 불이익을 고려하여 집행가능한 기간을 산정합니다. </P>
<P> </P>
<P>리스에서 생기는 자산과 부채는 최초에 현재가치기준으로 측정합니다. 리스부채는 다음 리스료의 순현재가치를 포함합니다.</P>
<P>·받을 리스 인센티브를 차감한 고정리스료(실질적인 고정리스료 포함)</P>
<P>·개시일 현재 지수나 요율을 사용하여 최초 측정한, 지수나 요율(이율)에 따라 달라지는 변동리스료</P>
<P>·잔존가치보증에 따라 회사(리스이용자)가 지급할 것으로 예상되는 금액</P>
<P>·회사(리스이용자)가 매수선택권을 행사할 것이 상당히 확실한 경우에 그 매수선택권의 행사가격</P>
<P>·리스기간이 회사(리스이용자)의 종료선택권 행사를 반영하는 경우에 그 리스를 종료하기 위하여 부담하는 금액</P>
<P> </P>
<P>리스의 내재이자율을 쉽게 산정할 수 있는 경우 그 이자율로 리스료를 할인합니다. 내재이자율을 쉽게 산정할 수 없는 경우에는 리스이용자가 비슷한 경제적 환경에서 비슷한 기간에 걸쳐 비슷한 담보로 사용권자산과 가치가 비슷한 자산을 획득하는 데 필요한 자금을 차입한다면 지급해야 할 이자율인 리스이용자의 증분차입이자율을 사용합니다.</P>
<P> </P>
<P>회사는 증분차입이자율을 다음과 같이 산정합니다.</P>
<P>·가능하다면 개별 리스이용자가 받은 최근 제3자 금융 이자율에 제3자 금융을 받은 이후 재무상태의 변경을 반영</P>
<P>·무담보 차입금이자율에 신용위험을 조정하는 상향 접근법을 사용</P>
<PGBRK></PGBRK>
<P></P>
<P>개별 리스이용자가 리스와 비슷한 지급일정을 가진 분할상환 차입금 이자율을 쉽게 관측(최근의 금융 또는 시장 자료를 통해)할 수 있는 경우, 회사는 증분차입이자율을 산정할 때 그 이자율을 시작점으로 사용합니다.</P>
<P> </P>
<P>회사는 지수나 요율에 따라 달라지는 변동리스료의 경우 지수나 요율이 유효할 때까지 리스부채에 포함하지 않는 변동리스료의 잠재적 미래 증가 위험에 노출되어 있습니다. 지수나 요율에 따라 달라지는 리스료의 조정액이 유효한 시점에서 리스부채를 재평가하고 사용권자산을 조정합니다.</P>
<P> </P>
<P>각 리스료는 리스부채의 상환과 금융원가로 배분합니다. 금융원가는 각 기간의 리스부채 잔액에 대하여 일정한 기간 이자율이 산출되도록 계산된 금액을 리스기간에 걸쳐 당기손익으로 인식합니다. </P>
<P> </P>
<P>사용권자산은 다음 항목들로 구성된 원가로 측정합니다.</P>
<P>·리스부채의 최초 측정금액</P>
<P>·받은 리스 인센티브를 차감한 리스개시일이나 그 전에 지급한 리스료</P>
<P>·리스이용자가 부담하는 리스개설직접원가</P>
<P>·복구원가의 추정치</P>
<P> </P>
<P>사용권자산은 리스개시일부터 사용권자산의 내용연수 종료일과 리스기간 종료일 중 이른 날까지의 기간동안 감가상각합니다. 회사가 매수선택권을 행사할 것이 상당히 확실한(reasonably certain) 경우 사용권자산은 기초자산의 내용연수에 걸쳐 감가상각합니다. </P>
<P></P>
<P>서. 주당손익  </P>
<P>기본주당손익은 주주에게 귀속되는 포괄손익계산서상 당기순손익을 보고기간 동안의 회사의 가중평균 유통보통주식수로 나누어 산정한 것입니다.</P>
<PGBRK></PGBRK>
<P> </P>
<P>희석주당손익은 주주에게 귀속되는 포괄손익계산서상 당기순손익을 보고기간 동안의 회사의 가중평균 유통보통주식수와 가중평균 잠재적 희석증권주식수로 나누어 산정한 것입니다. 잠재적 희석증권은 희석효과가 발생하는 경우에만 희석주당손익의 계산에 반영됩니다.</P>
<P USERMARK=" 0X0000FF"></P>
<P>기본주당이익은 주주에게 귀속되는 포괄손익계산서상 당기순이익을 보고기간 동안의 회사의 가중평균 유통보통주식수로 나누어 산정한 것입니다.</P>
<P> </P>
<P>희석주당이익은 주주에게 귀속되는 포괄손익계산서상 당기순이익을 보고기간 동안의 회사의 가중평균 유통보통주식수와 가중평균 잠재적 희석증권주식수로 나누어 산정한 것입니다. 잠재적 희석증권은 희석효과가 발생하는 경우에만 희석주당이익의 계산에 반영됩니다.</P>
<P>어. 영업부문 영업부문별 정보는 최고영업의사결정자에게 내부적으로 보고되는 방식에 기초하여 공시됩니다. 최고영업의사결정자는 영업부문에 배부될 자원과 영업부문의 성과를 평가하는데 책임이 있으며, 회사는 전략적 의사결정을 수행하는 이사회를 최고의사결정자로 보고 있습니다.</P>
<P>3. 중요한 회계추정 및 가정 </P>
<P></P>
<P>주석 2에서 기술된 회사의 회계정책을 적용함에 있어서, 경영진은 재무제표에 인식되는 금액에 유의적인 영향을 미치는 판단을 하여야 하며(추정 관련된 사항은 제외), 다른 자료로부터 쉽게 식별할 수 없는 자산과 부채의 장부금액에 대한 추정 및 가정을 하여야 합니다. 추정치와 관련 가정은 과거 경험 및 관련이 있다고 여겨지는 기타 요인에 근거합니다. 또한 실제 결과는 이러한 추정치들과 다를 수도 있습니다.  </P>
<P> </P>
<P>추정과 기초적인 가정은 계속하여 검토됩니다. 회계추정에 대한 수정은 그러한 수정이 오직 당해 기간에만 영향을 미칠 경우 수정이 이루어진 기간에 인식되며, 당기와 미래 기간 모두 영향을 미칠 경우 수정이 이루어진 기간과 미래 기간에 인식됩니다.</P>
<P>4. 재무위험관리 가. 재무위험관리요소   회사가 노출되어 있는 재무위험 및 이러한 위험이 회사의 미래 성과에 미칠 수 있는 영향은 다음과 같습니다. </P>
<P>(1) 이자율위험  회사는 이자율 변동으로 인한 금융자산, 부채의 가치변동 위험 및 투자, 차입에서 비롯한 이자수익(비용)의 변동위험 등의 이자율변동위험에 노출되어 있습니다. (2) 신용위험관리 신용위험은 회사의 통상적인 거래 및 투자활동에서 발생하며 고객 또는 거래상대방이 계약조건을 지키지 못하였을 경우 발생합니다. 이러한 신용위험을 관리하기 위하여 회사는 주기적으로 고객과 거래상대방의 재무상태와 과거 경험 등의 요소들을 고려하여 금융자산을 관리하고 있습니다.당기 중 중요한 손상의 징후나 회수기일이 초과된 금융자산에 포함된 미수금 등은 발생하지 않았으며 회사는 당기말 현재 채무불이행 등이 발생할 징후는 낮은 것으로 판단하고 있습니다.신용위험은 현금및현금성자산, 각종 예금 등과 같은 금융기관과의 거래에서도 발생할 수 있습니다. 이러한 위험을 줄이기 위해 회사는 신용도가 높은 금융기관들에 대해서만 거래를 하고 있습니다.</P>
<P>한편, 당기 및 전기말 현재 신용위험의 최대노출도는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="610">

<COLGROUP>
<COL WIDTH="195"></COL>
<COL WIDTH="194"></COL>
<COL WIDTH="194"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="610" VALIGN="MIDDLE" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" COLSPAN="3">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구  분</TH>
<TH WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당기말</TH>
<TH WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30"> 현금및현금성자산</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,819,470</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,256,127</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30"> 매출채권</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40,911</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,731,265</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30"> 기타채권</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">507,091</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,055,238</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30"> 기타비유동금융자산</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,298,120</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">742,176</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합   계</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,665,592</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,784,806</TD>
</TR>
</TBODY>
</TABLE>
<P>(3) 유동성 위험 유동성위험관리에 대한 궁극적인 책임은 회사의 단기 및 중장기 자금조달과 유동성관리규정을 적절하게 관리하기 위한 기본정책을 수립하는 이사회에 있습니다. 회사는 충분한 적립금과 차입한도를 유지하고 예측현금흐름과 실제현금흐름을 계속하여 관찰하고 금융자산과 금융부채의 만기구조를 대응시키면서 유동성위험을 관리하고 있습니다. 당기 및 전기말  현재 회사의 유동성 내역은 다음과 같습니다.1) 당기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="791">

<COLGROUP>
<COL WIDTH="162"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="791" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="6">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="171" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부가액</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1년 미만</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1~5년</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">5년 초과</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합  계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" VALIGN="MIDDLE" HEIGHT="30">기타금융채무(유동)</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,516,309</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,516,309</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,516,309</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" VALIGN="MIDDLE" HEIGHT="30">기타금융채무(비유동)</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,815</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,815</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,815</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" VALIGN="MIDDLE" HEIGHT="30">리스부채</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,800,268</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,263,465</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,238,127</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,501,593</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합   계</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,330,392</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,779,774</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,251,942</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,031,717</TD>
</TR>
</TBODY>
</TABLE>
<P>2) 전기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="791">

<COLGROUP>
<COL WIDTH="164"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="791" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="6">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부가액</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1년 미만</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1~5년</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">5년 초과</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합  계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" VALIGN="MIDDLE" HEIGHT="30">기타금융채무(유동)</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,112,117</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,112,117</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,112,117</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" VALIGN="MIDDLE" HEIGHT="30">리스부채</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,971,665</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,324,529</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,159,954</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,484,483</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,083,782</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,436,646</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,159,954</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,596,600</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>나. 자본위험 관리 </P>
<P>회사는 부채와 자본 잔액의 최적화를 통하여 주주이익을 극대화시키는 동시에 계속기업으로서 지속될 수 있도록 자본을 관리하고 있습니다. 회사는 자본관리지표로 부채비율을 이용하고 있고, 이 비율은 총부채를 총자본으로 나누어 산출하고 있습니다.당기 및 전기말 현재 부채비율은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="200"></COL>
<COL WIDTH="200"></COL>
<COL WIDTH="200"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="627" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구     분</P>
</TH>

<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>당기말</P>
</TH>

<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>전기말</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>총차입금 </P>
</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>차감: 현금및현금성자산 </P>
</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">23,819,470</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">19,256,127</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>순부채 </P>
</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(23,819,470)</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(19,256,127)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30">
<P>자본총계  </P>
</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">30,434,805</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">26,491,195</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" HEIGHT="30" VALIGN="BOTTOM">
<P>자본조달비율 (주1)</P>
</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P>(주1) 순부채가 음수이므로 자본조달비율은 계산하지 아니하였습니다. </P>
<P>5. 금융상품 공정가치 가. 금융상품 종류별 공정가치 당기 및 전기말 현재 금융상품의 종류별 장부금액 및 공정가치는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="654">

<COLGROUP>
<COL WIDTH="230"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="94"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="654" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="239" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">구  분</TH>

<TH WIDTH="208" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>당기말</P>
</TH>

<TH WIDTH="207" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>전기말</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="104" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>장부금액</P>
</TH>

<TH WIDTH="104" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>공정가치</P>
</TH>

<TH WIDTH="104" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>장부금액</P>
</TH>

<TH WIDTH="103" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>공정가치</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="654" HEIGHT="30" COLSPAN="5">
<P USERMARK=" BC0XF2F2F2">금융자산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="239" HEIGHT="30"> 현금및현금성자산</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">23,819,470</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">23,819,470</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">19,256,127</TD>
<TD WIDTH="103" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">19,256,127</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="239" HEIGHT="30"> 매출채권(주1)</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">40,911</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">40,911</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,731,265</TD>
<TD WIDTH="103" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,731,265</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="239" HEIGHT="30"> 기타채권(주1)</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">507,091</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">507,091</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,055,238</TD>
<TD WIDTH="103" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,055,238</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="239" HEIGHT="30"> 기타금융자산(주1)</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,298,120</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,298,120</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">742,176</TD>
<TD WIDTH="103" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">742,176</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="239" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합   계</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">25,665,592</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">25,665,592</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">22,784,806</TD>
<TD WIDTH="103" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">22,784,806</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="654" HEIGHT="30" COLSPAN="5" VALIGN="MIDDLE">
<P USERMARK=" BC0XF2F2F2">금융부채</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="239" HEIGHT="30">매입채무 및 기타채무(주1)</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,530,124</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,530,124</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,112,117</TD>
<TD WIDTH="103" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,112,117</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="239" HEIGHT="30"> 리스부채(주1)</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2,800,268</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2,800,268</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">3,971,665</TD>
<TD WIDTH="103" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">3,971,665</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="239" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합   계</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">4,330,392</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">4,330,392</TD>
<TD WIDTH="104" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">5,083,782</TD>
<TD WIDTH="103" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">5,083,782</TD>
</TR>
</TBODY>
</TABLE>
<P>(주1) 장부금액과 공정가치의 차이가 중요하지 않으므로 장부가액을 공정가치로 산출하였습니다.나. 공정가치 서열체계 공정가치란 측정일에 시장참여자 사이의 정상거래에서 자산을 매도할 때 받거나 부채를 이전할 때 지급하게 될 가격을 의미합니다. 공정가치 측정은 측정일에 현행 시장 상황에서 자산을 매도하거나 부채를 이전하는 시장참여자 사이의 정상거래에서의가격을 추정하는 것으로, 회사는 공정가치 평가시 시장정보를 최대한 사용하고, 관측가능하지 않은 변수는 최소한으로 사용하고 있습니다.</P>
<P></P>
<P>회사는 공정가치로 측정되는 자산·부채를 공정가치 측정에 사용된 투입변수에 따라다음과 같은 공정가치 서열체계로 분류하였습니다. </P>
<P>수준1 : 활성시장에서 공시되는 가격을 공정가치로 측정하는 자산·부채의 경우 동 자산·부채의 공정가치는 수준1로 분류됩니다. 수준2 : 가치평가기법을 사용하여 자산·부채의 공정가치를 측정하는 경우, 모든 유의적인 투입변수가 시장에서 관측한 정보에 해당하면 자산·부채의 공정가치는 수준2로 분류됩니다. 수준3 : 가치평가기법을 사용하여 자산·부채의 공정가치를 측정하는 경우, 하나 이상의 유의적인 투입변수가 시장에서 관측불가능한 정보에 해당하면 동 금융상품의 공정가치는 수준3으로 분류됩니다. 당기와 전기 모두 수준 3의 금융부채를 보유하고 있지 않습니다.</P>
<PGBRK></PGBRK>
<P>6. 범주별 금융상품 가. 당기 및 전기말 현재 금융자산의 범주별 장부금액은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="605" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="299"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="139"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="605" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="308" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구    분</TH>

<TH WIDTH="149" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>당기말</P>
</TH>

<TH WIDTH="148" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>전기말</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">상각후원가 금융자산</TD>
<TD WIDTH="149" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="148" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">  현금및현금성자산</TD>
<TD WIDTH="149" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">23,819,470</TD>
<TD WIDTH="148" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">19,256,127</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">  매출채권</TD>
<TD WIDTH="149" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">40,911</TD>
<TD WIDTH="148" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">1,731,265</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">  기타채권</TD>
<TD WIDTH="149" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">507,091</TD>
<TD WIDTH="148" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">1,055,238</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">  기타비유동금융자산</TD>
<TD WIDTH="149" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">1,298,120</TD>
<TD WIDTH="148" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">742,176</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합     계</TD>
<TD WIDTH="149" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">25,665,592</TD>
<TD WIDTH="148" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">22,784,806</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>나. 당기 및 전기말 현재 금융부채의 범주별 장부금액은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="602" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="301"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="137"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="602" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="310" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구    분</TH>

<TH WIDTH="146" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>당기말</P>
</TH>

<TH WIDTH="146" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>전기말</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30">상각후원가 금융부채</TD>
<TD WIDTH="146" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="146" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30">  매입채무 및 기타채무</TD>
<TD WIDTH="146" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">1,530,124</TD>
<TD WIDTH="146" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">1,112,117</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30">  리스부채</TD>
<TD WIDTH="146" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">2,800,268</TD>
<TD WIDTH="146" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">3,971,665</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합     계</TD>
<TD WIDTH="146" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">4,330,392</TD>
<TD WIDTH="146" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">5,083,782</TD>
</TR>
</TBODY>
</TABLE>
<P>다. 당기 및 전기 중 금융상품 범주별 순손익은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="603" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="301"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="137"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="603" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="310" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구    분</TH>
<TH WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당기</TH>
<TH WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" VALIGN="BOTTOM" HEIGHT="30">상각후원가 금융자산</TD>
<TD WIDTH="147" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="146" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" VALIGN="BOTTOM" HEIGHT="30">  이자수익</TD>
<TD WIDTH="147" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">189,223</TD>
<TD WIDTH="146" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">41,102</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" VALIGN="BOTTOM" HEIGHT="30">  외환손익</TD>
<TD WIDTH="147" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">74,365</TD>
<TD WIDTH="146" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">(20,387)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" VALIGN="BOTTOM" HEIGHT="30">상각후원가 금융부채</TD>
<TD WIDTH="147" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="146" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" VALIGN="BOTTOM" HEIGHT="30">  이자비용</TD>
<TD WIDTH="147" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">(103,353)</TD>
<TD WIDTH="146" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">(110,472)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합     계</TD>
<TD WIDTH="147" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">160,235</TD>
<TD WIDTH="146" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">(89,757)</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>7. 현금및현금성자산 가. 당기 및 전기말 현재 현금및현금성자산의 구성 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="606">

<COLGROUP>
<COL WIDTH="193"></COL>
<COL WIDTH="193"></COL>
<COL WIDTH="193"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="606" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="202" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구  분</TH>

<TH WIDTH="202" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>당기말</P>
</TH>

<TH WIDTH="202" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>전기말</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" VALIGN="MIDDLE" HEIGHT="30">보통예금</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,744,819</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,252,886</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" VALIGN="MIDDLE" HEIGHT="30">정기예금</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,074,651</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,003,241</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,819,470</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,256,127</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" B">
<SPAN USERMARK=" !B">나. 당기 및 전기말 현재 사용이 제한된 예금은 없습니다.8. 매출채권및기타채권과 기타금융자산가. 당기 및 전기말 현재 매출채권및기타채권과 기타금융자산의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="614">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="614" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">구  분</TH>

<TH COLSPAN="2" WIDTH="228" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>당기말</P>
</TH>

<TH COLSPAN="2" WIDTH="228" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>전기말</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유동</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비유동</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유동</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비유동</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="614" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="5">매출채권및기타채권</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">  매출채권</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40,911</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,731,265</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">  미수금</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">420,416</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,040,207</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">  미수수익</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">86,676</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,031</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">소     계</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">548,003</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,786,503</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="614" VALIGN="MIDDLE" HEIGHT="31" COLSPAN="5">기타금융자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">  장기대여금</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">692,608</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" HEIGHT="30">  보증금</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">605,512</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">742,176</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합     계</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">548,003</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,298,120</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,786,503</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">742,176</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" B">
<SPAN USERMARK=" !B">나. 당기 및 전기말 현재 매출채권및기타채권 중 연체된 채권은 없습니다.</SPAN>
</P>
<PGBRK></PGBRK>

<P USERMARK=" B">
<SPAN USERMARK=" !B">다. 당기 및 전기말 현재 매출채권및기타채권과 기타금융자산 중 손상된 자산은 없습니다.9. 기타자산 당기 및 전기말 현재 기타자산의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="616">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="616" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="5">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">구  분</TH>

<TH COLSPAN="2" WIDTH="234" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>당기말</P>
</TH>

<TH COLSPAN="2" WIDTH="232" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>전기말</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="117" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">유동</TH>
<TH WIDTH="117" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">비유동</TH>
<TH WIDTH="116" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">유동</TH>
<TH WIDTH="116" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">비유동</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" VALIGN="MIDDLE" HEIGHT="30">선급금</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">719,208</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,529</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" VALIGN="MIDDLE" HEIGHT="30">선급비용</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">41,853</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,908</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" VALIGN="MIDDLE" HEIGHT="30">부가세대급금</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,329</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합     계</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">761,061</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">55,766</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>10. 재고자산 가. 당기 및 전기말 현재 재고자산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="670">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="163"></COL>
<COL WIDTH="163"></COL>
<COL WIDTH="162"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="670" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="4">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="155" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">구  분</TH>

<TH WIDTH="515" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">
<P>당기말</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="172" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">취득원가</TH>
<TH WIDTH="172" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">평가손실충당금</TH>
<TH WIDTH="171" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">미착품</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,919</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,919</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">원재료</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">54,337</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">54,337</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">제품</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">287,706</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(218,595)</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">69,111</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">349,962</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(218,595)</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">131,367</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="670">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="163"></COL>
<COL WIDTH="163"></COL>
<COL WIDTH="162"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="670" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="4">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="155" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">구  분</TH>

<TH WIDTH="515" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">
<P>전기말</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="172" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">취득원가</TH>
<TH WIDTH="172" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">평가손실충당금</TH>
<TH WIDTH="171" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">원재료</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">43,089</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">43,089</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">제품</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">47,756</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(19,469)</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,287</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">90,845</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(19,469)</TD>
<TD WIDTH="171" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">71,376</TD>
</TR>
</TBODY>
</TABLE>
<P>나. 당기 중 재고자산평가손실 199,125천원(전기: 19,469천원)을 인식하였습니다.11. 유형자산 가. 당기 및 전기말 현재 유형자산의 내역은 다음과 같습니다.(1) 당기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="645">

<COLGROUP>
<COL WIDTH="171"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="645" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각누계액</TH>
<TH WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">정부보조금</TH>
<TH WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">토지</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">71,256</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">71,256</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">건물</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">311,247</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(36,312)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">274,935</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">사용권자산</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,820,045</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,980,603)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,839,442</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">기계장치</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,861,245</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,241,813)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(8,937)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,610,495</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">비품</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,787,825</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(610,485)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(59,962)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,117,378</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">시설장치</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,880,834</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(689,217)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,191,617</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">건설중인자산</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">449,700</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">449,700</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,182,152</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(5,558,430)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(68,899)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,554,823</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(2) 전기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="644">

<COLGROUP>
<COL WIDTH="172"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="106"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="644" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="5">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="181" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구  분</TH>
<TH WIDTH="116" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">취득원가</TH>
<TH WIDTH="116" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">감가상각누계액</TH>
<TH WIDTH="116" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">정부보조금</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" VALIGN="MIDDLE" HEIGHT="30">토지</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">71,256</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">71,256</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" VALIGN="MIDDLE" HEIGHT="30">건물</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">311,247</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(25,937)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">285,310</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" VALIGN="MIDDLE" HEIGHT="30">사용권자산</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,752,921</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,773,575)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,979,346</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" VALIGN="MIDDLE" HEIGHT="30">기계장치</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,294,939</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,659,204)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(57,086)</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,578,649</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" VALIGN="MIDDLE" HEIGHT="30">비품</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,252,531</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(313,160)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(44,704)</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">894,667</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" VALIGN="MIDDLE" HEIGHT="30">시설장치</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,699,128</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(319,267)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,379,861</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" VALIGN="MIDDLE" HEIGHT="30">건설중인자산</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">123,997</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">123,997</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,506,019</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,091,143)</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(101,790)</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,313,086</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>나. 당기 및 전기 중 유형자산의 변동내역은 다음과 같습니다.(1) 당기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="809">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="809" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="7">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="155" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구  분</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기  초</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">취  득</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">처  분</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">상 각</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">대체</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">토지</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">71,256</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">71,256</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">건물</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">285,310</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(10,374)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">274,936</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">사용권자산</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,979,346</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">44,393</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,172,133)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(12,165)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,839,441</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">기계장치</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,578,649</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">481,759</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(534,460)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">84,547</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,610,495</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">비품</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">894,667</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">503,245</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(280,533)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,117,379</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">시설장치</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,379,862</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">142,255</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(369,951)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">39,450</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,191,616</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">건설중인자산</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">123,997</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">449,700</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(123,997)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">449,700</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,313,087</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,621,352</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,367,451)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(12,165)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,554,823</TD>
</TR>
</TBODY>
</TABLE>
<P>(2) 전기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="809">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="809" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="7">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="155" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구  분</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기  초</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">취  득</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">처  분</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">상 각</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">대체</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">토지</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">544,617</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(473,361)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">71,256</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">건물</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,862,321</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">69,980</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,631,013)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(15,979)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">285,309</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">사용권자산</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,038,446</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,857,479</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(916,577)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,979,348</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">기계장치</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">705,486</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">473,800</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,920)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(481,233)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">884,515</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,578,648</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">비품</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">366,294</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">642,350</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,476)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(158,999)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">47,497</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">894,666</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">시설장치</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">449,370</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">834,511</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(108)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(230,781)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">326,870</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,379,862</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">건설중인자산</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,258,882</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">123,997</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,258,882)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">123,997</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,225,416</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,002,117</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,110,878)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,803,569)</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,313,086</TD>
</TR>
</TBODY>
</TABLE>
<P>다. 당기 및 전기말 현재 보유토지의 공시지가 현황은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="809">

<COLGROUP>
<COL WIDTH="364"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="809" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="5">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="373" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">보유토지</TH>
<TH COLSPAN="2" WIDTH="218" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기말</TH>
<TH COLSPAN="2" WIDTH="218" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">장부금액</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">공시지가</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">장부금액</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">공시지가</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="373" VALIGN="MIDDLE" HEIGHT="30">경기도 성남시 중원구 상대원동 5445 제101호</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">71,256</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">54,988</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">71,256</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49,554</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="373" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합   계</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">71,256</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">54,988</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">71,256</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49,554</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>라. 당기와 전기 중 정부보조금의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="626">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="147"></COL>
<COL WIDTH="147"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="4" WIDTH="626" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" WIDTH="314" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="156" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="156" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="314" VALIGN="MIDDLE" HEIGHT="30">기초 미사용잔액</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="314" VALIGN="MIDDLE" HEIGHT="30">정부보조금 수령액</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,469,140 </TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">593,038 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" WIDTH="155" VALIGN="MIDDLE" HEIGHT="150">정부보조금 사용액</TD>
<TD WIDTH="159" VALIGN="MIDDLE" HEIGHT="30">경상연구개발비</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,432,229 </TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">560,843 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" HEIGHT="30">유형자산 취득</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">32,049 </TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,961 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" HEIGHT="30">무형자산 취득</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,862 </TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" HEIGHT="30">기타비용</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,234 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" HEIGHT="30">소 계</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,469,140 </TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">593,038 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="314" VALIGN="MIDDLE" HEIGHT="30">기말 미사용잔액</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P>마. 당기와 전기 중 유형자산의 취득에 사용된 정부보조금 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="623">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="3" WIDTH="623" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="207" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">기초잔액</TD>
<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">101,791</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">190,705</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">자산취득액</TD>
<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">32,050</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,961</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">감가상각비계상액</TD>
<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(64,941)</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(110,875)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">자산 처분 또는 손상액</TD>
<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">기말잔액</TD>
<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">68,900</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">101,791</TD>
</TR>
</TBODY>
</TABLE>
<P>바. 당기와 전기 중 무형자산의 취득에 사용된 정부보조금의 내역은 다음과 같습니다</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="622" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE">기초잔액</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">96,358 </TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">114,702 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE">자산취득액</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,862 </TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE">감가상각비계상액</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(15,982) </TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(13,104)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE">자산 처분 또는 손상액</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(5,240)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE">기말잔액</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">85,238 </TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">96,358 </TD>
</TR>
</TBODY>
</TABLE>
<P>사. 당기와 전기 중 회사의 상환의무가 있는 정부보조금의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="3" WIDTH="622" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="207" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="207" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">기초잔액</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,518</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,748</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">증가</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,770</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">감소</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,424)</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">기말잔액</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,094</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,518</TD>
</TR>
</TBODY>
</TABLE>
<P>회사는 상환의무가 있는 정부보조금을 기타지급채무(미지급금)으로 계상하고 있으며당기말 이후 1년 이내 상환할 정부보조금은 11,094천원 입니다.12. 리스 가. 당기 및 전기말 현재 기초자산 유형별 사용권자산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="875">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="875" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="7">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">구  분</TH>
<TH WIDTH="375" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">당기말</TH>
<TH WIDTH="375" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">취득원가</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">감가상각</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">순장부가액</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">취득원가</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">감가상각</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">순장부가액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="30">부동산</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,102,700</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,597,592)</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,505,108</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,051,422</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,526,378)</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,525,044</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="30">기계장치</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">518,259</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(293,680)</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">224,579</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">518,259</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(190,028)</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">328,231</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="30">차량운반구</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">199,086</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(89,331)</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">109,755</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">183,240</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(57,169)</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">126,071</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,820,045</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,980,603)</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,839,442</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,752,921</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,773,575)</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,979,346</TD>
</TR>
</TBODY>
</TABLE>
<P>당기 및 전기 중 증가된 사용권자산은 각각 44,393천원과 1,857,479천원입니다.</P>
<PGBRK></PGBRK>
<P>나. 당기 및 전기 중 리스와 관련해 손익으로 인식된 금액은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="608">

<COLGROUP>
<COL WIDTH="321"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="608" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="330" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구  분</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="330" HEIGHT="30">사용권자산의 감가상각비</TD>
<TD VALIGN="MIDDLE" WIDTH="139" HEIGHT="30"></TD>
<TD VALIGN="MIDDLE" WIDTH="139" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="330" HEIGHT="30"> 부동산</TD>
<TD VALIGN="MIDDLE" WIDTH="139" HEIGHT="30" ALIGN="RIGHT">1,007,771</TD>
<TD VALIGN="MIDDLE" WIDTH="139" HEIGHT="30" ALIGN="RIGHT">769,274</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="330" HEIGHT="30"> 기계장치</TD>
<TD VALIGN="MIDDLE" WIDTH="139" HEIGHT="30" ALIGN="RIGHT">103,652</TD>
<TD VALIGN="MIDDLE" WIDTH="139" HEIGHT="30" ALIGN="RIGHT">103,652</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="330" HEIGHT="30"> 차량운반구</TD>
<TD VALIGN="MIDDLE" WIDTH="139" HEIGHT="30" ALIGN="RIGHT">60,709</TD>
<TD VALIGN="MIDDLE" WIDTH="139" HEIGHT="30" ALIGN="RIGHT">43,653</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="330" HEIGHT="30" ALIGN="CENTER">소   계</TD>
<TD VALIGN="MIDDLE" WIDTH="139" HEIGHT="30" ALIGN="RIGHT">1,172,132</TD>
<TD VALIGN="MIDDLE" WIDTH="139" HEIGHT="30" ALIGN="RIGHT">916,579</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="330" HEIGHT="30">리스부채에 대한 이자비용</TD>
<TD VALIGN="MIDDLE" WIDTH="139" HEIGHT="30" ALIGN="RIGHT">101,214</TD>
<TD VALIGN="MIDDLE" WIDTH="139" HEIGHT="30" ALIGN="RIGHT">97,310</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="330" HEIGHT="30">단기리스료</TD>
<TD VALIGN="MIDDLE" WIDTH="139" HEIGHT="30" ALIGN="RIGHT">10,100</TD>
<TD VALIGN="MIDDLE" WIDTH="139" HEIGHT="30" ALIGN="RIGHT">17,453</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="330" HEIGHT="30">단기리스가 아닌 소액자산 리스료</TD>
<TD VALIGN="MIDDLE" WIDTH="139" HEIGHT="30" ALIGN="RIGHT">13,764</TD>
<TD VALIGN="MIDDLE" WIDTH="139" HEIGHT="30" ALIGN="RIGHT">9,357</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="330" HEIGHT="30" ALIGN="CENTER">합   계</TD>
<TD VALIGN="MIDDLE" WIDTH="139" HEIGHT="30" ALIGN="RIGHT">1,297,210</TD>
<TD VALIGN="MIDDLE" WIDTH="139" HEIGHT="30" ALIGN="RIGHT">1,040,699</TD>
</TR>
</TBODY>
</TABLE>
<P> 다. 당기 및 전기말 현재 리스부채의 유동성분류 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="607">

<COLGROUP>
<COL WIDTH="194"></COL>
<COL WIDTH="193"></COL>
<COL WIDTH="193"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="607" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="203" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구  분</TH>
<TH WIDTH="202" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">당기말</TH>
<TH WIDTH="202" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" VALIGN="MIDDLE" HEIGHT="30">유동</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,070,240</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,214,088</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" VALIGN="MIDDLE" HEIGHT="30">비유동</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,730,027</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,757,577</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,800,267</TD>
<TD WIDTH="202" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,971,665</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>13.  무형자산 가. 당기 및 전기말 현재 무형자산의 내역은 다음과 같습니다.(1) 당기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="613">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="613" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="5">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="155" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="34">구  분</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="34">취득원가</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="34">상각누계액</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="34">정부보조금</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="34">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">산업재산권</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">868,180</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(122,835)</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(85,238)</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">660,107</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">소프트웨어</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">127,553</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(56,637)</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">70,916</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">995,733</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(179,472)</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(85,238)</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">731,023</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>(2) 전기말</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="615">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="615" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각누계액</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">정부보조금</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">산업재산권</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">603,940</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(70,476)</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(96,358)</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">437,106</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">소프트웨어</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">94,253</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(36,122)</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">58,131</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">698,193</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(106,598)</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(96,358)</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">495,237</TD>
</TR>
</TBODY>
</TABLE>
<P>나. 당기 및 전기 중 무형자산의 변동내역은 다음과 같습니다.(1) 당기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="958">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="958" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="8">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기  초</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취  득</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">정부보조금사용</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">정부보조금상각</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대체(주1)</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">산업재산권</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">437,106</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">264,239</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,862)</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(52,358)</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,982</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">660,107</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">소프트웨어</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">58,131</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33,300</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(20,516)</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">70,915</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합   계</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">495,237</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">297,539</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(4,862)</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(72,874)</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,982</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">731,022</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(2) 전기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="959">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="105"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="959" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="8">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기  초</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취  득</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">정부보조금사용</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">정부보조금상각</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대체(주1)</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">산업재산권</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">273,860</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">190,803</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(38,348)</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,104</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,312)</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">437,106</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30">소프트웨어</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">57,725</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,700</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(15,294)</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">58,131</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합   계</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">331,585</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">206,503</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(53,642)</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,104</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,312)</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">495,238</TD>
</TR>
</TBODY>
</TABLE>
<P>(주1) 산업재산권에서 경상연구개발비로 2,312천원 대체되었습니다.</P>
<P>다. 무형자산상각비는 (포괄)손익계산서상 10,061천원(전기: 4,599천원)은 판매비및관리비에 46,831천원(전기: 35,938천원)은 경상연구개발비에 포함되었습니다.</P>
<PGBRK></PGBRK>
<P>14. 매입채무와기타채무  당기 및 전기말 현재 매입채무와기타채무의 내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="655" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="194"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="655" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" COLSPAN="5">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="203" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60" ALIGN="CENTER" ROWSPAN="2" VALIGN="MIDDLE">구  분</TH>

<TH WIDTH="226" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" COLSPAN="2">
<P>당기말</P>
</TH>
<TH WIDTH="226" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" COLSPAN="2">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="113" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">유동</TH>
<TH WIDTH="113" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">비유동</TH>
<TH WIDTH="113" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">유동</TH>
<TH WIDTH="113" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">비유동</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30">미지급금</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">1,307,485</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">13,815</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">688,684</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30">미지급비용</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">208,824</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">423,433</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">1,516,309</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">13,815</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">1,112,117</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>
</TBODY>
</TABLE>
<P>15. 기타부채당기 및 전기말 현재 기타부채의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="655">

<COLGROUP>
<COL WIDTH="194"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="655" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="203" HEIGHT="60" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE">구  분</TH>

<TH WIDTH="226" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>당기말</P>
</TH>
<TH WIDTH="226" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="113" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유동</TH>
<TH WIDTH="113" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비유동</TH>
<TH WIDTH="113" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유동</TH>
<TH WIDTH="113" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비유동</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30">예수금</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">14,371</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">77,275</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30">선수금</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">8,160</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="203" HEIGHT="30">합  계</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">22,531</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">77,275</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>
</TBODY>
</TABLE>
<P>16. 차입금 회사는 전기 중 1,800,000천원 차입금을 전액 상환하였으며 당기말 현재 차입금의 내역은 없습니다.</P>
<P>17. 확정기여제도 당기 및 전기 중 확정기여제도와 관련해 비용으로 인식한 금액은 당기 460,232천원, 전기 393,980천원 입니다.</P>
<PGBRK></PGBRK>
<P></P>
<P>18. 법인세비용 및 이연법인세 가. 당기 및 전기의 법인세비용차감전순손익과 법인세비용 간의 관계는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="616">

<COLGROUP>
<COL WIDTH="200"></COL>
<COL WIDTH="193"></COL>
<COL WIDTH="196"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="616" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="209" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구  분</TH>
<TH WIDTH="202" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="205" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="209" HEIGHT="30">세전이익(손실)</TD>
<TD VALIGN="MIDDLE" WIDTH="202" HEIGHT="30" ALIGN="RIGHT">(10,595,329)</TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">(9,271,261)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="209" HEIGHT="30">적용세율</TD>
<TD VALIGN="MIDDLE" WIDTH="202" HEIGHT="30" ALIGN="RIGHT">22.0%</TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">22.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="209" HEIGHT="30">적용세율에 따른 법인세</TD>
<TD VALIGN="MIDDLE" WIDTH="202" HEIGHT="30" ALIGN="RIGHT">(2,330,972)</TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">(2,039,677)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="209" HEIGHT="30">조정사항</TD>
<TD VALIGN="MIDDLE" WIDTH="202" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="209" HEIGHT="31">  비공제비용</TD>
<TD VALIGN="MIDDLE" WIDTH="202" HEIGHT="31" ALIGN="RIGHT">115,901</TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="31" ALIGN="RIGHT">35,827</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="209" HEIGHT="30">  이연법인세 미계상</TD>
<TD VALIGN="MIDDLE" WIDTH="202" HEIGHT="30" ALIGN="RIGHT">1,853,581</TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">2,003,850</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="209" HEIGHT="30">  기타(세율변경효과)</TD>
<TD VALIGN="MIDDLE" WIDTH="202" HEIGHT="30" ALIGN="RIGHT">361,490 </TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="209" HEIGHT="30">법인세비용(주1)</TD>
<TD VALIGN="MIDDLE" WIDTH="202" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30">(주1) 당기 및 전기 중 세전순손실로 인하여 유효법인세율은 산출하지 아니하였습니다.</TD>
</TR>
</TBODY>
</TABLE>
<P>나. 당기 및 전기말 현재 이연법인세자산과 부채의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="609">

<COLGROUP>
<COL WIDTH="294"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="144"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="609" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="303" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">　구  분</TH>
<TH WIDTH="153" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기말</TH>
<TH WIDTH="153" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="303" VALIGN="MIDDLE" HEIGHT="30">이연법인세자산</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="303" VALIGN="MIDDLE" HEIGHT="30"> 12개월 이내에 회수될 이연법인세자산</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,115</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,307</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="303" VALIGN="MIDDLE" HEIGHT="30"> 12개월 이후에 회수될 이연법인세자산</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">546,506</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">803,245</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="303" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="303" VALIGN="MIDDLE" HEIGHT="30">이연법인세부채</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="303" VALIGN="MIDDLE" HEIGHT="30">  12개월 이내에 결제될 이연법인세부채</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(18,115)</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(3,307)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="303" VALIGN="MIDDLE" HEIGHT="30">  12개월 이후에 결제될 이연법인세부채</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(546,506)</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(803,245)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="303" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="303" VALIGN="MIDDLE" HEIGHT="30">이연법인세자산(부채) 순액  </TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>다. 당기와 전기 중 동일 과세당국과 관련된 금액을 상계하기 이전의 이연법인세자산(부채) 변동은 다음과 같습니다.(1) 당기 </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="861">

<COLGROUP>
<COL WIDTH="183"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="158"></COL>
<COL WIDTH="158"></COL>
<COL WIDTH="158"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="861" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="5">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="192" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">　구  분</TH>
<TH WIDTH="168" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기  초</TH>
<TH WIDTH="167" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">포괄손익계산서</TH>
<TH WIDTH="167" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기타포괄손익</TH>
<TH WIDTH="167" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30">이연법인세부채</TD>
<TD WIDTH="168" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="167" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="167" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="167" VALIGN="MIDDLE" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30">  사용권자산</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">(803,245)</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">256,739</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">(546,506)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30">  미수수익</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">(3,307)</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">(14,808)</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">(18,115)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"></TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30">이연법인세자산</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"> 리스부채</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">821,917</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">(252,630)</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">569,287</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"> 복구충당부채</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">15,848</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">(345)</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">15,503</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"> 재고자산평가손실충당금</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">4,283</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">41,403</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">45,686</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"> 선급비용(리스)</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">8,235</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">(8,235)</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"> 미지급비용</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">10,588</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">3,192 </TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">13,780</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"> 국고보조금</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">43,593</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">(11,379)</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">32,214</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"> 미지급금</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">2,441</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">447</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">2,888</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"> 주식매입선택권</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">592,383</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">33,651</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">626,034</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"> 이월결손금</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">4,321,992</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">1,805,546</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">6,127,538</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"></TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30">실현불확실성</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">(5,014,728)</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">(1,853,581)</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">(6,868,309)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER"></TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P></P>
<P>(2) 전기 </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="861">

<COLGROUP>
<COL WIDTH="183"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="158"></COL>
<COL WIDTH="158"></COL>
<COL WIDTH="158"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="861" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="5">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="192" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">　구  분</TH>
<TH WIDTH="168" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기  초</TH>
<TH WIDTH="167" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">포괄손익계산서</TH>
<TH WIDTH="167" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기타포괄손익</TH>
<TH WIDTH="167" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30">이연법인세부채</TD>
<TD WIDTH="168" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="167" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="167" VALIGN="MIDDLE" HEIGHT="30">　</TD>
<TD WIDTH="167" VALIGN="MIDDLE" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30">  사용권자산</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">(573,444)</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">(229,801)</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">(803,245)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30">  미수수익</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">(3,307)</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">(3,307)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"></TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30">이연법인세자산</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"> 리스부채</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">581,248</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">240,669</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">821,917</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"> 복구충당부채</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">5,772</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">10,076</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">15,848</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"> 재고자산평가손실충당금</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">4,283</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">4,283</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"> 선급비용(리스)</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">4,071</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">4,164</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">8,235</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"> 미지급비용</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">11,168</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">(580)</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">10,588</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"> 국고보조금</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">67,189</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">(23,596)</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">43,593</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"> 장기미지급금</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">1,924</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">(1,924)</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"> 미지급금</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">2,441</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">2,441</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"> 주식매입선택권</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">346,542</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">245,841</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">592,383</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"> 이월결손금</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">2,566,408</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">1,755,584</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">4,321,992</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30"></TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30">실현불확실성</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">(3,010,878)</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">(2,003,850)</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">(5,014,728)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER"></TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="192" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD VALIGN="MIDDLE" WIDTH="168" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>라. 당기말 현재 미사용결손금의 만료 시기는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="603">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="192"></COL>
<COL WIDTH="192"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="603" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구  분</P>
</TH>

<TH WIDTH="201" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>당기말</P>
</TH>

<TH WIDTH="201" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>만  기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2015-12-31</TD>
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">142,152</TD>
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2025-12-31</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2016-12-31</TD>
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">607,274</TD>
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2026-12-31</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017-12-31</TD>
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">891,962</TD>
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2027-12-31</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2018-12-31</TD>
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,757,399</TD>
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2028-12-31</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019-12-31</TD>
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">3,392,474</TD>
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2029-12-31</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020-12-31</TD>
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">4,874,231</TD>
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2035-12-31</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021-12-31</TD>
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">7,979,928</TD>
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2036-12-31</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022-12-31</TD>
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">           9,672,947</TD>
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2037-12-31</TD>
</TR>
</TBODY>
</TABLE>
<P>이월결손금에 대해 미래과세소득의 발생가능성이 불확실하여 이연법인세자산을 인식하지 않았습니다. </P>
<P>19. 자본금과 주식발행초과금 가. 회사가 발행할 주식의 총수는 50,000,000 주이고, 발행한 주식수는 보통주식 8,351,348주(전기: 7,134,148주)이며 1주당 액면금액은 500원입니다. 회사는 2022년 11월 22일 코스닥시장 공모를 실시하여 1,040,000주(발행가액 12,000원)를 발행하였으며, 회사가 발행한 주식은 전액(12,480,000천원) 납입 완료됐습니다.   </P>
<P></P>
<P>나. 당기 및 전기 중 자본금과 주식발행초과금의 변동은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="708" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="228"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="108"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="708" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" COLSPAN="5">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="237" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>구     분</P>
</TH>

<TH WIDTH="118" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>주식수 (단위 : 주)</P>
</TH>

<TH WIDTH="118" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>보통주</P>
</TH>

<TH WIDTH="118" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>주식발행 초과금</P>
</TH>

<TH WIDTH="117" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>합   계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" VALIGN="BOTTOM" HEIGHT="30">전기초</TD>
<TD WIDTH="118" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">6,416,548</TD>
<TD WIDTH="118" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">3,208,274</TD>
<TD WIDTH="118" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">54,916,280</TD>
<TD WIDTH="117" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">58,124,554</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" VALIGN="BOTTOM" HEIGHT="30">  결손금의 보전</TD>
<TD WIDTH="118" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">(42,959,279)</TD>
<TD WIDTH="117" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">(42,959,279)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30">  유상증자</TD>
<TD WIDTH="118" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">717,600</TD>
<TD WIDTH="118" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">358,800</TD>
<TD WIDTH="118" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">17,577,726</TD>
<TD WIDTH="117" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">17,936,526</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30">전기말</TD>
<TD WIDTH="118" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">7,134,148</TD>
<TD WIDTH="118" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">3,567,074</TD>
<TD WIDTH="118" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">29,534,727</TD>
<TD WIDTH="117" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">33,101,801</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30">  유상증자</TD>
<TD WIDTH="118" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">1,071,200</TD>
<TD WIDTH="118" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">535,600</TD>
<TD WIDTH="118" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">12,314,343</TD>
<TD WIDTH="117" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">12,849,943</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30">  스톡옵션 행사</TD>
<TD WIDTH="118" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">146,000</TD>
<TD WIDTH="118" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">73,000</TD>
<TD WIDTH="118" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">1,613,245</TD>
<TD WIDTH="117" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">1,686,245</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30">당기말</TD>
<TD WIDTH="118" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">8,351,348</TD>
<TD WIDTH="118" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">4,175,674</TD>
<TD WIDTH="118" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">43,462,315</TD>
<TD WIDTH="117" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">47,637,989</TD>
</TR>
</TBODY>
</TABLE>
<P>20. 주식기준보상 가. 회사는 주주총회 결의에 의거해서 회사의 임직원에게 주식선택권을 부여했으며, 그 주요 내용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="19"></COL>
<COL WIDTH="16"></COL>
<COL WIDTH="538"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="28" HEIGHT="30">ㆍ</TD>
<TD COLSPAN="2" WIDTH="572" HEIGHT="30">주식선택권으로 발행한 주식의 종류: 기명식 보통주식</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="28" HEIGHT="30">ㆍ</TD>
<TD COLSPAN="2" WIDTH="572" HEIGHT="30">부여방법: 보통주 신주발행 또는 자기주식 교부</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="28" HEIGHT="30">ㆍ</TD>
<TD COLSPAN="2" WIDTH="572" HEIGHT="30">가득조건 및 행사 가능 시점:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="28" HEIGHT="30"></TD>
<TD WIDTH="25" HEIGHT="30">- </TD>
<TD WIDTH="547" HEIGHT="30">1차 : 2018-05-17~2025-05-16의 기간에 행사 가능</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="28" HEIGHT="30"></TD>
<TD WIDTH="25" HEIGHT="30"></TD>
<TD WIDTH="547" HEIGHT="30">2차 : 2020-12-19~2027-12-18의 기간에 행사 가능</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="28" HEIGHT="30"></TD>
<TD WIDTH="25" HEIGHT="30">- </TD>
<TD WIDTH="547" HEIGHT="30">3차~10차: 부여후 3년후와 상장일 중 나중에 도래하는날~ 부여후 10년이내</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>나. 주식선택권의 수량과 가중평균 행사가격의 변동은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="739" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="190"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="199" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE">
<P>구  분</P>
</TH>

<TH COLSPAN="2" WIDTH="270" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>주식매수선택권 수량(단위 : 주)</P>
</TH>

<TH COLSPAN="2" WIDTH="270" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>가중평균 행사가격(단위 : 원)</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="135" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>당기</P>
</TH>

<TH WIDTH="135" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>전기</P>
</TH>

<TH WIDTH="135" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>당기</P>
</TH>

<TH WIDTH="135" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>전기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">기초 잔여주</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">571,308</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">438,708</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">7,225</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">4,940</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">부여</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">140,500</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">14,324</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">행사</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">(146,000)</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">4,842</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">소멸</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">(1,000)</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">(7,900)</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">5,000</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">6,582</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">기말 잔여주</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">424,308</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">571,308</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">7,229</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">7,225</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">기말 행사가능한 주식수</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">179,208</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">80,208</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">8,620</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">3,987</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>당기말 현재 유효한 주식선택권의 행사가격은 1,167 ~ 17,500 원입니다. </P>
<P>다. 회사는 전기 중 부여된 주식선택권의 보상원가를 이항모형을 이용한 공정가치접근법을 적용하여 산정했으며, 보상원가를 산정하기 위한 제반 가정 및 변수는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="455" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="302"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="311" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구     분</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="144" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>전기 </P>
</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="311" HEIGHT="30">
<P>당기 중 부여된 선택권의 가중평균 공정가치</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="144" HEIGHT="30">11,890원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="311" HEIGHT="30">
<P>주가변동성(*1)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="144" HEIGHT="30">20.97%~24.54%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="311" HEIGHT="30">
<P>배당수익률 </P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="144" HEIGHT="30">0.00%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="311" HEIGHT="30">
<P>기대만기(*2)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="144" HEIGHT="30">6.5년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="311" HEIGHT="30">
<P>무위험수익률 </P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="144" HEIGHT="30">1.75%~2.35%</TD>
</TR>
</TBODY>
</TABLE>
<P>(*1) 주가변동성은 대용기업의 당시 180영업일별 주가분석에 기초하여 산출한 주식의 연속복리 투자수익률의 표준 편차입니다. (*2) 경영자의 최선의 추정치를 기반으로 양도 불가능, 행사 제한(옵션에 부가된 시장조건충족가능성 포함) 등에 대한 영향을 기대 만기 산정에 고려했습니다.라. 당기와 전기 중 비용으로 인식한 주식기준보상은 각각 982,725천원과 1,117,102천원이며, 전액 주식결제형 주식기준보상과 관련된 비용입니다.</P>
<PGBRK></PGBRK>
<P>21. 기타자본항목 및 자본잉여금당기 및 전기말 현재 기타자본 및 자본잉여금의 구성내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="599">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="190"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="599" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="200" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구  분</P>
</TH>

<TH WIDTH="200" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>당기말</P>
</TH>
<TH WIDTH="199" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="BOTTOM">주식발행초과금</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">43,462,315</TD>
<TD WIDTH="199" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="BOTTOM">주식매입선택권</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">2,663,407</TD>
<TD WIDTH="199" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">2,660,655</TD>
</TR>
</TBODY>
</TABLE>
<P>22. 이익잉여금(결손금) 가. 당기 및 전기말 현재 이익잉여금(결손금)의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="607">

<COLGROUP>
<COL WIDTH="279"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="150"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="607" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위 : 원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="288" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>구  분</P>
</TH>

<TH WIDTH="160" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>당기말</P>
</TH>
<TH WIDTH="159" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" VALIGN="MIDDLE" HEIGHT="30">기초</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(9,271,261,264)</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(42,959,279,493)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" VALIGN="MIDDLE" HEIGHT="30">당기순이익(손실)</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(10,595,328,992)</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(9,271,261,264)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" VALIGN="MIDDLE" HEIGHT="30">결손금 보전</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">42,959,279,493</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" VALIGN="MIDDLE" HEIGHT="30">기말</TD>
<TD WIDTH="160" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(19,866,590,256)</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(9,271,261,264)</TD>
</TR>
</TBODY>
</TABLE>
<P>나. 당기 및 전기의 결손금처리계산서는 2023년 3월 30일 주주총회에서 처분될 예정입니다. (전기 처분 확정일: 2022년 3월 25일)</P>

<TABLE WIDTH="591" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="245"></COL>
<COL WIDTH="160"></COL>
<COL WIDTH="159"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="591" VALIGN="MIDDLE" ALIGN="RIGHT" COLSPAN="3" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위 : 원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="254" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="169" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="254" VALIGN="MIDDLE" HEIGHT="30">Ⅰ.미처리결손금</TD>
<TD WIDTH="169" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,866,590,256</TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,271,261,264</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="254" VALIGN="MIDDLE" HEIGHT="30">   전기이월미처리결손금</TD>
<TD WIDTH="169" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,271,261,264</TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="254" VALIGN="MIDDLE" HEIGHT="30">   회계기준 변경 효과</TD>
<TD WIDTH="169" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="254" VALIGN="MIDDLE" HEIGHT="30">   당기순손실</TD>
<TD WIDTH="169" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,595,328,992</TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,271,261,264</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="254" VALIGN="MIDDLE" HEIGHT="30">Ⅱ.결손금 처리액</TD>
<TD WIDTH="169" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　-</TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="254" VALIGN="MIDDLE" HEIGHT="30">Ⅲ.차기이월미처리결손금(Ⅰ-Ⅱ)</TD>
<TD WIDTH="169" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,866,590,256</TD>
<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,271,261,264</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>23. 고객과의 계약에서 생기는 수익 및 관련 계약자산가. 당기 및 전기의 고객과의 계약에서 생기는 수익의 구분은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="601">

<COLGROUP>
<COL WIDTH="254"></COL>
<COL WIDTH="160"></COL>
<COL WIDTH="160"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="601" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="263" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="169" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="169" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="601" HEIGHT="30" COLSPAN="3" VALIGN="MIDDLE">재화 또는 용역의 유형:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30" VALIGN="MIDDLE">  제품매출</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">54,747</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">92,358</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30" VALIGN="MIDDLE">  기술이전</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,638,936</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,619,397</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30" VALIGN="MIDDLE">  기타매출</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,000</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">150,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30" VALIGN="MIDDLE">고객과의 계약에서 생기는 수익 합계</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,723,683</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,861,755</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="601" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="3">지리적 시장:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30" VALIGN="MIDDLE">  국내</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,284,747</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,742,358</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30" VALIGN="MIDDLE">  해외</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,438,936</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">119,397</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30" VALIGN="MIDDLE">고객과의 계약에서 생기는 수익 합계</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,723,683</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,861,755</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="601" HEIGHT="30" COLSPAN="3" VALIGN="MIDDLE">수익인식 시점: </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="263" HEIGHT="30" VALIGN="MIDDLE">
<P>  한 시점에 인식</P>
</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,054,747</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,742,358</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="263" HEIGHT="30" VALIGN="MIDDLE">
<P>  기간에 걸쳐 인식</P>
</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,668,936</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">119,397</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30" VALIGN="MIDDLE">고객과의 계약에서 생기는 수익 합계</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,723,683</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,861,755</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>나. 당기 및 전기말 현재 계약잔액은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="603">

<COLGROUP>
<COL WIDTH="253"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="149"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="603" HEIGHT="30" ALIGN="RIGHT" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" VALIGN="MIDDLE">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="262" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="183" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="158" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30">매출채권</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">40,911</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">1,720,644</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30">계약자산(주1)</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">10,621</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합   계</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">40,911</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">1,731,265</TD>
</TR>
</TBODY>
</TABLE>
<P>(주1) 전기 글로벌 V사와 체결한 화학적거세제의 공동개발 계약과 관련하여, 기간에 걸쳐 이행하는 계약자산 10,621천원(EUR 7,912)이며 재무상태표 상 전기 매출채권에 포함되어 있습니다. </P>
<PGBRK></PGBRK>
<P>24. 판매비와 관리비 및 비용의 성격별 분류가. 당기 및 전기 중 판매비와 관리비의 상세내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="610" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="195"></COL>
<COL WIDTH="194"></COL>
<COL WIDTH="194"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="610" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3" VALIGN="MIDDLE">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="204" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구  분</TH>
<TH WIDTH="203" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">당기</TH>
<TH WIDTH="203" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30">급여</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">1,166,897</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">841,266</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">134,063</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">158,767</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30">주식보상비용</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">141,780</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">435,093</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30">경상연구개발비</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">10,957,546</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">8,795,546</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30">복리후생비</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">209,176</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">123,643</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30">감가상각비</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">394,660</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">366,490</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30">무형자산상각비</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">10,061</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">4,599</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30">지급수수료</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">1,018,720</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">295,582</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30">기타</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">191,366</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">163,993</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">14,224,269</TD>
<TD WIDTH="203" HEIGHT="30" ALIGN="RIGHT">11,184,979</TD>
</TR>
</TBODY>
</TABLE>
<P>나. 당기 및 전기 중 비용의 성격별 분류는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="610">

<COLGROUP>
<COL WIDTH="195"></COL>
<COL WIDTH="194"></COL>
<COL WIDTH="194"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="610" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="204" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구  분</TH>
<TH WIDTH="203" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="203" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30">재고자산의변동</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(41,692)</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(23,350)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30">원재료 등의 사용액</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,429</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">34,012</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30">급여</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,348,914</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,213,991</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">460,233</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">393,980</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30">주식보상비용</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">982,725</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,117,102</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30">경상연구개발비</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,913,927</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,182,701</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30">복리후생비</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">229,175</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">131,949</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30">감가상각비</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,367,451</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,803,568</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30">무형자산상각비</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">56,892</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40,537</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30">지급수수료</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,049,434</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">308,681</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30">기타</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">239,001</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">216,492</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합  계</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,625,489</TD>
<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,419,663</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>25. 기타수익과 기타비용 당기 및 전기 중 기타수익 및 기타비용의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="612">

<COLGROUP>
<COL WIDTH="195"></COL>
<COL WIDTH="195"></COL>
<COL WIDTH="195"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="612" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="204" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구  분</TH>
<TH WIDTH="204" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="204" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="612" VALIGN="MIDDLE" COLSPAN="3" HEIGHT="30">기타수익</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30"> 유형자산처분이익</TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">295,626</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30"> 잡이익</TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">149,451</TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">106,983</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">149,451</TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">402,609</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="612" VALIGN="MIDDLE" COLSPAN="3" HEIGHT="30">기타비용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30"> 유형자산폐기손실</TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,504</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30"> 잡손실</TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,209</TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,703</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합  계</TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,209</TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,207</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>26. 금융수익과 금융비용 당기 및 전기 중 금융수익 및 금융비용의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="607">

<COLGROUP>
<COL WIDTH="225"></COL>
<COL WIDTH="178"></COL>
<COL WIDTH="177"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="607" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="234" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구  분</TH>
<TH WIDTH="187" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기 </TH>
<TH WIDTH="186" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="607" VALIGN="MIDDLE" COLSPAN="3" HEIGHT="30">금융수익</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30">  이자수익</TD>
<TD WIDTH="187" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">189,223</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">41,102</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30">  외환차익</TD>
<TD WIDTH="187" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">102,186</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">620</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30">  외화환산이익</TD>
<TD WIDTH="187" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,072</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">368</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="187" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">292,481</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">42,090</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="607" VALIGN="MIDDLE" COLSPAN="3" HEIGHT="30">금융비용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30">  이자비용</TD>
<TD WIDTH="187" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,948</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30">  이자비용(리스부채)</TD>
<TD WIDTH="187" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">101,214</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">97,310</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30">  이자비용(충당부채)</TD>
<TD WIDTH="187" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,139</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,214</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30">  외환차손</TD>
<TD WIDTH="187" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">27,784</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,375</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30">  외화환산손실</TD>
<TD WIDTH="187" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,109</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="187" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">132,246</TD>
<TD WIDTH="186" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">131,847</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>27. 현금흐름표 가. 당기 및 전기 중 영업으로부터 창출된 현금흐름은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="611">

<COLGROUP>
<COL WIDTH="346"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="611" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="355" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구  분</TH>
<TH WIDTH="128" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="128" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30">Ⅰ.당기순이익(손실)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(10,595,329)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(9,271,261)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30">Ⅱ.조정</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30"> 주식보상비용</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">982,725</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,117,102</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30"> 재고자산평가손실</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">199,125</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,469</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30"> 감가상각비</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,195,320</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">886,990</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30"> 사용권자산상각비</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,172,132</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">916,578</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30"> 무형자산상각비</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">56,892</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40,538</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30"> 유형자산폐기손실</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,504</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30"> 이자비용</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,948</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30"> 이자비용(리스부채)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">101,214</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">97,310</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30"> 이자비용(충당부채)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,139</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,214</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30"> 외화환산손실</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,109</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30"> 이자수익</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(189,223)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(41,102)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30"> 외화환산이익</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,072)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(368)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30">유형자산처분이익</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(295,626)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">소    계</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,520,361</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,760,557</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30">Ⅲ.영업활동으로 인한 자산부채의 변동</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30">매출채권의 감소(증가)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,690,317</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,597,338)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30">미수금의 감소(증가)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">619,791</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,040,097)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30">재고자산의 감소(증가)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(259,116)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(90,846)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30">선급금의 감소(증가)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(703,679)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(9,321)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30">선급비용의 감소(증가)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(16,945)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(30,910)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30">부가세대급금의 감소(증가)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,329</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">109,496</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30">미지급금의 증가(감소)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">692,016</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">469,867</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30">장기미지급금의 증가(감소)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,815</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,346</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30">미지급비용의 증가(감소)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(214,609)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">160,697</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30">예수금의 증가(감소)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(62,904)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,561</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30">선수금의 증가(감소)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,160</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">소    계</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,782,175</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,995,545)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" VALIGN="MIDDLE" HEIGHT="30">Ⅳ.영업활동에서 창출된 현금흐름(Ⅰ+Ⅱ+Ⅲ)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(5,292,793)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(8,506,249)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>나. 당기와 전기의 현금의 유입과 유출이 없는 주요거래는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="611">

<COLGROUP>
<COL WIDTH="346"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="611" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="355" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" HEIGHT="30" VALIGN="MIDDLE">건설중인자산의 본계정대체</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">249,732</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,341,744</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" HEIGHT="30" VALIGN="MIDDLE">리스부채와 사용권자산의 계상</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">32,229</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,812,892</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" HEIGHT="30" VALIGN="MIDDLE">유형자산취득 미지급금의 증가(감소)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(73,215)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(146,221)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" HEIGHT="30" VALIGN="MIDDLE">결손금의 보전</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">42,959,279</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">208,746</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45,967,694</TD>
</TR>
</TBODY>
</TABLE>
<P>다. 당기와 전기 중 재무활동에서 생기는 부채의 변동내역은 다음과 같습니다.(1) 당기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="743">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="743" HEIGHT="30" COLSPAN="6" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기  초</TH>
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상  환</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상  각</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비현금거래</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="30" VALIGN="MIDDLE">리스부채</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,971,665 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,304,840)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">101,214 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">32,229 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,800,268 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,971,665 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,304,840)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">101,214 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">32,229 </TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,800,268 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(2) 전기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="744">

<COLGROUP>
<COL WIDTH="123"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="744" HEIGHT="30" COLSPAN="6" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기  초</TH>
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상  환</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상  각</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비현금거래</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" VALIGN="MIDDLE">차입금</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,800,000</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,800,000)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" VALIGN="MIDDLE">리스부채</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,033,338</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(952,949)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">97,310</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,793,966</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,971,665</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,833,338</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,752,949)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">97,310</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,793,966</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,971,665</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>28. 주당손익가. 당기와 전기의 기본주당이익(손실)의 산정내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="606">

<COLGROUP>
<COL WIDTH="283"></COL>
<COL WIDTH="148"></COL>
<COL WIDTH="148"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="606" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="3">(단위 : 주, 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="292" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구  분</TH>
<TH WIDTH="157" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="157" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" VALIGN="MIDDLE" HEIGHT="30">당기순이익(손실)</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(10,595,329)</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(9,271,261)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" VALIGN="MIDDLE" HEIGHT="30">가중평균유통보통주식수(*1)</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,270,613</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,739,154</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="292" VALIGN="MIDDLE" HEIGHT="30">기본주당이익(손실)(원)</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,457)</TD>
<TD WIDTH="157" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,376)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(*1) 가중평균유통보통주식수의 산출내역은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="603" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="287"></COL>
<COL WIDTH="145"></COL>
<COL WIDTH="144"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="603" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">(단위 : 주)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="296" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="296" VALIGN="MIDDLE" HEIGHT="30">기초발행주식수</TD>
<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,134,148</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,416,548</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="296" VALIGN="MIDDLE" HEIGHT="30"> 유상증자</TD>
<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">132,065</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">322,606</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="296" VALIGN="MIDDLE" HEIGHT="30"> 주식매수선택권의 행사</TD>
<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,400</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="296" VALIGN="MIDDLE" HEIGHT="30">기말가중평균유통보통주식수</TD>
<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,270,613</TD>
<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,739,154</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>나. 희석주당이익(손실)희석주당이익(손실)은 모든 희석성 잠재적보통주가 보통주로 전환된다고 가정하여 조정한 가중평균유통보통주식수를 적용하여 산정하고 있습니다. 회사가 보유하고 있는 희석성 잠재적보통주로는 주식매수선택권이 있습니다. 당기와 전기는 희석효과가 발생하지 않아 희석주당손익은 기본주당손익과 동일합니다.29. 우발상황 및 약정사항 가. 당기말 및 전기말 현재 담보제공된 자산의 내역은 없습니다.</P>
<P>나. 회사는 치매치료(IVL 3003) 및 알콜의존증 치료 장기지속형주사제(IVL 3004)의 임상1상 시험을 진행을 위해 호주달러 10,000천불을 한도로 하는  임상보험계약에 각각 가입하고 있습니다.다. 회사는 당기말 현재 서울보증보험으로부터 지급 및 이행보증등을 위하여 560,740천원을 보증받고 있습니다. </P>
<P>30. 특수관계자거래가. 당기 및 전기말 현재 최상위 지배자는 김주희입니다. </P>
<P></P>
<P>나. 당기 및 전기 중 특수관계자에 대한 채권, 채무 내역은 없습니다.</P>
<P>다. 당기 및 전기 중 특수관계자와의 매출, 매입 등 거래내역은 다음과 같습니다.(1) 당기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="601">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="183"></COL>
<COL WIDTH="182"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="601" HEIGHT="30" COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="218" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계자명</TH>
<TH WIDTH="192" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이자수익</TH>
<TH WIDTH="191" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지급수수료 등</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">임직원 </TD>
<TD WIDTH="192" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">451 </TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">포항공과대학교 주1)</TD>
<TD WIDTH="192" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">40,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합  계</TD>
<TD WIDTH="192" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">451 </TD>
<TD WIDTH="191" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">40,000 </TD>
</TR>
</TBODY>
</TABLE>
<P>주1) 포항공과대학교는 상장된 날로부터 2년간 의결권 공동행사를 약정하였습니다.(2) 전기전기 중 특수관계자와의 매출, 매입 등 거래내역은 없습니다.라. 당기와 전기 중 특수관계자와의 중요한 자금거래 내역은 다음과 같습니다.(1) 당기</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="607">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="100"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="607" HEIGHT="30" COLSPAN="6" ALIGN="RIGHT" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="128" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">특수관계자명</TH>
<TH WIDTH="72" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계정과목</TH>
<TH WIDTH="100" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기초</TH>
<TH WIDTH="99" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="99" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
<TH WIDTH="109" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">임직원 </TD>
<TD WIDTH="72" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대여금</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">325,000 </TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">325,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">우리사주조합</TD>
<TD WIDTH="72" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대여금</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">367,608 </TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">367,608 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="72" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">　</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">692,608 </TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">- </TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">692,608 </TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P>(2) 전기전기 중 특수관계자와의 중요한 자금거래 내역은 없습니다.</P>
<P>마. 주요 경영진은 대표이사와 부사장 2명 및 전무이사 2명을 포함하고 있습니다. 종업원용역의 대가로서 주요 경영진에게 지급됐거나 지급될 보상금액은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="601" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="183"></COL>
<COL WIDTH="182"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="601" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3" VALIGN="MIDDLE">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="218" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">
<P>구     분</P>
</TH>

<TH WIDTH="192" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">
<P>당기</P>
</TH>

<TH WIDTH="191" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">
<P>전기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">급여등</TD>
<TD WIDTH="192" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">                   1,083,799 </TD>
<TD WIDTH="191" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">             752,495 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">주식보상비용</TD>
<TD WIDTH="192" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">                      258,130 </TD>
<TD WIDTH="191" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">             453,810 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="192" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">                      179,987 </TD>
<TD WIDTH="191" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">             210,995 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30" VALIGN="MIDDLE">스톡옵션 행사차액(주1)</TD>
<TD WIDTH="192" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">                      585,000 </TD>
<TD WIDTH="191" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">                       - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합  계</TD>
<TD WIDTH="192" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">                   2,106,916 </TD>
<TD WIDTH="191" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">           1,417,300 </TD>
</TR>
</TBODY>
</TABLE>
<P>주1) 스톡옵션 행사차액과 관련된 주요 경영진의 스톡옵션 행사주식수 130,000주는 2025년 11월 21일까지(상장일로부터 3년) 의무보유 대상입니다.31. 영업부문 정보가. 회사는 한국채택국제회계기준 제1108호 (영업부문)에 따른 보고부문이 단일부문이므로 부문별 정보를 공시하지 않습니다.</P>
<P>나. 주요 고객에 대한 정보회사 수익의 10% 이상을 차지하는 고객의 당기와 전기의 매출액은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="601" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="183"></COL>
<COL WIDTH="182"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="601" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="RIGHT" COLSPAN="3" VALIGN="MIDDLE">(단위 : 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="218" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">
<P>구     분</P>
</TH>

<TH WIDTH="192" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">
<P>당기</P>
</TH>

<TH WIDTH="191" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">
<P>전기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">고객A </TD>
<TD WIDTH="192" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">1,000,000</TD>
<TD WIDTH="191" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">150,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">고객B</TD>
<TD WIDTH="192" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">1,438,936</TD>
<TD WIDTH="191" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">119,397</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">고객C</TD>
<TD WIDTH="192" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">1,000,000</TD>
<TD WIDTH="191" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" HEIGHT="30">고객D</TD>
<TD WIDTH="192" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="191" VALIGN="BOTTOM" HEIGHT="30" ALIGN="RIGHT">1,500,000</TD>
</TR>
</TBODY>
</TABLE>
<P>32. 재무제표 승인회사의 재무제표는 2023년 2월 28일자로 이사회에서 승인되었으며, 정기주주총회에서 수정승인 될 수 있습니다. 이 경우 정정보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다.</P>
<PGBRK></PGBRK>
</SECTION-2>
</LIBRARY>


<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-6-0">6. 배당에 관한 사항</TITLE>
<P>당사는 현재까지 배당을 결의 및 지급한 이력이 없습니다. 당사의 배당에 관한 중요한 정책, 배당의 제한에 관한 사항 등은 다음과 같이 당사 정관에서 규정하고 있습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="872" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="154"></COL>
<COL WIDTH="700"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">정관규정</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="709" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="53">제 12 조(신주의 동등배당)</TD>

<TD VALIGN="MIDDLE" WIDTH="709" HEIGHT="53">
<P>회사가 정한 배당기준일 전에 유상증자, 무상증자 및 주식배당에 의하여 발행한 주식에 대하여는 동등배당한다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="145">제 54 조(이익배당)</TD>

<TD VALIGN="MIDDLE" WIDTH="709" HEIGHT="145">
<P>① 이익의 배당은 금전 또는 금전 외의 재산으로 할 수 있다. </P>
<P>② 전항의 배당은 이사회결의로 정하는 배당기준일 현재의 주주명부에 기재된 주주 또는 등록된 질권자에게 지급한다.</P>
<P>③ 이익의 배당을 주식으로 하는 경우 회사가 수종의 주식을 발행한 때에는 주주총회의 결의로 그와 다른 종류의 주식으로도 할 수 있다.</P>
<P>④ 이익배당은 주주총회의 결의로 정한다</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="329">제 55 조(중간배당)</TD>

<TD VALIGN="MIDDLE" WIDTH="709" HEIGHT="329">
<P>① 회사는 6월 30일 0시 현재의 주주에게 자본시장과 금융투자업에 관한 법률 제16조의12 에 의한 중간배당을 할 수 있다. 중간배당은 금전으로 한다.</P>
<P>② 제1항의 중간배당은 이사회의 결의로 하되, 그 결의는 제1항의 기준일 이후 45일 내에 하여야 한다. 단 이사수가 2인 이하인 경우에는 주주총회로 결의한다.</P>
<P>③ 중간배당은 직전결산기의 대차대조표상의 순자산액에서 다음 각호의 금액을 공제한 액을 한도로 한다.</P>
<P>1. 직전결산기의 자본의 액</P>
<P>2. 직전결산기까지 적립된 자본준비금과 이익준비금의 합계액</P>
<P>3. 직전결산기의 정기주주총회에서 이익배당하기로 정한 금액</P>
<P>4. 직전결산기까지 정관의 규정 또는 주주총회의 결의에 의하여 특정 목적을 위해 적립한 임의준비금</P>
<P>5. 중간배당에 따라 당해 결산기에 적립하여야 할 이익준비금</P>
<P>6. 상법시행령 제19조에서 정한 미실현이익</P>
<P>④ 제1항의 분기배당은 분기배당 기준일 전에 발행한 주식에 대하여 동등배당한다.</P>
<P>⑤ 제8조의 종류주식에 대한 중간배당은 보통주식과 동일한 배당률을 적용한다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="76">제 56 조(배당금 지급청구권소멸시효)</TD>
<TD VALIGN="MIDDLE" WIDTH="709" HEIGHT="76">배당금지급청구권은 5년간 이를 행사하지 아니하면 소멸시효가 완성한다. 소멸시효 완성으로 인한 배당금은 회사의 이익으로 귀속한다.</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK=" B">가. 주요배당지표</P>

<TABLE-GROUP ACLASS="DIVIDEND" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="607" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구   분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">당기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전전기</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">(제8기)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">(제7기)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">(제6기)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">주당액면가액(원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="1" VALIGN="MIDDLE">500</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="2" VALIGN="MIDDLE">500</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="3" VALIGN="MIDDLE">500</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(별도)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="1" VALIGN="MIDDLE">-10,595</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="2" VALIGN="MIDDLE">-9,271</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="3" VALIGN="MIDDLE">-12,880</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)주당순이익(원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="1" VALIGN="MIDDLE">-1,457</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="2" VALIGN="MIDDLE">-1,376</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="3" VALIGN="MIDDLE">-4,678</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">현금배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">주식배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)현금배당성향(%)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">현금배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주식배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주당 현금배당금(원)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주당 주식배당(주)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ4" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ4" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주) 주요배당지표의 (연결)주당순이익은 (별도)주당순이익입니다.</P>

<LIBRARY>
<P USERMARK=" B">나. 과거 배당 이력</P>

<TABLE-GROUP ACLASS="DIVIDEND_BCK" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="RIGHT">(단위: 회, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="300" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">연속 배당횟수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">평균 배당수익률</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">분기(중간)배당</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">결산배당</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최근 3년간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최근 5년간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="RIGHT" WIDTH="150" HEIGHT="30" ACODE="DIV_QUA" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="150" HEIGHT="30" ACODE="DIV_END" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="150" HEIGHT="30" ACODE="DIV_THR" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="149" HEIGHT="30" ACODE="DIV_FIV" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<PGBRK></PGBRK>
</LIBRARY>

</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-7-0">7. 증권의 발행을 통한 자금조달에 관한 사항</TITLE>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-7-1">7-1. 증권의 발행을 통한 자금조달 실적</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N">[지분증권의 발행 등과 관련된 사항]</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK=" B">가. 증자(감자)현황</P>

<TABLE-GROUP ACLASS="INC_STAT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="748" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="442"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="451" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="788" BORDER="1">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="167"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식발행(감소)일자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)형태</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="475" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)한 주식의 내용</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당액면가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당발행(감소)가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20150514">2015년 05월 14일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="-">-</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">100,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">500</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">설립자본금</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20150808">2015년 08월 08일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="02">유상증자(주주배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">66,667</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">1,500</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">주주배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20150813">2015년 08월 13일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="10">무상증자</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">133,333</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160107">2016년 01월 07일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">12,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">6,667</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">제3자배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160114">2016년 01월 14일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="10">무상증자</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">148,008</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160301">2016년 03월 01일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">81,200</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">616</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">제3자배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160315">2016년 03월 15일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">90,909</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">5,500</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">제3자배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160512">2016년 05월 12일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">전환우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">5,335</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">7,910</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">제3자배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160601">2016년 06월 01일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">126,422</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">7,910</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">제3자배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160610">2016년 06월 10일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="10">무상증자</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">전환우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">2,029,216</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20160610">2016년 06월 10일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="10">무상증자</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">806,910</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20170601">2017년 06월 01일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">전환우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">600,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">5,000</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">제3자배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20180621">2018년 06월 21일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">전환우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">908,057</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">8,810</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">제3자배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20181002">2018년 10월 02일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">전환우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">37,703</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">1,167</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">스톡옵션행사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20191225">2019년 12월 25일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">158,329</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">12,632</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">제3자배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20200124">2020년 01월 24일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">전환우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">356,238</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">12,632</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">제3자배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20200205">2020년 02월 05일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">전환우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">316,656</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">12,632</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">제3자배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20200222">2020년 02월 22일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">전환우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">158,328</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">12,632</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">제3자배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20200229">2020년 02월 29일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">전환우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">39,582</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">12,632</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">제3자배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20200513">2020년 05월 13일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">전환우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">83,326</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">12,001</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">제3자배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20200908">2020년 09월 08일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">36,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20200909">2020년 09월 09일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">158,329</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">12,632</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">제3자배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20201221">2020년 12월 21일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">283,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20201230">2020년 12월 30일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">3,242,431</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20210529">2021년 05월 29일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">40,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">25,000</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">제3자배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20210716">2021년 07월 16일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">477,600</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">25,000</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">제3자배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20210724">2021년 07월 24일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">120,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">25,000</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">제3자배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20210918">2021년 09월 18일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">80,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">25,000</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">제3자배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="34" AUNIT="INC_DT" AUNITVALUE="20221117">2022년 11월 17일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="34" AUNIT="INC_DR_KND" AUNITVALUE="01">유상증자(일반공모)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="34" ACODE="INC_STK_KND">보통주</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="34" ACODE="INC_CNT">
<P USERMARK="F-GL11">1,071,200</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="34" ACODE="INC_PAR_AMT">
<P USERMARK="F-GL11">500</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="34" ACODE="INC_SL_AMT">
<P USERMARK="F-GL11">12,000</P>
</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="34">신규상장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="34" AUNIT="INC_DT" AUNITVALUE="20221220">2022년 12월 20일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="34" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="34" ACODE="INC_STK_KND">보통주</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="34" ACODE="INC_CNT">
<P USERMARK="F-GL11">140,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="34" ACODE="INC_PAR_AMT">
<P USERMARK="F-GL11">500</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="34" ACODE="INC_SL_AMT">
<P USERMARK="F-GL11">5,000</P>
</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="34">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="34" AUNIT="INC_DT" AUNITVALUE="20221220">2022년 12월 20일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="34" AUNIT="INC_DR_KND" AUNITVALUE="07">주식매수선택권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="34" ACODE="INC_STK_KND">보통주</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="34" ACODE="INC_CNT">
<P USERMARK="F-GL11">6,000</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="34" ACODE="INC_PAR_AMT">
<P USERMARK="F-GL11">500</P>
</TE>

<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="34" ACODE="INC_SL_AMT">
<P USERMARK="F-GL11">1,167</P>
</TE>
<TD VALIGN="MIDDLE" WIDTH="108" HEIGHT="34">-</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N">[채무증권의 발행 등과 관련된 사항]</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE-GROUP ACLASS="SUB_PIS" ADELETETABLE="N">
<TITLE ATOC="N">채무증권 발행실적</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="747" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="445"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="147" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="454" HEIGHT="30" AUNIT="WONPERCENT" AUNITVALUE="1">(단위 : 원, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="748" BORDER="1">

<COLGROUP>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="67"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="69" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행회사</TH>
<TH WIDTH="69" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">증권종류</TH>
<TH WIDTH="70" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행방법</TH>
<TH WIDTH="70" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행일자</TH>
<TH WIDTH="80" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">권면(전자등록)총액</TH>
<TH WIDTH="73" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">이자율</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">평가등급(평가기관)</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">만기일</TH>
<TH WIDTH="68" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">상환여부</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주관회사</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_CMPY">-</TE>
<TU WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_KNN" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_STC" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_DAT" AUNITVALUE="-">-</TU>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MON">-</TE>
<TE WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATE">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEV">-</TE>
<TU WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_LAS" AUNITVALUE="-">-</TU>
<TE WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_REC">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUC">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_CMPY">-</TE>
<TU WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_KNN" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_STC" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_DAT" AUNITVALUE="-">-</TU>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MON">-</TE>
<TE WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATE">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEV">-</TE>
<TU WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_LAS" AUNITVALUE="-">-</TU>
<TE WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_REC">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUC">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합  계</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MONT">-</TE>
<TE WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATET">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEVT">-</TE>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_RECT">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUCT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_BLC" ADELETETABLE="N">
<TITLE ATOC="N">기업어음증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="820" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="514"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="523" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="820" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="43"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="106" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과30일이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과90일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과180일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과1년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과2년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과3년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년 초과</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_ELPN" ADELETETABLE="N">
<TITLE ATOC="N">단기사채 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="759" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="453"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="462" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="760" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과30일이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과90일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과180일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과1년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">발행 한도</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">잔여 한도</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_REM">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_CNC" ADELETETABLE="N">
<TITLE ATOC="N">회사채 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="762" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="456"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="465" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="761" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과2년이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과3년이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과4년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과5년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과10년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_NEF" ADELETETABLE="N">
<TITLE ATOC="N">신종자본증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="757" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="451"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="460" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="758" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과5년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과10년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과15년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">15년초과20년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과30년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_CEF" ADELETETABLE="N">
<TITLE ATOC="N">조건부자본증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="912" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="606"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="615" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="912" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과2년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과3년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과4년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과5년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과10년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과20년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과30년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<P></P>
</SECTION-3>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-7-2">7-2. 증권의 발행을 통해 조달된 자금의 사용실적</TITLE>
<P></P>

<LIBRARY>
<P USERMARK=" B">가. 공모자금의 사용내역</P>

<TABLE-GROUP ACLASS="FUND" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="928" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="619"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="68" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="628" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="929" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="168"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="121"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="177" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">회차</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">납입일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="219" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">증권신고서 등의 자금사용 계획</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="218" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제 자금사용 내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="130" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">차이발생 사유 등</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="110" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사용용도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">조달금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="177" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">코스닥시장 신규상장</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20221116">2022년 11월 16일</TU>
<TE ALIGN="CENTER" WIDTH="110" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">시설자금</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">4,367</TE>
<TE ALIGN="CENTER" WIDTH="109" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">시설자금</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="130" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="177" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">코스닥시장 신규상장</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20221116">2022년 11월 16일</TU>
<TE ALIGN="CENTER" WIDTH="110" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">3,177</TE>
<TE ALIGN="CENTER" WIDTH="109" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="130" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="177" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">코스닥시장 신규상장</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20221116">2022년 11월 16일</TU>
<TE ALIGN="CENTER" WIDTH="110" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">기타</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">4,696</TE>
<TE ALIGN="CENTER" WIDTH="109" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">기타</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="130" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="177" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">합계</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="-">-</TU>
<TE ALIGN="CENTER" WIDTH="110" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">12,240</TE>
<TE ALIGN="CENTER" WIDTH="109" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="130" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>


<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="931">

<COLGROUP>
<COL WIDTH="34"></COL>
<COL WIDTH="879"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="43" HEIGHT="30">주1)</TD>
<TD WIDTH="888" HEIGHT="30">자금사용 계획과 실제 자금사용 현황의 차액은 상기와 같으며, 미사용자금은 안정성이 높은 예금에 예치하여 운용하고 있습니다.</TD>
</TR>
</TBODY>
</TABLE>

<LIBRARY>
<P USERMARK=" B">나. 사모자금의 사용내역</P>

<TABLE-GROUP ACLASS="FUND_SA" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="935" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="626"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="68" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="635" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="936" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">회차</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">납입일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="255" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">주요사항보고서의 자금사용 계획</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="255" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제 자금사용 내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">차이발생 사유 등</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사용용도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">조달금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">설립자본</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20150514">2015년 05월 14일</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">설립자본금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">50 </TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">설립자본금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">50 </TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">주주배정</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20150808">2015년 08월 08일</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">100 </TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">100 </TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20160107">2016년 01월 07일</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">80 </TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">80 </TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20160301">2016년 03월 01일</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">50 </TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">50 </TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20160315">2016년 03월 15일</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">500 </TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">500 </TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20160512">2016년 05월 12일</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">42 </TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">42 </TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20160601">2016년 06월 01일</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">1,000 </TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">1,000 </TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20170601">2017년 06월 01일</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">3,000 </TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">3,000 </TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20180621">2018년 06월 21일</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">8,000 </TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">8,000 </TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">스톡옵션행사</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20181002">2018년 10월 02일</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">44 </TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">44 </TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20191225">2019년 12월 25일</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금 및 시설자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">2,000 </TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금 및 시설자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">2,000 </TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20200124">2020년 01월 24일</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금 및 시설자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">4,500 </TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금 및 시설자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">4,500 </TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20200205">2020년 02월 05일</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금 및 시설자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">4,000 </TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금 및 시설자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">4,000 </TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20200222">2020년 02월 22일</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">2,000 </TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">2,000 </TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20200229">2020년 02월 29일</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금 및 시설자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">500 </TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금 및 시설자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">500 </TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20200513">2020년 05월 13일</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">1,000 </TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">- </TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20200909">2020년 09월 09일</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">2,000 </TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">- </TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20210529">2021년 05월 29일</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금 및 시설자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">1,000 </TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금 및 시설자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">1,000 </TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20210716">2021년 07월 16일</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금 및 시설자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">11,940 </TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금 및 시설자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">11,940 </TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20210724">2021년 07월 24일</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금 및 시설자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">3,000 </TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금 및 시설자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">3,000 </TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20210918">2021년 09월 18일</TU>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">2,000 </TE>
<TE ALIGN="CENTER" WIDTH="163" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">- </TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">주1)</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>


<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="931">

<COLGROUP>
<COL WIDTH="34"></COL>
<COL WIDTH="879"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="43" HEIGHT="30">주1)</TD>
<TD WIDTH="888" HEIGHT="30">자금사용 계획과 실제 자금사용 현황의 차액은 상기와 같으며, 미사용자금은 안정성이 높은 예금에 예치하여 운용하고 있습니다.</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<LIBRARY>
<P USERMARK=" B">다. 미사용자금의 운용내역</P>

<TABLE-GROUP ACLASS="UNS_HIY" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="728" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="361"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="370" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="729" BORDER="1">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="151"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="110"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="160" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금융상품명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">운용금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="210" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계약기간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="119" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">실투자기간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" WIDTH="120" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="A" VALIGN="MIDDLE">예ㆍ적금</TU>
<TE ALIGN="CENTER" WIDTH="160" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">신한S드림정기예금</TE>
<TE ALIGN="RIGHT" WIDTH="120" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">3,000</TE>
<TU ALIGN="CENTER" WIDTH="210" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202208-202303" VALIGN="MIDDLE">2022년 08월 ~ 2023년 03월</TU>
<TE ALIGN="CENTER" WIDTH="119" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">1년 5개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="120" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="A" VALIGN="MIDDLE">예ㆍ적금</TU>
<TE ALIGN="CENTER" WIDTH="160" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">신한S드림정기예금</TE>
<TE ALIGN="RIGHT" WIDTH="120" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">2,000</TE>
<TU ALIGN="CENTER" WIDTH="210" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202211-202302" VALIGN="MIDDLE">2022년 11월 ~ 2023년 02월</TU>
<TE ALIGN="CENTER" WIDTH="119" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">1년 5개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="120" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="A" VALIGN="MIDDLE">예ㆍ적금</TU>
<TE ALIGN="CENTER" WIDTH="160" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">국민슈퍼예금</TE>
<TE ALIGN="RIGHT" WIDTH="120" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">5,000</TE>
<TU ALIGN="CENTER" WIDTH="210" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202212-202306" VALIGN="MIDDLE">2022년 12월 ~ 2023년 06월</TU>
<TE ALIGN="CENTER" WIDTH="119" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">1개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="120" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="A" VALIGN="MIDDLE">예ㆍ적금</TU>
<TE ALIGN="CENTER" WIDTH="160" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">국민슈퍼예금</TE>
<TE ALIGN="RIGHT" WIDTH="120" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">5,000</TE>
<TU ALIGN="CENTER" WIDTH="210" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202212-202303" VALIGN="MIDDLE">2022년 12월 ~ 2023년 03월</TU>
<TE ALIGN="CENTER" WIDTH="119" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">1개월</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="120" HEIGHT="30" AUNIT="UNS_KND" AUNITVALUE="A" VALIGN="MIDDLE">예ㆍ적금</TU>
<TE ALIGN="CENTER" WIDTH="160" HEIGHT="30" ACODE="UNS_NAM" VALIGN="MIDDLE">국민슈퍼예금</TE>
<TE ALIGN="RIGHT" WIDTH="120" HEIGHT="30" ACODE="UNS_MNY" VALIGN="MIDDLE">2,240</TE>
<TU ALIGN="CENTER" WIDTH="210" HEIGHT="30" AUNIT="UNS_PER" AUNITVALUE="202212-202301" VALIGN="MIDDLE">2022년 12월 ~ 2023년 01월</TU>
<TE ALIGN="CENTER" WIDTH="119" HEIGHT="30" ACODE="UNS_TRM" VALIGN="MIDDLE">1개월</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="280" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="2" AUPDATECONT="N">계</TD>
<TE ALIGN="RIGHT" WIDTH="120" HEIGHT="30" ACODE="UNS_MNY_SUM" VALIGN="MIDDLE">17,240</TE>
<TD ALIGN="CENTER" WIDTH="329" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="2" AUPDATECONT="N">-</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>

<PGBRK></PGBRK>
</SECTION-3>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-8-0">8. 기타 재무에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 재무제표 재작성 등 유의사항</SPAN>
<SPAN USERMARK=" B">(1) 재무제표 재작성</SPAN>당사는 재무제표 재작성 내역이 없습니다. 
<SPAN USERMARK=" B">(2) 합병, 분할, 자산양수도, 영업양수도</SPAN>현재 해당사항이 없습니다.
<SPAN USERMARK=" B">(3) 자산유동화와 관련한 자산매각의 회계처리 및 우발채무 등에 관한 사항</SPAN>현재 해당사항이 없습니다.
<SPAN USERMARK=" B">(4) 기타 재무제표 이용에 유의하여야 할 사항</SPAN>현재 해당사항이 없습니다.
</P>

<P>
<SPAN USERMARK=" B">나. 대손충당금 설정현황</SPAN>
</P>
<P USERMARK=" B">(1) 계정과목별 대손충당금 설정내역</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="300" HEIGHT="30">(별도)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="300" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="602">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계정과목</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권금액</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대손충당금주1)</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대손충당금설정률</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">2022년(제8기)</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">매출채권</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40,911</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">0.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미수금</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">420,416</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">0.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">461,327</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">0.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">2021년(제7기)</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">매출채권</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,731,265</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">0.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미수금</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,040,207</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">0.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,771,472</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">0.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">2020년(제6기)</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">매출채권</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">0.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미수금</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">85,928</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">0.0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">85,928</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">0.0%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">주1) 당사는 보고서 작성기준일까지 대손이 발생한 내역이 없습니다. </SPAN>
<SPAN USERMARK=" B">(2) 매출채권관련 대손충당금 설정방침</SPAN>
</P>
<P>(가) 개별평가결산일 현재 채권자의 신용상태 및 거래상황을 파악하여 개별채권의 회수가능여부를 판단합니다. 회수가능성이 없다고 판단되는 경우(파산 등) 채권에 대하여 대손충당금을 설정 합니다. (나) 집합평가채권을 결산일 현재 발생일로부터 기간별로 구분(3개월 이하, 3개월~6개월 이하, 6개월~9개월 이하, 9개월~12개월 이하, 12개월~15개월 이하, 15개월 초과)합니다.  15개월 초과 경과된 채권에 대해서는 전액 대손충당금을 설정하며, 3개월 초과 15개월 이내 경과 매출채권에 대해서는 거래상대방의 과거 채무불이행 경험 및 현재의 재무상태 분석에 근거하여 결정된 미회수 추정금액으로 대손충당금 설정합니다.</P>
<P USERMARK=" B">(3) 당기말 현재 경과기간별 매출채권 잔액 현황</P>

<TABLE WIDTH="773" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="467"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="BOTTOM" HEIGHT="30">(기준일 : </TD>
<TD WIDTH="137" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">2022년 12월 31일</TD>
<TD WIDTH="81" VALIGN="BOTTOM" HEIGHT="30">)</TD>
<TD WIDTH="476" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="773">

<COLGROUP>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="76"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" WIDTH="172" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">구분</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">3월 이하</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">3월 초과6월 이하</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">6월 초과9월 이하</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">9월 초과12월 이하</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">12월 초과15월 이하</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">15월 초과</TH>
<TH WIDTH="85" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">금액</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">해외</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40,911</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40,911</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">국내</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">계</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40,911</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40,911</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">구성비율</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100%</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0%</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0%</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0%</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0%</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0%</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100%</TD>
</TR>
</TBODY>
</TABLE>
<P>주1) 당기말 외화 매출채권 잔액은 2023년 03월 기준으로 전액 회수 하였습니다.</P>

<P>
<SPAN USERMARK=" B">다. 재고자산 현황 등</SPAN>
</P>

<P>
<SPAN USERMARK=" B">(1) 재고자산 보유현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="659">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="350"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD WIDTH="359" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="660">

<COLGROUP>
<COL WIDTH="241"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7"> 사업부문 </TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7"> 계정과목 </TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7"> 2022년 (제8기) </TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7"> 2021년 (제 7기) </TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7"> 2020년 (제 6기) </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="250" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90"> 듀라하트 SR-3 주사액(목시덱틴) 심장사상충 예방 및 치료제 </TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"> 제품 </TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">69,111</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28,287</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">              -</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"> 원재료 </TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">54,337</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">43,089</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">              -</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미착품</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,919</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="338" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"> 합     계 </TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">131,367</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">71,376</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">              -</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="338" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53"> 총자산대비 재고자산 구성비율(%) [재고자산합계÷기말자산총계×100] </TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">0.38%</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">0.2%</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">              -</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="338" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53"> 재고자산회전율(회수) [연환산 매출원가÷{(기초재고+기말재고)÷2}] </TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">3.96회</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">19.7회</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">              -</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">(2) 재고자산의 실사내역</SPAN>당사는 분기 말 자체적으로 재고조사를 전수로 실시하고 있으며 독립적인 외부감사인의 입회하에 실시하는 재고조사는 매년 회계기준말일 기준으로 1회 실시하고 있습니다.
</P>

<TABLE BORDER="1" WIDTH="665" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">실사기준일</TH>
<TH WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">실사일자</TH>
<TH WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">실사입회자</TH>
<TH WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">제8기(2022년)</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">2022년 12월 31일</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">2023-01-03</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">생산본부 담당자및 회계팀 담당자와 대주회계법인 소속 공인회계사의 입회 하에 재고실사를 실시</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">재고자산 실사</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">라. 수주계약 현황</SPAN>현재 해당사항이 없습니다.
</P>

<P>
<SPAN USERMARK=" B">마. 공정가치 평가내역 </SPAN>
</P>

<P>
<SPAN USERMARK=" B">(1) 금융상품의 공정가치 평가내역 </SPAN>
</P>

<P USERMARK="F-GL">
<SPAN USERMARK="F-BT">별도 재무제표의 금융자산과 금융부채의 장부금액과 공정가치는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="616">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="310"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" HEIGHT="30" VALIGN="BOTTOM">(별도)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM"></TD>
<TD WIDTH="81" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="319" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" HEIGHT="30" VALIGN="BOTTOM">(기준일 : </TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM">2022년 12월 31일</TD>
<TD WIDTH="81" HEIGHT="30" VALIGN="BOTTOM">)</TD>
<TD WIDTH="319" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="617">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="155" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="83">재무상태표 상 자산</TH>
<TH COLSPAN="2" WIDTH="232" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">2022년 (제8기)</TH>
<TH COLSPAN="2" WIDTH="230" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">2021년 (제7기)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="116" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">장부금액</TH>
<TH WIDTH="116" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">공정가치</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">장부금액</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">공정가치</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="617" VALIGN="MIDDLE" HEIGHT="30"><상각후원가 측정 금융자산></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="155" HEIGHT="30"> 현금및현금성자산</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">      23,819,470</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     23,819,470</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,256,127</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,256,127</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="155" HEIGHT="30"> 매출채권</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">           40,911</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">          40,911</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,731,265</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,731,265</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="155" HEIGHT="30"> 기타채권</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">         507,091</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">         507,091</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,055,238</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,055,238</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="155" HEIGHT="30"> 기타금융자산</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">         605,512</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">         605,512</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">742,176</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">742,176</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="155" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">      24,972,984</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     24,972,984</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,784,806</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,784,806</TD>
</TR>
</TBODY>
</TABLE>
<P>(주1) 장부금액과 공정가치의 차이가 중요하지 않으므로 장부가액을 공정가치로 산출하였습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="617">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="311"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" HEIGHT="30" VALIGN="BOTTOM">(별도)</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM"></TD>
<TD WIDTH="81" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="320" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" HEIGHT="30" VALIGN="BOTTOM">(기준일 : </TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM">2022년 12월 31일</TD>
<TD WIDTH="81" HEIGHT="30" VALIGN="BOTTOM">)</TD>
<TD WIDTH="320" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="617">

<COLGROUP>
<COL WIDTH="147"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">재무상태표 상 부채</TH>
<TH COLSPAN="2" WIDTH="231" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2022년 (제8기)</TH>
<TH COLSPAN="2" WIDTH="230" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2021년 (제7기)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="617" VALIGN="MIDDLE" HEIGHT="30"><상각후원가 측정 금융부채></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="156" HEIGHT="30"> 기타채무</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       1,516,309</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       1,516,309 </TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,112,117</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,112,117</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="156" HEIGHT="30"> 리스부채</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       2,800,268</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       2,800,268 </TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,971,665</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,971,665</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       4,316,577</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       4,316,577 </TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,083,782</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,083,782</TD>
</TR>
</TBODY>
</TABLE>

<P>(주1) 장부금액과 공정가치의 차이가 중요하지 않으므로 장부가액을 공정가치로 산출하였습니다.
<SPAN USERMARK=" B">(2) 유형자산의 공정가치 평가내역</SPAN>현재 해당사항이 없습니다.
</P>

<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-4-0-0">IV. 이사의 경영진단 및 분석의견</TITLE>

<P USERMARK=" 0X0000FF B">
<SPAN USERMARK=" 0XFF0000">1. 예측정보에 대한 주의사항</SPAN>
<SPAN USERMARK=" 0X000000 !B">당사가 동 사업보고서에서 미래에 발생할 것으로 예상ㆍ예측한 활동, 사건 또는 현상은 당해 공시서류 작성시점의 사건 및 재무성과에 대하여 회사의 견해를 반영한 것 입니다. 동 예측정보는 미래 사업환경과 관련된 다양한 가정에 기초하고 있으며, 동 가정들은 결과적으로 부정확한 것으로 판명될 수도 있습니다.또한, 이러한 가정들에는 예측정보에서 기재한 예상치와 실제 경과 간에 중요한 차이를 초래할 수 있는 위험, 불확실성 및 기타 요인을 포함하고 있습니다. 이러한 중요한 차이를 초래할 수 있는 요인에는 회사 내부경영과 관련된 요인과 외부환경에 관한요인이 포함되어 있으며, 이에 한하지 않습니다.회사는 동 예측정보 작성시점 이후에 발생하는 위험 또는 불확실성을 반영하기 위하여 예측정보에 기재한 사항을 수정하는 정정보고서를 공시할 의무는 없습니다.결론적으로 동 이사의 경영진단 및 분석의견상에 회사가 예상한 결과 또는 사항이 실현되거나 회사가 당초에 예상한 영향이 발생한다는 확신을 제공할 수 없습니다. 동 보고서에 기재된 예측정보는 동 보고서 작성시점을 기준으로 작성한 것 이며, 회사가 이러한 위험요인이나 예측정보를 업데이트할 예정이 없음을 유의하시기 바랍니다.</SPAN>
<SPAN USERMARK=" 0XFF0000">2. 개요</SPAN>
<SPAN USERMARK=" 0X000000 !B">당사는 2022년 1월 1일부터 2022년 12월 31일까지 제 8기 사업연도의 회계 및 업무에 대한 경영진단을 실시하여 다음과 같이 진단한 의견을 제출합니다.회사의 경영에 대한 전반적인 사항을 파악하기 위하여 장부와 관련 서류를 열람하고 재무제표 및 동 부속명세서에 대해서도 면밀히 검토하였습니다. 경영진단을 위하여 필요하다고 인정되는 서류에 대한 보고를 받았으며 중요한 업무에 관한 서류를 열람하고 그 내용을 상세히 검토하는 등 적정할 방법을 사용하여 회사 경영에 대한 내용을 파악하였습니다.당사는 2015년 5월 14일 설립되었으며, 약물 전달 플랫폼(DDS) 기반의 사업을 영위하며 경기도 성남시에 위치하고 있습니다. 현재 당사는 축적된 DDS 기술력을 바탕으로 다수의 파이프라인을 통한 기술이전 및 공동개발 계약을 체결하였습니다. </SPAN>
<SPAN USERMARK=" 0XFF0000">3. 재무상태 및 영업실적</SPAN>
<SPAN USERMARK=" 0XFF0000">가. 재무상태</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="591">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="285"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM"></TD>
<TD WIDTH="81" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="294" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="591">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="151" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" B">과목</TH>
<TH VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="110" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" B">제8기</TH>
<TH VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="110" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" B">제7기</TH>
<TH VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="110" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" B">증감액</TH>
<TH VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="110" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" B">증감율(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="151" HEIGHT="30">Ⅰ.유동자산</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">25,278 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">22,174 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">3,104 </TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14.00%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="151" HEIGHT="30">Ⅱ.비유동자산</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">9,584 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">9,550 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">33 </TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.35%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="151" HEIGHT="30">    자산총계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">34,862 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">31,724 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">3,138 </TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9.89%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="151" HEIGHT="30">Ⅰ.유동부채</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">2,609 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">2,403 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">206 </TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8.55%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="151" HEIGHT="30">Ⅱ.비유동부채</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">1,818 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">2,830 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">(1,012)</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-35.75%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="151" HEIGHT="30">    부채총계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">4,427 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">5,233 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">(806)</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-15.40%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="151" HEIGHT="30">Ⅰ.자본금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">4,176 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">3,567 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">609 </TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17.06%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="151" HEIGHT="30">Ⅱ.자본잉여금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">43,462 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">29,535 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">13,928 </TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">47.16%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="151" HEIGHT="30">Ⅲ.자본조정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">2,663 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">2,661 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">3 </TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.10%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="151" HEIGHT="30">Ⅳ.결손금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">(19,867)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">(9,271)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">(10,595)</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-114.28%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="151" HEIGHT="30">    자본총계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">30,435 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">26,491 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">3,944 </TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14.89%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="151" HEIGHT="30">    부채와 자본총계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">34,862 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">31,724 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="110" HEIGHT="30">3,138 </TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9.89%</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X0000FF B">
<SPAN USERMARK=" 0X000000 !B">총 자산은 349억으로 전년대비 31억 (9.89%) 증가하였으며, 전체 자산 중 유동자산이 차지하는 비율은 73%입니다. 유동자산의 경우, 전기 대비 14% 상승하였고 이는 당기 중 한국 코스닥시장 신규 상장으로 인한 현금 129억의 유입이 가장 큰 요인입니다.총 부채는 전년대비 8억 (-15.40%) 감소하였는데, 비유동부채인 리스부채 10억 감소가 대부분을 차지합니다. 부채비율은 전기 대비 5% 감소한 15%이며, 2021년 이후 차입 없이 안정적인 부채비율을 유지하고 있습니다.자본 총액은 전기 대비 39억 (14.89%) 상승한 304억이며, 이는 공모에 따른 자본잉여금 증가로 인한 것입니다.</SPAN>
<SPAN USERMARK=" 0XFF0000">나. 영업실적</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="591">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="285"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM"></TD>
<TD WIDTH="81" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="294" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="591">

<COLGROUP>
<COL WIDTH="235"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="77"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="244" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" B">과목</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" B">제8기</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" B">제7기</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" B">증감액</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" B">증감율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" HEIGHT="30">Ⅰ.매출</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,724</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,862</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,862</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100.01%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" HEIGHT="30">Ⅱ.매출원가</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">401</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">235</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">167</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">70.96%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" HEIGHT="30">Ⅲ.매출총이익</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,322</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,627</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,695</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">104.20%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" HEIGHT="30"> 판매비와관리비</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,224</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,185</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,039</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">27.17%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" HEIGHT="30">Ⅳ.영업이익(손실)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(10,902)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(9,558)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,344)</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-14.06%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" HEIGHT="30"> 금융수익</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">292</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">42</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">250</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">594.90%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" HEIGHT="30"> 금융비용</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">132</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">132</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.30%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" HEIGHT="30"> 기타수익</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">149</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">403</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(253)</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-62.88%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" HEIGHT="30"> 기타비용</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(23)</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-87.75%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" HEIGHT="30">Ⅴ.법인세비용차감전순이익(손실)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(10,595)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(9,271)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,324)</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-14.28%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" HEIGHT="30">Ⅵ.법인세비용</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" HEIGHT="30">Ⅶ.당기순이익(손실)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(10,595)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(9,271)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,324)</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-14.28%</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X0000FF B">
<SPAN USERMARK=" 0X000000 !B">당사는 2022년 한 해 동안 37억의 매출로 전년과 비교하여 100% 증가하였으며, 이는 장기지속형 주사제 기술 관련 License Out 계약 건 입니다. 회사는 연구개발비 109억을 투자(전년 대비 22억 증가)하여 손실이 확대되었습니다. 경상연구개발비의 증가는 다양한 파이프라인의 폭 넓은 연구개발 활동에 따른 것입니다.</SPAN>
<SPAN USERMARK=" 0XFF0000">4. 유동성 및 자금조달과 지출</SPAN>
<SPAN USERMARK=" 0X000000 !B">당기말 유동비율은 969%로 주기적인 자금수지 예측 및 적정현금흐름 수준 추정 및 자금관리 등을 통하여 적정 유동성을 관리하고 있는 바, 보고서 작성일로부터 1년 이내에 유동성 부족이 예상되지 않습니다.</SPAN>
<SPAN USERMARK=" 0XFF0000">가. 유동성</SPAN>
<SPAN USERMARK=" 0XFF0000">1) 보고기간 종료일 현재 현금 및 현금성자산의 내역</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="360">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="19"></COL>
<COL WIDTH="23"></COL>
<COL WIDTH="212"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="28" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM"></TD>
<TD WIDTH="32" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="221" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="360">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" B">구  분</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" B">당기말</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" B">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">보통예금</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,745</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,253</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">정기예금</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,075</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,003</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합  계</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,819</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,256</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X0000FF B">
<SPAN USERMARK=" 0XFF0000">2) 유동비율</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="483">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="19"></COL>
<COL WIDTH="23"></COL>
<COL WIDTH="335"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="28" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM"></TD>
<TD WIDTH="32" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="344" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="485">

<COLGROUP>
<COL WIDTH="131"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="140" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" B">구  분</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" B">당기말</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" B">전기말</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" B">증감</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" USERMARK=" B">증감율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유동자산</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,278</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,174</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,104</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유동부채</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,609</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,403</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">206</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유동비율</TD>
<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">969%</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">923%</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">46%</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5%</TD>
</TR>
</TBODY>
</TABLE>

<P>2022년 11월 코스닥 상장에 따라 약 129억의 자금조달이 완료되었으며, 해당 자금은 연구개발 역량 강화 및 시설투자에 집행될 예정입니다.
<SPAN USERMARK=" 0XFF0000 B">나. 자금 조달 및 차입금 현황</SPAN>보고기간 종료일 현재 차입금은 없으며, 조기상환의무도 존재하지 않습니다. 또한, 추가적인 차입으로 인한 자금조달계획에 대해 확정된 바가 없습니다.
</P>

<P>당사는 Microsphere기반 장기지속형 주사제 및 세포·유전자 치료제의 제조를 위한 공정 플랫폼 고도화를 위해 지속적으로 연구개발을 진행하고 있습니다. 이를 위해, 장기지속형 주사제 플랫폼 기술 및 LNP 제조 공정 개발/고도화 연구, Microsphere 기반 장기지속형 주사제 설비 및 장비 제조를 위한 투자가 예정되어 있으나, 아직 확정된 사항은 없습니다.
<SPAN USERMARK=" 0XFF0000 B">5. 부외거래</SPAN>당사는 공시서류작성일 현재 부외거래가 없습니다.
<SPAN USERMARK=" 0XFF0000 B">6. 그 밖의 투자결정에 필요사항</SPAN>
<SPAN USERMARK=" 0XFF0000 B">가. 중요한 회계정책 및 추정에 관한 사항</SPAN> "중요한 회계정책 및 추정에 관한 사항"은 동 공시서류의 첨부서류인 감사보고서의"주석 2. 재무제표의 작성기준 및 중요한 회계정책" 및 "주석 3. 중요한 회계추정 및 가정" 을 참고하여 주시기 바랍니다.
<SPAN USERMARK=" 0XFF0000 B">나. 파생상품 및 위험관리정책에 관한 사항</SPAN>당사는 사업보고서 작성기준일 현재 해당사항 없습니다.
<SPAN USERMARK=" 0XFF0000 B">다. 법규상의 규제에 관한 사항</SPAN>법규상의 규제에 관한 사항은 'XI. 그밖에 투자자 보호를 위하여 필요한 사항'의 '3. 제재 등과 관련된 사항'을 참고하시기 바랍니다.
<SPAN USERMARK=" 0XFF0000 B">라. 환경 및 종업원 등에 관한 사항</SPAN>당사는 사업보고서 작성기준일 현재 해당사항 없습니다.
<SPAN USERMARK=" 0XFF0000 B">마. 그 밖의 투자결정에 필요한 사항</SPAN>당사는 사업보고서 작성기준일 현재 해당사항 없습니다.
</P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-5-0-0">V. 회계감사인의 감사의견 등</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-5-1-0">1. 외부감사에 관한 사항</TITLE>
<P></P>
<LIBRARY>
<P USERMARK=" B">가. 회계감사인의 명칭 및 감사의견</P>

<TABLE-GROUP ACLASS="AUD_OPN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="681" BORDER="1">

<COLGROUP>
<COL WIDTH="140"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="184"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사의견</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">강조사항 등</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="193" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">핵심감사사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TE ALIGN="CENTER" WIDTH="149" HEIGHT="35" ACODE="OPN_YEAR1" VALIGN="MIDDLE">
<P>2022년(제8기)</P>
</TE>

<TE ALIGN="CENTER" WIDTH="113" HEIGHT="35" ACODE="OPN_AUR1" VALIGN="MIDDLE">
<P>대주회계법인</P>
</TE>

<TE ALIGN="CENTER" WIDTH="113" HEIGHT="35" ACODE="OPN_CMT1" VALIGN="MIDDLE">
<P>적정</P>
</TE>

<TE ALIGN="CENTER" WIDTH="113" HEIGHT="35" ACODE="OPN_EMP1" VALIGN="MIDDLE">
<P>-</P>
</TE>

<TE ALIGN="CENTER" WIDTH="193" HEIGHT="35" ACODE="OPN_POT1" VALIGN="MIDDLE" USERMARK=" 0X0000FF B">
<SPAN USERMARK="F-BT12 0X000000 !B">주1)</SPAN>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">

<TE ALIGN="CENTER" WIDTH="149" HEIGHT="35" ACODE="OPN_YEAR2" VALIGN="MIDDLE">
<P>2021년(제7기)</P>
</TE>

<TE ALIGN="CENTER" WIDTH="113" HEIGHT="35" ACODE="OPN_AUR2" VALIGN="MIDDLE">
<P>신한회계법인</P>
</TE>

<TE ALIGN="CENTER" WIDTH="113" HEIGHT="35" ACODE="OPN_CMT2" VALIGN="MIDDLE">
<P>적정</P>
</TE>

<TE ALIGN="CENTER" WIDTH="113" HEIGHT="35" ACODE="OPN_EMP2" VALIGN="MIDDLE">
<P>-</P>
</TE>

<TE ALIGN="CENTER" WIDTH="193" HEIGHT="35" ACODE="OPN_POT2" VALIGN="MIDDLE">
<P>해당사항 없음</P>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">

<TE ALIGN="CENTER" WIDTH="149" HEIGHT="35" ACODE="OPN_YEAR3" VALIGN="MIDDLE">
<P>2020년(제6기)</P>
</TE>

<TE ALIGN="CENTER" WIDTH="113" HEIGHT="35" ACODE="OPN_AUR3" VALIGN="MIDDLE">
<P>삼덕회계법인</P>
</TE>

<TE ALIGN="CENTER" WIDTH="113" HEIGHT="35" ACODE="OPN_CMT3" VALIGN="MIDDLE">
<P>적정</P>
</TE>

<TE ALIGN="CENTER" WIDTH="113" HEIGHT="35" ACODE="OPN_EMP3" VALIGN="MIDDLE">
<P>-</P>
</TE>

<TE ALIGN="CENTER" WIDTH="193" HEIGHT="35" ACODE="OPN_POT3" VALIGN="MIDDLE">
<P>해당사항 없음</P>
</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1) 2022년 핵심감사사항은 매출수익인식 발생사실입니다. 핵심감사사항으로 결정된 이유는 재무제표에 대한 주석 2에 기재된 바와 같이, 회사는 신약개발과 관련된 기술 이전으로 발생한 수익을 매출로 인식합니다. 회사의 매출은 회사의 주요 재무성과 평가지표 중 하나입니다. 회사의 매출은 특정거래처에 대한 매출 집중도가 높으며 재무제표 상 금액적으로 중요한 부분을 차지하고 있습니다. 이에 따라 목표 또는 기대치를 달성하기 위한 수익의 과대계상 위험이 존재하므로 우리는 매출의 발생사실과 관련하여 유의적인 위험이 있는 것으로 판단하고 이 영역에 관심을 기울였습니다.핵심감사사항이 감사에서 다루어진 방법으로 핵심감사사항에 대응하기 위하여 감사인은 다음을 포함한 감사절차를 수행하였습니다.ㆍ회사의 수익인식과 관련한 회계정책이 회계기준에 부합하는지 주요 계약서등 검토ㆍ수익인식 관련 회사의 내부 통제의 이해ㆍ매출거래에 대해 표본추출을 통하여 거래원천증빙 확인ㆍ수익인식에 대응되는 매출채권에 대해 표본추출방식을 이용한 외부조회 확인</P>
<P></P>

<P>
<SPAN USERMARK=" B">나. 감사용역 체결현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="676">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="19"></COL>
<COL WIDTH="23"></COL>
<COL WIDTH="528"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="28" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM"></TD>
<TD WIDTH="32" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="537" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="AUD_SIGK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="683" BORDER="1">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="146"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="155" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">내 용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="165" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">감사계약내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="164" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제수행내역</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TE ALIGN="CENTER" WIDTH="78" HEIGHT="63" ACODE="SIGK_YEAR1" VALIGN="MIDDLE">
<P>2022년</P>
<P>(제8기)</P>
</TE>

<TE ALIGN="CENTER" WIDTH="121" HEIGHT="63" ACODE="SIGK_AUR1" VALIGN="MIDDLE">
<P>대주회계법인</P>
</TE>
<TE ALIGN="CENTER" WIDTH="155" HEIGHT="63" ACODE="SIGK_CNT1" VALIGN="MIDDLE">외부감사(재무제표 회계감사)</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="63" ACODE="SIGK_CPAY1" VALIGN="MIDDLE">37,500</TE>
<TE ALIGN="RIGHT" WIDTH="82" HEIGHT="63" ACODE="SIGK_CTIM1" VALIGN="MIDDLE">441</TE>
<TE ALIGN="RIGHT" WIDTH="82" HEIGHT="63" ACODE="SIGK_FPAY1" VALIGN="MIDDLE">37,500</TE>
<TE ALIGN="RIGHT" WIDTH="82" HEIGHT="63" ACODE="SIGK_FTIM1" VALIGN="MIDDLE">441</TE>
</TR>

<TR ACOPY="N" ADELETE="N">

<TE ALIGN="CENTER" WIDTH="78" HEIGHT="63" ACODE="SIGK_YEAR2" VALIGN="MIDDLE">
<P>2021년</P>
<P>(제7기)</P>
</TE>

<TE ALIGN="CENTER" WIDTH="121" HEIGHT="63" ACODE="SIGK_AUR2" VALIGN="MIDDLE">
<P>신한회계법인</P>
</TE>
<TE ALIGN="CENTER" WIDTH="155" HEIGHT="63" ACODE="SIGK_CNT2" VALIGN="MIDDLE">외부감사(재무제표 회계감사)</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="63" ACODE="SIGK_CPAY2" VALIGN="MIDDLE">60,000</TE>
<TE ALIGN="RIGHT" WIDTH="82" HEIGHT="63" ACODE="SIGK_CTIM2" VALIGN="MIDDLE">354</TE>
<TE ALIGN="RIGHT" WIDTH="82" HEIGHT="63" ACODE="SIGK_FPAY2" VALIGN="MIDDLE">60,000</TE>
<TE ALIGN="RIGHT" WIDTH="82" HEIGHT="63" ACODE="SIGK_FTIM2" VALIGN="MIDDLE">354</TE>
</TR>

<TR ACOPY="N" ADELETE="N">

<TE ALIGN="CENTER" WIDTH="78" HEIGHT="63" ACODE="SIGK_YEAR3" VALIGN="MIDDLE">
<P>2020년</P>
<P>(제6기)</P>
</TE>

<TE ALIGN="CENTER" WIDTH="121" HEIGHT="63" ACODE="SIGK_AUR3" VALIGN="MIDDLE">
<P>삼덕회계법인</P>
</TE>
<TE ALIGN="CENTER" WIDTH="155" HEIGHT="63" ACODE="SIGK_CNT3" VALIGN="MIDDLE">외부감사(재무제표 회계감사)</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="63" ACODE="SIGK_CPAY3" VALIGN="MIDDLE">28,500</TE>
<TE ALIGN="RIGHT" WIDTH="82" HEIGHT="63" ACODE="SIGK_CTIM3" VALIGN="MIDDLE">280</TE>
<TE ALIGN="RIGHT" WIDTH="82" HEIGHT="63" ACODE="SIGK_FPAY3" VALIGN="MIDDLE">28,500</TE>
<TE ALIGN="RIGHT" WIDTH="82" HEIGHT="63" ACODE="SIGK_FTIM3" VALIGN="MIDDLE">280</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>[임의감사 현황] </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="676">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="19"></COL>
<COL WIDTH="23"></COL>
<COL WIDTH="528"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="28" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM"></TD>
<TD WIDTH="32" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="537" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="685">

<COLGROUP>
<COL WIDTH="92"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="69"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="101" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업연도</TH>
<TH WIDTH="114" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감사인</TH>
<TH WIDTH="146" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내 용</TH>
<TH WIDTH="163" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감사계약내역</TH>
<TH WIDTH="161" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">실제수행내역</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="85" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보수</TH>
<TH WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">시간</TH>
<TH WIDTH="83" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보수</TH>
<TH WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">시간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="101" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2022년</P>
<P>(제8기 반기)</P>
</TD>
<TD WIDTH="114" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">대주회계법인</TD>
<TD WIDTH="146" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">반기 재무제표 검토</TD>
<TD WIDTH="85" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">20,000</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">198</TD>
<TD WIDTH="83" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">20,000</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">198</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK=" B">다. 회계감사인과의 비감사용역 계약체결 현황</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="843">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="19"></COL>
<COL WIDTH="23"></COL>
<COL WIDTH="695"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="28" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM"></TD>
<TD WIDTH="32" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="704" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="AUD_SIGL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="844" BORDER="1">

<COLGROUP>
<COL WIDTH="113"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="329"></COL>
<COL WIDTH="156"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계약체결일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="338" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="165" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역수행기간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TE ALIGN="CENTER" WIDTH="122" HEIGHT="34" ACODE="SIGL_YEAR1" VALIGN="MIDDLE">
<P USERMARK="F-GL11">2022년(제8기)</P>
</TE>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="34" ACODE="SIGL_CRT1" VALIGN="MIDDLE">2022.09.26</TE>
<TE ALIGN="CENTER" WIDTH="338" HEIGHT="34" ACODE="SIGL_CNT1" VALIGN="MIDDLE">감사인 재무확인서 발행</TE>
<TE ALIGN="CENTER" WIDTH="165" HEIGHT="34" ACODE="SIGL_TIM1" VALIGN="MIDDLE">2022.09 ~ 2022.10</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="34" ACODE="SIGL_PAY1" VALIGN="MIDDLE">10,000</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="34" ACODE="SIGL_NOTE1" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">

<TE ALIGN="CENTER" WIDTH="122" HEIGHT="68" ACODE="SIGL_YEAR2" VALIGN="MIDDLE" ROWSPAN="2">
<P USERMARK="F-GL11">2021년(제7기)</P>
</TE>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="34" ACODE="SIGL_CRT2" VALIGN="MIDDLE">2022.01.03</TE>

<TE ALIGN="CENTER" WIDTH="338" HEIGHT="34" ACODE="SIGL_CNT2" VALIGN="MIDDLE">
<P USERMARK="F-GL11">주식매입선택권 등 평가 외</P>
</TE>

<TE ALIGN="CENTER" WIDTH="165" HEIGHT="34" ACODE="SIGL_TIM2" VALIGN="MIDDLE">
<P USERMARK="F-GL11">2022.01 ~ 2022.03</P>
</TE>

<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="34" ACODE="SIGL_PAY2" VALIGN="MIDDLE">
<P USERMARK="F-GL11">16,000</P>
</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="34" ACODE="SIGL_NOTE2" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="34" ACODE="SIGL_CRT2" VALIGN="MIDDLE">2021.08.09</TE>

<TE ALIGN="CENTER" WIDTH="338" HEIGHT="34" ACODE="SIGL_CNT2" VALIGN="MIDDLE">
<P USERMARK="F-GL11">주식매입선택권  및 상환전환우선주 평가 외</P>
</TE>

<TE ALIGN="CENTER" WIDTH="165" HEIGHT="34" ACODE="SIGL_TIM2" VALIGN="MIDDLE">
<P USERMARK="F-GL11">2021.07 ~ 2022.03</P>
</TE>

<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="34" ACODE="SIGL_PAY2" VALIGN="MIDDLE">
<P USERMARK="F-GL11">28,000</P>
</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="34" ACODE="SIGL_NOTE2" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">

<TE ALIGN="CENTER" WIDTH="122" HEIGHT="94" ACODE="SIGL_YEAR3" VALIGN="MIDDLE" ROWSPAN="3">
<P USERMARK="F-GL11">2020년(제6기)</P>
</TE>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="34" ACODE="SIGL_CRT3" VALIGN="MIDDLE">2020.10.15</TE>

<TE ALIGN="CENTER" WIDTH="338" HEIGHT="34" ACODE="SIGL_CNT3" VALIGN="MIDDLE">
<P USERMARK="F-GL11">주식매수선택권 및 상환전환우선주 평가 외</P>
</TE>

<TE ALIGN="CENTER" WIDTH="165" HEIGHT="34" ACODE="SIGL_TIM3" VALIGN="MIDDLE">
<P USERMARK="F-GL11">2020.10 ~ 2021.03</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="34" ACODE="SIGL_PAY3" VALIGN="MIDDLE">120,000</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="34" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SIGL_CRT3" VALIGN="MIDDLE">2020.10.15</TE>
<TE ALIGN="CENTER" WIDTH="338" HEIGHT="30" ACODE="SIGL_CNT3" VALIGN="MIDDLE">재무제표의 IFRS 전환</TE>
<TE ALIGN="CENTER" WIDTH="165" HEIGHT="30" ACODE="SIGL_TIM3" VALIGN="MIDDLE">2020.10 ~ 2021.03</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="SIGL_PAY3" VALIGN="MIDDLE">120,000</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SIGL_CRT3" VALIGN="MIDDLE">2020.10.15</TE>
<TE ALIGN="CENTER" WIDTH="338" HEIGHT="30" ACODE="SIGL_CNT3" VALIGN="MIDDLE">내부회계관리제도 구축</TE>
<TE ALIGN="CENTER" WIDTH="165" HEIGHT="30" ACODE="SIGL_TIM3" VALIGN="MIDDLE">2020.10 ~ 2021.10</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="SIGL_PAY3" VALIGN="MIDDLE">120,000</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">주1)</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1) 기재된 용역보수는 전체 합계액입니다.</P>
</LIBRARY>

<P></P>

<LIBRARY>
<P USERMARK=" B">라. 재무제표 중 이해관계자의 판단에 상당한 영향을 미칠 수 있는 사항</P>

<TABLE-GROUP ACLASS="DIS_CUS" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="807" BORDER="1">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="194"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="325"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">일자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="203" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">참석자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="85" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">방식</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="334" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요 논의 내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">1</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20230315" VALIGN="MIDDLE">2023년 03월 15일</TU>
<TE ALIGN="CENTER" WIDTH="203" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE">회사측 1인 감사, 감사인 1인 담당이사 (총2인)</TE>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE">서면회의</TE>
<TE ALIGN="CENTER" WIDTH="334" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">감사에서의 유의적 발견사항, 핵심감사사항, 유의적 내부통제의 미비점, 감사인의 독립성 등</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">2</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20221220" VALIGN="MIDDLE">2022년 12월 20일</TU>
<TE ALIGN="CENTER" WIDTH="203" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE">회사측 1인 감사, 감사인 1인 담당이사 (총2인)</TE>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE">서면회의</TE>
<TE ALIGN="CENTER" WIDTH="334" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">감사팀 구성, 감사투입시간과 보수, 경영진 및 감사인의 책임, 감사인의 독립성, 핵심감사사항 등</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">3</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20220216" VALIGN="MIDDLE">2022년 02월 16일</TU>
<TE ALIGN="CENTER" WIDTH="203" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE">회사측 1인 감사, 감사인 1인 담당이사 (총2인)</TE>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE">대면회의</TE>
<TE ALIGN="CENTER" WIDTH="334" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">기말감사 결과 논의</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">4</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20211103" VALIGN="MIDDLE">2021년 11월 03일</TU>
<TE ALIGN="CENTER" WIDTH="203" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE">회사측 1인 감사, 감사인 1인 담당이사 (총2인)</TE>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE">대면회의</TE>
<TE ALIGN="CENTER" WIDTH="334" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">중간감사 결과 논의</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">5</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20211029" VALIGN="MIDDLE">2021년 10월 29일</TU>
<TE ALIGN="CENTER" WIDTH="203" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE">회사측 1인 감사, 감사인 1인 담당이사 (총2인)</TE>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE">서면회의</TE>
<TE ALIGN="CENTER" WIDTH="334" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">회계감사계획(일정, 인원 등)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">6</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20210910" VALIGN="MIDDLE">2021년 09월 10일</TU>
<TE ALIGN="CENTER" WIDTH="203" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE">회사측 1인 감사, 감사인 1인 담당이사 (총2인)</TE>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE">대면회의</TE>
<TE ALIGN="CENTER" WIDTH="334" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">반기 기말감사 결과논의</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="DIS_DIV" VALIGN="MIDDLE">7</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="DIS_DATE" AUNITVALUE="20210316" VALIGN="MIDDLE">2021년 03월 16일</TU>
<TE ALIGN="CENTER" WIDTH="203" HEIGHT="30" ACODE="DIS_ATT" VALIGN="MIDDLE">감사,책임회계사</TE>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="30" ACODE="DIS_WAY" VALIGN="MIDDLE">대면회의</TE>
<TE ALIGN="CENTER" WIDTH="334" HEIGHT="30" ACODE="DIS_CONT" VALIGN="MIDDLE">감사결과 보고</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="DIS_DIV" VALIGN="MIDDLE">8</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="30" AUNIT="DIS_DATE" AUNITVALUE="20201222" VALIGN="MIDDLE">2020년 12월 22일</TU>
<TE ALIGN="CENTER" WIDTH="203" HEIGHT="30" ACODE="DIS_ATT" VALIGN="MIDDLE">감사,책임회계사</TE>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="30" ACODE="DIS_WAY" VALIGN="MIDDLE">대면회의</TE>
<TE ALIGN="CENTER" WIDTH="334" HEIGHT="30" ACODE="DIS_CONT" VALIGN="MIDDLE">감사계획 보고 및 협의</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>


<P>
<SPAN USERMARK=" B">마. 회계감사인의 변경 </SPAN>당사는 코스닥시장 상장을 추진하는 과정에서 「주식회사 등의 외부감사에 관한 법률」 제11조 제1항 및 제2항, 동법 시행령 제17조 및 「외부감사 및 회계 등에 관한 규정」 제10조 및 제15조 제1항에 의거하여 금융감독원으로부터 제7기(2021.01.01 ~ 2021.12.31)에 대한 외부감사인으로 신한회계법인을 지정 통지받아 동 회계법인과 감사계약을 체결하였습니다.당사는 자유수임계약으로 당사의 제8기(2022.01.01 ~ 2022.12.31)에 대한 외부감사인으로 대주회계법인을 선임하였습니다. 
</P>

<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-5-2-0">2. 내부통제에 관한 사항</TITLE>
<P>당사는 2022년 11월 22일 주권상장법인으로 전환됨에 따라, 사업보고서 제출일 현재 「주식회사의 외부감사에 관한 법률」제8조에 따른 내부회계관리제도 운용 및 통제평가를 활성화하여 성실하게 운영 중에 있습니다. 또한, 대표이사는 내부회계관리제도의 운영실태를 평가하여 이를 이사회 및 감사, 그리고 주주총회 및 외부감사인에 보고하고, 동 내용을 외부감사인으로부터 검토 받고 있습니다. 감사인은 2022년 12월 31일 현재 내부회계관리제도의 운영실태평가보고서를 검토하였으며, 중요성의 관점에서 내부회계관리제도 모범규준의 규정에 따라 작성되지 않았다고 판단하게 하는 점이 발견되지 아니하였다는 의견을 표명하였습니다.아래는 당기 대표이사 및 내부회계관리자의 운영실태 보고 내용입니다.</P>

<TABLE BORDER="1" WIDTH="627" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="377"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">사업연도</TH>
<TH WIDTH="386" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">의견내용</TH>
<TH WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">2022연도제8기(당기)</TD>
<TD WIDTH="386" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">본 대표이사 및 내부회계관리자의 내부회계관리제도 운영실태 평가결과, 2022년 12월 31일 현재 당사의 내부회계관리제도는 ‘내부회계관리제도 모범규준’에 근거하여 볼 때, 중요성의 관점에서 효과적으로 설계되어 운영되고 있다고 판단됩니다.</TD>
<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">보고서 일자:2023년 2월 24일</TD>
</TR>
</TBODY>
</TABLE>
<P>이에 회계감사인은 사업보고서 기준일 현재 내부회계관리제도를 대상으로 검토하였으며, 아래는 회계감사인의 각 사업연도의 내부회계관리제도 검토 의견입니다.</P>

<TABLE BORDER="1" WIDTH="623" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="236"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">사업연도</TH>
<TH WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">의견내용</TH>
<TH WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">개선계획또는 결과</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">회계감사인</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">2022연도제8기(당기)</TD>
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">경영진의 내부회계관리제도 운영실태보고서에 대한 우리의 검토 결과, 상기 경영진의 운영실태보고 내용이 중요성의 관점에서 내부회계관리제도모범규준의 규정에 따라 작성되지 않았다고 판단하게 하는 점이 발견되지 아니하였습니다.</TD>
<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">없음</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">대주회계법인</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">보고서 일자:2023년 3월 22일</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VI. 이사회 등 회사의 기관에 관한 사항</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-1-0">1. 이사회에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 이사회 구성 개요</SPAN>
</P>

<P>
<SPAN USERMARK=" B">(1) 이사의수 및 이사회의 구성 현황</SPAN>현재 당사의 이사회는 총 7명(사내이사 5명, 사외이사 1명, 기타비상무이사 1명)으로 구성되어 있습니다. 이사회는 법령 또는 정관에 정하여진 사항, 주주총회로부터 위임 받은 사항, 회사 경영의 기본 방침 및 업무 집행에 관한 주요사항을 의결하며, 이사 및 경영진의 직무 집행을 감독하고 있습니다. 당사의 이사회 의장은 김주희 대표이사가 수행하고 있습니다.
</P>
<P></P>

<TABLE ACLASS="NORMAL" WIDTH="632" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="623"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="632" HEIGHT="30">【 이사회 의장 선임 배경 】</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="633" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="93"></COL>
<COL WIDTH="419"></COL>
<COL WIDTH="94"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이사회 의장</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="428" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">선임 이유</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대표이사겸직여부</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="76">김주희대표이사</TD>

<TD VALIGN="MIDDLE" WIDTH="428" HEIGHT="76">
<SPAN USERMARK=" BC0X31FFFF">ㆍ최대주주 및 대표이사로서 책임경영체제 확립ㆍ대표이사를 이사회 의장으로 선임함으로써 이사회 소집 및 운영의 효율성 제고</SPAN>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="76">여</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>당사는 상법 제363조 및 당사 정관 제23조의 규정에 따라 주주총회 소집일시, 장소 및 회의의 목적사항을 총회의 2주간 전에 서면 또는 각 주주의 동의를 받아 전자문서로 통지하고 있으며, 회의 목적 사항이 이사의 선임에 관한 사항일 경우에는 이사 후보자의 성명, 약력 등 후보자에 관한 사항을 통지하고 있습니다. 당사는 제출일 현재 구성된 이사회 구성원 중 주주제안권에 의해 추천된 이사는 없으며, 이사에 대하여 이사회의 추천을 받아 주주총회에서 선임하고 있습니다. 당사의 이사(등기임원) 중 최대주주와 친인척인 관계를 갖는 이사는 없습니다.</P>

<P>각 이사의 주요 이력, 인적사항(겸직 등) 및 주요 수행업무는  - Ⅶ. 임원 및 직원 등에 관한 사항』 부분을 참고하시기 바랍니다.
<SPAN USERMARK=" B">(2) 이사회 운영규정의 주요 내용</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="747">

<COLGROUP>
<COL WIDTH="125"></COL>
<COL WIDTH="604"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구분</P>
</TH>

<TH WIDTH="613" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>제 4 조구성</P>
</TD>

<TD WIDTH="613" VALIGN="MIDDLE" HEIGHT="122">
<P>① 이사회는 대표이사 및 이사로 구성한다.</P>
<P>② 이사회의 의장은 대표이사가 되며, 대표이사가 유고시에는 직제규정이 정하는 대표이사 직무대행 순서에 의하고, 상임이사가 모두 유고시에는 비상임 이사 중 호선에 의해 선임된 이사가 그 직무를 대행한다.</P>
<P>③ 이사는 제출된 안건을 심의하고 표결에 참여한다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>제 5 조회의 및 소집</P>
</TD>

<TD WIDTH="613" VALIGN="MIDDLE" HEIGHT="76">
<P>① 이사회는 정기회의와 수시회의로 구분한다.</P>
<P>② 정기회의는 년1회 2월중에 대표이사가 소집하고, 수시회의는 대표이사가 필요하다고 인정하거나, 재적이사 과반수 또는 감사의 요구가 있는 때 대표이사가 소집한다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="398">
<P>제 7 조의결사항</P>
</TD>

<TD WIDTH="613" VALIGN="MIDDLE" HEIGHT="398">
<P>① 다음 각 호의 사항은 이사회의 결의를 얻어야 한다.</P>
<P>  1) 주주총회 소집 및 부의안건에 관한 사항</P>
<P>  2) 주요 규정 및 개폐에 관한 사항</P>
<P>  3) 기본경영에 관한 사항</P>
<P>  4) 사업계획 및 예산</P>
<P>  5) 조직의 중요한 변경</P>
<P>  6) 재무제표의 승인</P>
<P>  7) 재무에 관한 사항</P>
<P>  8) 신주발행</P>
<P>  9) 준비금의 자본전입</P>
<P>  10) 장기자금의 차입 및 사채의 발행, 상환계획</P>
<P>  11) 이익잉여금의 및 결손금의 처분</P>
<P>  12) 기타 법령, 정관 및 주주총회에서 위임받은 사항</P>
<P>② 다음 각 호의 사항에 대하여는 이사회에 보고하여야 한다.</P>
<P>  1) 이사회 결의사항의 집행결과</P>
<P>  2) 투자심사위원회의 의결에 관한 사항</P>
<P>  3) 기타 이사회에서 필요하다고 인정하는 사항</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>제 8 조제출절차</P>
</TD>

<TD WIDTH="613" VALIGN="MIDDLE" HEIGHT="99">
<P>① 이사회에 의안을 제출하고자 하는 부서에서는 간사의 협의를 거쳐 대표이사의 결재를 받은 후 회의개최 10일전까지 간사에게 제출하여야 한다.   </P>
<P>② 간사는 의안의 접수순위에 따라 접수부에 기록하고 의안번호를 표기하여야 하며, 그 의안은 특별한 사유가 없는 한 회의개최 1주전까지 이사회 구성원에게 배부한다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제 9 조회의통지</P>
</TD>

<TD WIDTH="613" VALIGN="MIDDLE" HEIGHT="53">
<P>간사는 의안을 접수하고 회의일정을 검토하여 각 이사에게 회의개최 계획을 통지하여야 한다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제 10 조의안설명</P>
</TD>

<TD WIDTH="613" VALIGN="MIDDLE" HEIGHT="53">
<P>이사회의 제출안건은 소관부서의 장이 설명한다. 다만, 필요한 경우 관계직원으로 하여금 대리설명이나 의견 등을 진술하게 할 수 있다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제 11 조의안청취</P>
</TD>

<TD WIDTH="613" VALIGN="MIDDLE" HEIGHT="53">
<P>이사회는 의안심의에 필요한 경우, 전문가 또는 관계인을 참석하게 하여 의견을 들을 수 있다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제 12 조연기 및 속행</P>
</TD>

<TD WIDTH="613" VALIGN="MIDDLE" HEIGHT="53">
<P>① 이사회는 필요한 경우, 회의의 연기 및 속행의 결의를 할 수 있다.</P>
<P>② 제1항의 경우에는 회의소집 통지를 하지 아니한다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제 14 조감사의 의견진술</P>
</TD>

<TD WIDTH="613" VALIGN="MIDDLE" HEIGHT="53">
<P>감사는 이사회에 출석하여 의견을 진술할 수 있으며 표결권은 가지지 아니한다</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>제 15 조의결방법의 특례</P>
</TD>

<TD WIDTH="613" VALIGN="MIDDLE" HEIGHT="122">
<P>① 대표이사는 이사회 제출 안건 중 의안에 따라 이사회를 소집하지 않고 서면결의로서 이사회의 의결을 갈음할 수 있다.</P>
<P>② 대표이사는 긴급을 요하는 사항으로 이사회를 개최할 시간적 여유가 없을 경우, 이사회의 의결 없이 이를 집행할 수 있다. 다만, 다음 이사회에 그 전말을 보고하여 추진을 받아야 한다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>제 16 조권한의 위임</P>
</TD>

<TD WIDTH="613" VALIGN="MIDDLE" HEIGHT="99">
<P>① 이사회가 특별히 필요하다고 인정하는 경우, 제7조의 규정에 의한 권한의 일부를 대표이사에게 위임할 수 있다.</P>
<P>② 대표이사가 제1항의 규정에 의하여 그 권한을 위임받아 처리한 경우에는 이사회에 그 결과를 보고하여야 한다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>제 17 조의결사항의 통보</P>
</TD>

<TD WIDTH="613" VALIGN="MIDDLE" HEIGHT="99">
<P>① 이사회 주관부서의 장은 이사회 종료 후 제출안건에 대한 의결서를 작성하여 출석이사 전원의 기명날인 또는 서명을 받아야 한다.</P>
<P>② 이사회 주관부서의 장은 이사회 의결사항을 1주일 이내에 서면으로 관계부서에 통보하여야 한다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제 18 조회의록</P>
</TD>

<TD WIDTH="613" VALIGN="MIDDLE" HEIGHT="53">
<P>이사회 주관부서의 장은 이사회의 개최결과를 기록한 회의록을 작성하여 참석이사의 기명날인 또는 서명과 감사의 확인날인 또는 서명을 받은 후 비치하여야 한다.</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK=" B">나. 중요 의결사항 등</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1045">

<COLGROUP>
<COL WIDTH="20"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="286"></COL>
<COL WIDTH="48"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="29" HEIGHT="129" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>회차</P>
</TH>
<TH WIDTH="87" HEIGHT="129" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">개최일자</TH>

<TH WIDTH="295" HEIGHT="129" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>의안내용</P>
</TH>

<TH WIDTH="57" HEIGHT="129" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>가결여부</P>
</TH>
<TH WIDTH="370" HEIGHT="53" COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사내이사</TH>
<TH WIDTH="69" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타비상무이사</TH>
<TH WIDTH="138" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사외이사</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="73" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">김주희(출석률:100%)</TH>
<TH WIDTH="75" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">김동훈(출석률:100%)</TH>
<TH WIDTH="71" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">류충호(출석률:100%)</TH>
<TH WIDTH="78" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전찬희(출석률:100%)</TH>
<TH WIDTH="73" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이마세(출석률:100%)</TH>
<TH WIDTH="69" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">김태헌(출석률:86%)</TH>
<TH WIDTH="69" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">문응필(출석률:100%)</TH>
<TH WIDTH="69" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">김후균(출석률:100%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="29" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1</TD>
<TD WIDTH="87" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022.02.22</TD>

<TD WIDTH="295" HEIGHT="30" VALIGN="MIDDLE">
<P>1. 제7기 결산 재무제표 승인의 건</P>
</TD>
<TD WIDTH="57" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="73" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="75" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="73" HEIGHT="159" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="3">주2)</TD>
<TD WIDTH="69" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="69" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="69" HEIGHT="295" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="6">주3)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="29" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2</TD>
<TD WIDTH="87" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2022.03.07</TD>

<TD WIDTH="295" HEIGHT="76" VALIGN="MIDDLE">
<P>1. 제7기 정기주주총회 소집의 건2. 명의개서 대리인 설치의 건3. 주식매수선택권 부여 취소의 건</P>
</TD>
<TD WIDTH="57" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="73" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="75" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="71" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="78" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="69" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="69" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="29" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">3</TD>
<TD WIDTH="87" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2022.03.10</TD>

<TD WIDTH="295" HEIGHT="53" VALIGN="MIDDLE">
<P>1. 제7기 정기주주총회 목적사항 추가의 건</P>
</TD>
<TD WIDTH="57" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="73" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="75" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="71" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="69" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="69" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="29" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4</TD>
<TD WIDTH="87" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022.04.25</TD>

<TD WIDTH="295" HEIGHT="30" VALIGN="MIDDLE">
<P>1. 코스닥 시장 상장 결의의 건</P>
</TD>
<TD WIDTH="57" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="73" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="75" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="73" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="69" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="69" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="29" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">5</TD>
<TD WIDTH="87" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2022.07.13</TD>
<TD WIDTH="295" HEIGHT="76" VALIGN="MIDDLE">1. 임시주주총회 소집에 관한 건2. 임시주주총회 권리 주주 확정을 위한 명의개서 정지의 건</TD>
<TD WIDTH="57" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="73" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="75" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="71" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="78" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="73" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="69" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="69" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="29" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6</TD>
<TD WIDTH="87" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022.08.16</TD>
<TD WIDTH="295" HEIGHT="30" VALIGN="MIDDLE">1. 임시주주총회 소집일 변경의 건</TD>
<TD WIDTH="57" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="73" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="75" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="73" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="69" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="69" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">주1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="29" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">7</TD>
<TD WIDTH="87" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022.09.29</TD>
<TD WIDTH="295" HEIGHT="30" VALIGN="MIDDLE">1. 코스닥시장 상장을 위한 신주 발행의 건</TD>
<TD WIDTH="57" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="73" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="75" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="73" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="69" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
<TD WIDTH="69" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="1050">

<COLGROUP>
<COL WIDTH="40"></COL>
<COL WIDTH="992"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="49" HEIGHT="76">
<P>주1)주2)주3)</P>
</TD>

<TD WIDTH="1001" HEIGHT="76">
<P>문응필 사외이사는 2022년 7월 19일 일신상의 사유로 사임하였습니다.2022년 03월 25일 개최된 제7기 정기주주총회에서 이마세 사내이사가 신규 선임되었습니다.2022년 08월 31일, 임시주주총회를 통해 김후균 사외이사가 신규 선임되었습니다.</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">다. 이사회 내 위원회</SPAN>당사는 현재 이사회 내에 위원회를 설치하고 있지 아니합니다.
<SPAN USERMARK=" B">라. 이사의 독립성</SPAN>
<SPAN USERMARK=" B">(1) 이사회 구성 및 독립성</SPAN>당사의 이사는 주주총회에서 선임하며, 이사 후보자는 상법 등 관련 법령상 자격 기준을 준수함은 물론, 전문성, 독립성 등의 선정 기준에 따라 이사회에서 선정하여 주주총회에 제출할 의안으로 확정하고 있습니다. 현재 당사의 이사 현황은 다음과 같습니다.
</P>

<TABLE ACLASS="NORMAL" WIDTH="1090" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="1081"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1090" HEIGHT="30">【 이사회 구성 현황 】</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="1091" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="218"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="89"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>성명</P>
</TH>

<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>직위</P>
</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">추천인</TH>

<TH WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>담당업무</P>
</TH>
<TH WIDTH="227" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">선임배경</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">선임일</TH>
<TH WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임기</TH>

<TH WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>연임여부및 횟수</P>
</TH>

<TH WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>최대주주와의관계</P>
</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사와의거래</TH>

<TH WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">김주희</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>대표이사(상근/등기)</P>
</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">이사회</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>경영 총괄</P>
</TD>
<TD WIDTH="227" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회사의 주사업과 관련한 연구개발 전문가</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2021.05.14</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">3년</TD>
<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">연임(2회)</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>본인</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>이사회 의장</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">김동훈</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>사내이사(상근/등기)</P>
</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">이사회</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">경영기획총괄</TD>
<TD WIDTH="227" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회사의 주사업 관련 산업의재무, 경영전략 전문가</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2021.10.26</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">3년</TD>

<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>연임(1회)</P>
</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">이마세</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>사내이사(상근/등기)</P>
</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">이사회</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">CSO/IVC 본부장</TD>
<TD WIDTH="227" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회사의 주사업과 관련한 연구개발 전문가</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2022.03.28</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">3년</TD>
<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">신규</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>-</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">류충호</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>사내이사(상근/등기)</P>
</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">이사회</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">연구소장/IMC 본부장</TD>
<TD WIDTH="227" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회사의 주사업과 관련한 연구개발 전문가</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2022.03.28</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">3년</TD>
<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">연임(2회)</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">전찬희</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">사내이사(상근/등기)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">이사회</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">CTO/IPC본부장</TD>
<TD WIDTH="227" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회사의 주사업과 관련한 연구개발 전문가</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.03.25</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">3년</TD>

<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>신규</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>-</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">김후균</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">사외이사(비상근/등기)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">이사회</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">경영자문</TD>
<TD WIDTH="227" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">법률 관련 전문가</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2022.08.31</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">3년</TD>
<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">신규</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">김태헌</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">기타비상무이사(비상근/등기)</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">이사회</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">경영자문</TD>
<TD WIDTH="227" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">회사 경영 및 성장전략 전문가</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.03.25</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">3년</TD>
<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">신규</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">(2) 사외이사후보추천위원회</SPAN>
</P>
<P>당사는 사외이사를 선출하기 위한 별도 위원회를 설치 하고 있지는 않으나, 후보자의 사외이사 결격요건 해당 여부에 대하여 확인하고 있습니다. 당사의 사외이사는 결격요건에 해당하는 사항이 없습니다. </P>

<TABLE ACLASS="NORMAL" WIDTH="793" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="784"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="793" HEIGHT="30">【 사외이사의 결격요건 해당 여부 】</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="792" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="644"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="60"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="653" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">해당여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">김후균</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="792" HEIGHT="30" USERMARK=" B">상법 제382조 제3항 각호</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="653" HEIGHT="53">
<P>1. 회사의 상무에 종사하는 이사ㆍ집행임원 및 피용자 또는 최근 2년 이내에 회사의 상무에 종사한 이사ㆍ감사ㆍ집행임원 및 피용자</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="53">
<P>X</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="53">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="653" HEIGHT="30">
<P>2. 최대주주가 자연인인 경우 본인과 그 배우자 및 직계 존속ㆍ비속</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="30">
<P>X</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="653" HEIGHT="30">
<P>3. 최대주주가 법인인 경우 그 법인의 이사ㆍ감사ㆍ집행임원 및 피용자</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="30">
<P>X</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="653" HEIGHT="30">
<P>4. 이사ㆍ감사ㆍ집행임원의 배우자 및 직계 존속ㆍ비속</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="30">
<P>X</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="653" HEIGHT="30">
<P>5. 회사의 모회사 또는 자회사의 이사ㆍ감사ㆍ집행임원 및 피용자</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="30">
<P>X</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="653" HEIGHT="30">
<P>6. 회사와 거래관계 등 중요한 이해관계에 있는 법인의 이사ㆍ감사ㆍ집행임원 및 피용자</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="30">
<P>X</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="653" HEIGHT="53">
<P>7. 회사의 이사ㆍ집행임원 및 피용자가 이사ㆍ집행임원으로 있는 다른 회사의 이사ㆍ감사ㆍ집행임원 및 피용자</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="53">
<P>X</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="53">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="792" HEIGHT="30" USERMARK=" B">상법 제542조의8 제2항 각호</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="653" HEIGHT="30">
<P>1. 미성년자, 피성년후견인 또는 피한정후견인</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="30">
<P>X</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="653" HEIGHT="30">
<P>2. 파산선고를 받고 복권되지 아니한 자</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="30">
<P>X</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="653" HEIGHT="30">
<P>3. 금고 이상의 형을 선고받고 그 집행이 끝나거나 집행이 면제된 후 2년이 지나지 아니한 자</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="30">
<P>X</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="653" HEIGHT="30">
<P>4. 대통령령으로 별도로 정하는 법률을 위반하여 해임되거나 면직된 후 2년이 지나지 아니한 자</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="30">
<P>X</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="653" HEIGHT="76">
<P>5. 상장회사의 주주로서 의결권 없는 주식을 제외한 발행주식총수를 기준으로 본인 및 그와 대통령령으로 정하는 특수한 관계에 있는 자(이하 “특수관계인”이라 한다)가 소유하는 주식의 수가 가장 많은 경우 그 본인(이하 “최대주주”라 한다) 및 그의 특수관계인</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="76">
<P>X</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="76">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="653" HEIGHT="99">
<P>6. 누구의 명의로 하든지 자기의 계산으로 의결권 없는 주식을 제외한 발행주식총수의 100분의 10 이상의 주식을 소유하거나 이사ㆍ집행임원ㆍ감사의 선임과 해임 등 상장회사의 주요 경영사항에 대하여 사실상의 영향력을 행사하는 주주(이하 “주요주주”라 한다) 및 그의 배우자와 직계 존속ㆍ비속</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="99">
<P>X</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="99">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="653" HEIGHT="53">
<P>7. 그 밖에 사외이사로서의 직무를 충실하게 수행하기 곤란하거나 상장회사의 경영에 영향을 미칠 수 있는 자로서 대통령령으로 정하는 자</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="53">
<P>X</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="53">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">마. 사외이사의 전문성</SPAN>
<SPAN USERMARK=" B">(1) 사외이사 현황</SPAN>당사의 사외이사는 관련분야 전문가로서 이사로서 직무 수행에 있어 전문성을 갖추고 있습니다. 또한 이사회 전에 해당 안건 내용을 충분히 검토할 수 있도록 사전에 자료를 제공하고 기타 사내 주요 현안에 대해서도 수시로 정보를 제공하고 있습니다.
</P>

<TABLE ACLASS="NORMAL" WIDTH="663" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="654"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="663" HEIGHT="30">【 사외이사 주요경력 사항 】</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="664" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="104"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="406"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성명</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="551" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요경력</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">해당기간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="415" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요경력</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="122">김후균(비상근/등기)</TD>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="122">1994.021999.011999.02~2021.082021.09~현재2022.08~현재</TD>
<TD VALIGN="MIDDLE" WIDTH="415" HEIGHT="122">경북대학교 공법학과 졸업사법연수원 제28기 수료검찰청 차장검사 外법무법인(유한) 해광 대표변호사㈜인벤티지랩 사외이사</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">(2) 사외이사 지원조직 현황</SPAN>당사는 현재 사외이사의 직무수행을 보조하기 위한 별도의 지원조직을 운영하고 있지 않습니다.
</P>
<P USERMARK=" B">바. 사외이사 및 그 변동현황</P>

<TABLE-GROUP ACLASS="OUT_DIR" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="RIGHT">(단위 : 명)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="130" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">이사의 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사외이사 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="340" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">사외이사 변동현황</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">선임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">중도퇴임</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="RIGHT" WIDTH="130" HEIGHT="30" ACODE="DIR_NUM" VALIGN="MIDDLE">7</TE>
<TE ALIGN="RIGHT" WIDTH="129" HEIGHT="30" ACODE="ODIR_NUM" VALIGN="MIDDLE">1</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="ODIR_PRE" VALIGN="MIDDLE">1</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="ODIR_DIS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="ODIR_RET" VALIGN="MIDDLE">1</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="603">

<COLGROUP>
<COL WIDTH="37"></COL>
<COL WIDTH="548"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" HEIGHT="30">주1)</TD>
<TD WIDTH="557" HEIGHT="30">2022.07.19 사외이사 문응필은 일신상의 사유로 사임하였습니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="46" HEIGHT="30">주2)</TD>
<TD WIDTH="557" HEIGHT="30">2022.08.31 임시주주총회에서 사외이사 김후균 선임되었습니다.</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<LIBRARY>
<P USERMARK=" B">사. 사외이사 교육 미실시 내역</P>

<TABLE-GROUP ACLASS="ODRT_EDU_NOT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="200" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">사외이사 교육 실시여부</TH>
<TH WIDTH="400" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">사외이사 교육 미실시 사유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" AUPDATECONT="N">미실시</TD>
<TE WIDTH="400" VALIGN="MIDDLE" HEIGHT="76" ACODE="ODRT_EDU_NOT_DTL">당사의 사외이사는 전문성을 충분히 갖추고 있어 사외이사를 대상으로 교육을 실시하거나 위탁교육 등 외부기관이 제공하는 교육을 이수한 바 없습니다.</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>

</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-2-0">2. 감사제도에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 감사위원회(감사) 설치 여부 및 구성방법</SPAN>당사는 현재 감사위원회를 설치하고 있지 않으며, 주주총회 결의에 의하여 선임된 비상근 감사 1인이 당사 정관 제47조에서 규정하고 있는 감사의 직무에 따라 감사업무를 충실히 수행하고 있습니다.
<SPAN USERMARK=" B">나. 감사에 관한 사항</SPAN>
</P>

<P>
<SPAN USERMARK=" B">(1) 감사의 인적사항</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="663" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="654"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="663" HEIGHT="30">【 감사 주요경력 사항 】</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="664">

<COLGROUP>
<COL WIDTH="104"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="406"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="113" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성명</TH>
<TH WIDTH="551" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요경력</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">해당연월</TH>
<TH WIDTH="415" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요경력</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" HEIGHT="214" ALIGN="CENTER" VALIGN="MIDDLE">
<P>김병철(비상근/등기)</P>
</TD>
<TD WIDTH="136" HEIGHT="214" VALIGN="MIDDLE">1998.082008.112011.022011.02~2014.062014.06~2016.032016.03~2017.052017.05~2021.122015.05~현재2021.12~현재</TD>
<TD WIDTH="415" HEIGHT="214" VALIGN="MIDDLE">고려대학교 법학과 졸업제50회 사법시험 합격사법연수원 수료(40기)합동법률사무소 신해 대표변호사두인종합법률사무소 변호사법무법인 선린두인종합법률사무소 변호사(주)인벤티지랩 감사김병철 법률사무소 대표 변호사</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK=" B">(2) 감사의 독립성</SPAN>
</P>
<P>당사는 현재 감사 선출에 대한 별도의 기준을 마련하고 있지 않으나, 법령 및 정관에서 정한 사항을 모두 준수하고 있으며, 결격사유가 없는 자 중 이사회의 엄격한 심사를 거친 후 추천된 자를 주주총회에서 선임하고 있습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="864" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="855"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="864" HEIGHT="30">【 감사의 결격요건 해당 여부 】</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="865" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="644"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="653" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="106" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">해당여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="106" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="106" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">김병철</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="865" HEIGHT="30" USERMARK=" B">상법 제542조의10 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="653" HEIGHT="30">
<P>1. 제542조의8제2항제1호부터 제4호까지 및 제6호에 해당하는 자</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="106" HEIGHT="30">
<P>X</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="106" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="653" HEIGHT="76">
<P>2. 회사의 상무(常務)에 종사하는 이사ㆍ집행임원 및 피용자 또는 최근 2년 이내에 회사의 상무에 종사한 이사ㆍ집행임원 및 피용자. 다만, 이 절에 따른 감사위원회위원으로 재임 중이거나 재임하였던 이사는 제외한다.</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="106" HEIGHT="76">
<P>X</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="106" HEIGHT="76">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="653" HEIGHT="30">
<P>3. 제1호 및 제2호 외에 회사의 경영에 영향을 미칠 수 있는 자로서 대통령령으로 정하는 자</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="106" HEIGHT="30">
<P>X</P>
</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="106" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>주주총회에서 선임된 감사는 이사회에 참석하여 독립적으로 이사의 업무를 감독할 수 있으며, 이사회에 출석하여 의견을 진술할 수 있습니다. 또한 회계 등 제반업무와 관련하여 관련 장부 및 관계서류를 해당부서에 제출을 요구하여 내용을 확인할 수 있습니다. 또한 감사는 이사와 마찬가지로 직무상 지득한 회사의 영업 비밀은 준수할 의무를 가지고 있습니다. 당사의 정관 및 사내규정 내 감사의 권한과 직무는 아래와 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="811" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="802"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="811" HEIGHT="30">【 정관에 기재된 감사와 관련된 사항 】</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="813" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="145"></COL>
<COL WIDTH="650"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>

<TH WIDTH="659" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="65">
<P>정관 제44조</P>
<P>( 감사의 수 )</P>
</TD>

<TD WIDTH="659" VALIGN="MIDDLE" HEIGHT="65">
<P>이 회사의 감사는 1인 이상 2인 이내로 한다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="283">
<P>정관 제47조</P>
<P>( 감사의 직무 등 )</P>
</TD>

<TD WIDTH="659" VALIGN="MIDDLE" HEIGHT="283">
<P>① 감사는 회사의 회계와 업무를 감사한다.</P>
<P>② 감사는 회의의 목적사항과 소집의 이유를 기재한 서면을 이사회에 제출하여 임시주주총회의 소집을 청구할 수 있다. </P>
<P>③ 감사는 그 직무를 수행하기 위하여 필요한 때에는 자회사에 대하여 영업의 보고를 요구할 수 있다. 이 경우 자회사가 지체없이 보고를 하지 아니할 때 또는 그 보고의 내용을 확인할 필요가 있는 때에는 자회사의 업무와 재산상태를 조사할 수 있다.</P>
<P>④ 감사에 대해서는 제36조 3항의 규정을 준용한다.</P>
<P>⑤ 감사는 회사의 비용으로 전문가의 도움을 구할 수 있다.</P>
<P>⑥ 감사는 필요하면 회의의 목적사항과 소집이유를 적은 서면을 이사(소집권자가 있는 경우에는 소집권자)에게 제출하여 이사회 소집을 청구할 수 있다. </P>
<P>⑦ 제6항의 청구를 하였는데도 이사가 지체 없이 이사회를 소집하지 아니하면 그 청구한 감사가 이사회를 소집할 수 있다.</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">(3) 감사의 주요 활동내용</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="657">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="339"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="87"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="48" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>회차</P>
</TH>
<TH WIDTH="92" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">개최일자</TH>

<TH WIDTH="348" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>의안내용</P>
</TH>

<TH WIDTH="73" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>가결여부</P>
</TH>
<TH WIDTH="96" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022.02.22</TD>

<TD WIDTH="348" HEIGHT="30" VALIGN="MIDDLE">
<P>1. 제7기 결산 재무제표 승인의 건</P>
</TD>
<TD WIDTH="73" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2</TD>
<TD WIDTH="92" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2022.03.07</TD>

<TD WIDTH="348" HEIGHT="76" VALIGN="MIDDLE">
<P>1. 제7기 정기주주총회 소집의 건2. 명의개서 대리인 설치의 건3. 주식매수선택권 부여 취소의 건</P>
</TD>
<TD WIDTH="73" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="96" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022.03.10</TD>

<TD WIDTH="348" HEIGHT="30" VALIGN="MIDDLE">
<P>1. 제7기 정기주주총회 목적사항 추가의 건</P>
</TD>
<TD WIDTH="73" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022.04.25</TD>

<TD WIDTH="348" HEIGHT="30" VALIGN="MIDDLE">
<P>1. 코스닥 시장 상장 결의의 건</P>
</TD>
<TD WIDTH="73" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">5</TD>
<TD WIDTH="92" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2022.07.13</TD>
<TD WIDTH="348" HEIGHT="76" VALIGN="MIDDLE">1. 임시주주총회 소집에 관한 건2. 임시주주총회 권리 주주 확정을 위한 명의개서 정지의 건</TD>
<TD WIDTH="73" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="96" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022.08.16</TD>
<TD WIDTH="348" HEIGHT="30" VALIGN="MIDDLE">1. 임시주주총회 소집일 변경의 건</TD>
<TD WIDTH="73" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">7</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022.09.29</TD>
<TD WIDTH="348" HEIGHT="30" VALIGN="MIDDLE">1. 코스닥시장 상장을 위한 신주 발행의 건</TD>
<TD WIDTH="73" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">찬성</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<LIBRARY>
<P USERMARK=" B">다. 감사 교육 미실시 내역</P>

<TABLE-GROUP ACLASS="ADT_EDU_NOT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="200" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">감사 교육 실시여부</TH>
<TH WIDTH="400" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">감사 교육 미실시 사유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122" AUPDATECONT="N">미실시</TD>
<TE WIDTH="400" VALIGN="MIDDLE" HEIGHT="122" ACODE="ADT_EDU_NOT_DTL">이사회의 각 안건에 대한 내용과 경영현황에 대하여 감사에게 충분히 설명하고 필요한 자료를 제공하고 있습니다. 현재는 감사의 산업 및 회사에 대한 이해도가 높은 점을 고려하여 추가적인 교육은 실시하고 있지 않으나 추후 전문성을 높이기 위한 교육이 필요할 경우 실시할 예정입니다.</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P></P>

<LIBRARY>
<P USERMARK=" B">라. 감사 지원조직 현황</P>

<TABLE-GROUP ACLASS="ADT_OGN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">부서(팀)명</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직원수(명)</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위(근속연수)</TH>
<TH WIDTH="149" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주요 활동내역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ADT_OGN_NM">-</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ADT_OGN_CNT">-</TE>
<TE WIDTH="150" VALIGN="MIDDLE" HEIGHT="30" ACODE="ADT_OGN_PST" ALIGN="CENTER">-</TE>
<TE WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" ACODE="ADT_OGN_DTL" ALIGN="CENTER">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ADT_OGN_NM">-</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ADT_OGN_CNT">-</TE>
<TE WIDTH="150" VALIGN="MIDDLE" HEIGHT="30" ACODE="ADT_OGN_PST" ALIGN="CENTER">-</TE>
<TE WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" ACODE="ADT_OGN_DTL" ALIGN="CENTER">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>당사는 현재 별도의 감사 지원조직은 없으나 당사의 기획팀이 감사의 전문적인 직무수행이 가능하도록 보조하고 있습니다.</P>
</LIBRARY>

<P></P>

<LIBRARY>
</LIBRARY><P>
<SPAN USERMARK=" B">마. 준법지원인 등에 관한 사항</SPAN>당사는 해당사항이 없습니다.
</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-3-0">3. 주주총회 등에 관한 사항</TITLE>

<P>
<SPAN USERMARK=" B">가. 투표제도 현황</SPAN>당사는 현재 집중투표제, 서면투표제 및 전자투표제를 채택하지 아니하고, 주주총회에 주주 본인이 직접참석 또는 그 대리인이 참석하여 투표권을 행사하고 있습니다.
</P>

<TABLE-GROUP ACLASS="VOTE_CON" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="359"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="368" HEIGHT="30" AUPDATECONT="N">)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">투표제도 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">집중투표제</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">서면투표제</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전자투표제</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUPDATECONT="N">도입여부</TD>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUNIT="JVOTE_DYN" AUNITVALUE="N">배제</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUNIT="SVOTE_DYN" AUNITVALUE="N">미도입</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUNIT="DVOTE_DYN" AUNITVALUE="N">미도입</TU>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUPDATECONT="N">실시여부</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="JVOTE_SYN">미실시</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="SVOTE_SYN">미실시</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="DVOTE_SYN">미실시</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK=" B">나. 소수주주권의 행사여부</SPAN>현재까지 소수주주권의 행사 내역이 없습니다.
<SPAN USERMARK=" B">다. 경영권 경쟁</SPAN>현재까지 경영권 경쟁이 발생한 내역이 없습니다. 
</P>
<P USERMARK=" B">라. 의결권 현황</P>

<TABLE-GROUP ACLASS="VOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="294"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="303" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="229"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구     분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">발행주식총수(A)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISU_STK_KND">보통주식</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISU_STK">8,351,348</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISU_STK_KND">종류주식</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISU_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권없는 주식수(B)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISN_STK_KND">보통주식</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISN_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE1">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISN_STK_KND">종류주식</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISN_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">정관에 의하여 의결권 행사가 배제된 주식수(C)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISQ_STK_KND">보통주식</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISQ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE2">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISQ_STK_KND">종류주식</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISQ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">기타 법률에 의하여의결권 행사가 제한된 주식수(D)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISJ_STK_KND">보통주식</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISJ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE3">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISJ_STK_KND">종류주식</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISJ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권이 부활된 주식수(E)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISB_STK_KND">보통주식</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISB_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE4">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISB_STK_KND">종류주식</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISB_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권을 행사할 수 있는 주식수(F = A - B - C - D + E)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISH_STK_KND">보통주식</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISH_STK">8,351,348</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE5">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISH_STK_KND">종류주식</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISH_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE5">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>주) 2023년 2월 주식매수선택권 행사로 15,208주가 발행되어 2023년 3월 현재 발행주식총수는 8,366,556주 입니다.
<SPAN USERMARK=" B">마. 주식사무</SPAN>
</P>

<P USERMARK="F-GL">
<SPAN USERMARK="F-BT">현재 당사의 정관상 주식사무와 관련된 내용은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="706" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="301"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="789" USERMARK=" BC0XD7D7D7">정관제 10 조(신주인수권)</TD>
<TD COLSPAN="3" WIDTH="568" HEIGHT="789">① 당 회사의 주주는 신주발행에 있어서 그가 소유한 주식수에 비례하여 신주의 배정을 받을 권리를 가진다.② 전항의 규정에도 불구하고 다음 각호의 어느 하나에 해당하는 경우 이사회의 결의로 주주외의 자에게 신주를 배정할 수 있다.1. 발행주식총수의 100분의 25을 초과하지 않는 범위 내에서 "자본시장과 금융 투자업에 관한 법률" 제165조의 6의 규정에 의하여 일반공모증자 방식으로 신주를 발행하는 경우2. 발행하는 주식총수의 100분의 10 범위 내에서 우리사주조합원에게 신주를 우선 배정하는 경우3. "상법" 제340조의2 및 제542조의3에 따른 주식매수선택권의 행사로 인하여 신주를 발행하는 경우4. 자본시장과 금융투자업에 관한 법률 제165조의 16에 의하여 발행주식 총수의 100분의 20을 초과하지 않는 범위 내에서 주식예탁증서(DR)발행에 따라 신주를 발행하는 경우 5. 발행주식총수의 100분의 20을 초과하지 않는 범위 내에서 회사가 경영상 필요로 외국인투자촉진법에 의한 외국인 투자를 유치하기 위하여 신주를 외국법인 또는 외국인에게 우선 배정하는 경우 6. 발행주식총수의 100분의 20을 초과하지 않는 범위 내에서 긴급한 자금조달을 위하여 국내외 금융기관 또는 기관투자자에게 신주를 발행하는 경우7. 회사가 첨단기술의 도입, 사업다각화, 해외진출, 원활한 자금조달 등 전략제휴에 따라 발행주식총수의 100분의 20을 초과하지 않는 범위 내에서 법인 및 개인에게 신주를 배정하는 경우8. 발행주식총수의 100분의 20을 초과하지 않는 범위 내에서 회사가 경영상 긴급한 자금 조달의 필요성에 의하여 주주총회의 결의로 발행결의 당시의 적정시가에 의하여 국내외 법인 또는 개인투자자에게 신주를 발행하는 경우 9. 회사가 발행한 주권을 코스닥시장에 상장하기 위하여 신주를 모집하거나 인수인에게 인수하게 하는 경우10. 증권시장 상장을 위한 기업공개업무를 주관한 대표주관회사에게 기업공개 당시 공모주식총수의 100분의 10을 초과하지 않는 범위 내에서 신주를 발행하는 경우③ 주주가 신주인수권을 포기 또는 상실하거나 신주배정에서 단주가 발생하는 경우에 그 처리방법은 이사회의 결의로 정한다.④ 제2항 각 호 중 어느 하나의 규정에 의해 신주를 발행할 경우 발행할 주식의 종류와 수 및 발행가격 등은 이사회의 결의로 정한다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">결산일</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">12월 31일</TD>
<TD WIDTH="131" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" USERMARK=" BC0XD7D7D7">정기주주총회</TD>
<TD WIDTH="310" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">매사업년도 종료 후 3월 이내</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">주주명부 기준일</TD>
<TD COLSPAN="3" WIDTH="568" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">12월 31일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">공고방법</TD>
<TD COLSPAN="3" WIDTH="568" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">당사 홈페이지, 서울특별시에서 발행하는 한국경제신문</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="1594" USERMARK=" BC0XD7D7D7">주권의 종류</TD>
<TD COLSPAN="3" WIDTH="568" VALIGN="MIDDLE" HEIGHT="1594">제8조(주권의 종류) ① 당회사의 주식은 보통 주식과 종류주식으로 하며, 발행시 이사회의 결의에 의하여 정한다.② 회사가 발행하는 종류주식은 이익배당 또는 잔여재산분배에 관한 우선주식, 의결권 배제 또는 제한, 유지에 관한 주식, 상환주식, 전환주식 및 이들의 전부 또는 일부를 혼합한 주식으로 한다.제 8조의 2 (종류주식의 내용)① 회사가 발행할 종류주식에 대한 의결권 여부는 발행 당시 이사회가 정하는 바에 따른다.② 회사가 발행할 우선주식에 대한 이익배당에 관해서는 액면금액을 기준으로 하여 연 1% 이상에서 발행 시 이사회가 우선배당률을 정한다.③ 회사가 발행할 우선주식에 대하여 발행 당시 이사회 결의에 의하여 참가적 또는 비참가적, 누적적 또는 비누적적인 것으로 정할 수 있다.④ 의결권이 배제 또는 제한된 종류주식은 주주총회에서 의결권을 행사할 수 없다. 다만, 의결권이 배제 또는 제한된 종류주식에 대하여 소정의 배당을 아니한다는 결의가 있는 경우에는 그 결의가 있는 총회의 다음 총회부터 그 우선적 배당을 한다는 결의가 있는 총회의 종료시까지 의결권이 있는 것으로 한다. 한편, 의결권이 있는 우선주식은 원칙적으로 1주당 1표의 의결권이 있으며 보통주로의 전환비율조정이 있을 경우 보통주로 전환할 경우 전환 후 보유하게 될 보통주 1주당 의결권 1표를 갖는다.⑤ 회사가 유상증자 또는 무상증자를 실시하는 경우 종류주식에 대한 신주의 배정은 유상증자의 경우에는 이사회 결의로써 그 신주의 종류를 정하고, 무상증자의 경우에는 같은 종류의 종류주식으로 한다.⑥ 우선주식의 존속기간은 발행일로부터 10년 이내의 범위에서 발행시 이사회 결의로 정하며 이 기간만료와 동시에 보통주식으로 전환된다. 그러나 위 기간 중 소정의 배당을 하지 못한 경우에는 소정의 배당을 완료할 때까지 존속기간이 연장된다. 다만 주주의 청구에 의하여 보통주로 전환된 경우에는 그러하지 아니하다.⑦ 우선주식은 잔여재산 분배에 있어 최초 발행가액(할증발행의 경우 할증분 포함)과 미지급된 배당금의 한도까지 보통주 주주에 우선하는 청구권을 갖는다.  제 8조의 3 (주식의 전환에 관한 종류주식의 내용)① 회사는 주주의 청구 또는 회사의 이사회 결의로 보통주식 또는 종류주식으로 전환할 수 있는 주식을 이사회 결의에 의하여 발행할 수 있다.② 전환으로 인하여 발행하는 신주식의 발행가액은 전환 전의 주식의 발행가액으로 하며, 전환으로 인하여 발행할 주식의 수는 전환 전의 주식과 동일한 수로 한다. 단, 전환비율을 조정할 수 있는 종류주식을 발행하는 경우에는 발행 시에 이사회가 전환비율을 조정할 수 있다는 내용, 조정사유, 조정방법(산식)을 정하여야 한다.③ 전환의 기간 및 전환을 청구할 수 있는 기간은 발행일로부터 10년 이내의 범위에서 이사회 결의로 정하고, 전환의 기간 및 전환을 청구할 수 있는 기간 내에 전환권이 행사되지 아니하면, 전환기간 만료일에 보통주식으로 전환되는 것으로 정할 수 있다.④ 전환으로 인하여 발행하는 주식에 대한 이익의 배당에 관하여는 제12조의 규정을 준용한다. 제 8조의 4 (주식의 상환에 관한 종류주식의 내용)① 회사는 상환청구 또는 회사가 이사회 결의로 회사의 이익으로써 상환을 통해 종류주식 일부 또는 전부를 소각할 수 있는 종류주식(이하 상환주식이라 한다)을 발행할 수 있다.② 상환주식의 상환가액은 최소 1주당 발행가액과 발행 당시 이사회 결의로 정해진 금액을 합한 금원으로 한다.③ 상환주식의 상환기간 및 상환청구기간은 발행일로부터 10년이 되는 날이 속하는 회계연도에 대한 정기주주총회 종료 후 1개월이 되는 날 이내의 범위에서 이사회 결의로 정한다. 다만, 다음 각호의 1에 해당하는 사유가 발생하면 그 사유가 해소될 때까지 상환기간은 연장되는 것으로 정할 수 있다.1. 상환주식에 대하여 우선적 배당이 완료되지 아니한 경우2. 회사의 이익이 부족하여 상환이 청구되었음에도 불구하고 상환기간 내에 상환하지 못한 경우④ 주주의 요청에 따른 상환청구에는 발행 당시 이사회 결의의 상환방법에 우선을 두며, 별도의 정함이 없는 경우에는 주주의 요청에 따라 주주가 상환일로부터 1개월 이상의 기간 전에 회사 및 이해관계인에게 상환청구서를 발송하여 요청하는 방식으로 한다.⑤ 회사가 발행 당시 이사회 결의에 따라 상환주식을 발행하고자 할 경우에는 이사회 결의로 상환을 청구할 수 있다는 내용, 상환가액, 상환청구기간, 상환의 방법을 정하여 그 사실을 주주명부에 기재된 주주와 권리자에게 따로 통지하거나 공고로 갈음한다.⑥ 회사는 상환주식의 취득의 대가로 현금 외에 유가증권이나 그 밖의 자산을 교부할 수 있다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" USERMARK=" BC0XD7D7D7">명의개서대리인</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XF2F2F2">대리인의 명칭</TD>
<TD COLSPAN="2" WIDTH="441" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">㈜국민은행 증권대행부</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XF2F2F2">사무취급 장소</TD>
<TD COLSPAN="2" WIDTH="441" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">서울시 영등포구 국제금융로8길 26, 3층(여의도동, 국민은행 여의도 본점)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">주주의 특전</TD>
<TD COLSPAN="3" WIDTH="568" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">바. 주주총회 의사록 요약</SPAN>
</P>

<TABLE BORDER="1" WIDTH="694" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="328"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="69"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">개최일자</TH>
<TH WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="337" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">안건</TH>
<TH WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">결의내용</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2022.08.31</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임시주주총회</TD>
<TD WIDTH="337" VALIGN="MIDDLE" HEIGHT="30">1. 사외이사 선임의 건</TD>
<TD WIDTH="79" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">가결</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">2022.03.25</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">제7기정기주주총회</TD>
<TD WIDTH="337" VALIGN="MIDDLE" HEIGHT="145">1. 제7기 재무제표 승인의 건2. 정관 변경의 건3. 이사 선임의 건4. 이사 선임의 건5. 이사 보수 한도 승인의 건6. 감사 보수 한도 승인의 건</TD>
<TD WIDTH="79" VALIGN="MIDDLE" HEIGHT="145" ALIGN="CENTER">가결가결가결가결가결가결</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-7-0-0">VII. 주주에 관한 사항</TITLE>
<P></P>
<P USERMARK="F-16 B">가. 최대주주 및 특수관계인의 주식소유 현황</P>
<P></P>

<TABLE-GROUP ACLASS="BSH_SPCL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="655" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="335"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="SH5_CUR_DT" AUNITVALUE="20230216">2023년 02월 16일</TU>
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="344" HEIGHT="30" AUNIT="STOCKPERCENT" AUNITVALUE="1">(단위 : 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="657" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성 명</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">관 계</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의종류</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="310" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수 및 지분율</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 초</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="147" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 말</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">김주희</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">최대주주 본인</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">1,453,514</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">20.37</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">1,469,347</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">17.56</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">류충호</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">등기 임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">148,614</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">2.08</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">148,614</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">1.78</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">김동훈</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">등기 임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">27,004</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.38</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">127,004</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">1.52</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">이상노</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">미등기 임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">4,169</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.06</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">4,169</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.05</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">이마세</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">등기 임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">3,729</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.05</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">3,729</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.04</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">전찬희</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">등기 임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">3,729</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.05</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">33,729</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.40</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">김세연</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">미등기 임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">3,729</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.05</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">3,729</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.04</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">정병율</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">미등기 임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">2,962</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.04</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">2,962</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.04</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="236" HEIGHT="60" AUPDATECONT="N">계</TD>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE">1,647,450</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE">23.09</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE">1,793,283</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE">21.43</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE">우선주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE">0</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE">0</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE">0</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE">0</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1) 상기 주식소유현황은 2023년 2월 16일 제출된 대량보유보고서를 기초로 작성되었습니다. 따라서, 2022년 12월 31일자 주주명부와는 주식수가 같지 않습니다.주2) 기초 발행주식 총 수는 7,134,148주 입니다.주3) 2022년 11월 유상증자(코스닥시장 공모)로 1,071,200주, 2022년 12월 주식매수선택권 행사를 통해 146,000주 증가하였습니다.</P>
<P USERMARK="F-16 B">나. 최대주주의 주요경력 및 개요</P>

<P USERMARK=" B">
<SPAN USERMARK=" !B">(1) 최대주주의 주요경력</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="573">

<COLGROUP>
<COL WIDTH="63"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="72" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">성명</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="128" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">직위</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="373" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">주요 경력 (최근 5년간)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="120" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기간</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="109" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">경력사항</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="144" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">겸임 현황</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">김주희</TD>
<TD WIDTH="128" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">대표이사</TD>
<TD WIDTH="120" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2015.05 ~ 현재</TD>
<TD WIDTH="109" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">㈜인벤티지랩 대표이사</TD>
<TD WIDTH="144" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">해당사항 없음</TD>
</TR>
</TBODY>
</TABLE>

<P>(2) 최대주주의 변동을 초래할 수 있는 특정거래현재 해당사항이 없습니다.(3).최대주주의 최대주주(법인 또는 단체)의 개요해당사항이 없습니다.
<SPAN USERMARK=" B">다. 최대주주 변동내역</SPAN>해당사항이 없습니다.
</P>

<P></P>
<P USERMARK=" B">라. 주식 소유현황</P>

<TABLE-GROUP ACLASS="SH5_PRE_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="290"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20230216">2023년 02월 16일</TU>
<TD VALIGN="BOTTOM" WIDTH="72" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="299" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="86"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="183" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주명</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">소유주식수</TH>
<TH WIDTH="81" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">지분율(%)</TH>
<TH WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="156" ROWSPAN="3" AUPDATECONT="N">5% 이상 주주</TD>
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">김주희</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">1,469,347</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">17.56</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="N">

<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="63" ACODE="SH5_NM">
<P>스마일게이트소재부품투자펀드2014-3호</P>
</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="63" ACODE="SH5_TOT_CNT">589,361</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="63" ACODE="SH5_TOT_RT">7.04</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="63">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="63" ACODE="SH5_NM">
<P>스타셋제2호창업벤처전문사모투자(합)</P>
</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="63" ACODE="SH5_TOT_CNT">450,313</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="63" ACODE="SH5_TOT_RT">5.38</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="63">-</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="303" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="2" AUPDATECONT="N">우리사주조합</TD>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_WOO_CNT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_WOO_RT">-</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>주1) 상기 주식소유현황은 2023년 2월 16일 제출된 대량보유보고서를 기초로 작성되었습니다. 따라서, 2022년 12월 31일자 주주명부와는 소유주식수와 지분율이 같지 않습니다.
<SPAN USERMARK=" B">마. 최근 6개월 간의 주가 및 주식 거래실적</SPAN>(1). 국내증권시장
</P>

<TABLE WIDTH="865" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="559"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="BOTTOM" HEIGHT="31" USERMARK="F-BT12 B"></TD>
<TD WIDTH="151" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12 B"></TD>
<TD WIDTH="67" VALIGN="BOTTOM" HEIGHT="31" USERMARK="F-BT12 B"></TD>
<TD WIDTH="568" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="866">

<COLGROUP>
<COL WIDTH="56"></COL>
<COL WIDTH="56"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="95"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="3" WIDTH="205" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="31" USERMARK="F-BT12">종 류</TH>
<TH WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="31" USERMARK="F-BT12">2022년 12월</TH>
<TH WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="31" USERMARK="F-BT12">2022년 11월</TH>
<TH WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="31" USERMARK="F-BT12">2022년 10월</TH>
<TH WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="31" USERMARK="F-BT12">2022년 9월</TH>
<TH WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="31" USERMARK="F-BT12">2022년 8월</TH>
<TH WIDTH="104" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="31" USERMARK="F-BT12">2022년 7월</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="155" USERMARK="F-BT12">보통주</TD>
<TD ROWSPAN="3" WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="93" USERMARK="F-BT12">주가</TD>
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">최 고</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">13,200</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">14,950</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">최 저</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">9,500</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">13,000</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">평 균</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">10,808</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">14,236</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="65" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="62" USERMARK="F-BT12">거래량</TD>
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">최고(일)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">3,386,726(15)</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">17,210,873(22)</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31" USERMARK="F-BT12">최저(일)</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">240,657(09)</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">946,864(29)</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
<TD WIDTH="104" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31" USERMARK="F-BT12">-</TD>
</TR>
</TBODY>
</TABLE>
<P>주1) 상기 주가 및 거래실적은 한국거래소 자료를 기초로 작성되었습니다.주2) 상기 평균주가는 종가기준입니다.(2). 해외증권시장- 해당사항 없습니다.</P>

<LIBRARY>
<TABLE-GROUP ACLASS="SH4_PRE_STT" ADELETETABLE="N">
<TITLE ATOC="N">소액주주현황</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="295"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="304" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="638" BORDER="1">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="56"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="87"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">구 분</TH>
<TH WIDTH="193" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">주주</TH>
<TH WIDTH="229" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">소유주식</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">비 고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="65" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액주주수</TH>
<TH WIDTH="64" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">전체주주수</TH>
<TH WIDTH="64" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율(%)</TH>
<TH WIDTH="82" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액주식수</TH>
<TH WIDTH="83" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">총발행주식수</TH>
<TH WIDTH="64" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">소액주주</TD>
<TE WIDTH="65" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_JJ_CNT">5,884</TE>
<TE WIDTH="64" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_JJ_CNTT">5,902</TE>
<TE WIDTH="64" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_JJ_RT">99.70</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_BB_CNT">3,431,286</TE>
<TE WIDTH="83" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_BB_CNTT">8,351,348</TE>
<TE WIDTH="64" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_BB_RT">41.09</TE>
<TE WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VIII. 임원 및 직원 등에 관한 사항</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-1-0">1. 임원 및 직원 등의 현황</TITLE>
<P></P>
<P USERMARK=" B">가. 임원 현황</P>

<TABLE-GROUP ACLASS="SH5_DRCT_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="1302" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="953"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="108" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="962" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1299" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="44"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="57"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="57"></COL>
<COL WIDTH="363"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="51"></COL>
<COL WIDTH="128"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="53" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성별</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출생년월</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직위</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">등기임원여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">상근여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">담당업무</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="372" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요경력</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="166" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최대주주와의관계</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">재직기간</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">임기만료일</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권있는 주식</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권없는 주식</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="49" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">김주희</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="49" AUNIT="SH5_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="49" AUNIT="SH5_BIH" AUNITVALUE="197401" VALIGN="MIDDLE">1974.01</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="49" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">대표이사</TE>
<TU ALIGN="CENTER" WIDTH="123" HEIGHT="49" AUNIT="SH5_REG_DRCT" AUNITVALUE="3" VALIGN="MIDDLE">사내이사</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="49" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="49" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">CEO,경영총괄</TE>
<TE WIDTH="372" HEIGHT="49" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">ㆍ경북대학교 생화학 박사 졸업 ㆍ15.05~현재 : (주)인벤티지랩 대표이사</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">1,469,347</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="49" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-10">본인</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="49" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">7년7개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="49" AUNIT="SH5_FIH" AUNITVALUE="20240514" VALIGN="MIDDLE">2024년 05월 14일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="49" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">류충호</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="49" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="49" AUNIT="SH5_BIH" AUNITVALUE="197012" VALIGN="MIDDLE">1970.12</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="49" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">전무이사</TE>
<TU ALIGN="CENTER" WIDTH="123" HEIGHT="49" AUNIT="SH5_REG_DRCT" AUNITVALUE="3" VALIGN="MIDDLE">사내이사</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="49" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="49" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">연구소장</TE>
<TE WIDTH="372" HEIGHT="49" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">ㆍ중앙대학교 제약산업학 석사 졸업 ㆍ16.02~현재 : (주)인벤티지랩 연구소장 & IMC(생산) 본부장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">148,614</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="49" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="49" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">6년 10개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="49" AUNIT="SH5_FIH" AUNITVALUE="20250328" VALIGN="MIDDLE">2025년 03월 28일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="112" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">김동훈</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="112" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="112" AUNIT="SH5_BIH" AUNITVALUE="197003" VALIGN="MIDDLE">1970.03</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="112" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">부사장</TE>
<TU ALIGN="CENTER" WIDTH="123" HEIGHT="112" AUNIT="SH5_REG_DRCT" AUNITVALUE="3" VALIGN="MIDDLE">사내이사</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="112" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="112" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">경영기획총괄</TE>
<TE WIDTH="372" HEIGHT="112" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">ㆍ포항공과대학교 컴퓨터공학 졸업 ㆍ성균관대학교 경영학 MBA ㆍ09.09~15.05 : 큐브벤처파트너스 투자본부 파트너ㆍ16.02~18.08 : 메가인베스트먼트 투자본부 전무 ㆍ18.09~현재 : (주)인벤티지랩 기획본부 부사장 </TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="112" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">127,004</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="112" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="112" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="112" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">4년3개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="112" AUNIT="SH5_FIH" AUNITVALUE="20241026" VALIGN="MIDDLE">2024년 10월 26일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="82" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">전찬희</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="82" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="82" AUNIT="SH5_BIH" AUNITVALUE="196903" VALIGN="MIDDLE">1969.03</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="82" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">전무이사</TE>
<TU ALIGN="CENTER" WIDTH="123" HEIGHT="82" AUNIT="SH5_REG_DRCT" AUNITVALUE="3" VALIGN="MIDDLE">사내이사</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="82" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="82" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">CTO</TE>

<TE WIDTH="372" HEIGHT="82" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL10">ㆍUniv. of Tennessee 공학박사 졸업</P>
<P USERMARK="F-GL10">ㆍ15.03~19.01: ㈜세종메디칼 진단연구소 연구소장 ㆍ19.01~현재 : (주)인벤티지랩 IVL Platform Center 본부장 </P>
</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="82" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">33,729</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="82" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="82" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="82" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">3년11개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="82" AUNIT="SH5_FIH" AUNITVALUE="20230325" VALIGN="MIDDLE">2023년 03월 25일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="132" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">이마세</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="132" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="132" AUNIT="SH5_BIH" AUNITVALUE="196307" VALIGN="MIDDLE">1963.07</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="132" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">부사장</TE>
<TU ALIGN="CENTER" WIDTH="123" HEIGHT="132" AUNIT="SH5_REG_DRCT" AUNITVALUE="3" VALIGN="MIDDLE">사내이사</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="132" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="132" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">CSO</TE>

<TE WIDTH="372" HEIGHT="132" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL10">ㆍ일본 큐슈대학교 약학 박사 졸업 ㆍ17.03~19.11 : JW중외제약CMC 연구센터장 ㆍ19.12~21.06 : 동화약품 연구소장 ㆍ21.07~21.08 : 유틸렉스CTO ㆍ21.08~현재 : 주)인벤티지랩 IVL Value-Up Center 본부장 </P>
</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="132" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">3,729</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="132" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="132" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="132" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">1년4개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="132" AUNIT="SH5_FIH" AUNITVALUE="20250328" VALIGN="MIDDLE">2025년 03월 28일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="157" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">김태헌</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="157" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="157" AUNIT="SH5_BIH" AUNITVALUE="197501" VALIGN="MIDDLE">1975.01</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="157" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">이사</TE>
<TU ALIGN="CENTER" WIDTH="123" HEIGHT="157" AUNIT="SH5_REG_DRCT" AUNITVALUE="5" VALIGN="MIDDLE">기타비상무이사</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="157" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="157" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">경영자문이사회</TE>

<TE WIDTH="372" HEIGHT="157" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL10">ㆍPace Univ. Lubin School MBA 회계학 졸업 ㆍ06.01~18.07 : 스틱인베스트먼트㈜ 벤처본부 수석심사역</P>
<P USERMARK="F-GL10">ㆍ18.07~21.03 : 스틱벤처스(주) 투자본부 상무보ㆍ21.04~현재 : 지앤텍벤처투자㈜ 투자본부 전무ㆍ17.03~현재 : ㈜공게임즈 기타비상무이사 ㆍ20.03~현재 : (주)인벤티지랩 기타비상무이사 </P>
</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="157" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="157" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="157" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="157" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">2년9개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="157" AUNIT="SH5_FIH" AUNITVALUE="20230325" VALIGN="MIDDLE">2023년 03월 25일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="112" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">김후균</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="112" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="112" AUNIT="SH5_BIH" AUNITVALUE="197002" VALIGN="MIDDLE">1970.02</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="112" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">이사</TE>
<TU ALIGN="CENTER" WIDTH="123" HEIGHT="112" AUNIT="SH5_REG_DRCT" AUNITVALUE="4" VALIGN="MIDDLE">사외이사</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="112" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="112" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">경영자문이사회</TE>
<TE WIDTH="372" HEIGHT="112" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">ㆍ경북대학교 공법학과 졸업 ㆍ제28기 사법연수원 수료 ㆍ99.02~21.08 : 서울중앙지방검찰청 차장검사 外ㆍ21.09~현재 : 법무법인(유한) 해광 대표변호사ㆍ22.08~현재 : (주)인벤티지랩 사외이사</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="112" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="112" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="112" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="112" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">4개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="112" AUNIT="SH5_FIH" AUNITVALUE="20250831" VALIGN="MIDDLE">2025년 08월 31일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="112" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">김병철</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="112" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="112" AUNIT="SH5_BIH" AUNITVALUE="197311" VALIGN="MIDDLE">1973.11</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="112" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">감사</TE>
<TU ALIGN="CENTER" WIDTH="123" HEIGHT="112" AUNIT="SH5_REG_DRCT" AUNITVALUE="6" VALIGN="MIDDLE">감사</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="112" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="112" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">감사</TE>
<TE WIDTH="372" HEIGHT="112" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">ㆍ고려대학교 법학과 졸업 ㆍ사법연수원 제40기 수료 ㆍ17.05~21.12 : 두인종합법률사무소 변호사 ㆍ21.12~현재 : 김병철 법률사무소ㆍ15.05~현재 : (주)인벤티지랩 감사</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="112" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="112" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="112" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="112" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">7년7개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="112" AUNIT="SH5_FIH" AUNITVALUE="20240331" VALIGN="MIDDLE">2024년 03월 31일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="107" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">정병율</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="107" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="107" AUNIT="SH5_BIH" AUNITVALUE="197107" VALIGN="MIDDLE">1971.07</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="107" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">상무이사</TE>
<TU ALIGN="CENTER" WIDTH="123" HEIGHT="107" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="107" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="107" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">CFO</TE>

<TE WIDTH="372" HEIGHT="107" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL10">ㆍ인하대학교 행정학 졸업 </P>
<P USERMARK="F-GL10">ㆍ07.09~12.06 : ㈜일신바이오베이스 경영지원본부 본부장 ㆍ15.05~20.07 : ㈜와이디생명과학 경영지원 부서장 </P>
<P USERMARK="F-GL10">ㆍ20.07~현재 : ㈜인벤티지랩 경영지원팀 상무 </P>
</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="107" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">2,962</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="107" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="107" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="107" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">2년5개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="107" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="70" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">김세연</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="70" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="70" AUNIT="SH5_BIH" AUNITVALUE="197507" VALIGN="MIDDLE">1975.07</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="70" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">상무이사</TE>
<TU ALIGN="CENTER" WIDTH="123" HEIGHT="70" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="70" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="70" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">연구소부소장</TE>
<TE WIDTH="372" HEIGHT="70" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">ㆍ 단국대학교 화학 석사 졸업 ㆍ15.03~18.09 : ㈜유유제약 제제연구 부장 ㆍ18.10~현재 : ㈜인벤티지랩 연구소 부소장 </TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="70" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">3,729</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="70" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="70" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="70" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">4년 2개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="70" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="91" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">김완주</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="91" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="91" AUNIT="SH5_BIH" AUNITVALUE="197811" VALIGN="MIDDLE">1978.11</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="91" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">상무이사</TE>
<TU ALIGN="CENTER" WIDTH="123" HEIGHT="91" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="91" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="91" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">사업개발전략</TE>
<TE WIDTH="372" HEIGHT="91" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">ㆍ경성대학교 임상약학 석사 졸업ㆍ14.01~17.01 : 한국화이자 BD 매니저 ㆍ17.01~20.05 : 한국팜비오 BD 팀장 ㆍ20.06~현재 : ㈜인벤티지랩 IVL Value-Up Center 부본부장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="91" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="91" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="91" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="91" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">2년6개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="91" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="93" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">오정민</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="93" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="93" AUNIT="SH5_BIH" AUNITVALUE="197209" VALIGN="MIDDLE">1972.09</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="93" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">상무이사</TE>
<TU ALIGN="CENTER" WIDTH="123" HEIGHT="93" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="93" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="93" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">IPC부본부장</TE>
<TE WIDTH="372" HEIGHT="93" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">ㆍ포항공과대학 공학 박사 졸업ㆍ15.02~18.12 : 기초과학연구원 Research Fellowㆍ19.01~23.02 : SK실트론 CAE 팀장ㆍ23.02~현재 : ㈜인벤티지랩 IVL Platform Center 부본부장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="93" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="93" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="93" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="93" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">1개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="93" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="70" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">박동석</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="70" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="70" AUNIT="SH5_BIH" AUNITVALUE="197604" VALIGN="MIDDLE">1976.04</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="70" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">이사</TE>
<TU ALIGN="CENTER" WIDTH="123" HEIGHT="70" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="70" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="70" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">IMC부본부장</TE>
<TE WIDTH="372" HEIGHT="70" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">ㆍ수원대학교 화학 졸업 ㆍ05.11~20.01: ㈜바이오써포트 GMP컨설팅 사업본부장ㆍ20.02~현재 : ㈜인벤티지랩 IMC(생산) 부본부장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="70" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="70" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="70" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="70" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">2년10개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="70" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="49" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">이상노</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="49" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="49" AUNIT="SH5_BIH" AUNITVALUE="198302" VALIGN="MIDDLE">1983.02</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="49" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">이사</TE>
<TU ALIGN="CENTER" WIDTH="123" HEIGHT="49" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="49" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="49" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">제제연구개발</TE>
<TE WIDTH="372" HEIGHT="49" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">ㆍ전남대학교 생물약제학 석사 졸업 ㆍ16.09~현재 : ㈜인벤티지랩 제제연구1팀 팀장 </TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">4,169</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="49" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="49" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="49" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">6년3개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="49" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="112" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">김희선</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="112" AUNIT="SH5_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="112" AUNIT="SH5_BIH" AUNITVALUE="197611" VALIGN="MIDDLE">1976.11</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="112" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">이사</TE>
<TU ALIGN="CENTER" WIDTH="123" HEIGHT="112" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="112" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="112" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">임상개발전략</TE>
<TE WIDTH="372" HEIGHT="112" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">ㆍ숙명여자대학교 약학 석사 졸업 ㆍ17.01~18.12 : 대웅제약 임상개발센터 센터장 ㆍ19.01~20.04 : 대웅제약C&D 기조실 이사 ㆍ20.05~20.12 : 엠디바이오랩 최고개발책임자 ㆍ21.02~현재 : ㈜인벤티지랩 임상개발팀 팀장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="112" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="112" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="112" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="112" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">1년10개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="112" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="114" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">서영대</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="114" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="114" AUNIT="SH5_BIH" AUNITVALUE="197804" VALIGN="MIDDLE">1978.04</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="114" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">이사</TE>
<TU ALIGN="CENTER" WIDTH="123" HEIGHT="114" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="114" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="114" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">제제연구개발</TE>
<TE WIDTH="372" HEIGHT="114" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">ㆍ인하대학교 신약개발학 박사 졸업 ㆍ16.10~19.10 : 동광제약 제제연구소 팀장 ㆍ19.11~21.09 : 제일약품 제제기술연구소 부장 ㆍ21.09~22.03 : 환인제약 제제연구실장 ㆍ22.04~현재 : ㈜인벤티지랩 제제연구4팀 팀장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="114" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="114" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="114" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="114" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">8개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="114" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="135" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">최미연</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="135" AUNIT="SH5_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="135" AUNIT="SH5_BIH" AUNITVALUE="198004" VALIGN="MIDDLE">1980.04</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="135" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">이사</TE>
<TU ALIGN="CENTER" WIDTH="123" HEIGHT="135" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="135" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="135" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">법무총괄</TE>
<TE WIDTH="372" HEIGHT="135" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">ㆍ고려대학교 법학과 졸업ㆍ사업연수원 제45기 수료ㆍ16.02~17.11 : 보건복지부 기획조정실 규제개혁담당관 ㆍ17.11~19.05 : (주)서울제약 사내변호사 ㆍ19.06~21.03 : (주)비보존제약 사내변호사 ㆍ21.03~현재 : ㈜인벤티지랩 법무팀 팀장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="135" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="135" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="135" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="135" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">1년9개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="135" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="112" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">우상욱</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="112" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="112" AUNIT="SH5_BIH" AUNITVALUE="198302" VALIGN="MIDDLE">1983.02</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="112" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">이사</TE>
<TU ALIGN="CENTER" WIDTH="123" HEIGHT="112" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="112" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="112" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">제제연구개발</TE>
<TE WIDTH="372" HEIGHT="112" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">ㆍ05.02 : 대구가톨릭대학교 제약학 졸업 ㆍ07.02 : 대구가톨릭대학교 의약화학 석사 졸업 ㆍ07.02~12.04 : 한국콜마 제제연구팀 대리 ㆍ12.04~21.05: 콜마파마 제제연구팀 부장 ㆍ21.05~현재 : ㈜인벤티지랩 제제연구3팀 팀장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="112" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="112" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="112" ACODE="SH5_RLTN" VALIGN="MIDDLE" USERMARK="F-10">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="112" ACODE="SH5_PER" VALIGN="MIDDLE" USERMARK="F-10">1년7개월</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="112" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="114" ACODE="SH5_NM_T" VALIGN="MIDDLE" USERMARK="F-10">송순호</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="114" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="114" AUNIT="SH5_BIH" AUNITVALUE="197607" VALIGN="MIDDLE">1976.07</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="114" ACODE="SH5_LEV" VALIGN="MIDDLE" USERMARK="F-10">상무이사</TE>
<TU ALIGN="CENTER" WIDTH="123" HEIGHT="114" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="114" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="66" HEIGHT="114" ACODE="SH5_OBJ" VALIGN="MIDDLE" USERMARK="F-10">사업기획</TE>
<TE WIDTH="372" HEIGHT="114" ACODE="SH5_SKL" VALIGN="MIDDLE" USERMARK="F-10">ㆍDuke University 경영학 MBA ㆍ16.08~18.08 : 한국패링제약㈜ 마케팅&BD 이사ㆍ19.04~20.04 : ㈜인벤티지랩 사업개발팀 상무이사ㆍ20.04~23.03 : ㈜일리아스바이오로직스 COOㆍ23.03~현재 : ㈜인벤티지랩 기획실 실장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="114" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="114" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="114" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="114" ACODE="SH5_PER" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="114" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1) 상기 소유주식수는 2023년 2월 16일 제출된 대량보유보고서를 기초로 작성되었습니다. 따라서, 2022년 12월 31일자 주주명부와는 소유주식수가 같지 않습니다.주2) 오정민 상무이사는 2023년 2월 6일부로, 송순호 상무이사는 2023년 3월 20일부로 신규 선임 되었습니다.</P>

<LIBRARY>
<P USERMARK=" B">나. 등기임원 선임 후보자 및 해임 대상자 현황</P>

<TABLE-GROUP ACLASS="PSN_MBER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="597" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="338"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="170" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20230322">2023년 03월 22일</TU>
<TD VALIGN="BOTTOM" WIDTH="347" HEIGHT="30" AUPDATECONT="N">)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="965" BORDER="1">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="51"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="376"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성별</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출생년월</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사외이사후보자해당여부</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="385" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요경력</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">선ㆍ해임예정일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최대주주와의관계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="82" AUNIT="PSN_APP" AUNITVALUE="Y" VALIGN="MIDDLE">선임</TU>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="82" ACODE="PSN_NAM" VALIGN="MIDDLE">전찬희</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="82" AUNIT="PSN_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="82" AUNIT="PSN_BIH" AUNITVALUE="196903" VALIGN="MIDDLE">1969.03</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="82" ACODE="PSN_DIR" VALIGN="MIDDLE">사내이사</TE>

<TE WIDTH="385" HEIGHT="82" ACODE="PSN_CAR" VALIGN="MIDDLE" USERMARK=" 0X120FC8 B">
<P USERMARK="F-GL10">ㆍUniv. of Tennessee 공학박사 졸업</P>
<P USERMARK="F-GL10">ㆍ15.03~19.01: ㈜세종메디칼 진단연구소 연구소장 ㆍ19.01~현재 : (주)인벤티지랩 IVL Platform Center 본부장 </P>
</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="82" AUNIT="PSN_DAT" AUNITVALUE="20230330" VALIGN="MIDDLE">2023.03.30</TU>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="82" ACODE="PSN_RSP" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P USERMARK=" 0X120FC8 B"></P>
<P USERMARK=" B">다. 직원 등 현황</P>

<TABLE-GROUP ACLASS="EMPLOYEE" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="854" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="487"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="496" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="854" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="33"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="51"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="25"></COL>
<COL WIDTH="25"></COL>
<COL WIDTH="25"></COL>
<COL WIDTH="62"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="681" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="10">직원</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">소속 외근로자</TH>
<TH ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="189" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">사업부문</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="42" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">성별</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="343" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직 원 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">평 균근속연수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="72" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">연간급여총 액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="72" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">1인평균급여액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="34" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">남</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="34" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">여</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="34" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="136" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간의 정함이없는 근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="147" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간제근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">합 계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간근로자)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간근로자)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">사무</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TE ALIGN="CENTER" WIDTH="69" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">4</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="68" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">1</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">1</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">5</TE>
<TE ALIGN="CENTER" WIDTH="73" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">1.97</TE>
<TE ALIGN="CENTER" WIDTH="72" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">299</TE>
<TE ALIGN="CENTER" WIDTH="72" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">73</TE>
<TE ALIGN="CENTER" WIDTH="34" HEIGHT="210" ACODE="EMP_MAN" VALIGN="MIDDLE" ROWSPAN="7" USERMARK=" B">-</TE>
<TE ALIGN="CENTER" WIDTH="34" HEIGHT="210" ACODE="EMP_WOM" VALIGN="MIDDLE" ROWSPAN="7" USERMARK=" B">-</TE>
<TE ALIGN="CENTER" WIDTH="34" HEIGHT="210" ACODE="EMP_MW_TOTAL" VALIGN="MIDDLE" ROWSPAN="7" USERMARK=" B">-</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE" USERMARK=" B">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">사무</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TE ALIGN="CENTER" WIDTH="69" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">5</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="68" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">5</TE>
<TE ALIGN="CENTER" WIDTH="73" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">2.13</TE>
<TE ALIGN="CENTER" WIDTH="72" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">221</TE>
<TE ALIGN="CENTER" WIDTH="72" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">58</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE" USERMARK=" B">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">연구</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TE ALIGN="CENTER" WIDTH="69" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">29</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="68" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">29</TE>
<TE ALIGN="CENTER" WIDTH="73" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">2.09</TE>
<TE ALIGN="CENTER" WIDTH="72" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">1,337 </TE>
<TE ALIGN="CENTER" WIDTH="72" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">65</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE" USERMARK=" B">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">연구</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TE ALIGN="CENTER" WIDTH="69" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">8</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="68" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">3</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">2</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">11</TE>
<TE ALIGN="CENTER" WIDTH="73" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">1.69</TE>
<TE ALIGN="CENTER" WIDTH="72" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">534</TE>
<TE ALIGN="CENTER" WIDTH="72" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">61</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE" USERMARK=" B">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">생산</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TE ALIGN="CENTER" WIDTH="69" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">7</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="68" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">7</TE>
<TE ALIGN="CENTER" WIDTH="73" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">2.25</TE>
<TE ALIGN="CENTER" WIDTH="72" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">309</TE>
<TE ALIGN="CENTER" WIDTH="72" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">57</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE" USERMARK=" B">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">생산</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TE ALIGN="CENTER" WIDTH="69" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">2</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="68" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">2</TE>
<TE ALIGN="CENTER" WIDTH="73" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">2.08</TE>
<TE ALIGN="CENTER" WIDTH="72" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">69</TE>
<TE ALIGN="CENTER" WIDTH="72" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">45</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE" USERMARK=" B">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="121" HEIGHT="30" AUPDATECONT="N" COLSPAN="2" VALIGN="MIDDLE">합 계</TD>
<TE ALIGN="CENTER" WIDTH="69" HEIGHT="30" ACODE="EMP_REOT" VALIGN="MIDDLE">55</TE>
<TE ALIGN="CENTER" WIDTH="67" HEIGHT="30" ACODE="EMP_REOST" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="68" HEIGHT="30" ACODE="EMP_COCT" VALIGN="MIDDLE">4</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_COCST" VALIGN="MIDDLE">3</TE>
<TE ALIGN="CENTER" WIDTH="60" HEIGHT="30" ACODE="EMP_CNT" VALIGN="MIDDLE">59</TE>
<TE ALIGN="CENTER" WIDTH="73" HEIGHT="30" ACODE="EMP_AVYT" VALIGN="MIDDLE">2.03</TE>
<TE ALIGN="CENTER" WIDTH="72" HEIGHT="30" ACODE="EMP_AICT" VALIGN="MIDDLE">2,769 </TE>
<TE ALIGN="CENTER" WIDTH="72" HEIGHT="30" ACODE="EMP_VICT" VALIGN="MIDDLE">63</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="NOTET" VALIGN="MIDDLE" USERMARK=" B">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>주1) 평균 근속연수는 기준일 현재 재직 직원의 평균 근속연수 입니다.주2) 연간급여 총액은 소득세법 제20조에 따른 근로소득을 기준으로 하며, 중도퇴사자의 근로소득을 포함합니다.주3) 1인평균 급여액은 1월~12월까지의 월별 평균 급여액의 합계입니다.</P>

<P>
<SPAN USERMARK=" B">라. 타회사 임원 겸직 현황</SPAN>
</P>

<TABLE WIDTH="1044" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="813"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" VALIGN="BOTTOM" HEIGHT="30">(기준일 : </TD>
<TD WIDTH="143" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">2022년 12월 31일</TD>
<TD WIDTH="822" VALIGN="BOTTOM" HEIGHT="30">)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1043">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="189"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">겸직임원</TH>
<TH WIDTH="965" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="9" HEIGHT="30">겸직 근무지</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>성명</P>
</TH>

<TH WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>회사명</P>
</TH>
<TH WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">주요사업</TH>

<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>직책명</P>
</TH>

<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>담당업무</P>
</TH>

<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>재직기간주1)</P>
</TH>

<TH WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>겸직회사와 청구회사의 관계</P>
</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">보유주식수주2)</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">지분율</TH>

<TH WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">김희선</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>㈜넥스트젠바이오사이언스</P>
</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">신약개발</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>임상개발실장</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>임상개발</P>
</TD>

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>21.01~현재</P>
</TD>

<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>해당없음</P>
</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">300</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">0.03</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">김태헌</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>㈜공게임즈</P>
</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">모바일 게임 개발</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타비상무이사</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>경영자문</P>
</TD>

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>17.03~현재</P>
</TD>

<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>해당없음</P>
</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>지엔텍벤처투자㈜</P>
</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">벤처캐피탈</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>전무이사</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>투자심사</P>
</TD>

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>21.04~현재</P>
</TD>

<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>해당없음</P>
</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>김병철</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>김병철 법률사무소</P>
</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">법률컨설팅서비스</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>대표 변호사</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>변호사</P>
</TD>

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>21.12~현재</P>
</TD>

<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>해당없음</P>
</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>김후균</P>
</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">법무법인(유한) 해광</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">법률컨설팅서비스</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>대표 변호사</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>변호사</P>
</TD>

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>21.09~현재</P>
</TD>

<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>해당없음</P>
</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">11,000</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">14.67</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="1045">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="988"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30">주1)</TD>
<TD WIDTH="997" HEIGHT="30">재직기간은 입사일로부터 현재 기준으로 작성 하였습니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30">주2)</TD>
<TD WIDTH="997" HEIGHT="30">김후균 사외이사의 겸직 근무지인 법무법인 해광은 유한법인이므로 보유주식수란에 출자좌수를 기입하였습니다.</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">마. 미등기임원 보수 현황</SPAN>
</P>

<TABLE-GROUP ACLASS="UNRESISTER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="787" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="420"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="429" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="786" BORDER="1">

<COLGROUP>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="156"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="210"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="165" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">연간급여 총액</TH>
<TH WIDTH="164" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">1인평균 급여액</TH>
<TH WIDTH="219" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">미등기임원</TD>
<TE WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="URT_CNT">8</TE>
<TE WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="URT_PAY_TOT">707</TE>
<TE WIDTH="164" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="URT_PAY_AVR">105</TE>
<TE WIDTH="219" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="URT_NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="786">

<COLGROUP>
<COL WIDTH="30"></COL>
<COL WIDTH="738"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="39" HEIGHT="53">주1)</TD>
<TD WIDTH="747" HEIGHT="53">사업연도 중 내부 승진으로 인하여 신규 선임된 미등기이사의 경우, 당해 사업연도에 지급된 급여 총액을 포함하여 미등기 이사의 연간급여 총액과 1인평균급여액을 산정하였습니다.</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-2-0">2. 임원의 보수 등</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><이사ㆍ감사 전체의 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B">가. 주주총회 승인금액</P>

<TABLE-GROUP ACLASS="SUB_CMP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="169"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="178" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주총회 승인금액</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_SUB">등기이사</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_NUM">7</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_KMY">1,500</TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">사외이사 포함</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_SUB">감사</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_NUM">1</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_KMY">100</TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK=" B">나. 보수지급금액</P>
<P>나-1. 이사ㆍ감사 전체</P>

<TABLE-GROUP ACLASS="SUB_CMPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">1인당 평균보수액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="TRT_PAY_NUM">9</TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="TRT_PAY_SUM">1,661</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="TRT_PAY_VIC">185</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE5" USERMARK=" B">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1) 당사는 주주총회 결의로 이사 및 감사 보수의 한도를  정하고 있으며, 승인된 보수 한도 범위 내에서 각 담당 직무 및 직급, 리더쉽, 전문성, 회사기여도 등을 종합적으로 반영하여 내부 규정에 따라 지급하고 있습니다. 주2) 상기 보수총액 중 585백만원은 등기이사 김동훈, 전찬희의 주식매수선택권 행사에 따른 행사이익으로 등기임원의 근로소득지급명세서상 보수총액은 1,076백만원입니다.주3) 상기 인원수는 당해 사업연도 중 퇴임 및 신규 선임한 임원을 포함하였습니다. 보고서 작성기준일 현재 당사의 등기임원은 이사 7인, 감사1인입니다.주4) 1인당 평균보수액은 보수총액을 등기임원의 수로 단순평균하여 산출하였습니다.</P>
<P>나-2. 유형별</P>

<TABLE-GROUP ACLASS="SUB_CMPP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="245" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">구 분</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">인원수</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">보수총액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">1인당평균보수액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">등기이사(사외이사, 감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="RRT_PAY_NUM">6</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="RRT_PAY_SUM">1,654</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="RRT_PAY_VIC">276</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">사외이사(감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="ORT_PAY_NUM">2</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="ORT_PAY_SUM">1</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="ORT_PAY_VIC">1</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사위원회 위원</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="GRT_PAY_NUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="GRT_PAY_SUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="GRT_PAY_VIC">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="AUD_PAY_NUM">1</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="AUD_PAY_SUM">6</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="AUD_PAY_VIC">6</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE4">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상인 이사ㆍ감사의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P>1. 개인별 보수지급금액</P>

<TABLE-GROUP ACLASS="SUB_CMPK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="639" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="330"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="339" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="642" BORDER="1">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="370"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="379" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="CMPK_NM">김동훈</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="CMPK_LEV">부사장</TE>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="CMPK_PAY">721</TE>
<TE WIDTH="379" VALIGN="MIDDLE" HEIGHT="76" ACODE="CMPK_NOTPAY"> - 주식매수선택권 75,000주  (종목:인벤티지랩 보통주, 행사가격: 5,000원, 행사기간:2022년 11월 22일 ~ 2028년 10월 25일)</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주) 보수총액 중 450백만원은 2018년 10월과 2019년 3월에 기 부여받은 주식매수선택권 총 175,000주 중 100,000주 행사로  발생한 주식매수선택권 행사이익입니다.</P>
<P>2. 산정기준 및 방법</P>

<TABLE BORDER="0" WIDTH="602" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR>
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="803" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="343"></COL>
</COLGROUP>

<THEAD>

<TR>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="120" HEIGHT="30">이름</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="214" HEIGHT="30">보수의 종류</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="117" HEIGHT="30">총액</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="352" HEIGHT="30">산정기준 및 방법</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="120" HEIGHT="318">김동훈</TD>
<TD ROWSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="99" HEIGHT="258">근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="99">급여</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="117" HEIGHT="99">271</TD>
<TD VALIGN="MIDDLE" WIDTH="352" HEIGHT="99">주주총회에서 결정된 임원보수한도 내에서 당사의 임원보수지급규정에 따라 직무 및 직급(부사장), 리더쉽, 전문성, 회사기여도 등을 종합적으로 반영하여 연봉을 책정하고 매월 평균 22백만원 지급</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">상여</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="352" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="99">주식매수선택권 행사이익</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="117" HEIGHT="99">450</TD>
<TD VALIGN="MIDDLE" WIDTH="352" HEIGHT="99">주주총회 결의로 부여받은 주식매수선택권의 행사가격(5,000원)과 행사 당시 주가(9,500원)와의 차이에 행사수량(100,000주)을 곱하여 450백만원을 산출하였음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">기타 근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="352" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">퇴직소득</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="352" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">기타소득</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="352" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상 중 상위 5명의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P>1. 개인별 보수지급금액</P>

<TABLE-GROUP ACLASS="SUB_CMPK_HIGH" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="647" BORDER="1">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="372"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="381" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="CMPK_NM">김동훈</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="CMPK_LEV">부사장</TE>
<TE WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76" ACODE="CMPK_PAY">721</TE>
<TE WIDTH="381" VALIGN="MIDDLE" HEIGHT="76" ACODE="CMPK_NOTPAY"> - 주식매수선택권 75,000주  (종목:인벤티지랩 보통주, 행사가격: 5,000원, 행사기간:2022년 11월 22일 ~ 2028년 10월 25일)</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주) 상기 보수총액 중 450백만원은 2018년 10월과 2019년 3월에 기 부여받은 주식매수선택권 총 175,000주 중 일부행사(100,000주) 로 발생한 주식매수선택권행사이익입니다.</P>
<P>2. 산정기준 및 방법</P>

<TABLE BORDER="0" WIDTH="602" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="803" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="343"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="120" HEIGHT="30">이름</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="214" HEIGHT="30">보수의 종류</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="117" HEIGHT="30">총액</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="352" HEIGHT="30">산정기준 및 방법</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="120" HEIGHT="318">김동훈</TD>
<TD ROWSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="99" HEIGHT="258">근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="99">급여</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="117" HEIGHT="99">271</TD>
<TD VALIGN="MIDDLE" WIDTH="352" HEIGHT="99">주주총회에서 결정된 임원보수한도 내에서 당사의 임원보수지급규정에 따라 직무 및 직급(부사장), 리더쉽, 전문성, 회사기여도 등을 종합적으로 반영하여 연봉을 책정하고 매월 평균 22백만원 지급</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">상여</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="352" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="99">주식매수선택권 행사이익</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="117" HEIGHT="99">450</TD>
<TD VALIGN="MIDDLE" WIDTH="352" HEIGHT="99">주주총회 결의로 부여받은 주식매수선택권의 행사가격(5,000원)과 행사 당시 주가(9,500원)와의 차이에 행사수량(100,000주)을 곱하여 450백만원을 산출하였음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">기타 근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="352" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">퇴직소득</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="352" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">기타소득</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="352" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<LIBRARY>
<P><주식매수선택권의 부여 및 행사현황></P>
<P><표1></P>

<TABLE-GROUP ACLASS="SUB_SOPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="235"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="244" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">구 분</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">부여받은인원수</TH>
<TH WIDTH="136" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주식매수선택권의 공정가치 총액</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="244" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">등기이사(사외이사, 감사위원회 위원 제외)</TD>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="RRT_PAY_NUM">4</TE>
<TE WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="RRT_PAY_SUMT">946</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="244" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">사외이사(감사위원회 위원 제외)</TD>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="ORT_PAY_NUM">-</TE>
<TE WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="ORT_PAY_SUMT">-</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="244" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사위원회 위원 또는 감사</TD>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="GRT_PAY_NUM">-</TE>
<TE WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="GRT_PAY_SUMT">-</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="244" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">업무집행지시자 등</TD>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="JED_PAY_NUM">7</TE>
<TE WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="JED_PAY_SUMT">1,360</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE5">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="244" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="TRT_PAY_NUM">11</TE>
<TE WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="TRT_PAY_SUMT">2,306</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE4">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1) 부여된 주식매수선택권은 행사시점에 신주가 교부되는 주식매수선택권으로서 공정가치는 이항모형을 이용한 공정가치접근법을 적용하여 산정하였습니다. 주식매수 선택권의 공정가치 산출방법은 "III. 재무에관한사항 > 5. 재무제표주석 > 주석 20. 주식기준보상"을 참고하시기 바랍니다.<표2></P>

<TABLE-GROUP ACLASS="SOPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="1293" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="899"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="SH5_CUR_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="153" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="908" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1316" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="88"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="51"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="233"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="53"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">부여받은자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">관 계</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">부여일</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">부여방법</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의종류</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최초부여수량</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">당기변동수량</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="134" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">총변동수량</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기말미행사수량</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사기간</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사가격</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의무보유여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의무보유기간</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="46" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="46" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취소</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="46" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="46" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">OOO외 3인</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20160517">2016년 05월 17일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">87,187</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_MEXE_CNT">6,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_EXE_CNT">43,702</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_CNL_CNT">28,277</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">15,208</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="30" ACODE="SH5_PER">2018.05.17~2025.05.16</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_PRC">1,167</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">이상노</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20171219">2017년 12월 19일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">39,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">39,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="30" ACODE="SH5_PER">2020.12.19~2027.12.18</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_PRC">5,000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="30" ACODE="DUTY_HOLD_PD">주1) </TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">김범준</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="9">기타</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20171219">2017년 12월 19일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">20,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">20,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="30" ACODE="SH5_PER">2020.12.19~2027.12.18</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_PRC">5,000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">OOO외 1인</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20171219">2017년 12월 19일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">123,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_CNL_CNT">123,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="30" ACODE="SH5_PER">2020.12.19~2027.12.18</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_PRC">5,000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">김동훈</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="1">등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20181026">2018년 10월 26일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부 또는차액보상</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">100,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">25,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">25,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">75,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">상장일로부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">5,000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">김동훈</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="1">등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20190328">2019년 03월 28일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">75,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_MEXE_CNT">75,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_EXE_CNT">75,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="30" ACODE="SH5_PER">상장일로부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_PRC">5,000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="30" ACODE="DUTY_HOLD_PD">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">전찬희</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="1">등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20190328">2019년 03월 28일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">30,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_MEXE_CNT">30,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_EXE_CNT">30,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="30" ACODE="SH5_PER">상장일로부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_PRC">5,000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="30" ACODE="DUTY_HOLD_PD">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">김세연</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20190328">2019년 03월 28일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">20,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">20,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="30" ACODE="SH5_PER">상장일로부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_PRC">5,000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="30" ACODE="DUTY_HOLD_PD">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">OOO외 4인</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20190328">2019년 03월 28일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">50,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_MEXE_CNT">10,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_EXE_CNT">10,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_CNL_CNT">30,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">10,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="30" ACODE="SH5_PER">상장일로부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_PRC">5,000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">송순호</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20190510">2019년 05월 10일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">22,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_CNL_CNT">22,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="30" ACODE="SH5_PER">상장일로부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_PRC">5,000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACODE="SH5_NM">박현주</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20190510">2019년 05월 10일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">15,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_CNL_CNT">15,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="30" ACODE="SH5_PER">상장일로부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_PRC">5,000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="30" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">송순호</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20200325">2020년 03월 25일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">부여 3년 후와 상장일 중 나중에 도래하는 날부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">5,000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">박동석</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20200325">2020년 03월 25일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">20,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">20,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">부여 3년 후와 상장일 중 나중에 도래하는 날부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">5,000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">김세연</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20200325">2020년 03월 25일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">1,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">1,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">부여 3년 후와 상장일 중 나중에 도래하는 날부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">5,000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">OOO외 9인</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20200325">2020년 03월 25일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">43,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">1,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">3,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">40,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">부여 3년 후와 상장일 중 나중에 도래하는 날부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">5,000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">김완주</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20200911">2020년 09월 11일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">20,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">20,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">부여 3년 후와 상장일 중 나중에 도래하는 날부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">6,100</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">정병율</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20200911">2020년 09월 11일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">20,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">20,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">부여 3년 후와 상장일 중 나중에 도래하는 날부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">6,100</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20200911">2020년 09월 11일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">부여 3년 후와 상장일 중 나중에 도래하는 날부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">6,100</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">권준수</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="9">기타</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20200911">2020년 09월 11일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">5,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">부여 3년 후와 상장일 중 나중에 도래하는 날부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">6,100</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">전찬희</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="1">등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20210331">2021년 03월 31일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">5,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">부여 3년 후와 상장일 중 나중에 도래하는 날부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">10,000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">류충호</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="1">등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20210331">2021년 03월 31일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">5,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">부여 3년 후와 상장일 중 나중에 도래하는 날부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">10,000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">김완주</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20210331">2021년 03월 31일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">5,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">부여 3년 후와 상장일 중 나중에 도래하는 날부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">10,000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">김세연</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20210331">2021년 03월 31일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">1,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">1,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">부여 3년 후와 상장일 중 나중에 도래하는 날부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">10,000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">박동석</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20210331">2021년 03월 31일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">2,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">2,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">부여 3년 후와 상장일 중 나중에 도래하는 날부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">10,000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">이상노</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20210331">2021년 03월 31일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">4,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">4,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">부여 3년 후와 상장일 중 나중에 도래하는 날부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">10,000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">000외 17인</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20210331">2021년 03월 31일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">37,500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">1,400</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">36,100</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">부여 3년 후와 상장일 중 나중에 도래하는 날부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">10,000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">우상욱</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20210727">2021년 07월 27일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">15,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">15,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">부여 3년 후와 상장일 중 나중에 도래하는 날부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">17,500</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">000</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20210727">2021년 07월 27일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">5,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">부여 3년 후와 상장일 중 나중에 도래하는 날부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">17,500</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">전찬희</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="1">등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20211026">2021년 10월 26일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">10,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">10,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">부여 3년 후와 상장일 중 나중에 도래하는 날부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">17,500</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">이마세</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="1">등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20211026">2021년 10월 26일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">35,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">35,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">부여 3년 후와 상장일 중 나중에 도래하는 날부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">17,500</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">김희선</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20211026">2021년 10월 26일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">7,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">7,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">부여 3년 후와 상장일 중 나중에 도래하는 날부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">17,500</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="Y">O</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">주1)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACODE="SH5_NM">000외 4인</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="SH5_GV_DT" AUNITVALUE="20211026">2021년 10월 26일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_STK_KNDD">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_START_CNT">9,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="60" HEIGHT="53" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACODE="SH5_NEXE_CNT">9,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="53" ACODE="SH5_PER">부여 3년 후와 상장일 중 나중에 도래하는 날부터 부여 후 10년 이내</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="53" ACODE="SH5_PRC">17,500</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" AUNIT="DUTY_HOLD_AT" AUNITVALUE="N">X</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACODE="DUTY_HOLD_PD">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>※ 공시서류작성기준일(2022년 12월 29일) 현재 종가 : 9,780원</P>
</LIBRARY>

<P>주1) 등기/미등기 임원에게 부여된 주식매수선택권의 경우 행사 시 상장일로부터 3년까지(25년 11월 21일) 의무보유 대상입니다. 공시서류작성기준일 현재 의무보유대상 주식은 284,000주입니다.주2) 상기 2020년 3월 25일 부여받은 주식매수선택권 중 부여받은자 직원 1명은(1,000주)는 3년이상 재임 또는 재직하여야 하는 조건을 갖추지 못하고 2022년 퇴직함으로 인해 부여수량을 취소하였습니다.</P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-9-0-0">IX. 계열회사 등에 관한 사항</TITLE>
<P></P>
<P USERMARK=" B">가. 계열회사 현황(요약)</P>

<TABLE-GROUP ACLASS="AFF_CMP_SMR" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="253"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="106" HEIGHT="30" AUPDATECONT="N">)</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="262" HEIGHT="30" AUPDATECONT="N">(단위 : 사)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기업집단의 명칭</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="450" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계열회사의 수</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">상장</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비상장</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="BG_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="LST_COUNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="ULST_COUNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="AFF_TOT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="592"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="601" HEIGHT="30" AUPDATECONT="N">
<A REFNO="XII. 상세표|NEF-002|ADX-002">※상세 현황은 '상세표-2. 계열회사 현황(상세)' 참조</A>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK=" B">나. 타법인출자 현황(요약)</P>

<TABLE-GROUP ACLASS="INV_PRT_SMR" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="253"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="106" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="262" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="76"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="64"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="85" HEIGHT="113" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출자목적</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="222" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출자회사수</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="293" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">총 출자금액</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">상장</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">비상장</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">계</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">기초장부가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="146" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">증가(감소)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">기말장부가액</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취득(처분)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">평가손익</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="85" HEIGHT="30" AUPDATECONT="N">경영참여</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="MP_LST_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="MP_ULST_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="MP_TOT_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="MP_BASE_PRC">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="MP_PTM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="MP_PPM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="MP_FIN_PRC">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="85" HEIGHT="30" AUPDATECONT="N">일반투자</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="ETC_LST_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="ETC_ULST_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="ETC_TOT_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="ETC_BASE_PRC">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="ETC_PTM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="ETC_PPM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="ETC_FIN_PRC">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="85" HEIGHT="30" AUPDATECONT="N">단순투자</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="SC_LST_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="SC_ULST_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="SC_TOT_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="SC_BASE_PRC">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="SC_PTM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="SC_PPM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="SC_FIN_PRC">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="85" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="TOT_LST_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="TOT_ULST_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="TOT_TOT_CNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="TOT_BASE_PRC">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="TOT_PTM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="TOT_PPM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="TOT_FIN_PRC">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="593"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="602" HEIGHT="30" AUPDATECONT="N">
<A REFNO="XII. 상세표|NEF-003|ADX-003">※상세 현황은 '상세표-3. 타법인출자 현황(상세)' 참조</A>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-10-0-0">X. 대주주 등과의 거래내용</TITLE>
<P></P>
<P></P>

<P>
<SPAN USERMARK=" B">가. 대주주와의 거래내용</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">나. 대주주 이외의 이해관계자와의 거래</SPAN>(1) 특수관계자와의 매출, 매입 등 거래내역
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="402">

<COLGROUP>
<COL WIDTH="393"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="402" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">                                                              (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="404">

<COLGROUP>
<COL WIDTH="148"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="157" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">특수관계자명</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">이자수익</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">지급수수료 등</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" VALIGN="MIDDLE" HEIGHT="30">임직원 </TD>
<TD WIDTH="124" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">451 </TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" VALIGN="MIDDLE" HEIGHT="30">포항공과대학교 주1)</TD>
<TD WIDTH="124" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">40,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" VALIGN="MIDDLE" HEIGHT="30">합  계</TD>
<TD WIDTH="124" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">451 </TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">40,000 </TD>
</TR>
</TBODY>
</TABLE>
<P>주1) 포항공과대학교는 상장된 날로부터 2년간 의결권 공동행사를 약정하였습니다.(2) 특수관계자와의 중요한 자금거래 내역</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="617">

<COLGROUP>
<COL WIDTH="608"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="617" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">                                                                                                        (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="127"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="136" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">특수관계자명</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">계정과목</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기초</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">증가</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">감소</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">임직원 </TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">대여금</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">325,000 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">325,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" VALIGN="MIDDLE" HEIGHT="30">우리사주조합</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">대여금</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">367,608 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">367,608 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" VALIGN="MIDDLE" COLSPAN="2" ALIGN="CENTER" HEIGHT="30">합  계　</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">692,608 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">692,608 </TD>
</TR>
</TBODY>
</TABLE>
<P>(3) 주요 경영진에게 지급됐거나 지급될 보상 내역</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="463">

<COLGROUP>
<COL WIDTH="454"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="463" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">                                                             (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="466">

<COLGROUP>
<COL WIDTH="179"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="188" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구     분</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="188" HEIGHT="30">급여 등</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">   1,083,799</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">             752,495</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="188" HEIGHT="30">주식보상비용</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">      258,130</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">             453,810</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="188" HEIGHT="30">퇴직급여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">      179,987</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">             210,995</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="188" HEIGHT="30">스톡옵션 행사차액</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">      585,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">                       -</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="188" HEIGHT="30">합  계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">   2,106,916</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="139" HEIGHT="30">           1,417,300</TD>
</TR>
</TBODY>
</TABLE>
<P>주1) 주요 경영진은 대표이사와 부사장 2명 및 전무이사 2명을 포함하고 있습니다.주2) 스톡옵션 행사차액과 관련된 주요 경영진의 스톡옵션 행사주식수 130,000주는 상장일로부터 3년 의무보유 대상으로 2025년 11월 22일 반환 예정입니다.</P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-0-0">XI. 그 밖에 투자자 보호를 위하여 필요한 사항</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-1-0">1. 공시내용 진행 및 변경사항</TITLE>
<P>당사는 보고서 작성기준일 현재 해당사항이 없습니다.</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-2-0">2. 우발부채 등에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 중요한 소송사건</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다..
<SPAN USERMARK=" B">나. 견질 또는 담보용 어음ㆍ수표현황</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">다. 채무보증 현황</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">라. 채무인수약정 현황</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">마. 그 밖의 우발채무 등</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">바. 자본으로 인정되는 채무증권의 발행</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다..
</P>

<P></P>

<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-3-0">3. 제재 등과 관련된 사항</TITLE>

<P>
<SPAN USERMARK=" B">가. 제재현황 (최근 3개연도)</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">나. 한국거래소 등으로부터 받은 제재</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
<SPAN USERMARK=" B">다. 단기매매차익의 발생 및 반환에 관한 사항</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
</P>

<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-4-0">4. 작성기준일 이후 발생한 주요사항 등 기타사항</TITLE>
<P></P>

<P>
<SPAN USERMARK=" B">가. 작성 기준일 이후 발생한 주요사항</SPAN>당사는 보고서 작성기준일 현재 해당사항이 없습니다.
</P>

<P>
<SPAN USERMARK=" B">나. 중소기업기준 검토표</SPAN>당사는 보고서 제출일 현재 중소기업에 해당합니다.
</P>

<IMAGE>
<IMG WIDTH="594" HEIGHT="840" ALIGN="CENTER" HSPACE="0">2021년 법인세 세무조정계산서_1.jpg</IMG>
<IMG-CAPTION ATOC="N">종소기업 등 기준검토표 (1)</IMG-CAPTION>
</IMAGE>

<IMAGE>
<IMG WIDTH="594" HEIGHT="840" ALIGN="CENTER" HSPACE="0">2021년 법인세 세무조정계산서_2.jpg</IMG>
<IMG-CAPTION ATOC="N">종소기업 등 기준검토표 (2)</IMG-CAPTION>
</IMAGE>
<P></P>

<P></P>

<P></P>

<P></P>

<LIBRARY>
<P USERMARK=" B">다. 보호예수 현황</P>

<TABLE-GROUP ACLASS="PROT_STA" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="830" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="47"></COL>
<COL WIDTH="521"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="164" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20230322">2023년 03월 22일</TU>
<TD VALIGN="BOTTOM" WIDTH="56" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="530" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="830" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="89"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="186"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">예수주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">예수일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">반환예정일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="151" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보호예수기간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="195" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보호예수사유</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">총발행주식수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="53" ACODE="PROT_KND" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="93" HEIGHT="53" ACODE="PROT_CNT" VALIGN="MIDDLE">1,647,450</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="53" AUNIT="PROT_DAT" AUNITVALUE="20221122" VALIGN="MIDDLE">2022.11.22</TU>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="53" AUNIT="PROT_DATE" AUNITVALUE="20251122" VALIGN="MIDDLE">2025.11.22</TU>
<TE ALIGN="CENTER" WIDTH="151" HEIGHT="53" ACODE="PROT_PRD" VALIGN="MIDDLE">상장일로부터 3년</TE>
<TE ALIGN="CENTER" WIDTH="195" HEIGHT="53" ACODE="PROT_RSN" VALIGN="MIDDLE">코스닥시장 상장규정에 따른 보호예수 (최대주주 등)</TE>
<TE ALIGN="RIGHT" WIDTH="108" HEIGHT="53" ACODE="PROT_TONT" VALIGN="MIDDLE">8,366,556</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="PROT_KND" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="93" HEIGHT="30" ACODE="PROT_CNT" VALIGN="MIDDLE">228,804</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="30" AUNIT="PROT_DAT" AUNITVALUE="20221122" VALIGN="MIDDLE">2022.11.22</TU>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="30" AUNIT="PROT_DATE" AUNITVALUE="20241122" VALIGN="MIDDLE">2024.11.22</TU>
<TE ALIGN="CENTER" WIDTH="151" HEIGHT="30" ACODE="PROT_PRD" VALIGN="MIDDLE">상장일로부터 2년</TE>
<TE ALIGN="CENTER" WIDTH="195" HEIGHT="30" ACODE="PROT_RSN" VALIGN="MIDDLE">기타 보호예수 필요 주주</TE>
<TE ALIGN="RIGHT" WIDTH="108" HEIGHT="30" ACODE="PROT_TONT" VALIGN="MIDDLE">8,366,556</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="PROT_KND" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="93" HEIGHT="30" ACODE="PROT_CNT" VALIGN="MIDDLE">48,446</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="30" AUNIT="PROT_DAT" AUNITVALUE="20221122" VALIGN="MIDDLE">2022.11.22</TU>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="30" AUNIT="PROT_DATE" AUNITVALUE="20231122" VALIGN="MIDDLE">2023.11.22</TU>
<TE ALIGN="CENTER" WIDTH="151" HEIGHT="30" ACODE="PROT_PRD" VALIGN="MIDDLE">상장일로부터 1년</TE>
<TE ALIGN="CENTER" WIDTH="195" HEIGHT="30" ACODE="PROT_RSN" VALIGN="MIDDLE">우리사주조합</TE>
<TE ALIGN="RIGHT" WIDTH="108" HEIGHT="30" ACODE="PROT_TONT" VALIGN="MIDDLE">8,366,556</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="PROT_KND" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="93" HEIGHT="30" ACODE="PROT_CNT" VALIGN="MIDDLE">80,000</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="30" AUNIT="PROT_DAT" AUNITVALUE="20221122" VALIGN="MIDDLE">2022.11.22</TU>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="30" AUNIT="PROT_DATE" AUNITVALUE="20231122" VALIGN="MIDDLE">2023.11.22</TU>
<TE ALIGN="CENTER" WIDTH="151" HEIGHT="30" ACODE="PROT_PRD" VALIGN="MIDDLE">상장일로부터 1년</TE>
<TE ALIGN="CENTER" WIDTH="195" HEIGHT="30" ACODE="PROT_RSN" VALIGN="MIDDLE">최대주주(제3자배정)</TE>
<TE ALIGN="RIGHT" WIDTH="108" HEIGHT="30" ACODE="PROT_TONT" VALIGN="MIDDLE">8,366,556</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="PROT_KND" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="93" HEIGHT="30" ACODE="PROT_CNT" VALIGN="MIDDLE">130,000</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="30" AUNIT="PROT_DAT" AUNITVALUE="20230106" VALIGN="MIDDLE">2023.01.06</TU>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="30" AUNIT="PROT_DATE" AUNITVALUE="20251122" VALIGN="MIDDLE">2025.11.22</TU>
<TE ALIGN="CENTER" WIDTH="151" HEIGHT="30" ACODE="PROT_PRD" VALIGN="MIDDLE">상장일로부터 3년</TE>
<TE ALIGN="CENTER" WIDTH="195" HEIGHT="30" ACODE="PROT_RSN" VALIGN="MIDDLE">주식매수선택권</TE>
<TE ALIGN="RIGHT" WIDTH="108" HEIGHT="30" ACODE="PROT_TONT" VALIGN="MIDDLE">8,366,556</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="53" ACODE="PROT_KND" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="93" HEIGHT="53" ACODE="PROT_CNT" VALIGN="MIDDLE">15,833</TE>
<TU ALIGN="CENTER" WIDTH="92" HEIGHT="53" AUNIT="PROT_DAT" AUNITVALUE="20230215" VALIGN="MIDDLE">2023.02.15</TU>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="53" AUNIT="PROT_DATE" AUNITVALUE="20241122" VALIGN="MIDDLE">2024.11.22</TU>
<TE ALIGN="CENTER" WIDTH="151" HEIGHT="53" ACODE="PROT_PRD" VALIGN="MIDDLE">상장일로부터 2년</TE>
<TE ALIGN="CENTER" WIDTH="195" HEIGHT="53" ACODE="PROT_RSN" VALIGN="MIDDLE">코스닥시장 상장규정에 따른 보호예수 (최대주주)</TE>
<TE ALIGN="RIGHT" WIDTH="108" HEIGHT="53" ACODE="PROT_TONT" VALIGN="MIDDLE">8,366,556</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>


<LIBRARY>
<P>
<SPAN USERMARK=" B">라. 특례상장기업의 재무사항 비교표</SPAN>
</P>

<TABLE-GROUP ACLASS="SPE_MGR" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="667" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="169"></COL>
<COL WIDTH="34"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="80" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(상장일 : </TD>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="132" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221122">2022년 11월 22일</TU>
<TD VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">, 인수인 : </TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="178" HEIGHT="30" ACODE="BASE_PRN">한국투자증권 주식회사</TE>
<TD VALIGN="MIDDLE" WIDTH="43" AUPDATECONT="N" HEIGHT="30">)</TD>
<TU ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="151" HEIGHT="30" AUNIT="WON2" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="664" BORDER="1">

<COLGROUP>
<COL WIDTH="104"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="113" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">추정대상</TH>
<TH WIDTH="99" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">계정과목</TH>
<TH WIDTH="151" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">예측치</TH>
<TH WIDTH="151" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">실적치</TH>
<TH WIDTH="150" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">괴리율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" ACODE="MGR_YEA1" ROWSPAN="3">2022년</TE>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">매출액</TD>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_PRD_SAL1">4,164</TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_RET_SAL1">3,724</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_GAP_SAL1">10</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">영업이익</TD>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_PRD_BSP1">-10,494</TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_RET_BSP1">-10,902</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_GAP_BSP1">-4</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">당기순이익</TD>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_PRD_GEP1">-10,494</TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_RET_GEP1">-10,595</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_GAP_GEP1">-1</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" ACODE="MGR_YEA2" ROWSPAN="3">2023년</TE>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">매출액</TD>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_PRD_SAL2">5,483</TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_RET_SAL2">-</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_GAP_SAL2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">영업이익</TD>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_PRD_BSP2">-7,683</TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_RET_BSP2">-</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_GAP_BSP2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">당기순이익</TD>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_PRD_GEP2">-7,683</TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_RET_GEP2">-</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_GAP_GEP2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" ACODE="MGR_YEA3" ROWSPAN="3">2024년</TE>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">매출액</TD>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_PRD_SAL3">12,311</TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_RET_SAL3">-</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_GAP_SAL3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">영업이익</TD>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_PRD_BSP3">-417</TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_RET_BSP3">-</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_GAP_BSP3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">당기순이익</TD>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_PRD_GEP3">-417</TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_RET_GEP3">-</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MGR_GAP_GEP3">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>주1) 당사는 기술성장기업 특례상장으로 2022년 11월 22일 코스닥 시장에 상장하였으며 증권신고서에 매출액, 영업이익, 당기순이익의 미래 영업실적을 추정하여 기재하였습니다.주2) 이번 보고서에는 증권신고서 상 기재된 재무사항 예측치와 실적을 비교하였으며 기업공시서식 작성기준 제11-4-13조의 작성지침에 의거 괴리율이 10%이상인 항목에 대해서는 발생 원인에 대해 기재하였습니다.주3) 괴리율은 (예측치-실적치)/예측치로 산정된 비율입니다.주4) 동물의약품의 공동연구개발 연구일정이 조정됨에 따라 매출이 예측 당시보다 적게 발생하였으며, 이에 따라 영업손실도 예측치보다 증가하였습니다.</P>
</LIBRARY>

<P></P>

<LIBRARY>
<P>
<SPAN USERMARK=" B">마. 특례상장기업 관리종목 지정유예 현황</SPAN>
</P>

<TABLE-GROUP ACLASS="SPE_MAG" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="805" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="499"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="MIDDLE" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="508" HEIGHT="30" AUNIT="WONPERCENT2" AUNITVALUE="3">(단위 : 백만원, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="752" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="154"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="56"></COL>
<COL WIDTH="97"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">관리종목 지정요건</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="347" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">요건별 회사 현황</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">관리종목지정요건해당여부</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="171" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">관리종목지정유예</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">항목</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="87" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액/비율</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="65" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해당여부</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="106" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">종료시점</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="163" HEIGHT="53" VALIGN="MIDDLE" AUPDATECONT="N">최근 사업연도말매출액 30억원 미만</TD>
<TD ALIGN="CENTER" WIDTH="137" HEIGHT="53" VALIGN="MIDDLE" AUPDATECONT="N">최근 사업연도말 매출액(별도)</TD>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="53" ACODE="SPE_LAT_YER" VALIGN="MIDDLE">2022년(제8기)</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="53" ACODE="SPE_LAT_AMO" VALIGN="MIDDLE">3,724</TE>
<TU ALIGN="CENTER" WIDTH="71" HEIGHT="53" AUNIT="SPE_LAT_ISYN" AUNITVALUE="N" VALIGN="MIDDLE">미해당</TU>
<TU ALIGN="CENTER" WIDTH="65" HEIGHT="53" AUNIT="SPE_LAT_OFF_YN" AUNITVALUE="Y" VALIGN="MIDDLE">해당</TU>
<TU ALIGN="CENTER" WIDTH="106" HEIGHT="53" AUNIT="SPE_LAT_OFF" AUNITVALUE="20271231" VALIGN="MIDDLE">2027년 12월 31일</TU>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="163" HEIGHT="212" VALIGN="MIDDLE" AUPDATECONT="N" ROWSPAN="4">최근 4사업연도 연속 영업손실 발생</TD>
<TD ALIGN="CENTER" WIDTH="137" HEIGHT="212" VALIGN="MIDDLE" AUPDATECONT="N" ROWSPAN="4">최근 4사업연도 각 영업손익(별도)</TD>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="53" ACODE="SPE_FOR_YER1" VALIGN="MIDDLE">2022년(제8기)</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="53" ACODE="SPE_FOR_AMO1" VALIGN="MIDDLE">-10,902</TE>
<TU ALIGN="CENTER" WIDTH="71" HEIGHT="212" AUNIT="SPE_FOR_ISYN" AUNITVALUE="Y" VALIGN="MIDDLE" ROWSPAN="4">해당</TU>
<TU ALIGN="CENTER" WIDTH="65" HEIGHT="212" AUNIT="SPE_FOR_OFF_YN" AUNITVALUE="Y" VALIGN="MIDDLE" ROWSPAN="4">해당</TU>
<TU ALIGN="CENTER" WIDTH="106" HEIGHT="212" AUNIT="SPE_FOR_OFF" AUNITVALUE="-" VALIGN="MIDDLE" ROWSPAN="4">-</TU>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="53" ACODE="SPE_FOR_YER2" VALIGN="MIDDLE">2021년(제7기)</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="53" ACODE="SPE_FOR_AMO2" VALIGN="MIDDLE">-9,558</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="53" ACODE="SPE_FOR_YER3" VALIGN="MIDDLE">2020년(제6기)</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="53" ACODE="SPE_FOR_AMO3" VALIGN="MIDDLE">-5,537</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="53" ACODE="SPE_FOR_YER4" VALIGN="MIDDLE">2019년(제5기)</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="53" ACODE="SPE_FOR_AMO4" VALIGN="MIDDLE">-4,276</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="163" HEIGHT="168" VALIGN="MIDDLE" AUPDATECONT="N" ROWSPAN="3">자기자본 50%이상(10억원 이상에 한함)의 법인세차감전계속사업손실이 최근 3년간 2회 이상 및 최근 사업연도 법인세차감전계속사업손실 발생</TD>
<TD ALIGN="CENTER" WIDTH="137" HEIGHT="168" VALIGN="MIDDLE" AUPDATECONT="N" ROWSPAN="3">최근 3사업연도각 자기자본대비 법인세차감전계속사업손익비율(연결)</TD>
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="53" ACODE="SPE_LOS_YER1" VALIGN="MIDDLE">2022년(제8기)</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="53" ACODE="SPE_LOS_RT1" VALIGN="MIDDLE">-10,595</TE>
<TU ALIGN="CENTER" WIDTH="71" HEIGHT="168" AUNIT="SPE_LOS_ISYN" AUNITVALUE="Y" VALIGN="MIDDLE" ROWSPAN="3">해당</TU>
<TU ALIGN="CENTER" WIDTH="65" HEIGHT="168" AUNIT="SPE_LOS_OFF_YN" AUNITVALUE="Y" VALIGN="MIDDLE" ROWSPAN="3">해당</TU>
<TU ALIGN="CENTER" WIDTH="106" HEIGHT="168" AUNIT="SPE_LOS_OFF" AUNITVALUE="20251231" VALIGN="MIDDLE" ROWSPAN="3">2025년 12월 31일</TU>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="53" ACODE="SPE_LOS_YER2" VALIGN="MIDDLE">2021년(제7기)</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="53" ACODE="SPE_LOS_RT2" VALIGN="MIDDLE">-9,271</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="87" HEIGHT="62" ACODE="SPE_LOS_YER3" VALIGN="MIDDLE">2020년(제6기)</TE>
<TE ALIGN="RIGHT" WIDTH="123" HEIGHT="62" ACODE="SPE_LOS_RT3" VALIGN="MIDDLE">-12,880</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>


<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="751">

<COLGROUP>
<COL WIDTH="46"></COL>
<COL WIDTH="687"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="55" HEIGHT="76">주1)</TD>
<TD WIDTH="696" HEIGHT="76"> 상장일 : 2022년 11월 22일 / 기술성장기업 특례상장 (당사는 코스닥시장상장규정 제2조 제31항에서 정하는 기술성장기업으로서, 동 규정 제7조 제2항의 신규상장심사요건 특례 요건을 적용하여 2022년 11월 22일 코스닥시장에 상장하였습니다.)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="55" HEIGHT="76">주2)</TD>
<TD WIDTH="696" HEIGHT="76">매출액 요건의 경우, 기술성장기업은 신규상장일이 속하는 사업연도의 그 다음 사업년도((상장일로부터 상장일이 속한 사업연도의 말일까지 기간이 3월미만인 경우에는 그 다음 사업연도)까지 연속하는 5개 사업연도까지 지정 유예되며, 2028년 부터 대상이 됩니다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="55" HEIGHT="99">주3)</TD>
<TD WIDTH="696" HEIGHT="99">기술성장기업은 관리종목 지정요건 중 영업손실 요건을 적용하지 않습니다. (당사는 기술성장기업에 해당하므로 최근 4사업연도 연속 영업손실 발생 요건을 적용받지 않습니다.  회사 현황에는 2019년부터 2022년도의 4개 사업연도 영업손익을 기재하였으며, 최근 4사업연도 연속 영업손실 발생 요건에도 해당하지 않습니다.)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="55" HEIGHT="76">주4)</TD>
<TD WIDTH="696" HEIGHT="76">자기자본 50% 이상의 법인세비용차감전계속사업손실 요건의 경우, 기술성장기업은 신규상장일이 속하는 사업연도(2022년)를 포함하는 연속하는 3개 사업연도(2024년까지)에 대해 해당 요건을 적용 받지 않습니다.</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="TTL_APPENDIX">XII. 상세표</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y">1. 연결대상 종속회사 현황(상세)</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="593"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="602" HEIGHT="30" AUPDATECONT="N">
<A REFNO="I. 회사의 개요|ADX-001|NEF-001">☞ 본문 위치로 이동</A>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="SUB_CMPN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="292"></COL>
<COL WIDTH="292"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="301" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="301" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="67"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="75"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">상호</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">설립일</TH>
<TH WIDTH="71" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주소</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주요사업</TH>
<TH WIDTH="121" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">최근사업연도말자산총액</TH>
<TH WIDTH="82" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">지배관계 근거</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주요종속회사 여부</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CRP_NM">-</TE>
<TE WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="EST_DT">-</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ADR">-</TE>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="M_IND">-</TE>
<TE WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="KEY_IND">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="RUL_REL">-</TE>
<TE WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="M_SUB_COM">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y">2. 계열회사 현황(상세)</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<A REFNO="IX. 계열회사 등에 관한 사항|ADX-002|NEF-002">☞ 본문 위치로 이동</A>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="AFF_CMP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="253"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="-">-</TU>
<TD VALIGN="BOTTOM" WIDTH="106" HEIGHT="30" AUPDATECONT="N">)</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="262" HEIGHT="30" AUPDATECONT="N">(단위 : 사)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="88"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">상장여부</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="87" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">회사수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="208" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기업명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">법인등록번호</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="60" AUPDATECONT="N">상장</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="87" HEIGHT="60" ROWSPAN="2" ACODE="LST_COUNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="208" HEIGHT="30" ACODE="LST_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACODE="LST_BNUM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="208" HEIGHT="30" ACODE="LST_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACODE="LST_BNUM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="60" AUPDATECONT="N">비상장</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="87" HEIGHT="60" ROWSPAN="2" ACODE="ULST_COUNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="208" HEIGHT="30" ACODE="ULST_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACODE="ULST_BNUM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="208" HEIGHT="30" ACODE="ULST_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="30" ACODE="ULST_BNUM">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y">3. 타법인출자 현황(상세)</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="610" BORDER="0">

<COLGROUP>
<COL WIDTH="601"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="610" HEIGHT="30" AUPDATECONT="N">
<A REFNO="IX. 계열회사 등에 관한 사항|ADX-003|NEF-003">☞ 본문 위치로 이동</A>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="INV_PRT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="880" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="426"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="-">-</TU>
<TD VALIGN="BOTTOM" WIDTH="213" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="435" HEIGHT="30" AUNIT="WONSTOCKPERCENT" AUNITVALUE="1">(단위 : 원, 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="881" BORDER="1">

<COLGROUP>
<COL WIDTH="53"></COL>
<COL WIDTH="53"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="38"></COL>
<COL WIDTH="38"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="52"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="38"></COL>
<COL WIDTH="35"></COL>
<COL WIDTH="50"></COL>
<COL WIDTH="31"></COL>
<COL WIDTH="53"></COL>
<COL WIDTH="47"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" WIDTH="62" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">법인명</TH>
<TH ROWSPAN="3" WIDTH="62" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">상장여부</TH>
<TH ROWSPAN="3" WIDTH="78" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">최초취득일자</TH>
<TH ROWSPAN="3" WIDTH="47" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">출자목적</TH>
<TH ROWSPAN="3" WIDTH="47" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">최초취득금액</TH>
<TH COLSPAN="3" WIDTH="167" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N">기초잔액</TH>
<TH COLSPAN="3" WIDTH="157" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N">증가(감소)</TH>
<TH COLSPAN="3" WIDTH="143" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N">기말잔액</TH>
<TH COLSPAN="2" WIDTH="118" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N">최근사업연도재무현황</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" WIDTH="55" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">수량</TH>
<TH ROWSPAN="2" WIDTH="61" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">지분율</TH>
<TH ROWSPAN="2" WIDTH="51" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">장부가액</TH>
<TH COLSPAN="2" WIDTH="110" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N">취득(처분)</TH>
<TH ROWSPAN="2" WIDTH="47" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">평가손익</TH>
<TH ROWSPAN="2" WIDTH="44" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">수량</TH>
<TH ROWSPAN="2" WIDTH="59" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">지분율</TH>
<TH ROWSPAN="2" WIDTH="40" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">장부가액</TH>
<TH ROWSPAN="2" WIDTH="62" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">총자산</TH>
<TH ROWSPAN="2" WIDTH="56" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">당기순손익</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="55" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N">수량</TH>
<TH WIDTH="55" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="62" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM">-</TE>
<TU WIDTH="62" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_YN" AUNITVALUE="-">-</TU>
<TU WIDTH="78" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="47" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ">-</TE>
<TE WIDTH="47" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM">-</TE>
<TE WIDTH="55" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN">-</TE>
<TE WIDTH="61" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR">-</TE>
<TE WIDTH="51" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM">-</TE>
<TE WIDTH="55" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN">-</TE>
<TE WIDTH="55" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM">-</TE>
<TE WIDTH="47" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM">-</TE>
<TE WIDTH="44" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN">-</TE>
<TE WIDTH="59" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR">-</TE>
<TE WIDTH="40" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM">-</TE>
<TE WIDTH="62" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM">-</TE>
<TE WIDTH="56" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="62" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM">-</TE>
<TU WIDTH="62" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_YN" AUNITVALUE="-">-</TU>
<TU WIDTH="78" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="-">-</TU>
<TE WIDTH="47" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ">-</TE>
<TE WIDTH="47" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM">-</TE>
<TE WIDTH="55" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN">-</TE>
<TE WIDTH="61" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR">-</TE>
<TE WIDTH="51" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM">-</TE>
<TE WIDTH="55" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN">-</TE>
<TE WIDTH="55" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM">-</TE>
<TE WIDTH="47" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM">-</TE>
<TE WIDTH="44" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN">-</TE>
<TE WIDTH="59" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR">-</TE>
<TE WIDTH="40" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM">-</TE>
<TE WIDTH="62" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM">-</TE>
<TE WIDTH="56" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="5" WIDTH="296" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE">합 계</TD>
<TE WIDTH="55" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTNT">-</TE>
<TE WIDTH="61" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPRT">-</TE>
<TE WIDTH="51" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTMT">-</TE>
<TE WIDTH="55" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTNT">-</TE>
<TE WIDTH="55" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTMT">-</TE>
<TE WIDTH="47" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPMT">-</TE>
<TE WIDTH="44" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTNT">-</TE>
<TE WIDTH="59" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPRT">-</TE>
<TE WIDTH="40" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTMT">-</TE>
<TE WIDTH="62" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTMT">-</TE>
<TE WIDTH="56" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPMT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P></P>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">【 전문가의 확인 】</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-1-0">1. 전문가의 확인</TITLE>
<P>해당사항이 없습니다.</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-2-0">2. 전문가와의 이해관계</TITLE>
<P>해당사항이 없습니다.</P>
</SECTION-2>
</SECTION-1>
</BODY>
</DOCUMENT>